data_2hgm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hgm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 115.385 1.624 . . . . 10.0 115.385 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.83 36.13 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.563 3.145 . . . . 10.0 114.934 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.39 101.36 0.32 Allowed Glycine 0 C--O 1.228 -0.229 0 CA-C-O 117.797 -1.557 . . . . 10.0 111.75 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 167.59 10.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.859 -1.904 . . . . 10.0 105.859 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.06 153.29 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.247 -1.797 . . . . 10.0 107.964 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 52.3 ttt180 -120.65 136.49 54.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.0 1.32 . . . . 10.0 111.959 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.88 147.19 29.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.409 3.084 . . . . 10.0 109.976 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -152.66 77.22 1.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.599 1.16 . . . . 10.0 109.936 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.07 9.4 0.02 OUTLIER Glycine 0 CA--C 1.532 1.125 0 N-CA-C 116.176 1.23 . . . . 10.0 116.176 -164.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.44 155.41 74.04 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.797 1.239 . . . . 10.0 111.313 -166.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -84.08 175.75 7.26 Favored 'Trans proline' 0 CA--C 1.532 0.384 1 C-N-CA 126.72 4.947 . . . . 10.0 112.489 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -63.98 135.17 56.24 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.421 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.58 15.1 70.47 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 118.247 -1.307 . . . . 10.0 115.585 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.34 147.43 31.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.053 1.927 . . . . 10.0 112.78 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 171.86 16.68 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.028 0.918 . . . . 10.0 112.146 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -38.44 -53.6 1.53 Allowed 'General case' 0 C--O 1.205 -1.237 0 CA-C-O 116.477 -1.725 . . . . 10.0 113.54 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.48 -19.76 63.89 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 121.585 1.993 . . . . 10.0 113.7 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -79.98 -29.39 39.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.16 -1.587 . . . . 10.0 110.767 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.12 -43.48 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.373 1.069 . . . . 10.0 111.17 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.64 -21.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.31 1.844 . . . . 10.0 113.303 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -96.39 -26.33 15.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.887 1.676 . . . . 10.0 112.37 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -58.81 -51.94 67.86 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.59 1.556 . . . . 10.0 109.864 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -112.75 30.98 6.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.305 1.042 . . . . 10.0 112.841 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.5 p -53.23 -21.86 5.95 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.173 0.805 . . . . 10.0 113.173 156.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.3 -31.91 43.31 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.073 1.796 . . . . 10.0 115.208 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.28 166.21 24.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.116 1.366 . . . . 10.0 112.875 -157.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.32 134.77 34.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.147 1.379 . . . . 10.0 111.649 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 71.2 mt -137.27 140.62 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 128.371 2.668 . . . . 10.0 106.978 -170.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.15 156.08 61.25 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.535 -0.728 . . . . 10.0 111.432 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.22 -19.24 16.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 120.957 3.407 . . . . 10.0 120.957 -162.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.8 35.48 2.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.633 1.106 . . . . 10.0 110.657 166.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.12 45.3 0.58 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 126.692 2.091 . . . . 10.0 114.228 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -143.58 136.13 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 119.964 1.882 . . . . 10.0 106.012 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -132.52 131.54 41.71 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.24 1.836 . . . . 10.0 112.569 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.94 84.06 59.23 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 127.263 2.225 . . . . 10.0 110.868 -171.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.69 -65.18 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 121.081 1.188 . . . . 10.0 113.237 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.84 169.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 128.328 2.651 . . . . 10.0 110.149 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.491 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.1 p-10 -68.5 173.3 3.51 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.533 . . . . 10.0 114.778 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.37 -1.98 0.54 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.754 3.636 . . . . 10.0 117.624 172.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.72 -31.89 3.14 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.537 1.971 . . . . 10.0 112.28 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.04 37.66 1.22 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.88 -0.955 . . . . 10.0 115.445 163.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.34 -2.95 2.44 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.997 1.398 . . . . 10.0 113.808 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG21 ' H ' ' A' ' 152' ' ' THR 0.285 0.0 OUTLIER -143.7 -118.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.782 1.233 . . . . 10.0 113.496 -178.373 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.461 ' H ' HG21 ' A' ' 151' ' ' ILE . 1.1 p -172.76 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.365 3.466 . . . . 10.0 107.051 -167.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.491 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.29 6.46 11.83 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 126.98 2.228 . . . . 10.0 114.751 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -132.08 156.55 46.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.016 0.912 . . . . 10.0 110.376 148.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.19 175.45 8.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 126.088 1.755 . . . . 10.0 110.423 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.553 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 86.1 m-85 -149.09 164.64 34.07 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.524 -169.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -159.41 119.52 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 114.381 1.252 . . . . 10.0 114.381 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -90.38 123.55 34.21 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 129.477 3.111 . . . . 10.0 111.055 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.2 m-85 -89.1 -165.45 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 123.143 0.577 . . . . 10.0 110.248 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.65 -10.3 59.74 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.88 -1.763 . . . . 10.0 113.632 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.4 m -158.48 160.95 37.31 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -58.63 -28.12 65.36 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -80.08 -48.15 13.71 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.782 1.233 . . . . 10.0 112.214 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.62 -37.7 63.32 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.349 1.46 . . . . 10.0 111.334 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.91 -8.87 57.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -112.99 -15.3 12.88 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.918 -1.739 . . . . 10.0 112.893 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -60.01 -37.46 79.8 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 156.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.34 72.15 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.549 2.055 . . . . 10.0 116.549 172.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mp -48.0 -35.07 10.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 120.527 1.512 . . . . 10.0 113.189 162.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.41 -15.16 30.44 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 125.622 1.582 . . . . 10.0 115.85 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -64.6 -26.33 68.35 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.56 1.68 . . . . 10.0 114.65 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.3 t60 60.58 -47.58 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.922 2.889 . . . . 10.0 117.328 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -145.1 -66.76 0.32 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.64 1.576 . . . . 10.0 112.611 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 36.82 -142.3 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.575 1.55 . . . . 10.0 113.186 -167.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -151.25 155.51 38.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.864 . . . . 10.0 110.199 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.93 135.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.151 2.58 . . . . 10.0 105.447 162.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 49.02 -86.95 0.01 OUTLIER Glycine 0 N--CA 1.474 1.167 0 C-N-CA 126.801 2.144 . . . . 10.0 114.178 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 5.04 3.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.632 1.573 . . . . 10.0 114.449 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.51 -179.53 5.21 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.25 1.82 . . . . 10.0 114.259 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -146.84 14.13 1.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.604 -1.18 . . . . 10.0 113.01 -124.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mt 42.96 107.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 116.983 2.216 . . . . 10.0 116.983 134.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 165.06 23.17 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 127.506 2.323 . . . . 10.0 113.649 160.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.6 140.34 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.664 0.786 . . . . 10.0 112.294 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -144.44 153.25 41.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.432 1.893 . . . . 10.0 110.507 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -74.31 154.62 38.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.809 0.844 . . . . 10.0 111.837 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.3 m -159.02 167.97 27.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.021 0.748 . . . . 10.0 113.021 -165.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.9 m -149.42 161.89 41.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.464 1.906 . . . . 10.0 109.64 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -31.62 -10.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 1 C-N-CA 132.467 4.307 . . . . 10.0 120.595 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.3 -6.32 3.8 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.232 -2.168 . . . . 10.0 112.066 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -23.05 39.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 149.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.553 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 9.5 m . . . . . 0 C--N 1.35 0.601 0 N-CA-C 115.443 1.646 . . . . 10.0 115.443 -164.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 122.012 0.91 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.08 45.22 0.09 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.591 3.156 . . . . 0.0 113.556 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.86 102.12 1.63 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.48 160.57 14.19 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.5 118.33 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.273 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -104.11 125.8 50.72 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 -164.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.37 151.59 23.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.467 2.307 . . . . 0.0 110.494 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -155.58 79.55 1.02 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.682 1.593 . . . . 0.0 108.582 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.39 -11.96 0.02 OUTLIER Glycine 0 CA--C 1.536 1.401 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -162.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.462 ' CD2' ' HG ' ' A' ' 122' ' ' CYS . 3.5 mt -73.36 152.69 90.07 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.608 1.163 . . . . 0.0 113.423 -155.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.02 171.35 17.32 Favored 'Trans proline' 0 CA--C 1.531 0.352 1 C-N-CA 126.753 4.969 . . . . 0.0 112.653 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -57.37 133.9 55.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.068 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.2 19.24 68.03 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 118.775 -1.014 . . . . 0.0 115.169 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.462 ' HG ' ' CD2' ' A' ' 118' ' ' LEU . 33.8 t -55.44 146.69 19.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.273 1.536 . . . . 0.0 111.722 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.0 t -150.7 163.5 38.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 112.164 -173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -39.2 -44.38 1.21 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 126.738 2.015 . . . . 0.0 115.684 173.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -69.84 -19.91 63.44 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.089 1.356 . . . . 0.0 112.957 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -78.12 -32.12 50.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.284 -1.51 . . . . 0.0 109.597 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.2 mt -69.59 -39.85 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 120.708 -1.245 . . . . 0.0 110.782 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.269 1.2 m -61.59 -13.46 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.613 1.565 . . . . 0.0 114.512 168.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -101.86 -21.19 14.62 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 121.031 1.741 . . . . 0.0 113.728 166.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -49.2 75.04 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.614 1.566 . . . . 0.0 110.732 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -118.84 31.49 6.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.224 1.41 . . . . 0.0 112.069 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 84.2 p -46.59 -25.7 0.75 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 153.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.22 70.52 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.65 2.071 . . . . 0.0 116.246 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.06 159.73 41.03 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.647 1.224 . . . . 0.0 113.14 -154.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.55 127.68 34.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.997 1.319 . . . . 0.0 112.04 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 46.8 mt -129.49 139.18 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 128.358 2.663 . . . . 0.0 108.494 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.01 151.3 80.88 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.309 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -52.83 -24.87 25.27 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 120.671 3.296 . . . . 0.0 120.671 -158.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.39 42.45 2.36 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.792 1.237 . . . . 0.0 110.078 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.74 -23.68 30.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.909 1.243 . . . . 0.0 114.967 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.12 144.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 125.629 1.572 . . . . 0.0 109.481 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 77.6 m -140.28 136.29 33.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.056 -1.653 . . . . 0.0 113.52 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.74 89.88 51.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.101 2.56 . . . . 0.0 111.129 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.07 -72.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.017 1.812 . . . . 0.0 113.728 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.07 167.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 127.034 2.134 . . . . 0.0 111.183 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.494 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.3 p-10 -70.22 173.38 4.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.087 1.755 . . . . 0.0 114.875 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.46 -3.28 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.691 3.594 . . . . 0.0 117.886 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.08 -36.68 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.814 2.097 . . . . 0.0 111.881 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.04 42.13 0.67 Allowed Glycine 0 CA--C 1.532 1.117 0 N-CA-C 115.27 0.868 . . . . 0.0 115.27 163.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.0 -2.81 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.742 1.217 . . . . 0.0 113.631 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -143.47 -117.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.063 1.345 . . . . 0.0 113.47 -178.401 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -175.7 76.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 130.72 3.608 . . . . 0.0 106.08 -169.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -117.67 3.6 17.47 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 127.971 2.7 . . . . 0.0 115.646 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.03 157.84 41.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 122.307 1.051 . . . . 0.0 109.753 148.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.44 177.69 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.527 2.331 . . . . 0.0 108.188 -171.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -152.38 159.52 43.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 122.624 0.369 . . . . 0.0 110.871 -163.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.43 129.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -104.23 138.53 40.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.382 2.273 . . . . 0.0 110.13 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 2.9 m-85 -106.02 -175.87 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.92 57.09 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.048 -1.658 . . . . 0.0 113.267 168.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.8 m -161.24 161.68 30.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.311 1.045 . . . . 0.0 112.444 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -62.57 -21.6 65.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.028 0.931 . . . . 0.0 113.122 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.5 -47.7 10.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.533 2.733 . . . . 0.0 112.776 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.37 -35.68 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.9 1.28 . . . . 0.0 111.139 168.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.05 -13.55 62.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.508 172.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -94.75 -29.57 14.7 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.147 -1.596 . . . . 0.0 110.644 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -61.24 -38.86 88.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.062 1.745 . . . . 0.0 109.844 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.25 -45.76 83.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.086 2.155 . . . . 0.0 116.02 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.59 -28.24 13.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 113.768 165.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.74 -19.52 55.28 Favored Glycine 0 CA--C 1.546 2.012 0 C-N-CA 125.344 1.45 . . . . 0.0 115.418 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -72.43 35.7 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.77 2.028 . . . . 0.0 113.402 164.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -50.16 -31.05 12.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -154.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 27.75 3.47 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.284 1.433 . . . . 0.0 113.371 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -66.96 -170.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -138.11 148.7 45.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.354 1.862 . . . . 0.0 111.361 -153.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.71 128.12 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 128.824 2.849 . . . . 0.0 106.41 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.88 -126.19 34.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -98.47 8.43 44.89 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.6 -179.94 4.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -153.03 111.69 3.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -119.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.7 mt -126.43 136.77 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 122.876 1.322 . . . . 0.0 112.6 -139.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 155.08 40.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.689 3.196 . . . . 0.0 113.287 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.67 132.47 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.749 0.82 . . . . 0.0 111.664 166.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.28 151.0 44.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.391 1.876 . . . . 0.0 110.328 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -74.25 143.95 44.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.206 1.003 . . . . 0.0 111.578 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.19 170.76 18.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.911 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.7 m -143.16 154.08 43.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.192 1.397 . . . . 0.0 110.018 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -29.33 4.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.139 1 C-N-CA 135.643 5.577 . . . . 0.0 120.305 174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -137.51 -24.58 1.05 Allowed 'General case' 0 C--N 1.322 -0.619 0 O-C-N 119.861 -1.774 . . . . 0.0 112.448 -164.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.36 -21.87 28.68 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 161.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 CA--C 1.52 -0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 113.215 -165.247 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 37.87 0.52 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.269 3.028 . . . . 0.0 112.774 -163.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.67 108.88 2.64 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -97.02 166.68 11.48 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 164.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.31 110.67 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.315 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -87.28 121.11 29.29 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.543 0.737 . . . . 0.0 111.585 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.07 151.41 28.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.735 2.014 . . . . 0.0 110.598 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.67 89.86 1.59 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.107 1.363 . . . . 0.0 108.784 168.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.14 -24.75 0.02 OUTLIER Glycine 0 N--CA 1.468 0.781 0 C-N-CA 117.797 -2.144 . . . . 0.0 114.313 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.75 144.39 25.78 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.879 2.472 . . . . 0.0 114.864 -157.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.38 172.52 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.503 1 C-N-CA 126.783 4.988 . . . . 0.0 112.938 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -48.31 123.15 6.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.455 1.502 . . . . 0.0 111.786 165.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.82 19.08 76.15 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.79 154.68 3.72 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.341 1.57 . . . . 0.0 112.489 166.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.7 t -150.2 162.63 40.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.587 0.755 . . . . 0.0 112.59 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -35.54 -47.11 0.44 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 126.845 2.058 . . . . 0.0 114.487 166.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.29 -18.74 64.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 120.737 1.608 . . . . 0.0 113.686 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.94 -30.51 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.287 -1.508 . . . . 0.0 110.646 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mt -68.17 -42.59 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.855 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -62.27 -14.69 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 113.92 170.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -25.77 14.9 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.581 1.537 . . . . 0.0 113.885 164.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -46.51 83.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 109.732 173.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.77 33.97 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.202 1.401 . . . . 0.0 113.686 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 t -53.78 -21.57 7.66 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.511 0.672 . . . . 0.0 112.094 157.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.34 -30.04 60.99 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.061 1.791 . . . . 0.0 115.821 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.05 167.45 22.03 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.455 1.128 . . . . 0.0 113.016 -156.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.65 131.52 40.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 111.931 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.2 mt -128.82 137.83 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 128.277 2.631 . . . . 0.0 108.49 -171.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 m -65.7 154.4 88.72 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.732 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.21 -13.37 6.88 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.398 3.399 . . . . 0.0 119.85 -167.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -135.67 26.12 3.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.85 1.66 . . . . 0.0 111.438 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.03 67.07 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 -169.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.65 137.31 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.678 1.191 . . . . 0.0 108.91 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.0 m -131.68 138.4 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.042 1.737 . . . . 0.0 111.814 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.15 92.27 49.19 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 127.017 2.127 . . . . 0.0 110.873 -172.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.8 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.762 3.641 . . . . 0.0 113.14 -173.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.68 173.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 130.123 3.369 . . . . 0.0 108.851 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.401 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.1 p-10 -77.91 172.78 8.9 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.851 2.061 . . . . 0.0 114.087 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.08 0.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 125.031 3.821 . . . . 0.0 117.499 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -126.5 -0.19 6.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.749 1.62 . . . . 0.0 111.938 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 35.46 48.2 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.514 -1.159 . . . . 0.0 115.961 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -130.05 -15.79 3.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.594 1.697 . . . . 0.0 112.635 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.326 0.0 OUTLIER -138.43 -98.4 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -170.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 164.33 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 129.917 3.287 . . . . 0.0 109.245 -165.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -124.8 4.47 8.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.71 3.528 . . . . 0.0 114.405 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -130.12 166.68 19.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.409 1.084 . . . . 0.0 108.866 145.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.85 175.83 4.35 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 128.046 2.539 . . . . 0.0 109.049 -171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 191' ' ' VAL . 97.5 m-85 -150.27 154.74 38.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.062 0.545 . . . . 0.0 110.713 -166.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.43 127.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -97.26 139.61 32.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.344 2.258 . . . . 0.0 111.403 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.1 m-85 -106.73 -177.4 3.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.387 0.675 . . . . 0.0 110.697 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.63 -10.22 59.54 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.143 -1.598 . . . . 0.0 112.946 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.1 m -159.86 157.33 28.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.237 1.015 . . . . 0.0 112.033 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -72.86 -13.87 61.37 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.651 -0.656 . . . . 0.0 112.446 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 41.6 tp10 -75.07 -51.5 13.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.784 2.434 . . . . 0.0 112.394 169.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.4 mt -57.14 -38.16 73.1 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.996 0.918 . . . . 0.0 110.447 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.23 62.16 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -104.33 -27.1 12.18 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.374 -1.454 . . . . 0.0 110.629 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER -61.81 -32.13 72.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.164 0.985 . . . . 0.0 109.072 165.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.9 61.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mp -49.39 -33.51 13.95 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.031 1.287 . . . . 0.0 112.918 162.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.86 -16.61 32.26 Favored Glycine 0 CA--C 1.545 1.929 0 C-N-CA 125.823 1.678 . . . . 0.0 115.581 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -62.37 -33.48 74.82 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.642 1.721 . . . . 0.0 113.392 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 45.69 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 1 C-N-CA 132.418 4.287 . . . . 0.0 119.109 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 90.6 2.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.652 2.381 . . . . 0.0 109.726 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -130.55 -160.84 1.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.71 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -143.04 149.88 38.83 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 120.873 -1.142 . . . . 0.0 112.816 -156.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -140.06 133.09 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 128.306 2.643 . . . . 0.0 106.885 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 48.81 -136.31 19.26 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.229 1.871 . . . . 0.0 111.848 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.03 -8.21 54.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -179.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.686 1.194 . . . . 0.0 113.988 -160.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -137.87 118.39 13.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.503 -149.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.14 135.82 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.923 1.344 . . . . 0.0 110.952 -148.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 164.13 23.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.05 3.34 . . . . 0.0 115.449 169.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.02 132.14 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.808 1.243 . . . . 0.0 111.298 166.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.95 148.6 43.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.826 1.65 . . . . 0.0 110.966 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -71.33 135.09 47.18 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 111.122 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 m -146.87 167.56 23.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.044 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.4 m -154.32 156.12 36.37 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 0.0 112.375 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -32.86 2.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 1 C-N-CA 134.545 5.138 . . . . 0.0 121.151 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -130.4 -24.44 2.53 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.626 -1.921 . . . . 0.0 112.729 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -81.76 -7.18 59.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.01 1.324 . . . . 0.0 109.832 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.486 ' HA ' ' CE1' ' A' ' 156' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 128.566 2.746 . . . . 0.0 113.792 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 CA-C-O 121.942 0.877 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.0 42.08 2.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.028 1.731 . . . . 0.0 109.616 -155.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.21 113.19 3.59 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.452 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -106.41 162.48 13.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 172.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.31 119.5 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.924 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -96.27 120.96 37.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.142 1.377 . . . . 0.0 110.449 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.49 146.08 47.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.12 158.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -139.01 140.33 38.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 141.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.27 1.36 0.39 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.644 0.618 . . . . 0.0 114.644 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 64.8 mt -69.01 152.11 96.95 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.184 1.394 . . . . 0.0 113.33 -153.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.53 167.85 25.69 Favored 'Trans proline' 0 C--O 1.235 0.327 1 C-N-CA 125.722 4.281 . . . . 0.0 112.039 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -68.41 128.73 37.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.962 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.47 25.68 74.8 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.034 -0.87 . . . . 0.0 114.47 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -53.09 150.28 5.93 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.549 1.175 . . . . 0.0 113.417 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 t -147.29 160.32 42.64 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 120.787 -1.195 . . . . 0.0 113.434 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -39.11 -47.33 1.54 Allowed 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 126.663 1.985 . . . . 0.0 114.993 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -65.97 -19.64 65.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.589 1.541 . . . . 0.0 112.794 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -81.93 -29.45 32.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.4 -1.438 . . . . 0.0 109.744 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -70.11 -41.99 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.202 -0.936 . . . . 0.0 111.325 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.11 -12.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.173 1.789 . . . . 0.0 114.162 170.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.56 -21.97 15.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.981 1.264 . . . . 0.0 114.4 164.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -48.91 78.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 169.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.18 34.75 5.1 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.16 1.384 . . . . 0.0 112.694 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.33 -23.42 2.32 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 156.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.04 -31.03 67.78 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.142 1.83 . . . . 0.0 115.988 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.35 161.39 37.07 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.297 1.049 . . . . 0.0 113.603 -154.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.44 143.37 30.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.162 1.385 . . . . 0.0 112.986 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 74.5 mt -146.09 135.46 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.519 2.328 . . . . 0.0 107.587 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -60.4 154.6 53.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 111.506 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.97 -1.75 8.37 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.288 1.992 . . . . 0.0 116.672 -163.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -133.4 17.34 4.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.266 1.826 . . . . 0.0 111.439 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.2 -29.39 72.8 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 121.355 -0.841 . . . . 0.0 114.531 -165.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.6 mt -85.95 129.37 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.761 1.624 . . . . 0.0 108.671 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.0 m -121.05 131.18 54.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.267 1.827 . . . . 0.0 111.458 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.24 92.24 47.01 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 127.152 2.181 . . . . 0.0 110.106 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.86 -86.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.352 2.701 . . . . 0.0 112.442 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.8 172.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 128.141 2.577 . . . . 0.0 110.941 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.77 174.53 5.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.747 2.019 . . . . 0.0 113.027 167.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.07 -6.4 1.28 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.868 3.712 . . . . 0.0 117.52 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -115.28 -14.16 11.69 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.685 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.04 12.45 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.35 -1.25 . . . . 0.0 115.124 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -125.13 -16.77 5.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.719 1.759 . . . . 0.0 112.261 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.314 0.0 OUTLIER -140.74 -100.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 166.16 83.89 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 130.511 3.524 . . . . 0.0 107.909 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -113.03 -16.34 8.52 Favored Glycine 0 N--CA 1.47 0.959 1 C-N-CA 130.863 4.078 . . . . 0.0 113.585 176.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.68 163.95 25.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.726 1.61 . . . . 0.0 110.133 159.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.73 172.99 9.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.233 3.013 . . . . 0.0 107.213 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 90.3 m-85 -149.22 162.7 39.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 -167.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.45 120.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -90.71 126.15 35.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.856 2.063 . . . . 0.0 108.779 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.0 m-85 -84.43 -167.82 1.93 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.425 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.85 -11.29 59.8 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.018 -1.676 . . . . 0.0 112.407 166.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.0 m -161.17 165.14 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.837 1.255 . . . . 0.0 112.856 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -61.06 -31.33 70.99 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.425 1.49 . . . . 0.0 113.077 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -75.22 -48.05 25.29 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.975 2.11 . . . . 0.0 112.914 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 67.5 mt -57.54 -37.31 72.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.931 1.293 . . . . 0.0 110.697 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.51 63.92 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -92.1 -32.89 14.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.636 1.574 . . . . 0.0 109.979 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -36.1 82.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.435 1.494 . . . . 0.0 109.322 172.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.429 ' HB3' ' CE2' ' A' ' 159' ' ' PHE . . . -66.09 -43.16 88.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.545 1.938 . . . . 0.0 115.019 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.94 -19.73 32.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.12 -20.78 29.33 Favored Glycine 0 CA--C 1.548 2.118 0 C-N-CA 124.779 1.18 . . . . 0.0 114.579 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -71.09 43.84 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.099 2.16 . . . . 0.0 112.129 158.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -40.05 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.086 1.754 . . . . 0.0 113.937 -163.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -130.95 124.73 31.68 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.76 1.624 . . . . 0.0 107.525 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.0 -166.19 2.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.013 0.925 . . . . 0.0 110.959 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -129.27 149.3 51.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.265 1.426 . . . . 0.0 112.184 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.69 120.27 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 129.015 2.926 . . . . 0.0 106.716 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 60.04 -123.39 32.94 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -90.14 -9.86 46.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -175.07 2.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.997 1.319 . . . . 0.0 113.357 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -154.1 115.71 4.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -126.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.51 142.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.309 1.052 . . . . 0.0 112.094 -141.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.335 5.1 tp10 -89.04 163.88 15.31 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 129.465 3.106 . . . . 0.0 112.914 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 m -138.32 143.94 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.441 -0.787 . . . . 0.0 112.811 166.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.46 149.67 41.27 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.29 1.836 . . . . 0.0 110.605 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -68.32 152.78 44.95 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.615 0.766 . . . . 0.0 111.681 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.49 170.55 22.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.627 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.24 160.53 43.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.801 1.64 . . . . 0.0 111.275 166.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 tp-100 -42.68 5.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 131.722 4.009 . . . . 0.0 120.168 178.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.55 -17.84 3.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.441 -2.037 . . . . 0.0 114.707 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.56 -26.65 32.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.599 1.56 . . . . 0.0 108.691 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.607 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 17.5 m . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 128.056 2.542 . . . . 0.0 116.327 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.19 53.61 0.65 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.698 1.999 . . . . 0.0 114.246 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.03 97.86 0.46 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.686 1.136 . . . . 0.0 110.913 161.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE2' HG23 ' A' ' 191' ' ' VAL . 11.2 m-85 -108.15 163.82 12.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.76 150.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.661 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.409 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 39.3 ttt85 -121.14 143.72 48.95 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.058 1.343 . . . . 0.0 112.329 173.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.54 153.16 27.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.391 2.676 . . . . 0.0 111.124 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.22 71.47 0.51 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.052 1.741 . . . . 0.0 110.176 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.46 0.0 0.03 OUTLIER Glycine 0 N--CA 1.475 1.261 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -165.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 153.33 81.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 0.0 111.824 -165.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.84 171.85 11.5 Favored 'Trans proline' 0 CA--C 1.532 0.382 1 C-N-CA 126.704 4.936 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.37 123.02 16.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.933 0.893 . . . . 0.0 112.438 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.29 12.77 78.16 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.342 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 31.3 t -58.51 151.9 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.958 1.879 . . . . 0.0 112.712 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.3 t -148.06 165.12 31.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.655 0.782 . . . . 0.0 111.763 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -42.09 -49.84 4.76 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.315 2.246 . . . . 0.0 112.417 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 mp0 -63.1 -14.19 45.49 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -85.92 -26.79 25.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.731 -1.856 . . . . 0.0 109.938 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.24 -39.72 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.956 -0.465 . . . . 0.0 112.075 160.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.418 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.287 1.3 m -57.46 -18.52 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -97.7 -26.17 14.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.286 1.403 . . . . 0.0 114.124 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -62.67 -41.46 99.1 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.832 1.253 . . . . 0.0 111.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -121.89 33.77 5.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.484 1.114 . . . . 0.0 113.067 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -21.63 8.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.63 -0.668 . . . . 0.0 112.607 157.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.65 -33.44 41.65 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.93 1.729 . . . . 0.0 114.965 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.0 167.46 21.19 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.554 1.542 . . . . 0.0 112.067 -158.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.43 140.14 29.77 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.866 -1.146 . . . . 0.0 111.739 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 45.1 mt -135.48 136.57 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.531 2.732 . . . . 0.0 107.831 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.07 152.08 84.82 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 118.958 -0.544 . . . . 0.0 111.408 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.77 -14.66 11.1 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.947 3.098 . . . . 0.0 119.967 -165.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -128.54 19.94 6.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.145 1.378 . . . . 0.0 111.759 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.55 -27.42 61.09 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.961 1.144 . . . . 0.0 115.961 -163.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -92.05 137.63 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 125.955 1.702 . . . . 0.0 109.738 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.4 m -132.49 137.65 47.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.416 1.462 . . . . 0.0 113.465 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.29 90.06 50.87 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 127.192 2.197 . . . . 0.0 112.149 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.09 -63.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.103 1.202 . . . . 0.0 114.203 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.43 179.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 129.994 3.318 . . . . 0.0 108.081 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.46 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.3 p-10 -74.51 170.68 13.98 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 119.64 -1.913 . . . . 0.0 113.686 156.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.82 -0.61 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.727 3.618 . . . . 0.0 116.873 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -130.18 0.92 4.67 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.594 1.558 . . . . 0.0 111.556 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.01 39.4 23.98 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.119 1.207 . . . . 0.0 116.119 163.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -122.92 -25.55 4.57 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.496 1.518 . . . . 0.0 111.422 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.274 0.0 OUTLIER -149.05 -111.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.417 -1.277 . . . . 0.0 113.231 -157.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 p -179.0 78.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 129.75 3.22 . . . . 0.0 108.576 -166.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.46 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -130.65 7.55 5.86 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 127.901 2.667 . . . . 0.0 114.384 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -136.44 160.41 38.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.123 1.369 . . . . 0.0 109.244 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -171.04 176.78 3.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.735 1.614 . . . . 0.0 110.549 -169.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 114' ' ' ARG . 97.1 m-85 -148.37 159.58 43.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.408 1.083 . . . . 0.0 110.418 -171.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -163.48 124.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -94.14 132.48 38.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.042 2.137 . . . . 0.0 110.844 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.2 m-85 -92.73 -172.77 3.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.662 0.385 . . . . 0.0 110.701 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.35 -12.34 60.24 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.215 -1.553 . . . . 0.0 113.033 168.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.7 m -159.39 162.35 35.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.421 1.088 . . . . 0.0 113.202 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.42 -34.04 70.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.032 0.933 . . . . 0.0 113.015 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -71.49 -47.17 57.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.087 2.155 . . . . 0.0 112.782 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.24 -34.67 74.01 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.528 1.131 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.81 -16.93 60.02 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.151 0.501 . . . . 0.0 112.238 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -85.72 -33.13 21.57 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.389 -1.444 . . . . 0.0 109.363 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -36.79 85.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.778 1.631 . . . . 0.0 110.098 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.0 87.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.26 1.824 . . . . 0.0 115.424 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 mp -48.89 -27.56 3.17 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.65 -13.54 51.54 Favored Glycine 0 CA--C 1.545 1.952 0 C-N-CA 125.06 1.314 . . . . 0.0 115.386 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -64.98 -22.91 67.07 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.463 1.631 . . . . 0.0 114.455 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 41.51 -53.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 1 C-N-CA 131.92 4.088 . . . . 0.0 119.742 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -145.42 19.26 1.54 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.311 2.244 . . . . 0.0 112.694 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.81 -179.67 0.29 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -119.64 155.76 31.71 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -161.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.5 mt -139.74 131.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 130.061 3.344 . . . . 0.0 106.145 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.44 -85.36 0.01 OUTLIER Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.938 1.256 . . . . 0.0 113.368 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -147.06 13.98 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.405 1.882 . . . . 0.0 112.234 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -124.29 178.65 5.25 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.944 2.097 . . . . 0.0 111.19 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -149.92 91.27 1.77 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 123.231 1.491 . . . . 0.0 109.66 -113.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.6 mt -102.55 139.5 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.186 -141.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.69 151.26 45.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.334 2.254 . . . . 0.0 112.633 165.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.73 136.68 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.424 0.69 . . . . 0.0 112.075 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -142.74 150.53 40.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 109.884 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -61.36 152.47 29.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.935 0.894 . . . . 0.0 110.417 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.3 m -152.61 171.64 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.722 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -153.38 155.65 36.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.486 1.515 . . . . 0.0 111.16 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.404 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp-100 -35.22 -1.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 1 C-N-CA 133.496 4.718 . . . . 0.0 120.17 177.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -117.85 -28.38 5.96 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 119.881 -1.762 . . . . 0.0 112.961 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -84.2 -19.96 33.14 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.628 -1.295 . . . . 0.0 109.745 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 188' ' ' GLN . 21.2 m . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 128.185 2.594 . . . . 0.0 112.922 -165.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.892 0.853 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.33 50.59 1.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.739 -158.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.76 91.89 0.43 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 127.446 2.451 . . . . 0.0 112.03 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -99.0 166.81 11.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -146.81 128.07 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.899 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 66.1 ttt180 -104.0 138.73 40.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.254 1.022 . . . . 0.0 111.244 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 153.19 23.4 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.409 2.683 . . . . 0.0 109.531 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -155.07 81.22 1.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 109.782 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.77 -5.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.081 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -168.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.38 148.92 74.8 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.856 1.262 . . . . 0.0 111.119 -161.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 83.2 Cg_endo -80.42 170.75 15.65 Favored 'Trans proline' 0 N--CA 1.462 -0.37 1 C-N-CA 126.595 4.864 . . . . 0.0 113.056 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -53.75 118.44 3.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.555 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.61 66.53 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.304 -1.276 . . . . 0.0 115.73 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 6.2 t -55.35 149.75 12.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.317 2.059 . . . . 0.0 112.257 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.4 164.15 33.35 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.454 1.102 . . . . 0.0 111.249 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -43.69 -43.34 5.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.457 2.303 . . . . 0.0 113.164 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.5 mp0 -69.36 -18.0 63.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.949 1.299 . . . . 0.0 114.334 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.97 -27.59 49.2 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 119.709 -1.87 . . . . 0.0 110.458 166.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.9 mt -69.61 -36.83 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 110.465 166.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.274 1.4 m -63.57 -15.89 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.479 1.111 . . . . 0.0 113.701 169.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -96.73 -25.04 15.67 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.529 1.513 . . . . 0.0 114.142 165.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.61 -46.96 88.29 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.423 1.489 . . . . 0.0 110.782 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -119.98 35.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.322 1.049 . . . . 0.0 112.509 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.6 p -49.6 -24.8 2.36 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 155.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.03 -33.3 68.74 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.058 1.789 . . . . 0.0 115.353 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -139.29 160.45 39.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 113.139 -155.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.52 136.39 33.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 112.438 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 48.2 mt -135.71 137.69 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 129.633 3.173 . . . . 0.0 107.911 -171.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.07 151.88 79.45 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.821 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.19 -23.06 21.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 N-CA-C 120.952 3.405 . . . . 0.0 120.952 -158.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 39.52 2.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.604 1.162 . . . . 0.0 110.13 167.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.97 -25.42 9.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.219 1.39 . . . . 0.0 114.936 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.82 133.47 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.273 1.829 . . . . 0.0 109.631 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.1 m -129.18 136.62 50.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.078 1.751 . . . . 0.0 112.455 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.97 91.76 48.81 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 127.198 2.199 . . . . 0.0 111.142 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 -79.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 123.366 2.711 . . . . 0.0 113.634 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.26 168.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 129.224 3.01 . . . . 0.0 109.737 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.463 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.4 p-10 -80.61 171.74 11.56 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.966 1.706 . . . . 0.0 114.118 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.49 -1.16 0.19 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 124.973 3.782 . . . . 0.0 117.478 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -127.83 0.3 6.02 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.975 1.71 . . . . 0.0 111.795 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 39.43 68.21 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 115.796 1.079 . . . . 0.0 115.796 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -127.82 -17.15 4.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.859 1.664 . . . . 0.0 112.005 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.467 HG23 ' H ' ' A' ' 152' ' ' THR 0.307 0.0 OUTLIER -141.51 -104.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.296 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.467 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.5 OUTLIER 172.56 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.352 3.461 . . . . 0.0 108.525 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -123.41 2.52 9.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 128.714 3.054 . . . . 0.0 114.373 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.53 162.8 23.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.152 0.476 . . . . 0.0 109.726 142.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.89 177.2 5.1 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 127.036 2.135 . . . . 0.0 110.274 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.439 ' CE1' ' HD2' ' A' ' 114' ' ' ARG . 87.9 m-85 -148.88 160.28 43.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.037 0.935 . . . . 0.0 110.923 -166.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -162.29 121.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -90.19 132.74 35.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.838 2.055 . . . . 0.0 110.006 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.2 m-85 -89.12 -158.54 0.51 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.908 0.483 . . . . 0.0 110.197 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.47 -9.15 59.55 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 119.852 -1.78 . . . . 0.0 112.904 156.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.6 m -162.45 159.11 24.67 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -56.18 -30.99 63.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.158 1.383 . . . . 0.0 113.723 166.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -53.07 20.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.601 1.56 . . . . 0.0 111.414 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.64 -36.88 72.43 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.19 1.396 . . . . 0.0 111.319 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.08 61.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.57 -32.14 15.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.526 1.53 . . . . 0.0 110.444 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -61.57 -40.04 93.31 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 125.787 1.635 . . . . 0.0 110.508 167.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.24 86.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.24 1.816 . . . . 0.0 114.162 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -20.18 14.24 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -62.34 -14.29 47.52 Favored Glycine 0 CA--C 1.547 2.054 0 C-N-CA 124.646 1.117 . . . . 0.0 115.016 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -63.16 -27.52 69.43 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.324 1.562 . . . . 0.0 113.442 162.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.77 -42.01 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 1 C-N-CA 133.191 4.596 . . . . 0.0 120.166 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -153.49 36.83 0.46 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.305 1.442 . . . . 0.0 112.053 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.02 -174.04 0.22 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.621 1.168 . . . . 0.0 114.041 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.31 148.96 44.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.372 1.469 . . . . 0.0 112.682 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.3 mt -138.47 131.52 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 129.283 3.033 . . . . 0.0 105.798 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 54.41 -99.89 0.07 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.148 1.356 . . . . 0.0 112.33 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -118.36 -5.15 10.84 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.24 1.416 . . . . 0.0 113.532 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.71 -172.43 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.241 1.816 . . . . 0.0 112.49 -169.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -151.09 109.71 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.991 -132.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.27 128.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 122.783 1.278 . . . . 0.0 112.371 -139.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 160.58 13.23 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 127.559 2.344 . . . . 0.0 114.268 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.63 141.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.332 0.653 . . . . 0.0 112.433 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.81 142.75 31.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.198 1.799 . . . . 0.0 110.794 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -66.98 146.24 54.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.679 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -150.83 168.79 23.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.647 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.5 m -147.5 165.37 30.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.531 1.532 . . . . 0.0 110.761 164.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.429 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.7 tp60 -35.98 1.7 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 1 C-N-CA 133.32 4.648 . . . . 0.0 119.87 177.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -118.26 -30.26 5.31 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.636 -1.915 . . . . 0.0 112.669 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.662 -1.274 . . . . 0.0 109.611 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 188' ' ' GLN . 18.9 m . . . . . 0 C--N 1.332 -0.189 0 C-N-CA 127.585 2.354 . . . . 0.0 114.622 -153.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.8 p30 . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.37 36.91 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.181 3.793 . . . . 0.0 114.181 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -58.51 83.36 0.01 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 127.064 2.268 . . . . 0.0 113.602 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 158' ' ' GLN . 3.3 m-85 -92.31 160.53 15.08 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 168.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.08 113.13 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.736 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.341 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.445 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 77.3 ttt180 -89.02 131.02 35.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 123.459 0.704 . . . . 0.0 111.492 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.42 152.96 18.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 128.751 2.821 . . . . 0.0 110.438 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -157.84 70.92 0.59 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.91 1.284 . . . . 0.0 109.419 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.48 1.92 0.03 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 -162.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -79.4 153.89 76.56 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 119.186 1.493 . . . . 0.0 112.434 -162.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.87 175.06 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 1 C-N-CA 125.759 4.306 . . . . 0.0 113.299 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -67.15 132.08 47.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.204 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.64 70.07 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 117.694 -1.615 . . . . 0.0 115.71 -171.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.25 149.38 20.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 120.392 2.096 . . . . 0.0 113.517 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.4 p -135.0 164.1 28.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.1 1.76 . . . . 0.0 111.82 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -48.56 -42.33 33.17 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 126.448 1.899 . . . . 0.0 112.449 166.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 121.193 1.815 . . . . 0.0 113.792 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -75.43 -31.68 60.43 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.658 -1.901 . . . . 0.0 110.0 167.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.45 -39.04 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.496 0.718 . . . . 0.0 111.183 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -62.17 -17.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.376 1.07 . . . . 0.0 112.964 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -96.05 -31.92 12.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.874 1.216 . . . . 0.0 112.719 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.46 -41.66 90.23 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.066 1.746 . . . . 0.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.87 33.39 5.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.918 1.287 . . . . 0.0 113.771 170.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.1 p -52.21 -22.2 4.12 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 157.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.22 -32.96 30.05 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.156 1.836 . . . . 0.0 115.212 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.66 166.49 24.22 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.888 1.275 . . . . 0.0 112.876 -156.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.57 137.53 32.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.68 1.592 . . . . 0.0 111.377 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 72.1 mt -138.62 137.64 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 128.221 2.608 . . . . 0.0 106.824 -170.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -60.39 153.55 58.83 Favored Pre-proline 0 N--CA 1.486 1.365 0 CA-C-N 118.643 0.656 . . . . 0.0 111.447 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.02 -21.06 20.19 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 120.927 3.395 . . . . 0.0 120.927 -159.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.74 40.9 2.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.791 1.178 . . . . 0.0 109.993 167.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.17 -14.71 6.31 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.148 1.356 . . . . 0.0 116.38 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.2 mt -103.27 123.69 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 125.372 1.469 . . . . 0.0 109.384 -165.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.8 m -115.8 130.59 56.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.085 2.554 . . . . 0.0 112.695 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.76 78.78 56.64 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 127.014 2.126 . . . . 0.0 111.724 -170.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.27 -58.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.372 1.381 . . . . 0.0 113.249 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -178.3 173.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 130.681 3.592 . . . . 0.0 107.961 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.474 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.9 p-10 -69.63 169.44 12.49 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 120.236 -1.54 . . . . 0.0 113.747 159.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.41 2.59 0.1 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.931 3.754 . . . . 0.0 117.319 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -128.41 -2.76 5.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.555 1.542 . . . . 0.0 112.094 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.62 26.24 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -131.39 -15.52 3.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.415 1.607 . . . . 0.0 112.728 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 152' ' ' THR 0.29 0.0 OUTLIER -143.67 -114.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.738 1.215 . . . . 0.0 113.226 -170.134 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.24 75.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 129.342 3.057 . . . . 0.0 108.141 -167.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.474 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -125.25 4.68 8.27 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 127.561 2.505 . . . . 0.0 114.702 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.86 164.06 26.9 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.497 0.719 . . . . 0.0 109.972 150.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -172.34 168.98 5.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 126.834 2.054 . . . . 0.0 110.029 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CE2' ' HD2' ' A' ' 114' ' ' ARG . 97.0 m-85 -141.25 152.62 44.69 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.582 0.753 . . . . 0.0 109.673 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.23 123.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' A' ' 112' ' ' PHE . 39.3 tp60 -90.79 122.77 33.81 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.954 2.102 . . . . 0.0 110.344 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 5.1 m-85 -83.23 -165.55 1.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.576 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.79 -12.39 60.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.177 -1.577 . . . . 0.0 112.159 162.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.3 m -161.54 162.65 30.32 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.993 0.917 . . . . 0.0 113.411 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.67 -8.01 55.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.85 -53.2 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.324 2.25 . . . . 0.0 111.81 172.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.06 -37.89 67.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.026 1.73 . . . . 0.0 111.285 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.33 -15.84 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.68 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.46 -25.36 15.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.267 -1.521 . . . . 0.0 110.864 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.05 -41.08 97.51 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.323 1.449 . . . . 0.0 109.853 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.29 90.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.548 1.939 . . . . 0.0 115.808 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.5 mp -48.19 -21.48 0.5 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 165.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.48 -10.02 59.45 Favored Glycine 0 CA--C 1.544 1.864 0 C-N-CA 123.965 0.793 . . . . 0.0 113.697 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -59.59 -32.82 70.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.228 1.411 . . . . 0.0 114.321 164.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.6 -56.51 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 131.196 3.799 . . . . 0.0 119.0 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -148.17 24.31 1.04 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.289 1.836 . . . . 0.0 113.443 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.61 179.4 0.12 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.772 1.629 . . . . 0.0 113.731 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 149.65 45.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.342 1.457 . . . . 0.0 111.799 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.39 -16.64 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.5 1.12 . . . . 0.0 112.77 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.62 -41.96 0.08 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.394 1.473 . . . . 0.0 112.607 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -149.66 -42.04 0.14 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.312 1.445 . . . . 0.0 112.854 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -86.14 174.55 9.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.109 0.957 . . . . 0.0 111.753 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.73 97.49 3.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.937 -126.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.3 mt -99.78 119.48 47.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.733 -148.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 153.25 42.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.149 1.78 . . . . 0.0 112.372 163.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 132.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.499 0.719 . . . . 0.0 110.947 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -135.61 144.74 46.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.917 1.687 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -69.15 142.0 54.47 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.594 0.711 . . . . 0.0 110.41 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 m -150.38 164.12 36.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.09 -167.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 73.6 m -135.39 160.75 37.47 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.731 1.212 . . . . 0.0 110.916 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -46.66 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.768 1 C-N-CA 132.39 4.276 . . . . 0.0 118.148 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -128.67 -28.73 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.204 -1.56 . . . . 0.0 113.03 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.46 -23.48 62.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.859 -1.151 . . . . 0.0 110.564 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 1.7 p . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 124.676 1.191 . . . . 0.0 113.261 170.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -120.3 34.76 5.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.476 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 77.89 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 127.035 2.255 . . . . 0.0 113.353 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.49 156.96 16.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.1 108.72 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.678 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -86.05 124.84 32.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.609 0.763 . . . . 0.0 111.444 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.33 152.47 23.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.976 2.11 . . . . 0.0 110.808 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -155.1 76.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.263 1.425 . . . . 0.0 109.324 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.35 -11.01 0.02 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -161.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 13.0 mt -73.44 156.08 89.13 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -152.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.4 169.69 19.62 Favored 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 125.634 4.223 . . . . 0.0 112.543 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.23 125.96 28.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.68 24.54 75.39 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.739 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 36.2 t -54.96 154.49 5.26 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.277 1.538 . . . . 0.0 112.773 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.1 t -147.31 164.41 33.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.047 0.927 . . . . 0.0 112.144 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -45.55 -40.64 8.93 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 127.055 2.142 . . . . 0.0 113.126 171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -69.87 -16.7 63.29 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 121.596 1.998 . . . . 0.0 113.999 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -76.92 -35.09 57.57 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 120.043 -1.661 . . . . 0.0 109.327 166.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.9 mt -64.1 -40.29 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.036 0.835 . . . . 0.0 111.141 169.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.5 m -65.77 -16.52 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.897 1.279 . . . . 0.0 112.683 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -94.94 -31.48 13.63 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.94 1.245 . . . . 0.0 112.425 164.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.86 -38.23 75.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.188 1.795 . . . . 0.0 111.593 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.15 35.93 4.76 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.482 1.513 . . . . 0.0 112.68 167.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -64.37 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.173 1.463 . . . . 0.0 108.864 153.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.8 -48.04 0.08 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.795 -151.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.1 157.9 45.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.988 1.315 . . . . 0.0 112.09 -160.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.73 131.28 38.67 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.645 -0.659 . . . . 0.0 111.193 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 55.1 mt -131.08 132.26 63.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.832 2.453 . . . . 0.0 107.183 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.09 151.4 80.98 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.923 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.94 -16.89 12.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.069 3.179 . . . . 0.0 119.133 -165.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -122.95 16.43 10.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.593 1.557 . . . . 0.0 111.598 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.58 70.73 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 -159.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -95.17 134.77 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 124.856 1.262 . . . . 0.0 109.743 -166.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.4 m -133.44 133.55 42.46 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.575 1.55 . . . . 0.0 112.685 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.27 96.47 36.49 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 127.695 2.398 . . . . 0.0 111.326 -173.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.73 -81.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.078 1.852 . . . . 0.0 113.831 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.25 167.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 128.899 2.88 . . . . 0.0 109.991 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -70.86 170.65 10.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.493 1.917 . . . . 0.0 114.645 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.61 0.61 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 124.907 3.738 . . . . 0.0 117.576 170.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -126.91 -0.46 6.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.776 1.63 . . . . 0.0 111.928 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.28 37.32 54.75 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -129.16 -15.63 4.15 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.192 1.496 . . . . 0.0 112.37 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.299 0.0 OUTLIER -141.67 -105.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 170.96 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.981 3.312 . . . . 0.0 107.983 -166.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.81 -1.45 5.9 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 129.942 3.639 . . . . 0.0 114.476 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -131.8 158.63 40.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.473 149.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.61 -179.47 3.38 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.339 2.256 . . . . 0.0 108.472 -167.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -152.01 157.65 42.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.789 0.436 . . . . 0.0 111.273 -167.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.52 125.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -90.8 127.0 36.19 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.937 2.095 . . . . 0.0 111.266 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.5 m-85 -92.11 -173.16 3.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.342 1.057 . . . . 0.0 110.313 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.97 -13.17 60.84 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.212 -1.555 . . . . 0.0 113.064 166.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.4 m -160.24 159.97 32.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.477 1.111 . . . . 0.0 113.347 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -60.69 -21.43 62.86 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 29.0 tp10 -78.96 -50.32 11.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.681 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.07 -36.8 70.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.518 1.127 . . . . 0.0 111.13 170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.58 -20.86 63.64 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.975 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -91.06 -29.77 17.14 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.237 -1.54 . . . . 0.0 110.317 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -62.15 -34.08 75.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.916 0.886 . . . . 0.0 109.197 167.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.72 -42.63 63.95 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.2 mp -49.09 -31.88 8.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 120.615 1.552 . . . . 0.0 113.143 160.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -57.76 -16.47 23.86 Favored Glycine 0 CA--C 1.547 2.057 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 170.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -69.14 -19.72 64.02 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.171 1.986 . . . . 0.0 113.758 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 47.97 -65.51 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 130.969 3.708 . . . . 0.0 118.303 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -150.48 33.36 0.63 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.283 1.833 . . . . 0.0 112.484 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.83 -157.95 0.1 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.006 1.322 . . . . 0.0 113.312 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -135.35 149.11 49.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.895 2.078 . . . . 0.0 112.49 -169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -106.1 -17.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -170.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.16 -39.66 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.409 1.957 . . . . 0.0 111.58 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -151.7 -44.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.688 . . . . 0.0 111.773 169.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.7 177.97 5.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.441 1.096 . . . . 0.0 112.44 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.31 113.82 14.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.12 1.768 . . . . 0.0 109.891 -128.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 2.8 mt -121.16 111.83 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.57 1.652 . . . . 0.0 111.809 -146.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 150.94 33.64 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.206 -2.724 . . . . 0.0 112.494 158.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.17 123.16 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 110.204 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -119.63 146.45 45.54 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.683 1.593 . . . . 0.0 109.543 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -66.15 136.03 55.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -144.68 172.14 13.41 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -166.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.9 m -152.08 148.81 28.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.298 1.839 . . . . 0.0 109.729 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -31.29 -16.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 1 C-N-CA 132.147 4.179 . . . . 0.0 118.459 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -112.58 -16.71 12.79 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.91 1.684 . . . . 0.0 111.625 -168.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -80.48 -30.75 37.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 156.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -163.038 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.76 55.26 1.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.129 2.172 . . . . 0.0 112.179 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.23 95.13 0.57 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.093 1.33 . . . . 0.0 111.363 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 158' ' ' GLN . 23.8 m-85 -99.69 164.35 12.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.92 113.49 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.369 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 68.5 ttt180 -89.87 115.07 26.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.922 0.889 . . . . 0.0 110.455 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.66 146.53 53.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.317 157.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.82 151.09 48.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 140.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.9 -13.6 0.76 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.173 -1.579 . . . . 0.0 113.857 159.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 10.4 mt -67.91 153.21 95.61 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -141.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.09 171.21 18.03 Favored 'Trans proline' 0 C--N 1.346 0.416 1 C-N-CA 126.754 4.969 . . . . 0.0 112.368 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -68.71 132.74 47.35 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.093 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.59 25.22 62.98 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.647 -168.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.9 t -54.14 149.18 9.9 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.503 1.652 . . . . 0.0 113.124 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 t -145.54 161.17 40.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.738 1.256 . . . . 0.0 112.044 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -46.71 -37.72 8.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 127.774 2.43 . . . . 0.0 113.496 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -71.74 -19.54 62.02 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 121.083 1.765 . . . . 0.0 114.041 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.88 -31.91 57.11 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 120.208 -1.558 . . . . 0.0 109.156 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -68.73 -39.09 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.522 0.729 . . . . 0.0 111.338 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.43 -16.07 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.961 1.304 . . . . 0.0 112.803 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -95.67 -28.77 14.65 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.315 0.962 . . . . 0.0 112.794 164.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.4 t80 -61.45 -44.85 96.39 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.751 1.62 . . . . 0.0 111.011 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -118.53 34.99 4.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.357 1.463 . . . . 0.0 113.091 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.6 p -50.08 -24.02 2.45 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 155.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.64 -33.23 54.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.437 1.97 . . . . 0.0 115.673 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.1 mp -138.28 161.76 36.08 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.215 1.007 . . . . 0.0 113.092 -156.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.01 132.73 33.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.143 1.377 . . . . 0.0 112.321 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 53.2 mt -133.27 138.26 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 128.995 2.918 . . . . 0.0 108.13 -172.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.81 152.0 87.75 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.784 -0.573 . . . . 0.0 111.513 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.65 -14.69 10.76 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.026 3.151 . . . . 0.0 120.013 -165.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.59 21.85 5.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.308 1.443 . . . . 0.0 111.544 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.79 -24.57 57.68 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -166.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.5 130.73 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.187 1.395 . . . . 0.0 109.539 -167.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.9 m -124.62 132.0 53.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.058 1.743 . . . . 0.0 112.744 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.85 87.46 46.68 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 127.715 2.406 . . . . 0.0 110.412 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 -86.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.985 1.79 . . . . 0.0 112.646 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -165.22 156.98 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 128.945 2.898 . . . . 0.0 109.104 177.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 1.3 p-10 -64.28 178.24 0.47 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.001 3.321 . . . . 0.0 115.031 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.02 1.11 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.491 0 C-N-CA 124.48 3.453 . . . . 0.0 117.368 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -133.74 -32.84 1.1 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.279 1.854 . . . . 0.0 113.511 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.9 40.18 1.6 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.583 1.563 . . . . 0.0 114.911 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -132.35 -15.14 2.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 113.007 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -161.86 -163.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 127.793 2.437 . . . . 0.0 107.99 -168.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.492 ' H ' HD11 ' A' ' 151' ' ' ILE . 11.3 p -122.61 30.26 6.55 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 123.273 2.76 . . . . 0.0 112.988 -170.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' A' ' 146' ' ' ASP . . . -53.43 1.33 0.03 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.159 2.79 . . . . 0.0 117.245 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 152' ' ' THR . 6.0 pt-20 -147.25 152.59 38.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.095 0.95 . . . . 0.0 111.138 158.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.8 176.34 7.17 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 127.742 2.417 . . . . 0.0 108.938 -163.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.434 ' CE2' ' HD2' ' A' ' 114' ' ' ARG . 92.7 m-85 -149.42 163.41 37.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.709 -166.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.7 127.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 112' ' ' PHE . 46.1 tp60 -96.17 131.07 43.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.484 2.314 . . . . 0.0 110.3 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.2 m-85 -94.74 -168.43 1.82 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.289 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.2 -10.4 59.63 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.88 -1.763 . . . . 0.0 113.311 163.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 m -159.22 158.11 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.077 0.951 . . . . 0.0 113.096 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -57.13 -26.54 60.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.684 1.594 . . . . 0.0 114.483 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -54.8 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.822 1.649 . . . . 0.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.68 -37.81 66.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.85 1.66 . . . . 0.0 111.539 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.83 -17.2 64.43 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -110.3 -16.45 13.73 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.283 -1.511 . . . . 0.0 111.852 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.76 -38.69 86.1 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.963 0.905 . . . . 0.0 110.281 155.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -44.04 80.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 mp -51.09 -27.85 9.22 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.93 -1.106 . . . . 0.0 113.75 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.92 -14.85 32.78 Favored Glycine 0 CA--C 1.547 2.076 0 C-N-CA 125.262 1.411 . . . . 0.0 115.592 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -65.44 -17.66 64.72 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.886 1.843 . . . . 0.0 114.585 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 37.27 -47.57 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 C-N-CA 132.967 4.507 . . . . 0.0 120.982 171.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 19.5 1.11 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.166 1.787 . . . . 0.0 113.843 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -59.89 179.48 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.6 ttp85 -119.33 149.15 42.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.112 2.965 . . . . 0.0 109.043 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.441 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -115.88 -29.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.494 1.118 . . . . 0.0 113.041 -173.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -171.56 -112.02 0.27 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 127.074 2.273 . . . . 0.0 108.139 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -39.52 84.75 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.795 1.298 . . . . 0.0 113.151 164.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -177.87 3.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.462 1.505 . . . . 0.0 114.973 -164.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.685 1.594 . . . . 0.0 108.261 -140.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 5.1 mt -128.4 136.5 59.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.814 1.292 . . . . 0.0 112.362 -142.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.253 3.3 mp0 -83.13 156.42 23.27 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 130.589 3.556 . . . . 0.0 112.456 164.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.63 133.07 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.945 0.898 . . . . 0.0 111.091 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.24 144.75 47.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.967 1.707 . . . . 0.0 109.759 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -75.51 139.2 42.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.74 1.216 . . . . 0.0 110.703 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.7 m -149.39 166.77 28.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.741 -158.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 m -143.58 148.01 35.27 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.805 1.642 . . . . 0.0 108.798 165.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -13.79 -18.61 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 135.259 5.423 . . . . 0.0 120.642 169.104 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -122.46 -6.19 8.73 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 120.356 -1.465 . . . . 0.0 111.715 -167.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -76.51 -21.64 55.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.641 153.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.344 0.36 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -149.745 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.604 0.716 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.75 43.58 0.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 112.571 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.18 99.08 0.85 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.858 1.218 . . . . 0.0 111.218 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.12 163.09 13.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 167.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.79 115.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.582 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 42.8 ttt85 -92.32 137.35 32.44 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.126 0.97 . . . . 0.0 112.79 -173.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.62 151.16 23.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.236 2.614 . . . . 0.0 110.86 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -157.62 75.08 0.77 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.021 1.728 . . . . 0.0 108.599 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.67 -6.95 0.03 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -163.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -77.46 153.89 81.6 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-N 118.18 0.99 . . . . 0.0 113.653 -157.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.1 173.85 11.43 Favored 'Trans proline' 0 C--N 1.344 0.335 1 C-N-CA 126.937 5.091 . . . . 0.0 113.312 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -62.9 131.2 47.93 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.876 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.57 19.22 72.71 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 117.955 -1.469 . . . . 0.0 115.597 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.8 t -56.56 149.23 17.82 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 120.14 1.97 . . . . 0.0 113.842 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.0 t -143.73 161.59 38.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.553 1.168 . . . . 0.0 112.806 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -44.92 -42.4 8.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.598 2.759 . . . . 0.0 114.074 172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.48 -21.36 66.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 121.25 1.841 . . . . 0.0 114.307 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -79.37 -33.32 42.98 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 119.787 -1.821 . . . . 0.0 109.674 170.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.7 mt -62.8 -38.67 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.456 -0.778 . . . . 0.0 111.038 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.268 1.1 m -68.34 -12.46 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 113.702 173.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.62 -27.29 14.88 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.673 1.124 . . . . 0.0 113.355 161.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -64.12 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.122 1.769 . . . . 0.0 111.266 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -120.84 34.61 5.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.833 1.653 . . . . 0.0 112.786 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -50.93 -22.62 2.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 156.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.6 -35.14 51.14 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.787 1.661 . . . . 0.0 115.301 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.5 156.46 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.201 1.0 . . . . 0.0 112.575 -149.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.3 140.51 33.55 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.224 -0.922 . . . . 0.0 112.098 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 47.7 mt -136.04 137.7 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 128.269 2.627 . . . . 0.0 107.524 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -62.18 153.05 76.5 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.29 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.51 -8.51 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.525 3.483 . . . . 0.0 120.607 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -140.13 21.76 2.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.871 2.068 . . . . 0.0 111.516 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.8 -16.98 53.46 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.6 mt -105.35 134.74 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 119.081 1.44 . . . . 0.0 109.497 -163.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.3 m -129.57 135.43 48.57 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.564 1.545 . . . . 0.0 112.773 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.01 86.07 50.92 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 127.033 2.133 . . . . 0.0 111.369 -171.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.93 -66.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.338 2.025 . . . . 0.0 113.46 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.88 -179.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 130.188 3.395 . . . . 0.0 108.306 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -77.02 170.08 18.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 119.149 -2.219 . . . . 0.0 114.169 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -55.97 2.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 125.227 3.951 . . . . 0.0 117.198 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -127.65 2.28 6.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.603 1.561 . . . . 0.0 111.729 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.86 34.97 51.82 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.363 -1.243 . . . . 0.0 116.203 164.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -132.68 -14.35 2.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.654 1.727 . . . . 0.0 112.835 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.279 0.0 OUTLIER -143.85 -110.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 117.475 -1.25 . . . . 0.0 113.574 -168.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 p -178.78 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 130.088 3.355 . . . . 0.0 107.486 -167.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.84 1.3 2.84 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 129.258 3.313 . . . . 0.0 113.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -138.15 162.35 34.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.7 1.6 . . . . 0.0 109.445 159.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -173.73 -178.7 1.64 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.509 1.924 . . . . 0.0 110.733 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 114' ' ' ARG . 96.9 m-85 -153.71 152.99 31.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.694 1.198 . . . . 0.0 110.315 -168.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.42 127.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -91.51 133.81 35.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.555 2.342 . . . . 0.0 110.328 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.6 m-85 -97.44 -175.38 3.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.846 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.51 58.56 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.707 -1.246 . . . . 0.0 113.191 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.0 m -166.4 158.57 13.87 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 111.998 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -84.71 50.16 1.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.125 1.37 . . . . 0.0 110.272 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.6 -55.07 0.56 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.15 2.98 . . . . 0.0 108.485 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 49.3 mt -54.41 -41.49 69.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.749 2.02 . . . . 0.0 111.65 164.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -18.46 65.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.63 -29.15 15.6 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.794 -1.192 . . . . 0.0 109.15 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -66.12 -36.84 84.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.301 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 -39.03 87.41 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mp -51.27 -24.36 4.41 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 120.744 -1.223 . . . . 0.0 113.974 162.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -66.36 -17.46 66.32 Favored Glycine 0 CA--C 1.546 2.006 0 C-N-CA 124.98 1.276 . . . . 0.0 115.191 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -75.16 15.59 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.195 1.997 . . . . 0.0 115.605 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -51.82 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 130.317 3.447 . . . . 0.0 119.507 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.68 17.59 0.9 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.214 1.805 . . . . 0.0 114.222 -169.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -114.21 -170.8 1.79 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.059 1.344 . . . . 0.0 112.592 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.05 151.36 47.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.883 2.073 . . . . 0.0 110.977 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.0 OUTLIER -116.23 -38.05 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.131 1.372 . . . . 0.0 112.695 -174.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -156.41 -78.92 0.02 OUTLIER Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.951 1.262 . . . . 0.0 110.517 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -108.18 -18.84 13.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.407 1.083 . . . . 0.0 113.466 169.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -128.05 -178.06 4.38 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.14 1.776 . . . . 0.0 113.639 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -149.8 117.25 6.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -119.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 3.4 mt -123.96 129.26 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 123.537 1.637 . . . . 0.0 112.95 -138.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.16 153.18 36.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.843 2.857 . . . . 0.0 112.798 165.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.76 134.69 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 111.897 171.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -137.99 153.67 49.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.292 1.837 . . . . 0.0 110.258 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -75.03 145.99 41.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.386 0.675 . . . . 0.0 111.656 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.4 m -153.11 168.46 25.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 124.112 0.883 . . . . 0.0 111.728 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.2 m -149.62 158.3 44.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.422 1.489 . . . . 0.0 110.504 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -33.43 -0.85 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 1 C-N-CA 134.019 4.928 . . . . 0.0 119.926 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.91 -10.89 3.42 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 119.951 -1.718 . . . . 0.0 113.519 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.96 -29.97 28.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.456 -0.173 0 C-N-CA 124.718 1.207 . . . . 0.0 112.97 -158.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.256 4.5 p-10 -75.05 52.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.43 1.492 . . . . 0.0 113.628 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.03 99.64 1.3 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.686 2.088 . . . . 0.0 111.574 170.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 158' ' ' GLN . 25.7 m-85 -107.91 165.43 11.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.74 117.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.819 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 38.8 ttt85 -89.02 135.67 33.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.48 151.88 24.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.026 2.53 . . . . 0.0 110.467 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -157.66 76.13 0.8 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.098 1.759 . . . . 0.0 108.64 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.54 -13.2 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.756 1.462 . . . . 0.0 116.756 -163.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 151.13 82.84 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 118.422 1.111 . . . . 0.0 112.846 -153.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.82 175.13 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.271 1 C-N-CA 125.621 4.214 . . . . 0.0 113.431 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -68.47 134.44 50.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.87 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.38 14.7 67.06 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 117.935 -1.481 . . . . 0.0 115.179 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.91 151.48 18.1 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.412 2.106 . . . . 0.0 112.862 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.1 t -146.49 166.23 27.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.563 1.173 . . . . 0.0 111.45 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -47.49 -43.78 24.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 127.415 2.286 . . . . 0.0 112.488 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 40.6 mp0 -67.17 -18.77 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.568 1.531 . . . . 0.0 113.846 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -79.73 -25.36 41.13 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 119.498 -2.001 . . . . 0.0 110.807 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.6 mt -71.6 -36.54 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.484 0.714 . . . . 0.0 111.009 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.269 1.7 m -60.91 -18.73 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.326 168.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -97.82 -25.13 15.15 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.693 1.588 . . . . 0.0 113.347 165.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.88 -42.95 94.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.834 0.853 . . . . 0.0 110.333 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -117.74 42.04 2.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.529 1.131 . . . . 0.0 113.896 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.0 p -67.58 64.77 0.08 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.966 1.365 . . . . 0.0 110.822 154.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.32 -41.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.34 1.447 . . . . 0.0 112.178 -156.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.38 154.47 48.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.226 1.81 . . . . 0.0 110.785 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.11 140.53 45.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.114 0.965 . . . . 0.0 112.431 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.3 mt -143.9 131.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 128.903 2.881 . . . . 0.0 107.072 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.76 152.72 74.72 Favored Pre-proline 0 N--CA 1.486 1.373 0 CA-C-O 118.723 -0.655 . . . . 0.0 111.301 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.15 -25.47 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 120.287 3.149 . . . . 0.0 120.287 -160.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -133.36 41.75 3.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.631 1.173 . . . . 0.0 110.432 166.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.82 -29.14 49.5 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.028 1.299 . . . . 0.0 114.576 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -89.6 131.51 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 125.77 1.628 . . . . 0.0 109.342 -169.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -129.46 132.32 46.91 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.4 1.88 . . . . 0.0 112.888 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.7 92.13 43.57 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 126.981 2.112 . . . . 0.0 112.373 -166.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.32 -65.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.605 1.536 . . . . 0.0 114.352 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.8 177.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 129.43 3.092 . . . . 0.0 109.094 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.518 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.3 p-10 -81.23 172.07 10.66 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 120.006 -1.684 . . . . 0.0 114.273 163.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.11 -0.34 0.28 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 125.019 3.813 . . . . 0.0 117.166 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -127.76 -0.91 6.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 111.786 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.66 39.68 48.13 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.34 -17.18 3.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.956 1.703 . . . . 0.0 112.307 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.469 HG23 ' H ' ' A' ' 152' ' ' THR 0.298 0.0 OUTLIER -143.49 -112.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -169.633 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.469 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.84 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.644 3.178 . . . . 0.0 109.161 -167.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.518 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -113.96 6.3 23.78 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.993 2.711 . . . . 0.0 114.413 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -134.41 157.53 46.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.852 1.261 . . . . 0.0 108.926 157.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.32 -178.93 3.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.206 1.402 . . . . 0.0 110.665 -167.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 191' ' ' VAL . 95.6 m-85 -152.87 157.71 41.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.524 1.13 . . . . 0.0 109.421 -169.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.68 120.76 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 45.6 tp60 -83.18 135.43 34.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.546 1.938 . . . . 0.0 109.693 170.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.5 m-85 -92.39 -157.43 0.52 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.434 0.693 . . . . 0.0 110.335 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.04 59.26 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 120.131 -1.606 . . . . 0.0 112.335 157.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.65 166.99 31.38 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -61.28 -16.92 50.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.759 1.623 . . . . 0.0 114.638 165.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -48.03 3.76 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.844 1.657 . . . . 0.0 111.232 -166.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.29 -37.19 23.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.686 1.194 . . . . 0.0 111.957 161.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.21 -23.12 61.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -88.03 -32.38 18.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.775 2.03 . . . . 0.0 110.329 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.67 -40.69 88.59 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 126.207 1.803 . . . . 0.0 110.346 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -43.44 82.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 114.444 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -21.34 11.56 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.8 -12.84 7.25 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 125.138 1.351 . . . . 0.0 115.213 172.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -53.57 -46.88 70.45 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.403 1.602 . . . . 0.0 113.175 161.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 51.03 -52.87 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.847 3.659 . . . . 0.0 117.0 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -147.27 106.72 3.91 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.507 2.323 . . . . 0.0 108.652 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.67 -166.7 2.19 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.639 1.176 . . . . 0.0 112.125 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -130.81 152.14 50.48 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.92 1.691 . . . . 0.0 114.088 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.93 -22.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.639 1.176 . . . . 0.0 112.845 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -178.44 -52.83 0.07 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.545 1.069 . . . . 0.0 112.755 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 -10.85 0.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.25 1.42 . . . . 0.0 114.49 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -123.8 -179.86 4.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.242 1.417 . . . . 0.0 112.427 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.68 108.77 5.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.601 -1.636 . . . . 0.0 107.696 -118.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.0 mt -117.33 116.57 52.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 123.138 1.447 . . . . 0.0 110.232 -144.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.15 156.16 25.94 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 128.852 2.861 . . . . 0.0 113.161 165.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.97 132.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.651 0.781 . . . . 0.0 111.36 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.28 144.43 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.146 1.778 . . . . 0.0 110.017 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -72.49 152.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.706 -0.622 . . . . 0.0 111.289 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.66 170.08 20.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.009 -160.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.7 m -155.72 162.48 40.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.216 1.806 . . . . 0.0 111.783 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.415 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.8 tp-100 -37.34 5.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 1 C-N-CA 133.118 4.567 . . . . 0.0 120.245 177.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.56 2.17 1.23 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 168.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.73 -20.39 21.6 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.701 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.453 ' HA ' ' CE1' ' A' ' 156' ' ' PHE . 34.5 m . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 128.302 2.641 . . . . 0.0 112.805 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.66 42.95 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.286 2.234 . . . . 0.0 112.275 173.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.461 ' N ' HE22 ' A' ' 158' ' ' GLN . . . -53.06 99.24 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 128.15 2.786 . . . . 0.0 114.818 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.84 161.3 19.52 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.859 1.329 . . . . 0.0 108.593 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.4 125.73 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.109 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 39.4 ttt85 -94.08 142.36 27.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 0.0 111.227 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.89 154.66 21.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.044 2.538 . . . . 0.0 110.589 172.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -156.19 78.29 0.95 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 110.711 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.53 -15.36 0.02 OUTLIER Glycine 0 CA--C 1.544 1.844 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.28 159.15 68.36 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 128.444 2.698 . . . . 0.0 116.897 -153.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.83 167.94 14.26 Favored 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 126.186 4.591 . . . . 0.0 113.988 -173.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -69.59 98.22 1.13 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.511 2.325 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.535 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 97.72 23.51 13.64 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.394 1.473 . . . . 0.0 114.704 -168.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.3 t -53.2 152.89 4.06 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.191 1.995 . . . . 0.0 113.879 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 t -143.64 159.57 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.114 0.959 . . . . 0.0 112.331 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -44.08 -46.43 8.55 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.609 1.963 . . . . 0.0 112.097 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.414 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 39.4 mp0 -65.61 -12.54 54.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.911 1.685 . . . . 0.0 114.717 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -82.65 -33.19 27.85 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 119.995 -1.691 . . . . 0.0 108.873 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.49 -40.19 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.909 -0.494 . . . . 0.0 111.987 164.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.262 1.4 m -58.19 -22.02 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.605 170.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.72 -25.55 17.39 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.462 1.483 . . . . 0.0 113.012 169.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.437 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.1 t80 -62.35 -49.48 75.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.685 1.194 . . . . 0.0 110.08 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -113.14 31.88 6.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.736 1.214 . . . . 0.0 112.69 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -53.43 -20.96 5.27 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 157.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.75 43.74 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.989 1.757 . . . . 0.0 115.724 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.03 173.92 11.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 112.925 -156.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.1 118.93 33.66 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.39 1.476 . . . . 0.0 111.922 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.3 mt -118.29 135.23 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 128.885 2.874 . . . . 0.0 107.546 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.97 153.27 85.26 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.008 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.16 -13.83 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.662 1 N-CA-C 122.651 4.058 . . . . 0.0 122.651 -160.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -134.22 12.55 3.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.654 1.57 . . . . 0.0 111.906 172.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.87 -12.66 1.25 Allowed Glycine 0 N--CA 1.48 1.589 0 C-N-CA 128.016 2.722 . . . . 0.0 119.315 -150.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.9 mt -95.57 135.3 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 127.214 2.205 . . . . 0.0 109.826 -166.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.5 m -122.98 136.21 54.77 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.558 1.526 . . . . 0.0 113.381 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.38 97.33 40.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 127.64 2.376 . . . . 0.0 111.595 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.43 -86.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.429 2.086 . . . . 0.0 113.643 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.41 177.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 130.407 3.483 . . . . 0.0 107.972 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 6.7 p-10 -74.68 175.12 4.22 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.613 1.965 . . . . 0.0 114.669 171.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.55 -6.86 1.74 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.908 3.739 . . . . 0.0 117.789 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -118.08 -30.79 5.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.113 1.779 . . . . 0.0 111.342 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 111.41 37.5 1.61 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.927 161.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.82 -2.86 4.69 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.918 1.287 . . . . 0.0 113.506 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 121' ' ' GLY 0.302 0.0 OUTLIER -140.68 -100.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.501 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.481 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.4 OUTLIER 164.84 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.918 3.687 . . . . 0.0 108.785 -164.261 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.467 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.16 11.28 10.74 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 128.673 3.035 . . . . 0.0 114.707 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -140.41 158.99 43.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.946 1.698 . . . . 0.0 108.079 155.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.31 -179.86 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.689 1.996 . . . . 0.0 109.267 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 114' ' ' ARG . 97.9 m-85 -151.89 160.49 43.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.143 0.977 . . . . 0.0 110.031 -169.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -160.54 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.461 HE22 ' N ' ' A' ' 111' ' ' GLY . 67.9 tp60 -87.25 138.85 31.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.367 2.267 . . . . 0.0 111.575 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.3 m-85 -109.36 -175.67 2.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.496 1.518 . . . . 0.0 110.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.18 -10.2 59.52 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 119.396 -2.065 . . . . 0.0 113.025 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 m -161.87 158.7 25.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.589 1.156 . . . . 0.0 112.889 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.409 ' CD ' ' HA2' ' A' ' 111' ' ' GLY . 4.9 tp-100 -72.5 0.61 9.89 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.473 1.509 . . . . 0.0 113.696 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.75 -49.24 5.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.352 1.861 . . . . 0.0 111.429 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.3 mt -55.03 -36.57 65.65 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.754 1.222 . . . . 0.0 111.925 167.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.26 67.28 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.95 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -90.97 -27.62 18.56 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.659 1.584 . . . . 0.0 110.663 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -59.83 -36.43 76.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.884 1.273 . . . . 0.0 110.012 165.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.77 65.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.312 1.845 . . . . 0.0 115.685 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -33.27 56.98 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.181 -1.574 . . . . 0.0 112.183 162.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.55 -13.7 8.15 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.832 1.682 . . . . 0.0 115.706 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -59.1 -39.12 81.25 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.4 1.6 . . . . 0.0 113.135 164.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.83 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 130.559 3.543 . . . . 0.0 117.954 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.77 119.84 4.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.364 1.465 . . . . 0.0 110.981 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -151.37 -147.28 0.22 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.321 1.449 . . . . 0.0 110.691 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.1 ttp85 -147.65 148.02 30.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.775 2.83 . . . . 0.0 109.643 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.7 OUTLIER -114.71 -35.97 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.861 1.264 . . . . 0.0 111.585 -170.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -147.32 -117.94 1.02 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.413 1.958 . . . . 0.0 108.788 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -42.58 98.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.974 1.387 . . . . 0.0 111.954 162.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -95.94 -177.77 4.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.235 1.014 . . . . 0.0 113.708 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -133.98 116.94 16.13 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.065 2.146 . . . . 0.0 109.78 -144.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mp -122.84 157.42 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.789 1.757 . . . . 0.0 111.918 -149.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.262 1.1 mm-40 -128.2 159.42 35.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 130.992 3.717 . . . . 0.0 110.186 -164.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.69 142.61 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.28 150.14 35.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.097 2.159 . . . . 0.0 109.921 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -82.02 151.59 27.05 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.234 -0.916 . . . . 0.0 112.51 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 m -158.58 165.44 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.959 -161.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.35 156.48 42.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.749 1.619 . . . . 0.0 111.173 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -40.81 2.94 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 1 C-N-CA 133.873 4.869 . . . . 0.0 120.269 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -126.34 -22.24 4.05 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 119.772 -1.83 . . . . 0.0 112.247 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.48 -2.05 52.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.348 1.459 . . . . 0.0 110.558 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 128.752 2.821 . . . . 0.0 113.15 -160.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.72 44.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 130.223 3.409 . . . . 0.0 113.744 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.22 95.41 0.43 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.824 2.154 . . . . 0.0 110.25 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -105.49 161.62 14.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.72 121.82 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.118 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 36.5 ttt85 -94.4 133.66 37.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.445 1.098 . . . . 0.0 111.381 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.28 152.42 19.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.365 1.866 . . . . 0.0 111.994 167.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 135.33 39.08 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 146.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 166.03 -18.81 0.1 OUTLIER Glycine 0 CA--C 1.531 1.086 0 O-C-N 119.823 -1.798 . . . . 0.0 113.77 152.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.402 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 1.4 mt -55.52 148.6 33.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.284 3.034 . . . . 0.0 115.335 -152.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.72 175.59 11.1 Favored 'Trans proline' 0 C--N 1.344 0.294 1 C-N-CA 126.35 4.7 . . . . 0.0 112.796 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -66.75 135.09 53.46 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.491 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.3 57.89 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-O 117.929 -1.484 . . . . 0.0 114.959 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 118' ' ' LEU . 35.4 t -57.24 151.43 15.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.037 1.918 . . . . 0.0 112.18 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 165.09 28.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 123.177 1.465 . . . . 0.0 112.267 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -44.99 -40.6 6.58 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 127.872 2.469 . . . . 0.0 113.534 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -70.39 -17.88 63.04 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 121.317 1.871 . . . . 0.0 114.027 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.09 -31.99 56.35 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 119.894 -1.754 . . . . 0.0 108.96 168.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.5 mt -68.69 -38.1 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.155 -0.966 . . . . 0.0 111.815 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -63.72 -17.11 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.748 1.219 . . . . 0.0 112.924 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -23.7 15.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.11 1.323 . . . . 0.0 112.129 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.22 -49.38 77.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.047 1.339 . . . . 0.0 109.777 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.86 33.23 5.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.443 1.497 . . . . 0.0 112.698 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 90.9 p -50.17 -22.03 1.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 156.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -49.49 -37.75 26.55 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.085 1.802 . . . . 0.0 115.347 168.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.04 168.01 20.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.428 1.091 . . . . 0.0 113.65 -153.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.62 128.6 36.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.914 1.685 . . . . 0.0 112.019 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 65.1 mt -128.8 134.81 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.659 2.784 . . . . 0.0 107.418 -174.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.2 m -65.19 154.03 88.06 Favored Pre-proline 0 N--CA 1.484 1.226 0 O-C-N 121.81 -0.556 . . . . 0.0 111.544 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.38 -7.33 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.239 3.293 . . . . 0.0 119.814 -169.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -127.35 12.97 7.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.004 1.322 . . . . 0.0 112.209 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.53 72.03 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -152.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.93 132.23 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.832 1.253 . . . . 0.0 109.335 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.8 m -124.08 132.87 53.71 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.806 1.642 . . . . 0.0 112.67 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.95 93.13 48.75 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 127.511 2.324 . . . . 0.0 110.921 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.31 -65.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.235 1.29 . . . . 0.0 113.162 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.71 175.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 129.72 3.208 . . . . 0.0 109.163 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 11.0 p-10 -72.95 171.6 9.93 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 119.818 -1.801 . . . . 0.0 114.316 160.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.18 2.48 0.13 Allowed 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 124.729 3.619 . . . . 0.0 117.151 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -128.62 -1.32 5.48 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.686 1.594 . . . . 0.0 112.008 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.25 36.07 28.29 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -132.42 -16.22 2.74 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.713 1.756 . . . . 0.0 112.792 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -141.97 -112.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.508 -170.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -177.86 80.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.871 3.268 . . . . 0.0 107.433 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.47 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -128.56 5.59 6.64 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 128.151 2.786 . . . . 0.0 115.429 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.17 161.87 36.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.512 1.525 . . . . 0.0 108.365 157.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.43 -179.53 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.924 1.689 . . . . 0.0 109.063 -166.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 191' ' ' VAL . 97.7 m-85 -153.4 158.76 41.95 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.342 0.657 . . . . 0.0 110.25 -167.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -158.54 123.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -92.47 129.92 38.28 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 127.557 2.343 . . . . 0.0 110.99 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.4 m-85 -97.87 -168.5 1.68 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 110.046 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.02 -10.23 59.5 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.024 -1.672 . . . . 0.0 113.733 165.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.9 m -162.65 158.33 23.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -69.99 43.79 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.829 2.452 . . . . 0.0 112.831 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -149.82 -56.53 0.18 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.613 1.965 . . . . 0.0 110.252 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.1 mt -54.2 -41.66 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.418 1.487 . . . . 0.0 111.339 163.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.21 -12.47 61.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -31.06 12.53 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.572 -1.33 . . . . 0.0 109.656 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -63.62 -35.36 80.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.951 1.3 . . . . 0.0 109.537 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.5 73.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.215 1.806 . . . . 0.0 115.544 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.7 mp -52.62 -32.64 42.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.536 -1.353 . . . . 0.0 113.279 164.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.6 -11.87 11.77 Favored Glycine 0 CA--C 1.546 1.984 0 C-N-CA 125.573 1.558 . . . . 0.0 115.631 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -59.21 -38.26 79.48 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.187 1.494 . . . . 0.0 113.474 165.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.79 -60.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 129.527 3.131 . . . . 0.0 116.423 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 105.19 4.55 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.897 2.079 . . . . 0.0 110.754 -174.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -145.58 -163.25 1.68 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.184 1.794 . . . . 0.0 110.335 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.23 44.76 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 128.651 2.781 . . . . 0.0 109.283 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.77 -39.93 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.145 0.578 . . . . 0.0 111.509 -165.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.66 -98.56 0.48 Allowed Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.801 1.667 . . . . 0.0 109.956 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -46.28 14.64 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.799 1.3 . . . . 0.0 112.132 162.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -95.28 -178.1 4.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.919 1.288 . . . . 0.0 114.13 -167.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -132.78 125.68 30.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 110.568 -143.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.06 134.42 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 123.447 1.594 . . . . 0.0 112.553 -147.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.07 157.25 35.09 Favored 'General case' 0 CA--C 1.538 0.489 1 C-N-CA 132.127 4.171 . . . . 0.0 114.251 164.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.86 136.59 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.228 1.011 . . . . 0.0 111.463 168.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -138.91 151.64 47.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.076 2.151 . . . . 0.0 109.139 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -90.52 143.73 26.46 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.493 -0.754 . . . . 0.0 111.72 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -149.95 165.96 31.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.607 -157.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.12 160.26 42.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.107 1.763 . . . . 0.0 110.534 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -40.51 4.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 1 C-N-CA 133.478 4.711 . . . . 0.0 119.021 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.66 -15.18 5.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.769 2.028 . . . . 0.0 114.028 -175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -114.3 -19.96 11.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.511 2.325 . . . . 0.0 110.109 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' HA ' ' CE1' ' A' ' 156' ' ' PHE . 19.2 m . . . . . 0 CA--C 1.518 -0.27 0 C-N-CA 129.883 3.273 . . . . 0.0 114.31 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.49 51.15 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.477 1.132 . . . . 0.0 113.381 -163.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.26 89.6 0.9 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 126.169 1.842 . . . . 0.0 110.985 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 158' ' ' GLN . 5.0 m-85 -95.27 164.58 12.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.76 120.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 76.4 ttt180 -95.39 136.94 35.12 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.583 0.753 . . . . 0.0 111.95 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.67 148.89 26.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.653 2.781 . . . . 0.0 109.775 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -154.11 78.28 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 109.383 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 179.9 -3.81 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 151.43 73.57 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 118.61 1.205 . . . . 0.0 112.117 -161.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.17 174.91 10.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 1 C-N-CA 126.598 4.865 . . . . 0.0 113.715 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.35 127.68 32.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.732 1.213 . . . . 0.0 111.42 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.7 14.84 75.47 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 117.959 -1.467 . . . . 0.0 115.681 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 29.5 t -58.0 152.48 16.33 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.366 2.083 . . . . 0.0 112.543 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.23 164.24 32.9 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 122.847 1.308 . . . . 0.0 111.371 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -45.08 -42.91 9.13 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 127.799 2.44 . . . . 0.0 112.919 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.409 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 37.4 mp0 -68.92 -18.52 64.11 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.669 1.577 . . . . 0.0 113.893 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.65 -25.57 45.01 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.62 -1.925 . . . . 0.0 110.671 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.06 -37.14 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.724 0.81 . . . . 0.0 110.995 165.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.409 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.261 2.2 m -59.92 -20.89 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.266 1.026 . . . . 0.0 113.151 169.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -93.5 -28.59 16.0 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.909 1.231 . . . . 0.0 113.448 168.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.87 -45.81 91.3 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.394 1.477 . . . . 0.0 111.168 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -116.17 33.51 5.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.625 1.17 . . . . 0.0 113.108 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.0 p -53.3 -22.49 7.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.79 -32.49 40.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.297 1.903 . . . . 0.0 115.232 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.73 169.71 17.31 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.18 1.392 . . . . 0.0 112.172 -157.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -99.62 136.26 39.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.372 1.469 . . . . 0.0 112.166 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.4 mt -134.19 139.12 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 128.887 2.875 . . . . 0.0 108.79 -168.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.7 152.13 76.3 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.667 -0.646 . . . . 0.0 110.887 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.85 -24.05 22.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -158.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.09 40.5 2.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.935 1.294 . . . . 0.0 109.872 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.61 16.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.15 1.357 . . . . 0.0 115.674 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.5 mt -93.17 126.44 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 125.27 1.428 . . . . 0.0 109.451 -169.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.5 m -121.92 132.18 54.41 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.039 1.736 . . . . 0.0 112.869 -174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.67 91.35 49.79 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.178 2.191 . . . . 0.0 111.483 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.44 -70.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 121.771 1.647 . . . . 0.0 113.655 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.91 169.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 129.516 3.127 . . . . 0.0 108.809 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.494 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.4 p-10 -70.52 170.74 9.68 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 165.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.6 0.06 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 124.838 3.692 . . . . 0.0 117.13 171.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -129.15 0.38 5.19 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.74 1.616 . . . . 0.0 111.814 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.03 37.82 42.3 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -130.24 -16.72 3.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.161 1.481 . . . . 0.0 112.657 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 152' ' ' THR 0.294 0.0 OUTLIER -143.09 -112.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 113.482 -169.425 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -177.77 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.419 3.087 . . . . 0.0 108.028 -166.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -122.97 5.56 9.62 Favored Glycine 0 N--CA 1.466 0.7 0 C-N-CA 127.84 2.638 . . . . 0.0 114.685 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.36 159.04 42.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.22 0.608 . . . . 0.0 109.982 152.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.18 178.26 3.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.261 1.825 . . . . 0.0 110.751 -165.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 114' ' ' ARG . 92.0 m-85 -149.79 156.26 41.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.918 1.287 . . . . 0.0 109.283 -168.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.3 p -156.13 121.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 31.6 tp60 -90.0 129.8 36.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.544 1.938 . . . . 0.0 109.444 176.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.3 m-85 -86.96 -165.33 1.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.54 -14.6 60.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.965 -1.709 . . . . 0.0 112.307 161.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.7 m -158.66 163.9 36.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -56.78 -33.17 66.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.19 1.396 . . . . 0.0 114.679 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -72.58 -50.18 27.21 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 111.915 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.12 -35.87 69.99 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.069 1.348 . . . . 0.0 111.264 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.51 -17.38 59.3 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.216 0.532 . . . . 0.0 112.262 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -87.09 -32.05 20.14 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.611 -1.305 . . . . 0.0 109.698 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -35.77 81.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.392 1.477 . . . . 0.0 109.711 169.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.47 89.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.167 1.787 . . . . 0.0 115.592 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 mp -50.03 -25.74 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.8 -16.34 30.72 Favored Glycine 0 CA--C 1.547 2.09 0 C-N-CA 124.858 1.218 . . . . 0.0 115.335 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -68.97 -14.51 63.08 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.49 1.645 . . . . 0.0 114.77 167.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 39.96 -48.64 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 132.407 4.283 . . . . 0.0 121.16 170.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 15.79 0.66 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.324 1.85 . . . . 0.0 113.338 -173.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -55.09 174.27 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -110.75 155.68 22.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.652 1.581 . . . . 0.0 114.148 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.96 169.1 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 130.972 3.709 . . . . 0.0 106.558 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 2.49 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.475 1.274 0 C-N-CA 129.774 3.559 . . . . 0.0 116.616 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 -2.86 4.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 171.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -134.38 -179.01 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.406 1.482 . . . . 0.0 114.959 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -144.05 111.16 5.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.426 -126.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.1 mt -115.51 129.01 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.436 1.112 . . . . 0.0 111.898 -139.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 153.24 41.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.553 2.341 . . . . 0.0 113.195 166.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.25 135.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.399 0.68 . . . . 0.0 111.657 167.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -139.25 143.48 38.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.149 1.78 . . . . 0.0 109.386 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -75.35 136.91 40.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.725 0.774 . . . . 0.0 109.91 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 m -141.82 166.46 24.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.727 -164.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -143.5 157.18 44.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.91 0.884 . . . . 0.0 110.616 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -33.84 5.44 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.907 1 C-N-CA 134.945 5.298 . . . . 0.0 120.037 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -126.71 -22.45 3.89 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.09 -1.631 . . . . 0.0 112.851 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.51 -21.91 61.12 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.471 -1.393 . . . . 0.0 109.708 172.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.333 -0.144 0 C-N-CA 126.855 2.062 . . . . 0.0 113.447 -150.265 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.7 p30 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -52.66 41.68 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 1 C-N-CA 133.664 4.786 . . . . 0.0 116.371 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.12 90.17 0.06 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.931 1.253 . . . . 0.0 111.737 162.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' O ' ' HE2' ' A' ' 185' ' ' LYS . 2.7 m-85 -107.5 160.75 15.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.36 116.02 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 73.5 ttt180 -88.39 120.17 29.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.362 1.065 . . . . 0.0 111.382 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.45 151.21 41.18 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.525 1.53 . . . . 0.0 111.648 162.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 139.9 44.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 148.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.5 -20.65 0.82 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.523 -1.361 . . . . 0.0 112.885 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.452 HD23 ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -58.18 142.91 80.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.514 1.926 . . . . 0.0 113.544 -156.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.28 165.7 27.33 Favored 'Trans proline' 0 N--CA 1.458 -0.576 1 C-N-CA 126.231 4.621 . . . . 0.0 112.131 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.54 116.79 4.6 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.317 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.33 59.76 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.615 -1.103 . . . . 0.0 115.549 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.6 t -56.06 148.34 17.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.984 1.892 . . . . 0.0 110.938 165.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -144.32 171.05 14.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.952 0.882 . . . . 0.0 110.076 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -41.31 -40.93 1.79 Allowed 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 127.438 2.295 . . . . 0.0 112.978 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -58.52 -32.67 69.07 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.25 2.22 . . . . 0.0 116.069 173.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -77.01 -23.33 52.2 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 119.958 -1.714 . . . . 0.0 110.157 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.78 -37.33 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.641 -0.662 . . . . 0.0 110.993 166.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -62.15 -17.26 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.126 1.37 . . . . 0.0 113.054 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -98.17 -25.28 14.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.62 1.1 . . . . 0.0 113.937 168.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.81 -45.86 91.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.057 1.343 . . . . 0.0 110.575 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -121.48 33.25 5.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.038 1.335 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -54.24 -19.4 5.19 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.769 -0.582 . . . . 0.0 112.49 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.68 -35.0 44.99 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.588 1.566 . . . . 0.0 115.496 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.34 163.56 31.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -153.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.84 139.25 32.78 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 112.84 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 75.4 mt -144.51 133.37 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.639 2.375 . . . . 0.0 107.24 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.89 153.35 54.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.636 -0.665 . . . . 0.0 111.438 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.69 -23.96 28.2 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 120.842 3.362 . . . . 0.0 120.842 -160.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.48 39.43 2.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.674 1.19 . . . . 0.0 109.95 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.8 -26.45 17.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.89 1.233 . . . . 0.0 114.812 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -84.1 132.44 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.662 1.585 . . . . 0.0 108.883 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 m -126.19 131.57 51.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.263 1.825 . . . . 0.0 112.124 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.2 84.96 61.75 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 126.572 1.949 . . . . 0.0 112.61 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.83 -69.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 121.825 1.684 . . . . 0.0 115.512 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.64 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 127.252 2.221 . . . . 0.0 111.651 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.484 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.0 p-10 -79.06 173.26 8.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.893 2.077 . . . . 0.0 114.845 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.45 -4.31 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 125.074 3.849 . . . . 0.0 117.844 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.42 -32.0 3.94 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 121.35 1.886 . . . . 0.0 111.785 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 109.02 40.26 1.57 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.235 0.922 . . . . 0.0 114.641 165.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.4 -3.13 4.35 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 113.106 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.488 HG23 ' H ' ' A' ' 152' ' ' THR 0.318 0.0 OUTLIER -141.7 -102.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.998 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.488 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 165.98 68.0 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.444 3.498 . . . . 0.0 108.687 -159.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.484 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -114.58 4.02 23.15 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 129.266 3.317 . . . . 0.0 116.226 172.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -127.29 163.5 23.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.234 1.016 . . . . 0.0 109.632 142.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.85 178.36 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.405 2.282 . . . . 0.0 108.154 -168.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.532 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 97.3 m-85 -150.42 160.59 43.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.582 0.753 . . . . 0.0 109.512 -167.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.02 121.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 55.7 tp60 -92.69 123.87 36.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 127.222 2.209 . . . . 0.0 111.386 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 11.3 m-85 -86.99 -173.63 4.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.329 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.98 -8.74 57.94 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.224 -1.548 . . . . 0.0 113.105 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.6 m -160.39 161.29 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.566 1.147 . . . . 0.0 112.944 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -57.4 -31.24 65.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.212 1.405 . . . . 0.0 113.508 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -84.67 -42.78 14.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.523 1.529 . . . . 0.0 113.014 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.4 mt -54.69 -35.47 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.449 1.5 . . . . 0.0 111.411 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.23 -10.05 57.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.07 -13.81 11.2 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.322 -1.486 . . . . 0.0 112.004 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -62.32 -40.31 95.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.702 0.801 . . . . 0.0 109.2 153.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.47 79.03 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -50.58 -27.0 5.95 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.694 1.588 . . . . 0.0 114.287 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.89 -19.82 56.58 Favored Glycine 0 CA--C 1.546 1.991 0 C-N-CA 125.077 1.322 . . . . 0.0 114.798 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.59 41.64 0.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.717 2.007 . . . . 0.0 112.61 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -51.31 -30.48 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.697 2.399 . . . . 0.0 114.888 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -147.58 107.3 3.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.264 1.026 . . . . 0.0 111.051 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -137.64 -161.21 1.14 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.654 1.582 . . . . 0.0 109.927 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -140.75 148.04 40.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.065 1.346 . . . . 0.0 111.718 -155.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.01 132.72 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.319 2.248 . . . . 0.0 108.132 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 59.54 -67.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.419 0 C-N-CA 127.605 2.526 . . . . 0.0 115.831 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.8 -9.85 0.21 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.714 2.406 . . . . 0.0 113.566 169.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -108.53 -175.03 2.66 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 127.139 2.176 . . . . 0.0 112.765 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -149.63 116.74 6.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -135.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.452 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.8 mt -127.03 135.8 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 122.776 1.274 . . . . 0.0 111.771 -139.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.8 159.27 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 130.955 3.702 . . . . 0.0 114.348 169.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.04 137.44 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.923 1.289 . . . . 0.0 111.005 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -138.42 146.88 42.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.205 1.802 . . . . 0.0 109.806 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -70.82 142.84 51.27 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.782 1.233 . . . . 0.0 110.884 177.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.429 ' H ' ' HE2' ' A' ' 185' ' ' LYS . 3.3 m -153.79 161.88 41.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.357 -164.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.5 m -146.2 157.38 43.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.084 1.354 . . . . 0.0 111.148 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.4 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.3 tp60 -40.93 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.129 4.572 . . . . 0.0 119.674 -175.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 -16.0 3.91 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.976 -1.702 . . . . 0.0 114.369 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.44 -29.14 18.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.767 1.627 . . . . 0.0 108.915 173.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.532 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 35.7 m . . . . . 0 C--N 1.333 -0.133 0 C-N-CA 129.111 2.965 . . . . 0.0 115.42 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 119.928 -0.082 . . . . 10.0 110.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 m 42.59 -20.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 1 C-N-CA 132.951 4.501 . . . . 10.0 120.346 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.2 -30.09 0.06 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.44 2.296 . . . . 10.0 112.382 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.35 136.88 20.19 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.144 1.164 . . . . 10.0 114.144 -172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.9 p -147.25 -47.47 0.17 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 140.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -175.21 -41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.32 1.848 . . . . 10.0 113.212 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -124.54 -32.31 3.14 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.385 1.624 . . . . 10.0 115.385 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.83 36.13 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.563 3.145 . . . . 10.0 114.934 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.39 101.36 0.32 Allowed Glycine 0 C--O 1.228 -0.229 0 CA-C-O 117.797 -1.557 . . . . 10.0 111.75 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -111.03 167.59 10.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.859 -1.904 . . . . 10.0 105.859 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.06 153.29 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.247 -1.797 . . . . 10.0 107.964 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 52.3 ttt180 -120.65 136.49 54.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.0 1.32 . . . . 10.0 111.959 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.88 147.19 29.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.409 3.084 . . . . 10.0 109.976 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -152.66 77.22 1.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.599 1.16 . . . . 10.0 109.936 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.07 9.4 0.02 OUTLIER Glycine 0 CA--C 1.532 1.125 0 N-CA-C 116.176 1.23 . . . . 10.0 116.176 -164.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.44 155.41 74.04 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.797 1.239 . . . . 10.0 111.313 -166.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -84.08 175.75 7.26 Favored 'Trans proline' 0 CA--C 1.532 0.384 1 C-N-CA 126.72 4.947 . . . . 10.0 112.489 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -63.98 135.17 56.24 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.421 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.58 15.1 70.47 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 118.247 -1.307 . . . . 10.0 115.585 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.34 147.43 31.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.053 1.927 . . . . 10.0 112.78 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 171.86 16.68 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.028 0.918 . . . . 10.0 112.146 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -38.44 -53.6 1.53 Allowed 'General case' 0 C--O 1.205 -1.237 0 CA-C-O 116.477 -1.725 . . . . 10.0 113.54 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.48 -19.76 63.89 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 121.585 1.993 . . . . 10.0 113.7 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -79.98 -29.39 39.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.16 -1.587 . . . . 10.0 110.767 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -73.12 -43.48 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.373 1.069 . . . . 10.0 111.17 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.64 -21.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.31 1.844 . . . . 10.0 113.303 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -96.39 -26.33 15.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.887 1.676 . . . . 10.0 112.37 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -58.81 -51.94 67.86 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.59 1.556 . . . . 10.0 109.864 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -112.75 30.98 6.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.305 1.042 . . . . 10.0 112.841 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.5 p -53.23 -21.86 5.95 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.173 0.805 . . . . 10.0 113.173 156.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.3 -31.91 43.31 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.073 1.796 . . . . 10.0 115.208 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.28 166.21 24.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.116 1.366 . . . . 10.0 112.875 -157.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.32 134.77 34.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.147 1.379 . . . . 10.0 111.649 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 71.2 mt -137.27 140.62 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 128.371 2.668 . . . . 10.0 106.978 -170.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.15 156.08 61.25 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.535 -0.728 . . . . 10.0 111.432 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.22 -19.24 16.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 120.957 3.407 . . . . 10.0 120.957 -162.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.8 35.48 2.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.633 1.106 . . . . 10.0 110.657 166.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.12 45.3 0.58 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 126.692 2.091 . . . . 10.0 114.228 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.3 mt -143.58 136.13 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 119.964 1.882 . . . . 10.0 106.012 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -132.52 131.54 41.71 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.24 1.836 . . . . 10.0 112.569 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.94 84.06 59.23 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 127.263 2.225 . . . . 10.0 110.868 -171.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.69 -65.18 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 121.081 1.188 . . . . 10.0 113.237 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.84 169.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 128.328 2.651 . . . . 10.0 110.149 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.491 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.1 p-10 -68.5 173.3 3.51 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.533 . . . . 10.0 114.778 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.37 -1.98 0.54 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.754 3.636 . . . . 10.0 117.624 172.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.72 -31.89 3.14 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.537 1.971 . . . . 10.0 112.28 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.04 37.66 1.22 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.88 -0.955 . . . . 10.0 115.445 163.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.34 -2.95 2.44 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.997 1.398 . . . . 10.0 113.808 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG21 ' H ' ' A' ' 152' ' ' THR 0.285 0.0 OUTLIER -143.7 -118.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.782 1.233 . . . . 10.0 113.496 -178.373 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.461 ' H ' HG21 ' A' ' 151' ' ' ILE . 1.1 p -172.76 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.365 3.466 . . . . 10.0 107.051 -167.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.491 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.29 6.46 11.83 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 126.98 2.228 . . . . 10.0 114.751 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -132.08 156.55 46.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.016 0.912 . . . . 10.0 110.376 148.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.19 175.45 8.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 126.088 1.755 . . . . 10.0 110.423 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.553 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 86.1 m-85 -149.09 164.64 34.07 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.524 -169.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -159.41 119.52 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 114.381 1.252 . . . . 10.0 114.381 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -90.38 123.55 34.21 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 129.477 3.111 . . . . 10.0 111.055 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.2 m-85 -89.1 -165.45 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 123.143 0.577 . . . . 10.0 110.248 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.65 -10.3 59.74 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.88 -1.763 . . . . 10.0 113.632 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.4 m -158.48 160.95 37.31 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -58.63 -28.12 65.36 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -80.08 -48.15 13.71 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.782 1.233 . . . . 10.0 112.214 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.62 -37.7 63.32 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.349 1.46 . . . . 10.0 111.334 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.91 -8.87 57.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -112.99 -15.3 12.88 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.918 -1.739 . . . . 10.0 112.893 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -60.01 -37.46 79.8 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 156.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.82 -46.34 72.15 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.549 2.055 . . . . 10.0 116.549 172.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mp -48.0 -35.07 10.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 120.527 1.512 . . . . 10.0 113.189 162.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.41 -15.16 30.44 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 125.622 1.582 . . . . 10.0 115.85 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -64.6 -26.33 68.35 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.56 1.68 . . . . 10.0 114.65 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.3 t60 60.58 -47.58 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.922 2.889 . . . . 10.0 117.328 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -145.1 -66.76 0.32 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.64 1.576 . . . . 10.0 112.611 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 36.82 -142.3 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.575 1.55 . . . . 10.0 113.186 -167.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -151.25 155.51 38.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.864 . . . . 10.0 110.199 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.93 135.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.151 2.58 . . . . 10.0 105.447 162.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 49.02 -86.95 0.01 OUTLIER Glycine 0 N--CA 1.474 1.167 0 C-N-CA 126.801 2.144 . . . . 10.0 114.178 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 5.04 3.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.632 1.573 . . . . 10.0 114.449 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.51 -179.53 5.21 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.25 1.82 . . . . 10.0 114.259 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -146.84 14.13 1.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.604 -1.18 . . . . 10.0 113.01 -124.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.3 mt 42.96 107.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 116.983 2.216 . . . . 10.0 116.983 134.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 165.06 23.17 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 127.506 2.323 . . . . 10.0 113.649 160.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.6 140.34 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.664 0.786 . . . . 10.0 112.294 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -144.44 153.25 41.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.432 1.893 . . . . 10.0 110.507 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -74.31 154.62 38.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.809 0.844 . . . . 10.0 111.837 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.3 m -159.02 167.97 27.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.021 0.748 . . . . 10.0 113.021 -165.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.9 m -149.42 161.89 41.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.464 1.906 . . . . 10.0 109.64 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -31.62 -10.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 1 C-N-CA 132.467 4.307 . . . . 10.0 120.595 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.3 -6.32 3.8 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.232 -2.168 . . . . 10.0 112.066 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -23.05 39.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 149.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.553 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 9.5 m -91.55 -35.65 7.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 115.443 1.646 . . . . 10.0 115.443 -164.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.342 0.0 OUTLIER -82.89 53.39 2.4 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.093 1.146 . . . . 10.0 114.093 -165.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.3 m -58.87 -13.52 6.49 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.171 0.989 . . . . 10.0 113.148 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.359 0 C-N-CA 128.856 2.862 . . . . 10.0 107.95 165.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 189' ' ' GLU . 8.5 t-20 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.2 p 58.45 -29.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 130.907 3.683 . . . . 0.0 120.311 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.08 50.35 0.65 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.555 1.542 . . . . 0.0 111.308 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.82 171.99 4.78 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 m -155.24 70.53 0.75 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.179 1.792 . . . . 0.0 111.872 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.46 -44.45 0.17 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -171.73 -46.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.73 1.612 . . . . 0.0 110.981 -166.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.08 45.22 0.09 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.591 3.156 . . . . 0.0 113.556 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.86 102.12 1.63 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.48 160.57 14.19 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.5 118.33 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.273 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -104.11 125.8 50.72 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 -164.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.37 151.59 23.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.467 2.307 . . . . 0.0 110.494 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -155.58 79.55 1.02 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.682 1.593 . . . . 0.0 108.582 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.39 -11.96 0.02 OUTLIER Glycine 0 CA--C 1.536 1.401 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -162.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.462 ' CD2' ' HG ' ' A' ' 122' ' ' CYS . 3.5 mt -73.36 152.69 90.07 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.608 1.163 . . . . 0.0 113.423 -155.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.02 171.35 17.32 Favored 'Trans proline' 0 CA--C 1.531 0.352 1 C-N-CA 126.753 4.969 . . . . 0.0 112.653 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -57.37 133.9 55.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.068 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.2 19.24 68.03 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 118.775 -1.014 . . . . 0.0 115.169 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.462 ' HG ' ' CD2' ' A' ' 118' ' ' LEU . 33.8 t -55.44 146.69 19.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.273 1.536 . . . . 0.0 111.722 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.0 t -150.7 163.5 38.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 112.164 -173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -39.2 -44.38 1.21 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 126.738 2.015 . . . . 0.0 115.684 173.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -69.84 -19.91 63.44 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.089 1.356 . . . . 0.0 112.957 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -78.12 -32.12 50.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.284 -1.51 . . . . 0.0 109.597 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.2 mt -69.59 -39.85 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 120.708 -1.245 . . . . 0.0 110.782 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.269 1.2 m -61.59 -13.46 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.613 1.565 . . . . 0.0 114.512 168.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -101.86 -21.19 14.62 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 121.031 1.741 . . . . 0.0 113.728 166.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -49.2 75.04 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.614 1.566 . . . . 0.0 110.732 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -118.84 31.49 6.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.224 1.41 . . . . 0.0 112.069 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 84.2 p -46.59 -25.7 0.75 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 153.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.22 70.52 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.65 2.071 . . . . 0.0 116.246 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.06 159.73 41.03 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.647 1.224 . . . . 0.0 113.14 -154.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.55 127.68 34.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.997 1.319 . . . . 0.0 112.04 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 46.8 mt -129.49 139.18 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 128.358 2.663 . . . . 0.0 108.494 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.01 151.3 80.88 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.309 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -52.83 -24.87 25.27 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 120.671 3.296 . . . . 0.0 120.671 -158.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.39 42.45 2.36 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.792 1.237 . . . . 0.0 110.078 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.74 -23.68 30.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.909 1.243 . . . . 0.0 114.967 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.12 144.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 125.629 1.572 . . . . 0.0 109.481 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 77.6 m -140.28 136.29 33.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.056 -1.653 . . . . 0.0 113.52 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.74 89.88 51.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.101 2.56 . . . . 0.0 111.129 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.07 -72.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.017 1.812 . . . . 0.0 113.728 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.07 167.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 127.034 2.134 . . . . 0.0 111.183 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.494 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.3 p-10 -70.22 173.38 4.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.087 1.755 . . . . 0.0 114.875 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.46 -3.28 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.691 3.594 . . . . 0.0 117.886 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.08 -36.68 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.814 2.097 . . . . 0.0 111.881 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.04 42.13 0.67 Allowed Glycine 0 CA--C 1.532 1.117 0 N-CA-C 115.27 0.868 . . . . 0.0 115.27 163.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.0 -2.81 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.742 1.217 . . . . 0.0 113.631 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -143.47 -117.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.063 1.345 . . . . 0.0 113.47 -178.401 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -175.7 76.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 130.72 3.608 . . . . 0.0 106.08 -169.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -117.67 3.6 17.47 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 127.971 2.7 . . . . 0.0 115.646 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.03 157.84 41.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 122.307 1.051 . . . . 0.0 109.753 148.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.44 177.69 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.527 2.331 . . . . 0.0 108.188 -171.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -152.38 159.52 43.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 122.624 0.369 . . . . 0.0 110.871 -163.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.43 129.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -104.23 138.53 40.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.382 2.273 . . . . 0.0 110.13 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 2.9 m-85 -106.02 -175.87 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.92 57.09 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.048 -1.658 . . . . 0.0 113.267 168.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.8 m -161.24 161.68 30.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.311 1.045 . . . . 0.0 112.444 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -62.57 -21.6 65.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.028 0.931 . . . . 0.0 113.122 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.5 -47.7 10.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.533 2.733 . . . . 0.0 112.776 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.37 -35.68 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.9 1.28 . . . . 0.0 111.139 168.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.05 -13.55 62.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.508 172.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -94.75 -29.57 14.7 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.147 -1.596 . . . . 0.0 110.644 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -61.24 -38.86 88.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.062 1.745 . . . . 0.0 109.844 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.25 -45.76 83.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.086 2.155 . . . . 0.0 116.02 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.59 -28.24 13.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 113.768 165.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.74 -19.52 55.28 Favored Glycine 0 CA--C 1.546 2.012 0 C-N-CA 125.344 1.45 . . . . 0.0 115.418 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -72.43 35.7 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.77 2.028 . . . . 0.0 113.402 164.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -50.16 -31.05 12.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -154.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 27.75 3.47 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.284 1.433 . . . . 0.0 113.371 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -66.96 -170.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -138.11 148.7 45.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.354 1.862 . . . . 0.0 111.361 -153.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.71 128.12 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 128.824 2.849 . . . . 0.0 106.41 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.88 -126.19 34.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -98.47 8.43 44.89 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.6 -179.94 4.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -153.03 111.69 3.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -119.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.7 mt -126.43 136.77 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 122.876 1.322 . . . . 0.0 112.6 -139.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 155.08 40.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.689 3.196 . . . . 0.0 113.287 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.67 132.47 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.749 0.82 . . . . 0.0 111.664 166.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.28 151.0 44.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.391 1.876 . . . . 0.0 110.328 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -74.25 143.95 44.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.206 1.003 . . . . 0.0 111.578 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.19 170.76 18.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.911 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.7 m -143.16 154.08 43.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.192 1.397 . . . . 0.0 110.018 172.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -29.33 4.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.139 1 C-N-CA 135.643 5.577 . . . . 0.0 120.305 174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 103' ' ' ASN . 13.2 mt-10 -137.51 -24.58 1.05 Allowed 'General case' 0 C--N 1.322 -0.619 0 O-C-N 119.861 -1.774 . . . . 0.0 112.448 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.36 -21.87 28.68 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 161.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 32.4 m -77.76 -32.95 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 113.215 -165.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -87.11 36.62 0.74 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.231 1.812 . . . . 0.0 112.35 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.6 30.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 128.447 2.699 . . . . 0.0 117.894 -148.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 130.113 3.365 . . . . 0.0 113.159 -168.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.0 p -67.07 -165.15 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 131.002 3.721 . . . . 0.0 114.293 -3.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.31 -33.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.415 3.086 . . . . 0.0 116.087 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.97 144.8 50.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 0.0 108.382 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -146.39 -53.52 0.25 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.34 -72.82 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.817 1.247 . . . . 0.0 112.647 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.32 -18.62 2.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 37.87 0.52 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.269 3.028 . . . . 0.0 112.774 -163.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.67 108.88 2.64 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -97.02 166.68 11.48 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 164.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.31 110.67 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.315 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -87.28 121.11 29.29 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.543 0.737 . . . . 0.0 111.585 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.07 151.41 28.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.735 2.014 . . . . 0.0 110.598 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.67 89.86 1.59 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.107 1.363 . . . . 0.0 108.784 168.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.14 -24.75 0.02 OUTLIER Glycine 0 N--CA 1.468 0.781 0 C-N-CA 117.797 -2.144 . . . . 0.0 114.313 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.75 144.39 25.78 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.879 2.472 . . . . 0.0 114.864 -157.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.38 172.52 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.503 1 C-N-CA 126.783 4.988 . . . . 0.0 112.938 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -48.31 123.15 6.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.455 1.502 . . . . 0.0 111.786 165.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.82 19.08 76.15 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.79 154.68 3.72 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.341 1.57 . . . . 0.0 112.489 166.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.7 t -150.2 162.63 40.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.587 0.755 . . . . 0.0 112.59 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -35.54 -47.11 0.44 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 126.845 2.058 . . . . 0.0 114.487 166.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.29 -18.74 64.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 120.737 1.608 . . . . 0.0 113.686 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.94 -30.51 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.287 -1.508 . . . . 0.0 110.646 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mt -68.17 -42.59 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.855 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -62.27 -14.69 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 113.92 170.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -25.77 14.9 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.581 1.537 . . . . 0.0 113.885 164.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -46.51 83.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 109.732 173.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -121.77 33.97 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.202 1.401 . . . . 0.0 113.686 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 t -53.78 -21.57 7.66 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.511 0.672 . . . . 0.0 112.094 157.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.34 -30.04 60.99 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.061 1.791 . . . . 0.0 115.821 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.05 167.45 22.03 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.455 1.128 . . . . 0.0 113.016 -156.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.65 131.52 40.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 111.931 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.2 mt -128.82 137.83 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 128.277 2.631 . . . . 0.0 108.49 -171.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 m -65.7 154.4 88.72 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.732 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.21 -13.37 6.88 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.398 3.399 . . . . 0.0 119.85 -167.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -135.67 26.12 3.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.85 1.66 . . . . 0.0 111.438 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.03 67.07 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 -169.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.65 137.31 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.678 1.191 . . . . 0.0 108.91 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.0 m -131.68 138.4 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.042 1.737 . . . . 0.0 111.814 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.15 92.27 49.19 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 127.017 2.127 . . . . 0.0 110.873 -172.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.8 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.762 3.641 . . . . 0.0 113.14 -173.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.68 173.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 130.123 3.369 . . . . 0.0 108.851 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.1 p-10 -77.91 172.78 8.9 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.851 2.061 . . . . 0.0 114.087 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.08 0.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 125.031 3.821 . . . . 0.0 117.499 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -126.5 -0.19 6.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.749 1.62 . . . . 0.0 111.938 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 35.46 48.2 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.514 -1.159 . . . . 0.0 115.961 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -130.05 -15.79 3.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.594 1.697 . . . . 0.0 112.635 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.326 0.0 OUTLIER -138.43 -98.4 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -170.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 164.33 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 129.917 3.287 . . . . 0.0 109.245 -165.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -124.8 4.47 8.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.71 3.528 . . . . 0.0 114.405 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -130.12 166.68 19.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.409 1.084 . . . . 0.0 108.866 145.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.85 175.83 4.35 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 128.046 2.539 . . . . 0.0 109.049 -171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 191' ' ' VAL . 97.5 m-85 -150.27 154.74 38.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.062 0.545 . . . . 0.0 110.713 -166.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.43 127.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -97.26 139.61 32.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.344 2.258 . . . . 0.0 111.403 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.1 m-85 -106.73 -177.4 3.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.387 0.675 . . . . 0.0 110.697 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.63 -10.22 59.54 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.143 -1.598 . . . . 0.0 112.946 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.1 m -159.86 157.33 28.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.237 1.015 . . . . 0.0 112.033 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -72.86 -13.87 61.37 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.651 -0.656 . . . . 0.0 112.446 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 41.6 tp10 -75.07 -51.5 13.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.784 2.434 . . . . 0.0 112.394 169.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.4 mt -57.14 -38.16 73.1 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.996 0.918 . . . . 0.0 110.447 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.23 62.16 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -104.33 -27.1 12.18 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.374 -1.454 . . . . 0.0 110.629 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER -61.81 -32.13 72.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.164 0.985 . . . . 0.0 109.072 165.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.9 61.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mp -49.39 -33.51 13.95 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.031 1.287 . . . . 0.0 112.918 162.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.86 -16.61 32.26 Favored Glycine 0 CA--C 1.545 1.929 0 C-N-CA 125.823 1.678 . . . . 0.0 115.581 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -62.37 -33.48 74.82 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.642 1.721 . . . . 0.0 113.392 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 45.69 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 1 C-N-CA 132.418 4.287 . . . . 0.0 119.109 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 90.6 2.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.652 2.381 . . . . 0.0 109.726 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -130.55 -160.84 1.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.71 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -143.04 149.88 38.83 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 120.873 -1.142 . . . . 0.0 112.816 -156.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.0 mt -140.06 133.09 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 128.306 2.643 . . . . 0.0 106.885 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 48.81 -136.31 19.26 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.229 1.871 . . . . 0.0 111.848 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.03 -8.21 54.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -179.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.686 1.194 . . . . 0.0 113.988 -160.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -137.87 118.39 13.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.503 -149.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.14 135.82 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.923 1.344 . . . . 0.0 110.952 -148.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 164.13 23.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.05 3.34 . . . . 0.0 115.449 169.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.02 132.14 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.808 1.243 . . . . 0.0 111.298 166.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.95 148.6 43.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.826 1.65 . . . . 0.0 110.966 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -71.33 135.09 47.18 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 111.122 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 m -146.87 167.56 23.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.044 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.4 m -154.32 156.12 36.37 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 0.0 112.375 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -32.86 2.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 1 C-N-CA 134.545 5.138 . . . . 0.0 121.151 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -130.4 -24.44 2.53 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.626 -1.921 . . . . 0.0 112.729 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -81.76 -7.18 59.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.01 1.324 . . . . 0.0 109.832 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.486 ' HA ' ' CE1' ' A' ' 156' ' ' PHE . 16.5 m -103.11 -22.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 128.566 2.746 . . . . 0.0 113.792 -171.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.7 mtm105 -78.31 70.99 4.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.543 1.537 . . . . 0.0 110.064 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 7.9 t -62.33 -17.31 58.5 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.827 -0.546 . . . . 0.0 111.942 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.281 0 C-N-CA 127.393 2.277 . . . . 0.0 114.656 -172.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.1 m -48.87 102.64 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -152.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.63 19.44 0.82 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.669 2.388 . . . . 0.0 112.833 -5.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -142.52 83.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.495 1.118 . . . . 0.0 113.825 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.0 t -165.68 106.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.009 1.724 . . . . 0.0 110.018 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.46 -9.85 0.73 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 130.292 3.437 . . . . 0.0 113.289 -6.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.51 24.35 2.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.162 2.185 . . . . 0.0 109.835 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.0 42.08 2.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.028 1.731 . . . . 0.0 109.616 -155.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.21 113.19 3.59 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.452 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -106.41 162.48 13.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 172.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.31 119.5 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.924 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -96.27 120.96 37.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.142 1.377 . . . . 0.0 110.449 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.49 146.08 47.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.12 158.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -139.01 140.33 38.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 141.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.27 1.36 0.39 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.644 0.618 . . . . 0.0 114.644 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 64.8 mt -69.01 152.11 96.95 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.184 1.394 . . . . 0.0 113.33 -153.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.53 167.85 25.69 Favored 'Trans proline' 0 C--O 1.235 0.327 1 C-N-CA 125.722 4.281 . . . . 0.0 112.039 172.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -68.41 128.73 37.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.962 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.47 25.68 74.8 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.034 -0.87 . . . . 0.0 114.47 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -53.09 150.28 5.93 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.549 1.175 . . . . 0.0 113.417 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 t -147.29 160.32 42.64 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 120.787 -1.195 . . . . 0.0 113.434 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -39.11 -47.33 1.54 Allowed 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 126.663 1.985 . . . . 0.0 114.993 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -65.97 -19.64 65.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.589 1.541 . . . . 0.0 112.794 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -81.93 -29.45 32.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.4 -1.438 . . . . 0.0 109.744 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 mt -70.11 -41.99 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.202 -0.936 . . . . 0.0 111.325 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.11 -12.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.173 1.789 . . . . 0.0 114.162 170.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.56 -21.97 15.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.981 1.264 . . . . 0.0 114.4 164.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -48.91 78.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 169.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.18 34.75 5.1 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.16 1.384 . . . . 0.0 112.694 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.33 -23.42 2.32 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 156.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.04 -31.03 67.78 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.142 1.83 . . . . 0.0 115.988 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.35 161.39 37.07 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.297 1.049 . . . . 0.0 113.603 -154.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.44 143.37 30.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.162 1.385 . . . . 0.0 112.986 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 74.5 mt -146.09 135.46 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.519 2.328 . . . . 0.0 107.587 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -60.4 154.6 53.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 111.506 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.97 -1.75 8.37 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.288 1.992 . . . . 0.0 116.672 -163.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -133.4 17.34 4.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.266 1.826 . . . . 0.0 111.439 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.2 -29.39 72.8 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 121.355 -0.841 . . . . 0.0 114.531 -165.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.6 mt -85.95 129.37 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.761 1.624 . . . . 0.0 108.671 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.0 m -121.05 131.18 54.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.267 1.827 . . . . 0.0 111.458 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.24 92.24 47.01 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 127.152 2.181 . . . . 0.0 110.106 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.86 -86.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.352 2.701 . . . . 0.0 112.442 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.8 172.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 128.141 2.577 . . . . 0.0 110.941 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.77 174.53 5.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.747 2.019 . . . . 0.0 113.027 167.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.07 -6.4 1.28 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.868 3.712 . . . . 0.0 117.52 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -115.28 -14.16 11.69 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.685 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.04 12.45 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.35 -1.25 . . . . 0.0 115.124 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -125.13 -16.77 5.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.719 1.759 . . . . 0.0 112.261 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.314 0.0 OUTLIER -140.74 -100.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 166.16 83.89 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 130.511 3.524 . . . . 0.0 107.909 -165.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -113.03 -16.34 8.52 Favored Glycine 0 N--CA 1.47 0.959 1 C-N-CA 130.863 4.078 . . . . 0.0 113.585 176.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.68 163.95 25.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.726 1.61 . . . . 0.0 110.133 159.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.73 172.99 9.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.233 3.013 . . . . 0.0 107.213 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 90.3 m-85 -149.22 162.7 39.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 -167.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.45 120.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -90.71 126.15 35.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.856 2.063 . . . . 0.0 108.779 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.0 m-85 -84.43 -167.82 1.93 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.425 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.85 -11.29 59.8 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.018 -1.676 . . . . 0.0 112.407 166.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.0 m -161.17 165.14 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.837 1.255 . . . . 0.0 112.856 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -61.06 -31.33 70.99 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.425 1.49 . . . . 0.0 113.077 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -75.22 -48.05 25.29 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.975 2.11 . . . . 0.0 112.914 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 67.5 mt -57.54 -37.31 72.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.931 1.293 . . . . 0.0 110.697 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.2 -18.51 63.92 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -92.1 -32.89 14.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.636 1.574 . . . . 0.0 109.979 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -36.1 82.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.435 1.494 . . . . 0.0 109.322 172.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' HB3' ' CE2' ' A' ' 159' ' ' PHE . . . -66.09 -43.16 88.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.545 1.938 . . . . 0.0 115.019 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.94 -19.73 32.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.12 -20.78 29.33 Favored Glycine 0 CA--C 1.548 2.118 0 C-N-CA 124.779 1.18 . . . . 0.0 114.579 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -71.09 43.84 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.099 2.16 . . . . 0.0 112.129 158.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -40.05 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.086 1.754 . . . . 0.0 113.937 -163.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -130.95 124.73 31.68 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.76 1.624 . . . . 0.0 107.525 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.0 -166.19 2.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.013 0.925 . . . . 0.0 110.959 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -129.27 149.3 51.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.265 1.426 . . . . 0.0 112.184 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.69 120.27 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 129.015 2.926 . . . . 0.0 106.716 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 60.04 -123.39 32.94 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -90.14 -9.86 46.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -175.07 2.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.997 1.319 . . . . 0.0 113.357 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -154.1 115.71 4.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -126.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.51 142.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.309 1.052 . . . . 0.0 112.094 -141.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.335 5.1 tp10 -89.04 163.88 15.31 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 129.465 3.106 . . . . 0.0 112.914 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 m -138.32 143.94 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.441 -0.787 . . . . 0.0 112.811 166.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.46 149.67 41.27 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.29 1.836 . . . . 0.0 110.605 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -68.32 152.78 44.95 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.615 0.766 . . . . 0.0 111.681 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.49 170.55 22.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.627 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.24 160.53 43.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.801 1.64 . . . . 0.0 111.275 166.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 tp-100 -42.68 5.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 131.722 4.009 . . . . 0.0 120.168 178.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.55 -17.84 3.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.441 -2.037 . . . . 0.0 114.707 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.56 -26.65 32.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.599 1.56 . . . . 0.0 108.691 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.607 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 17.5 m -80.35 -11.85 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.056 2.542 . . . . 0.0 116.327 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -75.87 52.55 0.7 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.698 2.399 . . . . 0.0 113.735 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 49.6 m -68.68 -1.28 6.58 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.082 153.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 8.4 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 130.84 3.656 . . . . 0.0 111.775 172.023 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.23 158.22 43.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -154.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -120.23 8.84 10.94 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.869 2.067 . . . . 0.0 112.111 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.35 165.71 7.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.116 1.766 . . . . 0.0 112.377 166.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.0 m -146.92 128.66 15.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.988 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.65 -54.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.704 1.202 . . . . 0.0 111.679 166.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.99 -41.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.19 53.61 0.65 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.698 1.999 . . . . 0.0 114.246 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.03 97.86 0.46 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.686 1.136 . . . . 0.0 110.913 161.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE2' HG23 ' A' ' 191' ' ' VAL . 11.2 m-85 -108.15 163.82 12.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.76 150.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.661 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.409 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 39.3 ttt85 -121.14 143.72 48.95 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.058 1.343 . . . . 0.0 112.329 173.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.54 153.16 27.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.391 2.676 . . . . 0.0 111.124 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.22 71.47 0.51 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.052 1.741 . . . . 0.0 110.176 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.46 0.0 0.03 OUTLIER Glycine 0 N--CA 1.475 1.261 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -165.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 153.33 81.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 0.0 111.824 -165.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.84 171.85 11.5 Favored 'Trans proline' 0 CA--C 1.532 0.382 1 C-N-CA 126.704 4.936 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.37 123.02 16.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.933 0.893 . . . . 0.0 112.438 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.29 12.77 78.16 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.342 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 31.3 t -58.51 151.9 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.958 1.879 . . . . 0.0 112.712 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.3 t -148.06 165.12 31.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.655 0.782 . . . . 0.0 111.763 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -42.09 -49.84 4.76 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.315 2.246 . . . . 0.0 112.417 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 mp0 -63.1 -14.19 45.49 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -85.92 -26.79 25.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.731 -1.856 . . . . 0.0 109.938 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.24 -39.72 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.956 -0.465 . . . . 0.0 112.075 160.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.418 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.287 1.3 m -57.46 -18.52 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -97.7 -26.17 14.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.286 1.403 . . . . 0.0 114.124 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -62.67 -41.46 99.1 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.832 1.253 . . . . 0.0 111.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -121.89 33.77 5.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.484 1.114 . . . . 0.0 113.067 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -21.63 8.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.63 -0.668 . . . . 0.0 112.607 157.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.65 -33.44 41.65 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.93 1.729 . . . . 0.0 114.965 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.0 167.46 21.19 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.554 1.542 . . . . 0.0 112.067 -158.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.43 140.14 29.77 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.866 -1.146 . . . . 0.0 111.739 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 45.1 mt -135.48 136.57 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.531 2.732 . . . . 0.0 107.831 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.07 152.08 84.82 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 118.958 -0.544 . . . . 0.0 111.408 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.77 -14.66 11.1 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.947 3.098 . . . . 0.0 119.967 -165.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -128.54 19.94 6.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.145 1.378 . . . . 0.0 111.759 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.55 -27.42 61.09 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.961 1.144 . . . . 0.0 115.961 -163.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -92.05 137.63 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 125.955 1.702 . . . . 0.0 109.738 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.4 m -132.49 137.65 47.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.416 1.462 . . . . 0.0 113.465 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.29 90.06 50.87 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 127.192 2.197 . . . . 0.0 112.149 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.09 -63.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.103 1.202 . . . . 0.0 114.203 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.43 179.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 129.994 3.318 . . . . 0.0 108.081 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.46 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.3 p-10 -74.51 170.68 13.98 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 119.64 -1.913 . . . . 0.0 113.686 156.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.82 -0.61 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.727 3.618 . . . . 0.0 116.873 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -130.18 0.92 4.67 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.594 1.558 . . . . 0.0 111.556 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.01 39.4 23.98 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.119 1.207 . . . . 0.0 116.119 163.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -122.92 -25.55 4.57 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.496 1.518 . . . . 0.0 111.422 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.274 0.0 OUTLIER -149.05 -111.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.417 -1.277 . . . . 0.0 113.231 -157.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 p -179.0 78.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 129.75 3.22 . . . . 0.0 108.576 -166.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.46 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -130.65 7.55 5.86 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 127.901 2.667 . . . . 0.0 114.384 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -136.44 160.41 38.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.123 1.369 . . . . 0.0 109.244 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -171.04 176.78 3.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.735 1.614 . . . . 0.0 110.549 -169.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 114' ' ' ARG . 97.1 m-85 -148.37 159.58 43.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.408 1.083 . . . . 0.0 110.418 -171.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -163.48 124.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -94.14 132.48 38.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.042 2.137 . . . . 0.0 110.844 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.2 m-85 -92.73 -172.77 3.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.662 0.385 . . . . 0.0 110.701 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.35 -12.34 60.24 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.215 -1.553 . . . . 0.0 113.033 168.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.7 m -159.39 162.35 35.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.421 1.088 . . . . 0.0 113.202 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.42 -34.04 70.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.032 0.933 . . . . 0.0 113.015 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -71.49 -47.17 57.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.087 2.155 . . . . 0.0 112.782 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.24 -34.67 74.01 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.528 1.131 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.81 -16.93 60.02 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.151 0.501 . . . . 0.0 112.238 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -85.72 -33.13 21.57 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.389 -1.444 . . . . 0.0 109.363 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -36.79 85.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.778 1.631 . . . . 0.0 110.098 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.0 87.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.26 1.824 . . . . 0.0 115.424 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 mp -48.89 -27.56 3.17 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.65 -13.54 51.54 Favored Glycine 0 CA--C 1.545 1.952 0 C-N-CA 125.06 1.314 . . . . 0.0 115.386 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -64.98 -22.91 67.07 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.463 1.631 . . . . 0.0 114.455 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 41.51 -53.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 1 C-N-CA 131.92 4.088 . . . . 0.0 119.742 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -145.42 19.26 1.54 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.311 2.244 . . . . 0.0 112.694 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.81 -179.67 0.29 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -119.64 155.76 31.71 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -161.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.5 mt -139.74 131.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 130.061 3.344 . . . . 0.0 106.145 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.44 -85.36 0.01 OUTLIER Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.938 1.256 . . . . 0.0 113.368 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -147.06 13.98 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.405 1.882 . . . . 0.0 112.234 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -124.29 178.65 5.25 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.944 2.097 . . . . 0.0 111.19 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -149.92 91.27 1.77 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 123.231 1.491 . . . . 0.0 109.66 -113.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 6.6 mt -102.55 139.5 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.186 -141.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.69 151.26 45.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.334 2.254 . . . . 0.0 112.633 165.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.73 136.68 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.424 0.69 . . . . 0.0 112.075 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -142.74 150.53 40.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 109.884 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -61.36 152.47 29.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.935 0.894 . . . . 0.0 110.417 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.3 m -152.61 171.64 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.722 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -153.38 155.65 36.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.486 1.515 . . . . 0.0 111.16 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.404 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp-100 -35.22 -1.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 1 C-N-CA 133.496 4.718 . . . . 0.0 120.17 177.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -117.85 -28.38 5.96 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 119.881 -1.762 . . . . 0.0 112.961 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -84.2 -19.96 33.14 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.628 -1.295 . . . . 0.0 109.745 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 188' ' ' GLN . 21.2 m -87.96 -31.07 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 128.185 2.594 . . . . 0.0 112.922 -165.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 38.79 0.76 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.41 1.084 . . . . 0.0 111.556 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 36.7 m -69.5 30.42 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.401 1.881 . . . . 0.0 112.936 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 127.635 2.374 . . . . 0.0 111.542 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.473 ' H ' ' HA ' ' A' ' 105' ' ' ALA . 92.7 p -143.94 -16.51 0.6 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -175.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 104' ' ' SER . . . -148.09 -32.59 0.26 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 125.955 3.98 . . . . 0.0 113.819 -3.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -157.04 151.79 25.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.865 1.266 . . . . 0.0 112.78 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.1 m -161.57 8.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.679 2.792 . . . . 0.0 112.325 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 54.01 142.1 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.475 2.71 . . . . 0.0 115.528 -156.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.05 2.76 4.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 130.469 3.508 . . . . 0.0 111.934 -8.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.33 50.59 1.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.739 -158.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.76 91.89 0.43 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 127.446 2.451 . . . . 0.0 112.03 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -99.0 166.81 11.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -146.81 128.07 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.899 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 66.1 ttt180 -104.0 138.73 40.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.254 1.022 . . . . 0.0 111.244 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 153.19 23.4 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.409 2.683 . . . . 0.0 109.531 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -155.07 81.22 1.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 109.782 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.77 -5.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.081 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -168.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.38 148.92 74.8 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.856 1.262 . . . . 0.0 111.119 -161.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 83.2 Cg_endo -80.42 170.75 15.65 Favored 'Trans proline' 0 N--CA 1.462 -0.37 1 C-N-CA 126.595 4.864 . . . . 0.0 113.056 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -53.75 118.44 3.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.555 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.61 66.53 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.304 -1.276 . . . . 0.0 115.73 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 6.2 t -55.35 149.75 12.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.317 2.059 . . . . 0.0 112.257 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.4 164.15 33.35 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.454 1.102 . . . . 0.0 111.249 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -43.69 -43.34 5.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.457 2.303 . . . . 0.0 113.164 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.5 mp0 -69.36 -18.0 63.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.949 1.299 . . . . 0.0 114.334 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.97 -27.59 49.2 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 119.709 -1.87 . . . . 0.0 110.458 166.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.9 mt -69.61 -36.83 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 110.465 166.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.274 1.4 m -63.57 -15.89 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.479 1.111 . . . . 0.0 113.701 169.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -96.73 -25.04 15.67 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.529 1.513 . . . . 0.0 114.142 165.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.61 -46.96 88.29 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.423 1.489 . . . . 0.0 110.782 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -119.98 35.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.322 1.049 . . . . 0.0 112.509 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.6 p -49.6 -24.8 2.36 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 155.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.03 -33.3 68.74 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.058 1.789 . . . . 0.0 115.353 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -139.29 160.45 39.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 113.139 -155.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.52 136.39 33.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 112.438 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 48.2 mt -135.71 137.69 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 129.633 3.173 . . . . 0.0 107.911 -171.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.07 151.88 79.45 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.821 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.19 -23.06 21.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 N-CA-C 120.952 3.405 . . . . 0.0 120.952 -158.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 39.52 2.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.604 1.162 . . . . 0.0 110.13 167.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.97 -25.42 9.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.219 1.39 . . . . 0.0 114.936 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.82 133.47 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.273 1.829 . . . . 0.0 109.631 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.1 m -129.18 136.62 50.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.078 1.751 . . . . 0.0 112.455 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.97 91.76 48.81 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 127.198 2.199 . . . . 0.0 111.142 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 -79.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 123.366 2.711 . . . . 0.0 113.634 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.26 168.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 129.224 3.01 . . . . 0.0 109.737 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.463 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.4 p-10 -80.61 171.74 11.56 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.966 1.706 . . . . 0.0 114.118 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.49 -1.16 0.19 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 124.973 3.782 . . . . 0.0 117.478 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -127.83 0.3 6.02 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.975 1.71 . . . . 0.0 111.795 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 39.43 68.21 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 115.796 1.079 . . . . 0.0 115.796 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -127.82 -17.15 4.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.859 1.664 . . . . 0.0 112.005 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.467 HG23 ' H ' ' A' ' 152' ' ' THR 0.307 0.0 OUTLIER -141.51 -104.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.296 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.467 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.5 OUTLIER 172.56 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.352 3.461 . . . . 0.0 108.525 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -123.41 2.52 9.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 128.714 3.054 . . . . 0.0 114.373 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.53 162.8 23.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.152 0.476 . . . . 0.0 109.726 142.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.89 177.2 5.1 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 127.036 2.135 . . . . 0.0 110.274 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.439 ' CE1' ' HD2' ' A' ' 114' ' ' ARG . 87.9 m-85 -148.88 160.28 43.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.037 0.935 . . . . 0.0 110.923 -166.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -162.29 121.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -90.19 132.74 35.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.838 2.055 . . . . 0.0 110.006 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.2 m-85 -89.12 -158.54 0.51 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.908 0.483 . . . . 0.0 110.197 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.47 -9.15 59.55 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 119.852 -1.78 . . . . 0.0 112.904 156.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.6 m -162.45 159.11 24.67 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -56.18 -30.99 63.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.158 1.383 . . . . 0.0 113.723 166.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -53.07 20.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.601 1.56 . . . . 0.0 111.414 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.64 -36.88 72.43 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.19 1.396 . . . . 0.0 111.319 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.08 61.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.57 -32.14 15.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.526 1.53 . . . . 0.0 110.444 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -61.57 -40.04 93.31 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 125.787 1.635 . . . . 0.0 110.508 167.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.24 86.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.24 1.816 . . . . 0.0 114.162 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -20.18 14.24 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -62.34 -14.29 47.52 Favored Glycine 0 CA--C 1.547 2.054 0 C-N-CA 124.646 1.117 . . . . 0.0 115.016 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -63.16 -27.52 69.43 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.324 1.562 . . . . 0.0 113.442 162.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.77 -42.01 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 1 C-N-CA 133.191 4.596 . . . . 0.0 120.166 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -153.49 36.83 0.46 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.305 1.442 . . . . 0.0 112.053 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.02 -174.04 0.22 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.621 1.168 . . . . 0.0 114.041 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.31 148.96 44.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.372 1.469 . . . . 0.0 112.682 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.3 mt -138.47 131.52 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 129.283 3.033 . . . . 0.0 105.798 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 54.41 -99.89 0.07 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.148 1.356 . . . . 0.0 112.33 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -118.36 -5.15 10.84 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.24 1.416 . . . . 0.0 113.532 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.71 -172.43 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.241 1.816 . . . . 0.0 112.49 -169.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -151.09 109.71 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.991 -132.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.27 128.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 122.783 1.278 . . . . 0.0 112.371 -139.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 160.58 13.23 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 127.559 2.344 . . . . 0.0 114.268 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.63 141.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.332 0.653 . . . . 0.0 112.433 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.81 142.75 31.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.198 1.799 . . . . 0.0 110.794 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -66.98 146.24 54.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.679 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -150.83 168.79 23.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.647 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.5 m -147.5 165.37 30.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.531 1.532 . . . . 0.0 110.761 164.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.429 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.7 tp60 -35.98 1.7 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 1 C-N-CA 133.32 4.648 . . . . 0.0 119.87 177.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -118.26 -30.26 5.31 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.636 -1.915 . . . . 0.0 112.669 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.662 -1.274 . . . . 0.0 109.611 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 188' ' ' GLN . 18.9 m -102.35 -19.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 127.585 2.354 . . . . 0.0 114.622 -153.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -90.98 16.76 8.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.204 1.801 . . . . 0.0 112.518 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 m -75.21 44.71 0.26 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.217 2.607 . . . . 0.0 114.55 -169.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.823 2.049 . . . . 0.0 113.822 178.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.998 0.427 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.4 m -158.05 -20.43 0.08 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.996 2.118 . . . . 0.0 113.128 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -134.7 23.65 3.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.836 2.054 . . . . 0.0 110.126 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -172.39 162.69 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.079 2.152 . . . . 0.0 110.957 -157.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -140.66 -48.74 0.43 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.81 -57.85 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -139.5 -9.68 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.997 1.319 . . . . 0.0 114.472 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.37 36.91 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.181 3.793 . . . . 0.0 114.181 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -58.51 83.36 0.01 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 127.064 2.268 . . . . 0.0 113.602 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 158' ' ' GLN . 3.3 m-85 -92.31 160.53 15.08 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 168.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.08 113.13 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.736 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.341 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.445 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 77.3 ttt180 -89.02 131.02 35.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 123.459 0.704 . . . . 0.0 111.492 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.42 152.96 18.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 128.751 2.821 . . . . 0.0 110.438 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -157.84 70.92 0.59 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.91 1.284 . . . . 0.0 109.419 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.48 1.92 0.03 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 -162.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -79.4 153.89 76.56 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 119.186 1.493 . . . . 0.0 112.434 -162.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.87 175.06 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 1 C-N-CA 125.759 4.306 . . . . 0.0 113.299 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -67.15 132.08 47.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.204 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.64 70.07 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 117.694 -1.615 . . . . 0.0 115.71 -171.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.25 149.38 20.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 120.392 2.096 . . . . 0.0 113.517 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.4 p -135.0 164.1 28.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.1 1.76 . . . . 0.0 111.82 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -48.56 -42.33 33.17 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 126.448 1.899 . . . . 0.0 112.449 166.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 121.193 1.815 . . . . 0.0 113.792 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -75.43 -31.68 60.43 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.658 -1.901 . . . . 0.0 110.0 167.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.45 -39.04 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.496 0.718 . . . . 0.0 111.183 167.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -62.17 -17.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.376 1.07 . . . . 0.0 112.964 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -96.05 -31.92 12.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.874 1.216 . . . . 0.0 112.719 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.46 -41.66 90.23 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.066 1.746 . . . . 0.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.87 33.39 5.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.918 1.287 . . . . 0.0 113.771 170.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.1 p -52.21 -22.2 4.12 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 157.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.22 -32.96 30.05 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.156 1.836 . . . . 0.0 115.212 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.66 166.49 24.22 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.888 1.275 . . . . 0.0 112.876 -156.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.57 137.53 32.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.68 1.592 . . . . 0.0 111.377 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 72.1 mt -138.62 137.64 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 128.221 2.608 . . . . 0.0 106.824 -170.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -60.39 153.55 58.83 Favored Pre-proline 0 N--CA 1.486 1.365 0 CA-C-N 118.643 0.656 . . . . 0.0 111.447 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.02 -21.06 20.19 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 120.927 3.395 . . . . 0.0 120.927 -159.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.74 40.9 2.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.791 1.178 . . . . 0.0 109.993 167.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.17 -14.71 6.31 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.148 1.356 . . . . 0.0 116.38 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.2 mt -103.27 123.69 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 125.372 1.469 . . . . 0.0 109.384 -165.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.8 m -115.8 130.59 56.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.085 2.554 . . . . 0.0 112.695 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.76 78.78 56.64 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 127.014 2.126 . . . . 0.0 111.724 -170.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.27 -58.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.372 1.381 . . . . 0.0 113.249 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -178.3 173.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 130.681 3.592 . . . . 0.0 107.961 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.474 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.9 p-10 -69.63 169.44 12.49 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 120.236 -1.54 . . . . 0.0 113.747 159.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.41 2.59 0.1 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.931 3.754 . . . . 0.0 117.319 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -128.41 -2.76 5.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.555 1.542 . . . . 0.0 112.094 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.62 26.24 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -131.39 -15.52 3.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.415 1.607 . . . . 0.0 112.728 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 152' ' ' THR 0.29 0.0 OUTLIER -143.67 -114.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.738 1.215 . . . . 0.0 113.226 -170.134 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.24 75.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 129.342 3.057 . . . . 0.0 108.141 -167.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.474 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -125.25 4.68 8.27 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 127.561 2.505 . . . . 0.0 114.702 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.86 164.06 26.9 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.497 0.719 . . . . 0.0 109.972 150.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -172.34 168.98 5.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 126.834 2.054 . . . . 0.0 110.029 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.445 ' CE2' ' HD2' ' A' ' 114' ' ' ARG . 97.0 m-85 -141.25 152.62 44.69 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.582 0.753 . . . . 0.0 109.673 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.23 123.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' A' ' 112' ' ' PHE . 39.3 tp60 -90.79 122.77 33.81 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.954 2.102 . . . . 0.0 110.344 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 5.1 m-85 -83.23 -165.55 1.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.576 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.79 -12.39 60.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.177 -1.577 . . . . 0.0 112.159 162.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.3 m -161.54 162.65 30.32 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.993 0.917 . . . . 0.0 113.411 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.67 -8.01 55.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.85 -53.2 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.324 2.25 . . . . 0.0 111.81 172.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.06 -37.89 67.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.026 1.73 . . . . 0.0 111.285 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.33 -15.84 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.68 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.46 -25.36 15.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.267 -1.521 . . . . 0.0 110.864 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.05 -41.08 97.51 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.323 1.449 . . . . 0.0 109.853 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.29 90.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.548 1.939 . . . . 0.0 115.808 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.5 mp -48.19 -21.48 0.5 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 165.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.48 -10.02 59.45 Favored Glycine 0 CA--C 1.544 1.864 0 C-N-CA 123.965 0.793 . . . . 0.0 113.697 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -59.59 -32.82 70.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.228 1.411 . . . . 0.0 114.321 164.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.6 -56.51 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 131.196 3.799 . . . . 0.0 119.0 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -148.17 24.31 1.04 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.289 1.836 . . . . 0.0 113.443 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.61 179.4 0.12 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.772 1.629 . . . . 0.0 113.731 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 149.65 45.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.342 1.457 . . . . 0.0 111.799 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.39 -16.64 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.5 1.12 . . . . 0.0 112.77 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.62 -41.96 0.08 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.394 1.473 . . . . 0.0 112.607 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -149.66 -42.04 0.14 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.312 1.445 . . . . 0.0 112.854 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -86.14 174.55 9.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.109 0.957 . . . . 0.0 111.753 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.73 97.49 3.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.937 -126.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.3 mt -99.78 119.48 47.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.733 -148.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 153.25 42.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.149 1.78 . . . . 0.0 112.372 163.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 132.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.499 0.719 . . . . 0.0 110.947 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -135.61 144.74 46.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.917 1.687 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -69.15 142.0 54.47 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.594 0.711 . . . . 0.0 110.41 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 m -150.38 164.12 36.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.09 -167.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 73.6 m -135.39 160.75 37.47 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.731 1.212 . . . . 0.0 110.916 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -46.66 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.768 1 C-N-CA 132.39 4.276 . . . . 0.0 118.148 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -128.67 -28.73 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.204 -1.56 . . . . 0.0 113.03 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.46 -23.48 62.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.859 -1.151 . . . . 0.0 110.564 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 1.7 p -68.8 -35.82 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 124.676 1.191 . . . . 0.0 113.261 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -90.68 66.82 6.24 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.286 -1.325 . . . . 0.0 113.093 -138.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.1 p -82.61 -9.91 59.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 158.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.152 0 C-N-CA 130.196 3.399 . . . . 0.0 114.062 -175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.8 m -152.25 27.37 0.59 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.556 1.542 . . . . 0.0 111.405 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.42 8.0 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.053 1.341 . . . . 0.0 113.328 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.35 169.29 16.22 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.477 1.911 . . . . 0.0 112.333 -168.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.433 ' H ' ' HG3' ' A' ' 162' ' ' GLN . 82.7 p -140.68 -83.34 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.472 1.509 . . . . 0.0 110.527 166.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.2 -34.79 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 129.553 3.141 . . . . 0.0 111.455 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -137.02 13.67 3.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -163.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -120.3 34.76 5.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.476 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 77.89 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 127.035 2.255 . . . . 0.0 113.353 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -99.49 156.96 16.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.1 108.72 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.678 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -86.05 124.84 32.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.609 0.763 . . . . 0.0 111.444 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -85.33 152.47 23.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.976 2.11 . . . . 0.0 110.808 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -155.1 76.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.263 1.425 . . . . 0.0 109.324 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.35 -11.01 0.02 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -161.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 13.0 mt -73.44 156.08 89.13 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -152.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.4 169.69 19.62 Favored 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 125.634 4.223 . . . . 0.0 112.543 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.23 125.96 28.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.68 24.54 75.39 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.739 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 36.2 t -54.96 154.49 5.26 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.277 1.538 . . . . 0.0 112.773 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.1 t -147.31 164.41 33.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.047 0.927 . . . . 0.0 112.144 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -45.55 -40.64 8.93 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 127.055 2.142 . . . . 0.0 113.126 171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -69.87 -16.7 63.29 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 121.596 1.998 . . . . 0.0 113.999 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -76.92 -35.09 57.57 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 120.043 -1.661 . . . . 0.0 109.327 166.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.9 mt -64.1 -40.29 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.036 0.835 . . . . 0.0 111.141 169.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.5 m -65.77 -16.52 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.897 1.279 . . . . 0.0 112.683 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -94.94 -31.48 13.63 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.94 1.245 . . . . 0.0 112.425 164.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.86 -38.23 75.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.188 1.795 . . . . 0.0 111.593 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -122.15 35.93 4.76 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.482 1.513 . . . . 0.0 112.68 167.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -64.37 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.173 1.463 . . . . 0.0 108.864 153.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.8 -48.04 0.08 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.795 -151.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.1 157.9 45.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.988 1.315 . . . . 0.0 112.09 -160.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.73 131.28 38.67 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.645 -0.659 . . . . 0.0 111.193 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 55.1 mt -131.08 132.26 63.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.832 2.453 . . . . 0.0 107.183 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.09 151.4 80.98 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.923 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.94 -16.89 12.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.069 3.179 . . . . 0.0 119.133 -165.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -122.95 16.43 10.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.593 1.557 . . . . 0.0 111.598 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.58 70.73 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 -159.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -95.17 134.77 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 124.856 1.262 . . . . 0.0 109.743 -166.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.4 m -133.44 133.55 42.46 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.575 1.55 . . . . 0.0 112.685 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.27 96.47 36.49 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 127.695 2.398 . . . . 0.0 111.326 -173.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.73 -81.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.078 1.852 . . . . 0.0 113.831 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.25 167.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 128.899 2.88 . . . . 0.0 109.991 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -70.86 170.65 10.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.493 1.917 . . . . 0.0 114.645 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.61 0.61 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 124.907 3.738 . . . . 0.0 117.576 170.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -126.91 -0.46 6.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.776 1.63 . . . . 0.0 111.928 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.28 37.32 54.75 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -129.16 -15.63 4.15 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.192 1.496 . . . . 0.0 112.37 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.299 0.0 OUTLIER -141.67 -105.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 170.96 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.981 3.312 . . . . 0.0 107.983 -166.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.81 -1.45 5.9 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 129.942 3.639 . . . . 0.0 114.476 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -131.8 158.63 40.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.473 149.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.61 -179.47 3.38 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.339 2.256 . . . . 0.0 108.472 -167.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -152.01 157.65 42.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.789 0.436 . . . . 0.0 111.273 -167.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.52 125.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -90.8 127.0 36.19 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.937 2.095 . . . . 0.0 111.266 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.5 m-85 -92.11 -173.16 3.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.342 1.057 . . . . 0.0 110.313 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.97 -13.17 60.84 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.212 -1.555 . . . . 0.0 113.064 166.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.4 m -160.24 159.97 32.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.477 1.111 . . . . 0.0 113.347 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 107' ' ' SER . 19.5 mm-40 -60.69 -21.43 62.86 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 167.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 29.0 tp10 -78.96 -50.32 11.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.681 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.07 -36.8 70.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.518 1.127 . . . . 0.0 111.13 170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.58 -20.86 63.64 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.975 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -91.06 -29.77 17.14 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.237 -1.54 . . . . 0.0 110.317 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -62.15 -34.08 75.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.916 0.886 . . . . 0.0 109.197 167.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.72 -42.63 63.95 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.2 mp -49.09 -31.88 8.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 120.615 1.552 . . . . 0.0 113.143 160.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -57.76 -16.47 23.86 Favored Glycine 0 CA--C 1.547 2.057 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 170.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -69.14 -19.72 64.02 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.171 1.986 . . . . 0.0 113.758 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 47.97 -65.51 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 130.969 3.708 . . . . 0.0 118.303 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -150.48 33.36 0.63 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.283 1.833 . . . . 0.0 112.484 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.83 -157.95 0.1 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.006 1.322 . . . . 0.0 113.312 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -135.35 149.11 49.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.895 2.078 . . . . 0.0 112.49 -169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -106.1 -17.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -170.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.16 -39.66 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.409 1.957 . . . . 0.0 111.58 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -151.7 -44.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.688 . . . . 0.0 111.773 169.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.7 177.97 5.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.441 1.096 . . . . 0.0 112.44 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.31 113.82 14.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.12 1.768 . . . . 0.0 109.891 -128.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 2.8 mt -121.16 111.83 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.57 1.652 . . . . 0.0 111.809 -146.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 150.94 33.64 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.206 -2.724 . . . . 0.0 112.494 158.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.17 123.16 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 110.204 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -119.63 146.45 45.54 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.683 1.593 . . . . 0.0 109.543 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -66.15 136.03 55.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -144.68 172.14 13.41 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -166.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.9 m -152.08 148.81 28.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.298 1.839 . . . . 0.0 109.729 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -31.29 -16.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 1 C-N-CA 132.147 4.179 . . . . 0.0 118.459 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -112.58 -16.71 12.79 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.91 1.684 . . . . 0.0 111.625 -168.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -80.48 -30.75 37.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 156.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 4.2 m -79.38 -42.48 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -163.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -79.47 -9.35 59.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.4 m -95.47 34.87 1.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.498 1.519 . . . . 0.0 111.62 -157.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.904 2.482 . . . . 0.0 111.94 -155.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -55.25 133.23 49.22 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.769 1.622 . . . . 0.0 110.773 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -138.37 150.35 46.47 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -153.87 150.74 28.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.868 1.267 . . . . 0.0 112.111 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.3 p 48.09 -50.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 1 C-N-CA 131.961 4.104 . . . . 0.0 119.257 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 136.25 -28.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 1 C-N-CA 132.987 4.515 . . . . 0.0 110.787 -169.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -134.65 -25.98 1.42 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -165.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.76 55.26 1.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.129 2.172 . . . . 0.0 112.179 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.23 95.13 0.57 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.093 1.33 . . . . 0.0 111.363 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 158' ' ' GLN . 23.8 m-85 -99.69 164.35 12.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.92 113.49 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.369 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.434 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 68.5 ttt180 -89.87 115.07 26.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.922 0.889 . . . . 0.0 110.455 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.66 146.53 53.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.317 157.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.82 151.09 48.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 140.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.9 -13.6 0.76 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.173 -1.579 . . . . 0.0 113.857 159.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 10.4 mt -67.91 153.21 95.61 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -141.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.09 171.21 18.03 Favored 'Trans proline' 0 C--N 1.346 0.416 1 C-N-CA 126.754 4.969 . . . . 0.0 112.368 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -68.71 132.74 47.35 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.093 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.59 25.22 62.98 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.647 -168.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.9 t -54.14 149.18 9.9 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.503 1.652 . . . . 0.0 113.124 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 t -145.54 161.17 40.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.738 1.256 . . . . 0.0 112.044 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -46.71 -37.72 8.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 127.774 2.43 . . . . 0.0 113.496 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -71.74 -19.54 62.02 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 121.083 1.765 . . . . 0.0 114.041 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.88 -31.91 57.11 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 120.208 -1.558 . . . . 0.0 109.156 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.7 mt -68.73 -39.09 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.522 0.729 . . . . 0.0 111.338 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.43 -16.07 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.961 1.304 . . . . 0.0 112.803 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -95.67 -28.77 14.65 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.315 0.962 . . . . 0.0 112.794 164.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.4 t80 -61.45 -44.85 96.39 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.751 1.62 . . . . 0.0 111.011 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -118.53 34.99 4.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.357 1.463 . . . . 0.0 113.091 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.6 p -50.08 -24.02 2.45 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 155.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.64 -33.23 54.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.437 1.97 . . . . 0.0 115.673 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.1 mp -138.28 161.76 36.08 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.215 1.007 . . . . 0.0 113.092 -156.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.01 132.73 33.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.143 1.377 . . . . 0.0 112.321 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 53.2 mt -133.27 138.26 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 128.995 2.918 . . . . 0.0 108.13 -172.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.81 152.0 87.75 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.784 -0.573 . . . . 0.0 111.513 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.65 -14.69 10.76 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.026 3.151 . . . . 0.0 120.013 -165.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.59 21.85 5.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.308 1.443 . . . . 0.0 111.544 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.79 -24.57 57.68 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -166.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.5 130.73 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.187 1.395 . . . . 0.0 109.539 -167.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.9 m -124.62 132.0 53.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.058 1.743 . . . . 0.0 112.744 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -121.85 87.46 46.68 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 127.715 2.406 . . . . 0.0 110.412 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 -86.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.985 1.79 . . . . 0.0 112.646 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -165.22 156.98 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 128.945 2.898 . . . . 0.0 109.104 177.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 1.3 p-10 -64.28 178.24 0.47 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.001 3.321 . . . . 0.0 115.031 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.02 1.11 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.491 0 C-N-CA 124.48 3.453 . . . . 0.0 117.368 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -133.74 -32.84 1.1 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.279 1.854 . . . . 0.0 113.511 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.9 40.18 1.6 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.583 1.563 . . . . 0.0 114.911 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -132.35 -15.14 2.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 113.007 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -161.86 -163.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 127.793 2.437 . . . . 0.0 107.99 -168.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.492 ' H ' HD11 ' A' ' 151' ' ' ILE . 11.3 p -122.61 30.26 6.55 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 123.273 2.76 . . . . 0.0 112.988 -170.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' A' ' 146' ' ' ASP . . . -53.43 1.33 0.03 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.159 2.79 . . . . 0.0 117.245 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 152' ' ' THR . 6.0 pt-20 -147.25 152.59 38.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.095 0.95 . . . . 0.0 111.138 158.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.8 176.34 7.17 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 127.742 2.417 . . . . 0.0 108.938 -163.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.434 ' CE2' ' HD2' ' A' ' 114' ' ' ARG . 92.7 m-85 -149.42 163.41 37.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.709 -166.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.7 127.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 112' ' ' PHE . 46.1 tp60 -96.17 131.07 43.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.484 2.314 . . . . 0.0 110.3 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.2 m-85 -94.74 -168.43 1.82 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.289 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.2 -10.4 59.63 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.88 -1.763 . . . . 0.0 113.311 163.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 m -159.22 158.11 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.077 0.951 . . . . 0.0 113.096 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -57.13 -26.54 60.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.684 1.594 . . . . 0.0 114.483 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -54.8 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.822 1.649 . . . . 0.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.68 -37.81 66.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.85 1.66 . . . . 0.0 111.539 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.83 -17.2 64.43 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -110.3 -16.45 13.73 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.283 -1.511 . . . . 0.0 111.852 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.76 -38.69 86.1 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.963 0.905 . . . . 0.0 110.281 155.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -44.04 80.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 mp -51.09 -27.85 9.22 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.93 -1.106 . . . . 0.0 113.75 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.92 -14.85 32.78 Favored Glycine 0 CA--C 1.547 2.076 0 C-N-CA 125.262 1.411 . . . . 0.0 115.592 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -65.44 -17.66 64.72 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.886 1.843 . . . . 0.0 114.585 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 37.27 -47.57 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 C-N-CA 132.967 4.507 . . . . 0.0 120.982 171.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 19.5 1.11 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.166 1.787 . . . . 0.0 113.843 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -59.89 179.48 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.6 ttp85 -119.33 149.15 42.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.112 2.965 . . . . 0.0 109.043 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.441 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -115.88 -29.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.494 1.118 . . . . 0.0 113.041 -173.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -171.56 -112.02 0.27 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 127.074 2.273 . . . . 0.0 108.139 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -39.52 84.75 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.795 1.298 . . . . 0.0 113.151 164.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -177.87 3.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.462 1.505 . . . . 0.0 114.973 -164.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.685 1.594 . . . . 0.0 108.261 -140.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 5.1 mt -128.4 136.5 59.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.814 1.292 . . . . 0.0 112.362 -142.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.253 3.3 mp0 -83.13 156.42 23.27 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 130.589 3.556 . . . . 0.0 112.456 164.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.63 133.07 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.945 0.898 . . . . 0.0 111.091 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.24 144.75 47.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.967 1.707 . . . . 0.0 109.759 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -75.51 139.2 42.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.74 1.216 . . . . 0.0 110.703 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.7 m -149.39 166.77 28.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.741 -158.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 m -143.58 148.01 35.27 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.805 1.642 . . . . 0.0 108.798 165.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -13.79 -18.61 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 135.259 5.423 . . . . 0.0 120.642 169.104 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -122.46 -6.19 8.73 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 120.356 -1.465 . . . . 0.0 111.715 -167.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -76.51 -21.64 55.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.641 153.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.8 m -96.09 -35.15 5.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -149.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.61 5.33 52.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 0.0 113.218 -171.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.6 m -81.68 40.64 0.6 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.056 2.143 . . . . 0.0 114.766 -155.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 126.92 2.088 . . . . 0.0 114.321 -177.115 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.273 5.5 p30 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m 161.91 -41.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 129.322 3.049 . . . . 0.0 111.32 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.12 -13.1 28.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.714 1.206 . . . . 0.0 113.914 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -79.8 176.94 9.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.958 2.103 . . . . 0.0 113.813 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.9 p -138.28 148.46 44.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -165.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.29 -61.27 0.38 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.446 1.899 . . . . 0.0 112.068 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.61 -40.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.092 1.757 . . . . 0.0 112.312 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.75 43.58 0.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 112.571 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.18 99.08 0.85 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.858 1.218 . . . . 0.0 111.218 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -97.12 163.09 13.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 167.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.79 115.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.582 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.402 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 42.8 ttt85 -92.32 137.35 32.44 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.126 0.97 . . . . 0.0 112.79 -173.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.62 151.16 23.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.236 2.614 . . . . 0.0 110.86 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -157.62 75.08 0.77 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.021 1.728 . . . . 0.0 108.599 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.67 -6.95 0.03 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -163.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -77.46 153.89 81.6 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-N 118.18 0.99 . . . . 0.0 113.653 -157.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.1 173.85 11.43 Favored 'Trans proline' 0 C--N 1.344 0.335 1 C-N-CA 126.937 5.091 . . . . 0.0 113.312 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -62.9 131.2 47.93 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.876 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.57 19.22 72.71 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 117.955 -1.469 . . . . 0.0 115.597 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.8 t -56.56 149.23 17.82 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 120.14 1.97 . . . . 0.0 113.842 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.0 t -143.73 161.59 38.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.553 1.168 . . . . 0.0 112.806 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -44.92 -42.4 8.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.598 2.759 . . . . 0.0 114.074 172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.48 -21.36 66.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 121.25 1.841 . . . . 0.0 114.307 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -79.37 -33.32 42.98 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 119.787 -1.821 . . . . 0.0 109.674 170.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.7 mt -62.8 -38.67 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.456 -0.778 . . . . 0.0 111.038 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . 0.268 1.1 m -68.34 -12.46 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 113.702 173.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.62 -27.29 14.88 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.673 1.124 . . . . 0.0 113.355 161.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -64.12 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.122 1.769 . . . . 0.0 111.266 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -120.84 34.61 5.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.833 1.653 . . . . 0.0 112.786 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -50.93 -22.62 2.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 156.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.6 -35.14 51.14 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.787 1.661 . . . . 0.0 115.301 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.5 156.46 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.201 1.0 . . . . 0.0 112.575 -149.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.3 140.51 33.55 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.224 -0.922 . . . . 0.0 112.098 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 47.7 mt -136.04 137.7 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 128.269 2.627 . . . . 0.0 107.524 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -62.18 153.05 76.5 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.29 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.51 -8.51 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.525 3.483 . . . . 0.0 120.607 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -140.13 21.76 2.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.871 2.068 . . . . 0.0 111.516 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.8 -16.98 53.46 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.6 mt -105.35 134.74 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 119.081 1.44 . . . . 0.0 109.497 -163.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.3 m -129.57 135.43 48.57 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.564 1.545 . . . . 0.0 112.773 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.01 86.07 50.92 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 127.033 2.133 . . . . 0.0 111.369 -171.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.93 -66.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.338 2.025 . . . . 0.0 113.46 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.88 -179.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 130.188 3.395 . . . . 0.0 108.306 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -77.02 170.08 18.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 119.149 -2.219 . . . . 0.0 114.169 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -55.97 2.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 125.227 3.951 . . . . 0.0 117.198 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -127.65 2.28 6.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.603 1.561 . . . . 0.0 111.729 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.86 34.97 51.82 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.363 -1.243 . . . . 0.0 116.203 164.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -132.68 -14.35 2.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.654 1.727 . . . . 0.0 112.835 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.279 0.0 OUTLIER -143.85 -110.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 117.475 -1.25 . . . . 0.0 113.574 -168.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 p -178.78 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 130.088 3.355 . . . . 0.0 107.486 -167.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.84 1.3 2.84 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 129.258 3.313 . . . . 0.0 113.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -138.15 162.35 34.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.7 1.6 . . . . 0.0 109.445 159.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -173.73 -178.7 1.64 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.509 1.924 . . . . 0.0 110.733 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 114' ' ' ARG . 96.9 m-85 -153.71 152.99 31.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.694 1.198 . . . . 0.0 110.315 -168.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.42 127.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -91.51 133.81 35.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.555 2.342 . . . . 0.0 110.328 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.6 m-85 -97.44 -175.38 3.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.846 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.51 58.56 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.707 -1.246 . . . . 0.0 113.191 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.0 m -166.4 158.57 13.87 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 111.998 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -84.71 50.16 1.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.125 1.37 . . . . 0.0 110.272 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.6 -55.07 0.56 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.15 2.98 . . . . 0.0 108.485 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 49.3 mt -54.41 -41.49 69.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.749 2.02 . . . . 0.0 111.65 164.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.52 -18.46 65.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.63 -29.15 15.6 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.794 -1.192 . . . . 0.0 109.15 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -66.12 -36.84 84.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.301 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.87 -39.03 87.41 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.6 mp -51.27 -24.36 4.41 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 120.744 -1.223 . . . . 0.0 113.974 162.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -66.36 -17.46 66.32 Favored Glycine 0 CA--C 1.546 2.006 0 C-N-CA 124.98 1.276 . . . . 0.0 115.191 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -75.16 15.59 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.195 1.997 . . . . 0.0 115.605 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -51.82 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 130.317 3.447 . . . . 0.0 119.507 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.68 17.59 0.9 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.214 1.805 . . . . 0.0 114.222 -169.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -114.21 -170.8 1.79 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.059 1.344 . . . . 0.0 112.592 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.05 151.36 47.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.883 2.073 . . . . 0.0 110.977 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.0 OUTLIER -116.23 -38.05 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.131 1.372 . . . . 0.0 112.695 -174.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -156.41 -78.92 0.02 OUTLIER Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.951 1.262 . . . . 0.0 110.517 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -108.18 -18.84 13.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.407 1.083 . . . . 0.0 113.466 169.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -128.05 -178.06 4.38 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.14 1.776 . . . . 0.0 113.639 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -149.8 117.25 6.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -119.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 3.4 mt -123.96 129.26 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 123.537 1.637 . . . . 0.0 112.95 -138.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.16 153.18 36.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.843 2.857 . . . . 0.0 112.798 165.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.76 134.69 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 111.897 171.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -137.99 153.67 49.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.292 1.837 . . . . 0.0 110.258 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -75.03 145.99 41.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.386 0.675 . . . . 0.0 111.656 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.4 m -153.11 168.46 25.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 124.112 0.883 . . . . 0.0 111.728 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.2 m -149.62 158.3 44.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.422 1.489 . . . . 0.0 110.504 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -33.43 -0.85 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 1 C-N-CA 134.019 4.928 . . . . 0.0 119.926 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.91 -10.89 3.42 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 119.951 -1.718 . . . . 0.0 113.519 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.96 -29.97 28.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.44 -30.2 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.718 1.207 . . . . 0.0 112.97 -158.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -83.63 49.67 1.64 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.773 1.629 . . . . 0.0 111.409 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.0 t -66.93 -3.56 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.193 1.797 . . . . 0.0 114.163 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.276 0 C-N-CA 127.793 2.437 . . . . 0.0 115.17 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.9 p 59.65 -35.05 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 129.008 2.923 . . . . 0.0 117.127 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.63 -38.08 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.882 2.473 . . . . 0.0 111.837 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.33 159.06 43.04 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.5 t 169.18 -172.26 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 130.427 3.491 . . . . 0.0 107.65 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.46 59.82 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.747 -1.221 . . . . 0.0 113.667 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 -26.23 0.38 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -167.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.256 4.5 p-10 -75.05 52.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.43 1.492 . . . . 0.0 113.628 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.03 99.64 1.3 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.686 2.088 . . . . 0.0 111.574 170.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 158' ' ' GLN . 25.7 m-85 -107.91 165.43 11.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.74 117.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.819 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 38.8 ttt85 -89.02 135.67 33.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.48 151.88 24.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.026 2.53 . . . . 0.0 110.467 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -157.66 76.13 0.8 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.098 1.759 . . . . 0.0 108.64 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.54 -13.2 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.756 1.462 . . . . 0.0 116.756 -163.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.5 151.13 82.84 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 118.422 1.111 . . . . 0.0 112.846 -153.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.82 175.13 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.271 1 C-N-CA 125.621 4.214 . . . . 0.0 113.431 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -68.47 134.44 50.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.87 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.38 14.7 67.06 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 117.935 -1.481 . . . . 0.0 115.179 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.91 151.48 18.1 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.412 2.106 . . . . 0.0 112.862 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.1 t -146.49 166.23 27.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.563 1.173 . . . . 0.0 111.45 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -47.49 -43.78 24.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 127.415 2.286 . . . . 0.0 112.488 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 40.6 mp0 -67.17 -18.77 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.568 1.531 . . . . 0.0 113.846 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -79.73 -25.36 41.13 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 119.498 -2.001 . . . . 0.0 110.807 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.6 mt -71.6 -36.54 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.484 0.714 . . . . 0.0 111.009 164.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.269 1.7 m -60.91 -18.73 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.326 168.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -97.82 -25.13 15.15 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.693 1.588 . . . . 0.0 113.347 165.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.88 -42.95 94.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.834 0.853 . . . . 0.0 110.333 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -117.74 42.04 2.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.529 1.131 . . . . 0.0 113.896 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.0 p -67.58 64.77 0.08 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.966 1.365 . . . . 0.0 110.822 154.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.32 -41.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.34 1.447 . . . . 0.0 112.178 -156.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.38 154.47 48.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.226 1.81 . . . . 0.0 110.785 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.11 140.53 45.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.114 0.965 . . . . 0.0 112.431 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.3 mt -143.9 131.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 128.903 2.881 . . . . 0.0 107.072 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.76 152.72 74.72 Favored Pre-proline 0 N--CA 1.486 1.373 0 CA-C-O 118.723 -0.655 . . . . 0.0 111.301 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.15 -25.47 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 120.287 3.149 . . . . 0.0 120.287 -160.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -133.36 41.75 3.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.631 1.173 . . . . 0.0 110.432 166.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.82 -29.14 49.5 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.028 1.299 . . . . 0.0 114.576 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -89.6 131.51 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 125.77 1.628 . . . . 0.0 109.342 -169.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -129.46 132.32 46.91 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.4 1.88 . . . . 0.0 112.888 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.7 92.13 43.57 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 126.981 2.112 . . . . 0.0 112.373 -166.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.32 -65.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.605 1.536 . . . . 0.0 114.352 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.8 177.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 129.43 3.092 . . . . 0.0 109.094 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.518 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.3 p-10 -81.23 172.07 10.66 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 120.006 -1.684 . . . . 0.0 114.273 163.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.11 -0.34 0.28 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 125.019 3.813 . . . . 0.0 117.166 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -127.76 -0.91 6.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 111.786 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.66 39.68 48.13 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.34 -17.18 3.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.956 1.703 . . . . 0.0 112.307 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.469 HG23 ' H ' ' A' ' 152' ' ' THR 0.298 0.0 OUTLIER -143.49 -112.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -169.633 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.469 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.84 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.644 3.178 . . . . 0.0 109.161 -167.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.518 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -113.96 6.3 23.78 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.993 2.711 . . . . 0.0 114.413 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -134.41 157.53 46.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.852 1.261 . . . . 0.0 108.926 157.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.32 -178.93 3.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.206 1.402 . . . . 0.0 110.665 -167.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 191' ' ' VAL . 95.6 m-85 -152.87 157.71 41.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.524 1.13 . . . . 0.0 109.421 -169.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.68 120.76 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 45.6 tp60 -83.18 135.43 34.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.546 1.938 . . . . 0.0 109.693 170.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.5 m-85 -92.39 -157.43 0.52 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.434 0.693 . . . . 0.0 110.335 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.04 59.26 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 120.131 -1.606 . . . . 0.0 112.335 157.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.65 166.99 31.38 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -61.28 -16.92 50.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.759 1.623 . . . . 0.0 114.638 165.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -48.03 3.76 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.844 1.657 . . . . 0.0 111.232 -166.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.29 -37.19 23.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.686 1.194 . . . . 0.0 111.957 161.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.21 -23.12 61.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -88.03 -32.38 18.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.775 2.03 . . . . 0.0 110.329 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.67 -40.69 88.59 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 126.207 1.803 . . . . 0.0 110.346 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -43.44 82.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 114.444 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -21.34 11.56 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.8 -12.84 7.25 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 125.138 1.351 . . . . 0.0 115.213 172.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -53.57 -46.88 70.45 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.403 1.602 . . . . 0.0 113.175 161.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 51.03 -52.87 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.847 3.659 . . . . 0.0 117.0 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -147.27 106.72 3.91 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.507 2.323 . . . . 0.0 108.652 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.67 -166.7 2.19 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.639 1.176 . . . . 0.0 112.125 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -130.81 152.14 50.48 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.92 1.691 . . . . 0.0 114.088 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.93 -22.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.639 1.176 . . . . 0.0 112.845 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -178.44 -52.83 0.07 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.545 1.069 . . . . 0.0 112.755 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 -10.85 0.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.25 1.42 . . . . 0.0 114.49 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -123.8 -179.86 4.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.242 1.417 . . . . 0.0 112.427 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.68 108.77 5.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.601 -1.636 . . . . 0.0 107.696 -118.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.0 mt -117.33 116.57 52.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 123.138 1.447 . . . . 0.0 110.232 -144.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.15 156.16 25.94 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 128.852 2.861 . . . . 0.0 113.161 165.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.97 132.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.651 0.781 . . . . 0.0 111.36 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.28 144.43 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.146 1.778 . . . . 0.0 110.017 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -72.49 152.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.706 -0.622 . . . . 0.0 111.289 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.66 170.08 20.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.009 -160.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.7 m -155.72 162.48 40.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.216 1.806 . . . . 0.0 111.783 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.415 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.8 tp-100 -37.34 5.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 1 C-N-CA 133.118 4.567 . . . . 0.0 120.245 177.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.56 2.17 1.23 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 168.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.73 -20.39 21.6 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.701 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.453 ' HA ' ' CE1' ' A' ' 156' ' ' PHE . 34.5 m -84.17 -23.97 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 128.302 2.641 . . . . 0.0 112.805 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -83.56 37.36 0.57 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.815 2.846 . . . . 0.0 113.56 -168.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.0 t -65.5 -4.13 5.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.272 1.029 . . . . 0.0 112.36 163.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.256 0 C-N-CA 127.055 2.142 . . . . 0.0 110.043 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.4 p 179.91 172.49 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.821 1.248 . . . . 0.0 112.632 -169.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.54 -17.48 53.91 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 165.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -153.44 154.83 35.18 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.306 1.442 . . . . 0.0 111.662 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -156.75 -118.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.353 1.461 . . . . 0.0 112.906 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.02 -40.89 0.08 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.515 1.926 . . . . 0.0 113.034 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -125.44 -41.88 2.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -167.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.66 42.95 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.286 2.234 . . . . 0.0 112.275 173.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.461 ' N ' HE22 ' A' ' 158' ' ' GLN . . . -53.06 99.24 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 128.15 2.786 . . . . 0.0 114.818 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.84 161.3 19.52 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.859 1.329 . . . . 0.0 108.593 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.4 125.73 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.109 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 39.4 ttt85 -94.08 142.36 27.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 0.0 111.227 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.89 154.66 21.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.044 2.538 . . . . 0.0 110.589 172.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -156.19 78.29 0.95 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 110.711 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.53 -15.36 0.02 OUTLIER Glycine 0 CA--C 1.544 1.844 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.28 159.15 68.36 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 128.444 2.698 . . . . 0.0 116.897 -153.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.83 167.94 14.26 Favored 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 126.186 4.591 . . . . 0.0 113.988 -173.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -69.59 98.22 1.13 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.511 2.325 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.535 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 97.72 23.51 13.64 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.394 1.473 . . . . 0.0 114.704 -168.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.3 t -53.2 152.89 4.06 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.191 1.995 . . . . 0.0 113.879 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 t -143.64 159.57 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.114 0.959 . . . . 0.0 112.331 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -44.08 -46.43 8.55 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.609 1.963 . . . . 0.0 112.097 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.414 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 39.4 mp0 -65.61 -12.54 54.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.911 1.685 . . . . 0.0 114.717 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -82.65 -33.19 27.85 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 119.995 -1.691 . . . . 0.0 108.873 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.49 -40.19 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.909 -0.494 . . . . 0.0 111.987 164.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.262 1.4 m -58.19 -22.02 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.605 170.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.72 -25.55 17.39 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.462 1.483 . . . . 0.0 113.012 169.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.437 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.1 t80 -62.35 -49.48 75.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.685 1.194 . . . . 0.0 110.08 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -113.14 31.88 6.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.736 1.214 . . . . 0.0 112.69 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -53.43 -20.96 5.27 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 157.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.75 43.74 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.989 1.757 . . . . 0.0 115.724 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.03 173.92 11.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 112.925 -156.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.1 118.93 33.66 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.39 1.476 . . . . 0.0 111.922 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.3 mt -118.29 135.23 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 128.885 2.874 . . . . 0.0 107.546 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.97 153.27 85.26 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.008 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.16 -13.83 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.662 1 N-CA-C 122.651 4.058 . . . . 0.0 122.651 -160.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -134.22 12.55 3.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.654 1.57 . . . . 0.0 111.906 172.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.87 -12.66 1.25 Allowed Glycine 0 N--CA 1.48 1.589 0 C-N-CA 128.016 2.722 . . . . 0.0 119.315 -150.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.9 mt -95.57 135.3 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 127.214 2.205 . . . . 0.0 109.826 -166.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.5 m -122.98 136.21 54.77 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.558 1.526 . . . . 0.0 113.381 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.38 97.33 40.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 127.64 2.376 . . . . 0.0 111.595 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.43 -86.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.429 2.086 . . . . 0.0 113.643 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.41 177.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 130.407 3.483 . . . . 0.0 107.972 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.467 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 6.7 p-10 -74.68 175.12 4.22 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.613 1.965 . . . . 0.0 114.669 171.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.55 -6.86 1.74 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.908 3.739 . . . . 0.0 117.789 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -118.08 -30.79 5.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.113 1.779 . . . . 0.0 111.342 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 111.41 37.5 1.61 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.927 161.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.82 -2.86 4.69 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.918 1.287 . . . . 0.0 113.506 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 121' ' ' GLY 0.302 0.0 OUTLIER -140.68 -100.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.501 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.481 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.4 OUTLIER 164.84 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.918 3.687 . . . . 0.0 108.785 -164.261 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.467 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.16 11.28 10.74 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 128.673 3.035 . . . . 0.0 114.707 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -140.41 158.99 43.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.946 1.698 . . . . 0.0 108.079 155.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.31 -179.86 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.689 1.996 . . . . 0.0 109.267 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 114' ' ' ARG . 97.9 m-85 -151.89 160.49 43.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.143 0.977 . . . . 0.0 110.031 -169.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -160.54 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.461 HE22 ' N ' ' A' ' 111' ' ' GLY . 67.9 tp60 -87.25 138.85 31.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.367 2.267 . . . . 0.0 111.575 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.3 m-85 -109.36 -175.67 2.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.496 1.518 . . . . 0.0 110.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.18 -10.2 59.52 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 119.396 -2.065 . . . . 0.0 113.025 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 m -161.87 158.7 25.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.589 1.156 . . . . 0.0 112.889 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.409 ' CD ' ' HA2' ' A' ' 111' ' ' GLY . 4.9 tp-100 -72.5 0.61 9.89 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.473 1.509 . . . . 0.0 113.696 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.75 -49.24 5.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.352 1.861 . . . . 0.0 111.429 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.3 mt -55.03 -36.57 65.65 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.754 1.222 . . . . 0.0 111.925 167.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.26 67.28 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.95 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -90.97 -27.62 18.56 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.659 1.584 . . . . 0.0 110.663 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -59.83 -36.43 76.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.884 1.273 . . . . 0.0 110.012 165.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.77 65.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.312 1.845 . . . . 0.0 115.685 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -33.27 56.98 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.181 -1.574 . . . . 0.0 112.183 162.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.55 -13.7 8.15 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.832 1.682 . . . . 0.0 115.706 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -59.1 -39.12 81.25 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.4 1.6 . . . . 0.0 113.135 164.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.83 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 130.559 3.543 . . . . 0.0 117.954 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.77 119.84 4.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.364 1.465 . . . . 0.0 110.981 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -151.37 -147.28 0.22 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.321 1.449 . . . . 0.0 110.691 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.1 ttp85 -147.65 148.02 30.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.775 2.83 . . . . 0.0 109.643 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.7 OUTLIER -114.71 -35.97 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.861 1.264 . . . . 0.0 111.585 -170.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -147.32 -117.94 1.02 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.413 1.958 . . . . 0.0 108.788 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -42.58 98.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.974 1.387 . . . . 0.0 111.954 162.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -95.94 -177.77 4.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.235 1.014 . . . . 0.0 113.708 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -133.98 116.94 16.13 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.065 2.146 . . . . 0.0 109.78 -144.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.9 mp -122.84 157.42 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.789 1.757 . . . . 0.0 111.918 -149.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.262 1.1 mm-40 -128.2 159.42 35.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 130.992 3.717 . . . . 0.0 110.186 -164.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.69 142.61 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.28 150.14 35.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.097 2.159 . . . . 0.0 109.921 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -82.02 151.59 27.05 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.234 -0.916 . . . . 0.0 112.51 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 m -158.58 165.44 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.959 -161.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.35 156.48 42.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.749 1.619 . . . . 0.0 111.173 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -40.81 2.94 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 1 C-N-CA 133.873 4.869 . . . . 0.0 120.269 -175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -126.34 -22.24 4.05 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 119.772 -1.83 . . . . 0.0 112.247 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.48 -2.05 52.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.348 1.459 . . . . 0.0 110.558 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.7 m -118.72 -25.68 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 128.752 2.821 . . . . 0.0 113.15 -160.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -89.59 50.84 1.97 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.426 1.49 . . . . 0.0 111.481 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 7.2 t -69.63 8.1 0.72 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.825 2.05 . . . . 0.0 114.081 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.39 2.276 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.1 t -44.84 -42.98 8.38 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 -153.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.1 35.9 1.92 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.74 1.155 . . . . 0.0 111.793 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -159.78 -172.86 3.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.72 2.008 . . . . 0.0 111.799 -160.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 p -34.11 109.01 0.07 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.241 2.216 . . . . 0.0 114.743 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.86 -33.77 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.502 2.721 . . . . 0.0 114.596 1.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -127.25 -20.72 4.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.72 44.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 130.223 3.409 . . . . 0.0 113.744 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.22 95.41 0.43 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.824 2.154 . . . . 0.0 110.25 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -105.49 161.62 14.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 173.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.72 121.82 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.118 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 36.5 ttt85 -94.4 133.66 37.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.445 1.098 . . . . 0.0 111.381 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.28 152.42 19.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.365 1.866 . . . . 0.0 111.994 167.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 135.33 39.08 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 146.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 166.03 -18.81 0.1 OUTLIER Glycine 0 CA--C 1.531 1.086 0 O-C-N 119.823 -1.798 . . . . 0.0 113.77 152.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.402 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 1.4 mt -55.52 148.6 33.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.284 3.034 . . . . 0.0 115.335 -152.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.72 175.59 11.1 Favored 'Trans proline' 0 C--N 1.344 0.294 1 C-N-CA 126.35 4.7 . . . . 0.0 112.796 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -66.75 135.09 53.46 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.491 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.3 57.89 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-O 117.929 -1.484 . . . . 0.0 114.959 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 118' ' ' LEU . 35.4 t -57.24 151.43 15.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.037 1.918 . . . . 0.0 112.18 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 165.09 28.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 123.177 1.465 . . . . 0.0 112.267 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -44.99 -40.6 6.58 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 127.872 2.469 . . . . 0.0 113.534 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -70.39 -17.88 63.04 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 121.317 1.871 . . . . 0.0 114.027 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.09 -31.99 56.35 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 119.894 -1.754 . . . . 0.0 108.96 168.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.5 mt -68.69 -38.1 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.155 -0.966 . . . . 0.0 111.815 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -63.72 -17.11 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.748 1.219 . . . . 0.0 112.924 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -23.7 15.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.11 1.323 . . . . 0.0 112.129 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.22 -49.38 77.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.047 1.339 . . . . 0.0 109.777 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.86 33.23 5.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.443 1.497 . . . . 0.0 112.698 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 90.9 p -50.17 -22.03 1.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 156.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -49.49 -37.75 26.55 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.085 1.802 . . . . 0.0 115.347 168.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.04 168.01 20.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.428 1.091 . . . . 0.0 113.65 -153.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.62 128.6 36.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.914 1.685 . . . . 0.0 112.019 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 65.1 mt -128.8 134.81 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.659 2.784 . . . . 0.0 107.418 -174.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.2 m -65.19 154.03 88.06 Favored Pre-proline 0 N--CA 1.484 1.226 0 O-C-N 121.81 -0.556 . . . . 0.0 111.544 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.38 -7.33 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.239 3.293 . . . . 0.0 119.814 -169.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -127.35 12.97 7.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.004 1.322 . . . . 0.0 112.209 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.53 72.03 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -152.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.1 mt -93.93 132.23 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.832 1.253 . . . . 0.0 109.335 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.8 m -124.08 132.87 53.71 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.806 1.642 . . . . 0.0 112.67 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.95 93.13 48.75 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 127.511 2.324 . . . . 0.0 110.921 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.31 -65.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.235 1.29 . . . . 0.0 113.162 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.71 175.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 129.72 3.208 . . . . 0.0 109.163 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 11.0 p-10 -72.95 171.6 9.93 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 119.818 -1.801 . . . . 0.0 114.316 160.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.18 2.48 0.13 Allowed 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 124.729 3.619 . . . . 0.0 117.151 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -128.62 -1.32 5.48 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.686 1.594 . . . . 0.0 112.008 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.25 36.07 28.29 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -132.42 -16.22 2.74 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.713 1.756 . . . . 0.0 112.792 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.288 0.0 OUTLIER -141.97 -112.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.508 -170.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p -177.86 80.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.871 3.268 . . . . 0.0 107.433 -170.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.47 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -128.56 5.59 6.64 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 128.151 2.786 . . . . 0.0 115.429 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.17 161.87 36.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.512 1.525 . . . . 0.0 108.365 157.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.43 -179.53 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.924 1.689 . . . . 0.0 109.063 -166.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 191' ' ' VAL . 97.7 m-85 -153.4 158.76 41.95 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.342 0.657 . . . . 0.0 110.25 -167.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -158.54 123.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -92.47 129.92 38.28 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 127.557 2.343 . . . . 0.0 110.99 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.4 m-85 -97.87 -168.5 1.68 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 110.046 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.02 -10.23 59.5 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.024 -1.672 . . . . 0.0 113.733 165.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.9 m -162.65 158.33 23.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -69.99 43.79 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.829 2.452 . . . . 0.0 112.831 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -149.82 -56.53 0.18 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.613 1.965 . . . . 0.0 110.252 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.1 mt -54.2 -41.66 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.418 1.487 . . . . 0.0 111.339 163.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.21 -12.47 61.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -31.06 12.53 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.572 -1.33 . . . . 0.0 109.656 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -63.62 -35.36 80.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.951 1.3 . . . . 0.0 109.537 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.5 73.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.215 1.806 . . . . 0.0 115.544 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.7 mp -52.62 -32.64 42.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.536 -1.353 . . . . 0.0 113.279 164.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.6 -11.87 11.77 Favored Glycine 0 CA--C 1.546 1.984 0 C-N-CA 125.573 1.558 . . . . 0.0 115.631 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -59.21 -38.26 79.48 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.187 1.494 . . . . 0.0 113.474 165.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.79 -60.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 129.527 3.131 . . . . 0.0 116.423 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 105.19 4.55 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.897 2.079 . . . . 0.0 110.754 -174.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -145.58 -163.25 1.68 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.184 1.794 . . . . 0.0 110.335 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.23 44.76 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 128.651 2.781 . . . . 0.0 109.283 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.77 -39.93 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.145 0.578 . . . . 0.0 111.509 -165.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.66 -98.56 0.48 Allowed Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.801 1.667 . . . . 0.0 109.956 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -46.28 14.64 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.799 1.3 . . . . 0.0 112.132 162.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -95.28 -178.1 4.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.919 1.288 . . . . 0.0 114.13 -167.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -132.78 125.68 30.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 110.568 -143.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 1.8 mp -125.06 134.42 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 123.447 1.594 . . . . 0.0 112.553 -147.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.07 157.25 35.09 Favored 'General case' 0 CA--C 1.538 0.489 1 C-N-CA 132.127 4.171 . . . . 0.0 114.251 164.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.86 136.59 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.228 1.011 . . . . 0.0 111.463 168.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -138.91 151.64 47.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.076 2.151 . . . . 0.0 109.139 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -90.52 143.73 26.46 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.493 -0.754 . . . . 0.0 111.72 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -149.95 165.96 31.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.607 -157.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.12 160.26 42.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.107 1.763 . . . . 0.0 110.534 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -40.51 4.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 1 C-N-CA 133.478 4.711 . . . . 0.0 119.021 177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.66 -15.18 5.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.769 2.028 . . . . 0.0 114.028 -175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -114.3 -19.96 11.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.511 2.325 . . . . 0.0 110.109 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' HA ' ' CE1' ' A' ' 156' ' ' PHE . 19.2 m -79.21 -23.08 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 129.883 3.273 . . . . 0.0 114.31 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.43 63.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.252 1.821 . . . . 0.0 109.193 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.1 m -54.79 -31.65 59.2 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.779 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.229 0 C-N-CA 128.4 2.68 . . . . 0.0 113.657 156.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.3 p30 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.4 m -147.3 32.65 0.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.31 1.844 . . . . 0.0 111.539 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.66 54.83 1.59 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.9 2.48 . . . . 0.0 107.998 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.34 159.45 26.07 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -147.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.2 t -166.79 -176.85 3.62 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.605 2.762 . . . . 0.0 108.964 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.45 -28.16 41.63 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.917 -1.114 . . . . 0.0 112.966 163.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -34.37 0.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 -167.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.49 51.15 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.477 1.132 . . . . 0.0 113.381 -163.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.26 89.6 0.9 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 126.169 1.842 . . . . 0.0 110.985 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 158' ' ' GLN . 5.0 m-85 -95.27 164.58 12.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.76 120.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 76.4 ttt180 -95.39 136.94 35.12 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.583 0.753 . . . . 0.0 111.95 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.67 148.89 26.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.653 2.781 . . . . 0.0 109.775 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -154.11 78.28 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 109.383 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 179.9 -3.81 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.88 151.43 73.57 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 118.61 1.205 . . . . 0.0 112.117 -161.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.17 174.91 10.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 1 C-N-CA 126.598 4.865 . . . . 0.0 113.715 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.35 127.68 32.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.732 1.213 . . . . 0.0 111.42 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.7 14.84 75.47 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 117.959 -1.467 . . . . 0.0 115.681 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 29.5 t -58.0 152.48 16.33 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.366 2.083 . . . . 0.0 112.543 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.23 164.24 32.9 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 122.847 1.308 . . . . 0.0 111.371 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -45.08 -42.91 9.13 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 127.799 2.44 . . . . 0.0 112.919 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.409 ' HA ' ' CG1' ' A' ' 128' ' ' VAL . 37.4 mp0 -68.92 -18.52 64.11 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.669 1.577 . . . . 0.0 113.893 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.65 -25.57 45.01 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.62 -1.925 . . . . 0.0 110.671 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.06 -37.14 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.724 0.81 . . . . 0.0 110.995 165.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.409 ' CG1' ' HA ' ' A' ' 125' ' ' GLU 0.261 2.2 m -59.92 -20.89 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.266 1.026 . . . . 0.0 113.151 169.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -93.5 -28.59 16.0 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.909 1.231 . . . . 0.0 113.448 168.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.87 -45.81 91.3 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.394 1.477 . . . . 0.0 111.168 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -116.17 33.51 5.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.625 1.17 . . . . 0.0 113.108 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.0 p -53.3 -22.49 7.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.79 -32.49 40.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.297 1.903 . . . . 0.0 115.232 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.73 169.71 17.31 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.18 1.392 . . . . 0.0 112.172 -157.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -99.62 136.26 39.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.372 1.469 . . . . 0.0 112.166 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.4 mt -134.19 139.12 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 128.887 2.875 . . . . 0.0 108.79 -168.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.7 152.13 76.3 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.667 -0.646 . . . . 0.0 110.887 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.85 -24.05 22.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -158.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.09 40.5 2.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.935 1.294 . . . . 0.0 109.872 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.61 16.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.15 1.357 . . . . 0.0 115.674 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.5 mt -93.17 126.44 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 125.27 1.428 . . . . 0.0 109.451 -169.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.5 m -121.92 132.18 54.41 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.039 1.736 . . . . 0.0 112.869 -174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.67 91.35 49.79 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.178 2.191 . . . . 0.0 111.483 -169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.44 -70.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 121.771 1.647 . . . . 0.0 113.655 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.91 169.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 129.516 3.127 . . . . 0.0 108.809 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.494 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.4 p-10 -70.52 170.74 9.68 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 165.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.6 0.06 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 124.838 3.692 . . . . 0.0 117.13 171.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -129.15 0.38 5.19 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.74 1.616 . . . . 0.0 111.814 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.03 37.82 42.3 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -130.24 -16.72 3.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.161 1.481 . . . . 0.0 112.657 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 152' ' ' THR 0.294 0.0 OUTLIER -143.09 -112.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 113.482 -169.425 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -177.77 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.419 3.087 . . . . 0.0 108.028 -166.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -122.97 5.56 9.62 Favored Glycine 0 N--CA 1.466 0.7 0 C-N-CA 127.84 2.638 . . . . 0.0 114.685 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.36 159.04 42.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.22 0.608 . . . . 0.0 109.982 152.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.18 178.26 3.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.261 1.825 . . . . 0.0 110.751 -165.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 114' ' ' ARG . 92.0 m-85 -149.79 156.26 41.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.918 1.287 . . . . 0.0 109.283 -168.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.3 p -156.13 121.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 31.6 tp60 -90.0 129.8 36.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.544 1.938 . . . . 0.0 109.444 176.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.3 m-85 -86.96 -165.33 1.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.54 -14.6 60.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.965 -1.709 . . . . 0.0 112.307 161.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.7 m -158.66 163.9 36.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -56.78 -33.17 66.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.19 1.396 . . . . 0.0 114.679 167.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -72.58 -50.18 27.21 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 111.915 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.12 -35.87 69.99 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.069 1.348 . . . . 0.0 111.264 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.51 -17.38 59.3 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.216 0.532 . . . . 0.0 112.262 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -87.09 -32.05 20.14 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.611 -1.305 . . . . 0.0 109.698 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -35.77 81.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.392 1.477 . . . . 0.0 109.711 169.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.47 89.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.167 1.787 . . . . 0.0 115.592 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 mp -50.03 -25.74 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.8 -16.34 30.72 Favored Glycine 0 CA--C 1.547 2.09 0 C-N-CA 124.858 1.218 . . . . 0.0 115.335 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -68.97 -14.51 63.08 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.49 1.645 . . . . 0.0 114.77 167.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 39.96 -48.64 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 132.407 4.283 . . . . 0.0 121.16 170.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 15.79 0.66 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.324 1.85 . . . . 0.0 113.338 -173.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -55.09 174.27 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -110.75 155.68 22.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.652 1.581 . . . . 0.0 114.148 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.96 169.1 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 130.972 3.709 . . . . 0.0 106.558 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 2.49 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.475 1.274 0 C-N-CA 129.774 3.559 . . . . 0.0 116.616 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 -2.86 4.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 171.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -134.38 -179.01 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.406 1.482 . . . . 0.0 114.959 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -144.05 111.16 5.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.426 -126.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.1 mt -115.51 129.01 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.436 1.112 . . . . 0.0 111.898 -139.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 153.24 41.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.553 2.341 . . . . 0.0 113.195 166.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.25 135.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.399 0.68 . . . . 0.0 111.657 167.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -139.25 143.48 38.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.149 1.78 . . . . 0.0 109.386 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -75.35 136.91 40.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.725 0.774 . . . . 0.0 109.91 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 m -141.82 166.46 24.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.727 -164.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -143.5 157.18 44.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.91 0.884 . . . . 0.0 110.616 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -33.84 5.44 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.907 1 C-N-CA 134.945 5.298 . . . . 0.0 120.037 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -126.71 -22.45 3.89 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.09 -1.631 . . . . 0.0 112.851 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.51 -21.91 61.12 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.471 -1.393 . . . . 0.0 109.708 172.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.8 m -96.35 -28.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 126.855 2.062 . . . . 0.0 113.447 -150.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 56.34 3.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.793 1.237 . . . . 0.0 110.132 176.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.8 t -61.54 -13.13 18.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.381 2.272 . . . . 0.0 112.624 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.91 0.386 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.3 p -157.82 -15.4 0.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.791 2.037 . . . . 0.0 114.673 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.47 83.06 0.69 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.241 2.217 . . . . 0.0 108.238 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -150.52 159.2 44.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 0.0 112.752 -160.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.6 -60.08 0.89 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.58 -39.72 0.06 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -149.55 -23.02 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -52.66 41.68 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 1 C-N-CA 133.664 4.786 . . . . 0.0 116.371 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.12 90.17 0.06 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.931 1.253 . . . . 0.0 111.737 162.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' O ' ' HE2' ' A' ' 185' ' ' LYS . 2.7 m-85 -107.5 160.75 15.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.36 116.02 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 73.5 ttt180 -88.39 120.17 29.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.362 1.065 . . . . 0.0 111.382 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.45 151.21 41.18 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.525 1.53 . . . . 0.0 111.648 162.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 139.9 44.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 148.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.5 -20.65 0.82 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.523 -1.361 . . . . 0.0 112.885 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.452 HD23 ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -58.18 142.91 80.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.514 1.926 . . . . 0.0 113.544 -156.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.28 165.7 27.33 Favored 'Trans proline' 0 N--CA 1.458 -0.576 1 C-N-CA 126.231 4.621 . . . . 0.0 112.131 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.54 116.79 4.6 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.317 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.33 59.76 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.615 -1.103 . . . . 0.0 115.549 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.6 t -56.06 148.34 17.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.984 1.892 . . . . 0.0 110.938 165.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -144.32 171.05 14.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.952 0.882 . . . . 0.0 110.076 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -41.31 -40.93 1.79 Allowed 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 127.438 2.295 . . . . 0.0 112.978 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -58.52 -32.67 69.07 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.25 2.22 . . . . 0.0 116.069 173.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -77.01 -23.33 52.2 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 119.958 -1.714 . . . . 0.0 110.157 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.78 -37.33 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.641 -0.662 . . . . 0.0 110.993 166.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -62.15 -17.26 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.126 1.37 . . . . 0.0 113.054 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -98.17 -25.28 14.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.62 1.1 . . . . 0.0 113.937 168.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.81 -45.86 91.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.057 1.343 . . . . 0.0 110.575 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -121.48 33.25 5.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.038 1.335 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -54.24 -19.4 5.19 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.769 -0.582 . . . . 0.0 112.49 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.68 -35.0 44.99 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.588 1.566 . . . . 0.0 115.496 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.34 163.56 31.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -153.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.84 139.25 32.78 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 112.84 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 75.4 mt -144.51 133.37 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.639 2.375 . . . . 0.0 107.24 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.89 153.35 54.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.636 -0.665 . . . . 0.0 111.438 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.69 -23.96 28.2 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 120.842 3.362 . . . . 0.0 120.842 -160.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.48 39.43 2.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.674 1.19 . . . . 0.0 109.95 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.8 -26.45 17.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.89 1.233 . . . . 0.0 114.812 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -84.1 132.44 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.662 1.585 . . . . 0.0 108.883 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 m -126.19 131.57 51.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.263 1.825 . . . . 0.0 112.124 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.2 84.96 61.75 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 126.572 1.949 . . . . 0.0 112.61 -167.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.83 -69.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 121.825 1.684 . . . . 0.0 115.512 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.64 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 127.252 2.221 . . . . 0.0 111.651 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.484 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.0 p-10 -79.06 173.26 8.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.893 2.077 . . . . 0.0 114.845 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.45 -4.31 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 125.074 3.849 . . . . 0.0 117.844 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.42 -32.0 3.94 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 121.35 1.886 . . . . 0.0 111.785 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 109.02 40.26 1.57 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.235 0.922 . . . . 0.0 114.641 165.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.4 -3.13 4.35 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 113.106 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.488 HG23 ' H ' ' A' ' 152' ' ' THR 0.318 0.0 OUTLIER -141.7 -102.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.998 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.488 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 165.98 68.0 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.444 3.498 . . . . 0.0 108.687 -159.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.484 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -114.58 4.02 23.15 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 129.266 3.317 . . . . 0.0 116.226 172.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -127.29 163.5 23.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.234 1.016 . . . . 0.0 109.632 142.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.85 178.36 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.405 2.282 . . . . 0.0 108.154 -168.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.532 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 97.3 m-85 -150.42 160.59 43.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.582 0.753 . . . . 0.0 109.512 -167.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.02 121.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 55.7 tp60 -92.69 123.87 36.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 127.222 2.209 . . . . 0.0 111.386 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 11.3 m-85 -86.99 -173.63 4.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.329 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.98 -8.74 57.94 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.224 -1.548 . . . . 0.0 113.105 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.6 m -160.39 161.29 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.566 1.147 . . . . 0.0 112.944 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -57.4 -31.24 65.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.212 1.405 . . . . 0.0 113.508 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -84.67 -42.78 14.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.523 1.529 . . . . 0.0 113.014 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.4 mt -54.69 -35.47 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.449 1.5 . . . . 0.0 111.411 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.23 -10.05 57.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.07 -13.81 11.2 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.322 -1.486 . . . . 0.0 112.004 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -62.32 -40.31 95.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.702 0.801 . . . . 0.0 109.2 153.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.47 79.03 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -50.58 -27.0 5.95 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.694 1.588 . . . . 0.0 114.287 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.89 -19.82 56.58 Favored Glycine 0 CA--C 1.546 1.991 0 C-N-CA 125.077 1.322 . . . . 0.0 114.798 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.59 41.64 0.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.717 2.007 . . . . 0.0 112.61 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -51.31 -30.48 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.697 2.399 . . . . 0.0 114.888 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -147.58 107.3 3.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.264 1.026 . . . . 0.0 111.051 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -137.64 -161.21 1.14 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.654 1.582 . . . . 0.0 109.927 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -140.75 148.04 40.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.065 1.346 . . . . 0.0 111.718 -155.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.01 132.72 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.319 2.248 . . . . 0.0 108.132 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 59.54 -67.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.419 0 C-N-CA 127.605 2.526 . . . . 0.0 115.831 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.8 -9.85 0.21 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.714 2.406 . . . . 0.0 113.566 169.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -108.53 -175.03 2.66 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 127.139 2.176 . . . . 0.0 112.765 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -149.63 116.74 6.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -135.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.452 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.8 mt -127.03 135.8 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 122.776 1.274 . . . . 0.0 111.771 -139.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.8 159.27 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 130.955 3.702 . . . . 0.0 114.348 169.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.04 137.44 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.923 1.289 . . . . 0.0 111.005 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -138.42 146.88 42.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.205 1.802 . . . . 0.0 109.806 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -70.82 142.84 51.27 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.782 1.233 . . . . 0.0 110.884 177.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.429 ' H ' ' HE2' ' A' ' 185' ' ' LYS . 3.3 m -153.79 161.88 41.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.357 -164.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.5 m -146.2 157.38 43.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.084 1.354 . . . . 0.0 111.148 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.4 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.3 tp60 -40.93 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.129 4.572 . . . . 0.0 119.674 -175.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 -16.0 3.91 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.976 -1.702 . . . . 0.0 114.369 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.44 -29.14 18.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.767 1.627 . . . . 0.0 108.915 173.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.532 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 35.7 m -73.23 -26.18 22.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 129.111 2.965 . . . . 0.0 115.42 172.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -73.45 28.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.251 2.621 . . . . 0.0 114.644 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.9 m -62.27 -7.87 4.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.464 1.105 . . . . 0.0 112.41 160.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 C-N-CA 128.287 2.635 . . . . 0.0 107.216 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 115.385 1.624 . . . . 10.0 115.385 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.83 36.13 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.563 3.145 . . . . 10.0 114.934 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -61.39 101.36 0.32 Allowed Glycine 0 C--O 1.228 -0.229 0 CA-C-O 117.797 -1.557 . . . . 10.0 111.75 173.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.683 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -111.03 167.59 10.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.859 -1.904 . . . . 10.0 105.859 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.0 t -134.06 153.29 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.247 -1.797 . . . . 10.0 107.964 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 52.3 ttt180 -120.65 136.49 54.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.0 1.32 . . . . 10.0 111.959 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.88 147.19 29.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.409 3.084 . . . . 10.0 109.976 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -152.66 77.22 1.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.599 1.16 . . . . 10.0 109.936 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.07 9.4 0.02 OUTLIER Glycine 0 CA--C 1.532 1.125 0 N-CA-C 116.176 1.23 . . . . 10.0 116.176 -164.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.6 mt -80.44 155.41 74.04 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.797 1.239 . . . . 10.0 111.313 -166.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.511 ' CD ' HG22 ' A' ' 176' ' ' ILE . 23.8 Cg_endo -84.08 175.75 7.26 Favored 'Trans proline' 0 CA--C 1.532 0.384 1 C-N-CA 126.72 4.947 . . . . 10.0 112.489 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -63.98 135.17 56.24 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.421 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 69.58 15.1 70.47 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 118.247 -1.307 . . . . 10.0 115.585 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 176' ' ' ILE . 39.7 t -58.34 147.43 31.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.053 1.927 . . . . 10.0 112.78 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 171.86 16.68 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.028 0.918 . . . . 10.0 112.146 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 128' ' ' VAL . 6.7 mttm -38.44 -53.6 1.53 Allowed 'General case' 0 C--O 1.205 -1.237 0 CA-C-O 116.477 -1.725 . . . . 10.0 113.54 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.48 -19.76 63.89 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 121.585 1.993 . . . . 10.0 113.7 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -79.98 -29.39 39.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.16 -1.587 . . . . 10.0 110.767 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 143' ' ' LEU . 46.3 mt -73.12 -43.48 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.373 1.069 . . . . 10.0 111.17 168.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.3 m -56.64 -21.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.31 1.844 . . . . 10.0 113.303 169.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -96.39 -26.33 15.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.887 1.676 . . . . 10.0 112.37 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -58.81 -51.94 67.86 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.59 1.556 . . . . 10.0 109.864 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 39.8 m-85 -112.75 30.98 6.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.305 1.042 . . . . 10.0 112.841 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.5 p -53.23 -21.86 5.95 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.173 0.805 . . . . 10.0 113.173 156.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.3 -31.91 43.31 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.073 1.796 . . . . 10.0 115.208 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.28 166.21 24.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.116 1.366 . . . . 10.0 112.875 -157.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.32 134.77 34.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.147 1.379 . . . . 10.0 111.649 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 71.2 mt -137.27 140.62 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 128.371 2.668 . . . . 10.0 106.978 -170.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.15 156.08 61.25 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.535 -0.728 . . . . 10.0 111.432 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.22 -19.24 16.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 120.957 3.407 . . . . 10.0 120.957 -162.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.8 35.48 2.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.633 1.106 . . . . 10.0 110.657 166.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.12 45.3 0.58 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 126.692 2.091 . . . . 10.0 114.228 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 128' ' ' VAL . 86.3 mt -143.58 136.13 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 119.964 1.882 . . . . 10.0 106.012 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -132.52 131.54 41.71 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.24 1.836 . . . . 10.0 112.569 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 127' ' ' ILE . 2.9 mm? -124.94 84.06 59.23 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 127.263 2.225 . . . . 10.0 110.868 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.69 -65.18 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 121.081 1.188 . . . . 10.0 113.237 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.84 169.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 128.328 2.651 . . . . 10.0 110.149 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.1 p-10 -68.5 173.3 3.51 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.533 . . . . 10.0 114.778 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.37 -1.98 0.54 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.754 3.636 . . . . 10.0 117.624 172.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.72 -31.89 3.14 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.537 1.971 . . . . 10.0 112.28 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.04 37.66 1.22 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.88 -0.955 . . . . 10.0 115.445 163.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -135.34 -2.95 2.44 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.997 1.398 . . . . 10.0 113.808 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.611 HG23 ' H ' ' A' ' 152' ' ' THR 0.285 0.0 OUTLIER -143.7 -118.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.782 1.233 . . . . 10.0 113.496 -178.373 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.611 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.1 p -172.76 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.365 3.466 . . . . 10.0 107.051 -167.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.547 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.29 6.46 11.83 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 126.98 2.228 . . . . 10.0 114.751 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -132.08 156.55 46.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.016 0.912 . . . . 10.0 110.376 148.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.19 175.45 8.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 126.088 1.755 . . . . 10.0 110.423 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 86.1 m-85 -149.09 164.64 34.07 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.524 -169.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -159.41 119.52 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 114.381 1.252 . . . . 10.0 114.381 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 49.6 tp60 -90.38 123.55 34.21 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 129.477 3.111 . . . . 10.0 111.055 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.2 m-85 -89.1 -165.45 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 123.143 0.577 . . . . 10.0 110.248 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.65 -10.3 59.74 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.88 -1.763 . . . . 10.0 113.632 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.4 m -158.48 160.95 37.31 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.428 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 2.2 tp60 -58.63 -28.12 65.36 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 171.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -80.08 -48.15 13.71 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.782 1.233 . . . . 10.0 112.214 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.62 -37.7 63.32 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.349 1.46 . . . . 10.0 111.334 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.91 -8.87 57.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -112.99 -15.3 12.88 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.918 -1.739 . . . . 10.0 112.893 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -60.01 -37.46 79.8 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 156.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -67.82 -46.34 72.15 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.549 2.055 . . . . 10.0 116.549 172.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mp -48.0 -35.07 10.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 120.527 1.512 . . . . 10.0 113.189 162.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.41 -15.16 30.44 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 125.622 1.582 . . . . 10.0 115.85 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -64.6 -26.33 68.35 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.56 1.68 . . . . 10.0 114.65 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.3 t60 60.58 -47.58 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.922 2.889 . . . . 10.0 117.328 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -145.1 -66.76 0.32 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.64 1.576 . . . . 10.0 112.611 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 36.82 -142.3 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.575 1.55 . . . . 10.0 113.186 -167.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -151.25 155.51 38.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.864 . . . . 10.0 110.199 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.511 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.5 mt -132.93 135.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.151 2.58 . . . . 10.0 105.447 162.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 49.02 -86.95 0.01 OUTLIER Glycine 0 N--CA 1.474 1.167 0 C-N-CA 126.801 2.144 . . . . 10.0 114.178 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 5.04 3.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.632 1.573 . . . . 10.0 114.449 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.51 -179.53 5.21 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.25 1.82 . . . . 10.0 114.259 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -146.84 14.13 1.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.604 -1.18 . . . . 10.0 113.01 -124.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 176' ' ' ILE . 1.3 mt 42.96 107.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 116.983 2.216 . . . . 10.0 116.983 134.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 165.06 23.17 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 127.506 2.323 . . . . 10.0 113.649 160.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.6 140.34 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.664 0.786 . . . . 10.0 112.294 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -144.44 153.25 41.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.432 1.893 . . . . 10.0 110.507 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -74.31 154.62 38.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.809 0.844 . . . . 10.0 111.837 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.3 m -159.02 167.97 27.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.021 0.748 . . . . 10.0 113.021 -165.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 14.9 m -149.42 161.89 41.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.464 1.906 . . . . 10.0 109.64 159.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HG22 ' A' ' 191' ' ' VAL . 30.1 tp60 -31.62 -10.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 1 C-N-CA 132.467 4.307 . . . . 10.0 120.595 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.3 -6.32 3.8 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.232 -2.168 . . . . 10.0 112.066 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -23.05 39.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 149.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.683 HG11 ' CD2' ' A' ' 112' ' ' PHE . 9.5 m . . . . . 0 C--N 1.35 0.601 0 N-CA-C 115.443 1.646 . . . . 10.0 115.443 -164.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 122.012 0.91 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.08 45.22 0.09 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.591 3.156 . . . . 0.0 113.556 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.86 102.12 1.63 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.639 ' CD2' HG11 ' A' ' 191' ' ' VAL . 3.2 m-85 -99.48 160.57 14.19 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.5 118.33 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.273 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -104.11 125.8 50.72 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 -164.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.37 151.59 23.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.467 2.307 . . . . 0.0 110.494 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -155.58 79.55 1.02 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.682 1.593 . . . . 0.0 108.582 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.39 -11.96 0.02 OUTLIER Glycine 0 CA--C 1.536 1.401 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -162.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.828 HD23 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -73.36 152.69 90.07 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.608 1.163 . . . . 0.0 113.423 -155.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.481 ' CD ' HG22 ' A' ' 176' ' ' ILE . 69.7 Cg_endo -78.02 171.35 17.32 Favored 'Trans proline' 0 CA--C 1.531 0.352 1 C-N-CA 126.753 4.969 . . . . 0.0 112.653 173.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -57.37 133.9 55.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.068 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.2 19.24 68.03 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 118.775 -1.014 . . . . 0.0 115.169 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 118' ' ' LEU . 33.8 t -55.44 146.69 19.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.273 1.536 . . . . 0.0 111.722 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.0 t -150.7 163.5 38.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 112.164 -173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.5 mttt -39.2 -44.38 1.21 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 126.738 2.015 . . . . 0.0 115.684 173.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -69.84 -19.91 63.44 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.089 1.356 . . . . 0.0 112.957 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 2.2 mm-40 -78.12 -32.12 50.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.284 -1.51 . . . . 0.0 109.597 169.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.445 HD12 HD21 ' A' ' 143' ' ' LEU . 16.2 mt -69.59 -39.85 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 120.708 -1.245 . . . . 0.0 110.782 169.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 124' ' ' LYS 0.269 1.2 m -61.59 -13.46 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.613 1.565 . . . . 0.0 114.512 168.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.4 pp0? -101.86 -21.19 14.62 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 121.031 1.741 . . . . 0.0 113.728 166.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -49.2 75.04 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.614 1.566 . . . . 0.0 110.732 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -118.84 31.49 6.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.224 1.41 . . . . 0.0 112.069 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 84.2 p -46.59 -25.7 0.75 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 153.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.22 70.52 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.65 2.071 . . . . 0.0 116.246 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.06 159.73 41.03 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.647 1.224 . . . . 0.0 113.14 -154.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.55 127.68 34.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.997 1.319 . . . . 0.0 112.04 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 46.8 mt -129.49 139.18 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 128.358 2.663 . . . . 0.0 108.494 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.01 151.3 80.88 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.309 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -52.83 -24.87 25.27 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 120.671 3.296 . . . . 0.0 120.671 -158.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.39 42.45 2.36 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.792 1.237 . . . . 0.0 110.078 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.74 -23.68 30.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.909 1.243 . . . . 0.0 114.967 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.12 144.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 125.629 1.572 . . . . 0.0 109.481 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 77.6 m -140.28 136.29 33.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.056 -1.653 . . . . 0.0 113.52 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -125.74 89.88 51.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.101 2.56 . . . . 0.0 111.129 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.07 -72.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.017 1.812 . . . . 0.0 113.728 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.07 167.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 127.034 2.134 . . . . 0.0 111.183 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.3 p-10 -70.22 173.38 4.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.087 1.755 . . . . 0.0 114.875 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.46 -3.28 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.691 3.594 . . . . 0.0 117.886 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.08 -36.68 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.814 2.097 . . . . 0.0 111.881 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.04 42.13 0.67 Allowed Glycine 0 CA--C 1.532 1.117 0 N-CA-C 115.27 0.868 . . . . 0.0 115.27 163.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -134.0 -2.81 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.742 1.217 . . . . 0.0 113.631 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.626 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -143.47 -117.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.063 1.345 . . . . 0.0 113.47 -178.401 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.626 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -175.7 76.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 130.72 3.608 . . . . 0.0 106.08 -169.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -117.67 3.6 17.47 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 127.971 2.7 . . . . 0.0 115.646 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.03 157.84 41.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 122.307 1.051 . . . . 0.0 109.753 148.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.44 177.69 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.527 2.331 . . . . 0.0 108.188 -171.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.572 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -152.38 159.52 43.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 122.624 0.369 . . . . 0.0 110.871 -163.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.43 129.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 53.4 tp60 -104.23 138.53 40.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.382 2.273 . . . . 0.0 110.13 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 2.9 m-85 -106.02 -175.87 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.92 57.09 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.048 -1.658 . . . . 0.0 113.267 168.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.8 m -161.24 161.68 30.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.311 1.045 . . . . 0.0 112.444 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -62.57 -21.6 65.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.028 0.931 . . . . 0.0 113.122 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.5 -47.7 10.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.533 2.733 . . . . 0.0 112.776 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.37 -35.68 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.9 1.28 . . . . 0.0 111.139 168.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.05 -13.55 62.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.508 172.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -94.75 -29.57 14.7 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.147 -1.596 . . . . 0.0 110.644 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -61.24 -38.86 88.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.062 1.745 . . . . 0.0 109.844 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.25 -45.76 83.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.086 2.155 . . . . 0.0 116.02 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.59 -28.24 13.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 113.768 165.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.74 -19.52 55.28 Favored Glycine 0 CA--C 1.546 2.012 0 C-N-CA 125.344 1.45 . . . . 0.0 115.418 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -72.43 35.7 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.77 2.028 . . . . 0.0 113.402 164.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.416 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 1.6 t-80 -50.16 -31.05 12.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -154.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 27.75 3.47 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.284 1.433 . . . . 0.0 113.371 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -66.96 -170.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -138.11 148.7 45.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.354 1.862 . . . . 0.0 111.361 -153.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.8 mt -139.71 128.12 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 128.824 2.849 . . . . 0.0 106.41 173.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.88 -126.19 34.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -98.47 8.43 44.89 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.6 -179.94 4.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -153.03 111.69 3.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -119.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.828 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.7 mt -126.43 136.77 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 122.876 1.322 . . . . 0.0 112.6 -139.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 155.08 40.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.689 3.196 . . . . 0.0 113.287 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 172' ' ' HIS . 1.7 m -141.67 132.47 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.749 0.82 . . . . 0.0 111.664 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.28 151.0 44.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.391 1.876 . . . . 0.0 110.328 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -74.25 143.95 44.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.206 1.003 . . . . 0.0 111.578 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.19 170.76 18.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.911 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 191' ' ' VAL . 69.7 m -143.16 154.08 43.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.192 1.397 . . . . 0.0 110.018 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -29.33 4.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.139 1 C-N-CA 135.643 5.577 . . . . 0.0 120.305 174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -137.51 -24.58 1.05 Allowed 'General case' 0 C--N 1.322 -0.619 0 O-C-N 119.861 -1.774 . . . . 0.0 112.448 -164.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.36 -21.87 28.68 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 161.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 112' ' ' PHE . 32.4 m . . . . . 0 CA--C 1.52 -0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 113.215 -165.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 37.87 0.52 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.269 3.028 . . . . 0.0 112.774 -163.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.67 108.88 2.64 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CD2' HG11 ' A' ' 191' ' ' VAL . 15.1 m-85 -97.02 166.68 11.48 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 164.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.31 110.67 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.315 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -87.28 121.11 29.29 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.543 0.737 . . . . 0.0 111.585 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.07 151.41 28.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.735 2.014 . . . . 0.0 110.598 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.67 89.86 1.59 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.107 1.363 . . . . 0.0 108.784 168.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.14 -24.75 0.02 OUTLIER Glycine 0 N--CA 1.468 0.781 0 C-N-CA 117.797 -2.144 . . . . 0.0 114.313 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -52.75 144.39 25.78 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.879 2.472 . . . . 0.0 114.864 -157.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.38 172.52 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.503 1 C-N-CA 126.783 4.988 . . . . 0.0 112.938 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -48.31 123.15 6.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.455 1.502 . . . . 0.0 111.786 165.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.82 19.08 76.15 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.79 154.68 3.72 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.341 1.57 . . . . 0.0 112.489 166.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.7 t -150.2 162.63 40.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.587 0.755 . . . . 0.0 112.59 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.4 mttt -35.54 -47.11 0.44 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 126.845 2.058 . . . . 0.0 114.487 166.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.29 -18.74 64.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 120.737 1.608 . . . . 0.0 113.686 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.94 -30.51 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.287 -1.508 . . . . 0.0 110.646 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 143' ' ' LEU . 18.8 mt -68.17 -42.59 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.855 167.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 124' ' ' LYS 0.25 1.0 OUTLIER -62.27 -14.69 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 113.92 170.528 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -25.77 14.9 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.581 1.537 . . . . 0.0 113.885 164.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -46.51 83.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 109.732 173.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.555 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 27.8 m-85 -121.77 33.97 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.202 1.401 . . . . 0.0 113.686 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 t -53.78 -21.57 7.66 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.511 0.672 . . . . 0.0 112.094 157.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.34 -30.04 60.99 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.061 1.791 . . . . 0.0 115.821 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.05 167.45 22.03 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.455 1.128 . . . . 0.0 113.016 -156.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.65 131.52 40.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 111.931 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.2 mt -128.82 137.83 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 128.277 2.631 . . . . 0.0 108.49 -171.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 m -65.7 154.4 88.72 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.732 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.21 -13.37 6.88 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.398 3.399 . . . . 0.0 119.85 -167.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -135.67 26.12 3.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.85 1.66 . . . . 0.0 111.438 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.03 67.07 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 -169.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.65 137.31 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.678 1.191 . . . . 0.0 108.91 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.0 m -131.68 138.4 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.042 1.737 . . . . 0.0 111.814 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -123.15 92.27 49.19 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 127.017 2.127 . . . . 0.0 110.873 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' A' ' 155' ' ' ALA . 88.9 Cg_endo -79.8 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.762 3.641 . . . . 0.0 113.14 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.68 173.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 130.123 3.369 . . . . 0.0 108.851 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.1 p-10 -77.91 172.78 8.9 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.851 2.061 . . . . 0.0 114.087 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.08 0.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 125.031 3.821 . . . . 0.0 117.499 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -126.5 -0.19 6.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.749 1.62 . . . . 0.0 111.938 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 35.46 48.2 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.514 -1.159 . . . . 0.0 115.961 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -130.05 -15.79 3.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.594 1.697 . . . . 0.0 112.635 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.326 0.0 OUTLIER -138.43 -98.4 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -170.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 164.33 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 129.917 3.287 . . . . 0.0 109.245 -165.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -124.8 4.47 8.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.71 3.528 . . . . 0.0 114.405 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -130.12 166.68 19.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.409 1.084 . . . . 0.0 108.866 145.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 144' ' ' PRO . . . -170.85 175.83 4.35 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 128.046 2.539 . . . . 0.0 109.049 -171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.5 m-85 -150.27 154.74 38.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.062 0.545 . . . . 0.0 110.713 -166.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.43 127.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -97.26 139.61 32.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.344 2.258 . . . . 0.0 111.403 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.1 m-85 -106.73 -177.4 3.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.387 0.675 . . . . 0.0 110.697 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.63 -10.22 59.54 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.143 -1.598 . . . . 0.0 112.946 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.1 m -159.86 157.33 28.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.237 1.015 . . . . 0.0 112.033 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -72.86 -13.87 61.37 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.651 -0.656 . . . . 0.0 112.446 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.415 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 41.6 tp10 -75.07 -51.5 13.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.784 2.434 . . . . 0.0 112.394 169.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.4 mt -57.14 -38.16 73.1 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.996 0.918 . . . . 0.0 110.447 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.23 62.16 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -104.33 -27.1 12.18 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.374 -1.454 . . . . 0.0 110.629 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER -61.81 -32.13 72.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.164 0.985 . . . . 0.0 109.072 165.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -69.69 -47.9 61.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mp -49.39 -33.51 13.95 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.031 1.287 . . . . 0.0 112.918 162.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.86 -16.61 32.26 Favored Glycine 0 CA--C 1.545 1.929 0 C-N-CA 125.823 1.678 . . . . 0.0 115.581 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -62.37 -33.48 74.82 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.642 1.721 . . . . 0.0 113.392 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 45.69 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 1 C-N-CA 132.418 4.287 . . . . 0.0 119.109 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 90.6 2.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.652 2.381 . . . . 0.0 109.726 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -130.55 -160.84 1.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.71 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -143.04 149.88 38.83 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 120.873 -1.142 . . . . 0.0 112.816 -156.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 118' ' ' LEU . 9.0 mt -140.06 133.09 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 128.306 2.643 . . . . 0.0 106.885 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 48.81 -136.31 19.26 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.229 1.871 . . . . 0.0 111.848 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.03 -8.21 54.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -179.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.686 1.194 . . . . 0.0 113.988 -160.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -137.87 118.39 13.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.503 -149.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 118' ' ' LEU . 1.7 mp -123.14 135.82 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.923 1.344 . . . . 0.0 110.952 -148.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 164.13 23.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.05 3.34 . . . . 0.0 115.449 169.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.02 132.14 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.808 1.243 . . . . 0.0 111.298 166.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.95 148.6 43.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.826 1.65 . . . . 0.0 110.966 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -71.33 135.09 47.18 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 111.122 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 m -146.87 167.56 23.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.044 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.4 m -154.32 156.12 36.37 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 0.0 112.375 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.496 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.1 tp-100 -32.86 2.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 1 C-N-CA 134.545 5.138 . . . . 0.0 121.151 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -130.4 -24.44 2.53 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.626 -1.921 . . . . 0.0 112.729 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -81.76 -7.18 59.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.01 1.324 . . . . 0.0 109.832 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.764 HG12 ' CD1' ' A' ' 156' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 128.566 2.746 . . . . 0.0 113.792 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 CA-C-O 121.942 0.877 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.0 42.08 2.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.028 1.731 . . . . 0.0 109.616 -155.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.21 113.19 3.59 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.452 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.559 ' CD2' HG11 ' A' ' 191' ' ' VAL . 16.8 m-85 -106.41 162.48 13.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.31 119.5 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.924 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -96.27 120.96 37.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.142 1.377 . . . . 0.0 110.449 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 181' ' ' ILE . 2.0 mm? -72.49 146.08 47.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.12 158.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -139.01 140.33 38.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 141.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.27 1.36 0.39 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.644 0.618 . . . . 0.0 114.644 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.671 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 64.8 mt -69.01 152.11 96.95 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.184 1.394 . . . . 0.0 113.33 -153.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.461 ' CD ' HG22 ' A' ' 176' ' ' ILE . 68.7 Cg_endo -75.53 167.85 25.69 Favored 'Trans proline' 0 C--O 1.235 0.327 1 C-N-CA 125.722 4.281 . . . . 0.0 112.039 172.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -68.41 128.73 37.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.962 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.47 25.68 74.8 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.034 -0.87 . . . . 0.0 114.47 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 176' ' ' ILE . 42.8 t -53.09 150.28 5.93 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.549 1.175 . . . . 0.0 113.417 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 t -147.29 160.32 42.64 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 120.787 -1.195 . . . . 0.0 113.434 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.608 ' O ' HG13 ' A' ' 128' ' ' VAL . 5.0 mttm -39.11 -47.33 1.54 Allowed 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 126.663 1.985 . . . . 0.0 114.993 171.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -65.97 -19.64 65.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.589 1.541 . . . . 0.0 112.794 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 58.2 mt-10 -81.93 -29.45 32.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.4 -1.438 . . . . 0.0 109.744 171.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.437 HD12 HD21 ' A' ' 143' ' ' LEU . 31.9 mt -70.11 -41.99 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.202 -0.936 . . . . 0.0 111.325 166.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -62.11 -12.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.173 1.789 . . . . 0.0 114.162 170.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -100.56 -21.97 15.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.981 1.264 . . . . 0.0 114.4 164.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -48.91 78.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 169.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.18 34.75 5.1 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.16 1.384 . . . . 0.0 112.694 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.33 -23.42 2.32 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 156.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.04 -31.03 67.78 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.142 1.83 . . . . 0.0 115.988 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.35 161.39 37.07 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.297 1.049 . . . . 0.0 113.603 -154.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.44 143.37 30.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.162 1.385 . . . . 0.0 112.986 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 74.5 mt -146.09 135.46 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.519 2.328 . . . . 0.0 107.587 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -60.4 154.6 53.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 111.506 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.97 -1.75 8.37 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.288 1.992 . . . . 0.0 116.672 -163.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -133.4 17.34 4.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.266 1.826 . . . . 0.0 111.439 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.2 -29.39 72.8 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 121.355 -0.841 . . . . 0.0 114.531 -165.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.6 mt -85.95 129.37 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.761 1.624 . . . . 0.0 108.671 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.0 m -121.05 131.18 54.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.267 1.827 . . . . 0.0 111.458 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -120.24 92.24 47.01 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 127.152 2.181 . . . . 0.0 110.106 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.86 -86.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.352 2.701 . . . . 0.0 112.442 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.8 172.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 128.141 2.577 . . . . 0.0 110.941 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.77 174.53 5.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.747 2.019 . . . . 0.0 113.027 167.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.07 -6.4 1.28 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.868 3.712 . . . . 0.0 117.52 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -115.28 -14.16 11.69 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.685 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.04 12.45 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.35 -1.25 . . . . 0.0 115.124 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -125.13 -16.77 5.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.719 1.759 . . . . 0.0 112.261 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 152' ' ' THR 0.314 0.0 OUTLIER -140.74 -100.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -170.021 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.2 OUTLIER 166.16 83.89 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 130.511 3.524 . . . . 0.0 107.909 -165.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -113.03 -16.34 8.52 Favored Glycine 0 N--CA 1.47 0.959 1 C-N-CA 130.863 4.078 . . . . 0.0 113.585 176.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.68 163.95 25.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.726 1.61 . . . . 0.0 110.133 159.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.73 172.99 9.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.233 3.013 . . . . 0.0 107.213 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.648 ' CD2' HG12 ' A' ' 191' ' ' VAL . 90.3 m-85 -149.22 162.7 39.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 -167.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.45 120.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 43.2 tp60 -90.71 126.15 35.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.856 2.063 . . . . 0.0 108.779 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.0 m-85 -84.43 -167.82 1.93 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.425 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.85 -11.29 59.8 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.018 -1.676 . . . . 0.0 112.407 166.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.0 m -161.17 165.14 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.837 1.255 . . . . 0.0 112.856 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -61.06 -31.33 70.99 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.425 1.49 . . . . 0.0 113.077 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 31.5 tp10 -75.22 -48.05 25.29 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.975 2.11 . . . . 0.0 112.914 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 67.5 mt -57.54 -37.31 72.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.931 1.293 . . . . 0.0 110.697 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.2 -18.51 63.92 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -92.1 -32.89 14.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.636 1.574 . . . . 0.0 109.979 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -65.49 -36.1 82.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.435 1.494 . . . . 0.0 109.322 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.498 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.09 -43.16 88.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.545 1.938 . . . . 0.0 115.019 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -57.94 -19.73 32.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.12 -20.78 29.33 Favored Glycine 0 CA--C 1.548 2.118 0 C-N-CA 124.779 1.18 . . . . 0.0 114.579 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -71.09 43.84 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.099 2.16 . . . . 0.0 112.129 158.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -40.05 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.086 1.754 . . . . 0.0 113.937 -163.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -130.95 124.73 31.68 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.76 1.624 . . . . 0.0 107.525 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.0 -166.19 2.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.013 0.925 . . . . 0.0 110.959 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -129.27 149.3 51.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.265 1.426 . . . . 0.0 112.184 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.461 HG22 ' CD ' ' A' ' 119' ' ' PRO . 4.0 mt -139.69 120.27 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 129.015 2.926 . . . . 0.0 106.716 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 60.04 -123.39 32.94 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -90.14 -9.86 46.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -175.07 2.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.997 1.319 . . . . 0.0 113.357 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -154.1 115.71 4.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -126.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.531 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.8 mt -129.51 142.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.309 1.052 . . . . 0.0 112.094 -141.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.335 5.1 tp10 -89.04 163.88 15.31 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 129.465 3.106 . . . . 0.0 112.914 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 m -138.32 143.94 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.441 -0.787 . . . . 0.0 112.811 166.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.46 149.67 41.27 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.29 1.836 . . . . 0.0 110.605 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -68.32 152.78 44.95 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.615 0.766 . . . . 0.0 111.681 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.49 170.55 22.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.627 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.24 160.53 43.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.801 1.64 . . . . 0.0 111.275 166.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 tp-100 -42.68 5.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 131.722 4.009 . . . . 0.0 120.168 178.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.55 -17.84 3.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.441 -2.037 . . . . 0.0 114.707 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.56 -26.65 32.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.599 1.56 . . . . 0.0 108.691 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.648 HG12 ' CD2' ' A' ' 156' ' ' PHE . 17.5 m . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 128.056 2.542 . . . . 0.0 116.327 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.19 53.61 0.65 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.698 1.999 . . . . 0.0 114.246 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.03 97.86 0.46 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.686 1.136 . . . . 0.0 110.913 161.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 191' ' ' VAL . 11.2 m-85 -108.15 163.82 12.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 1.8 t -137.76 150.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.661 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -121.14 143.72 48.95 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.058 1.343 . . . . 0.0 112.329 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.54 153.16 27.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.391 2.676 . . . . 0.0 111.124 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.22 71.47 0.51 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.052 1.741 . . . . 0.0 110.176 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.46 0.0 0.03 OUTLIER Glycine 0 N--CA 1.475 1.261 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -165.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -77.63 153.33 81.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 0.0 111.824 -165.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.84 171.85 11.5 Favored 'Trans proline' 0 CA--C 1.532 0.382 1 C-N-CA 126.704 4.936 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.37 123.02 16.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.933 0.893 . . . . 0.0 112.438 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 83.29 12.77 78.16 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.342 -174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.461 ' SG ' HG21 ' A' ' 176' ' ' ILE . 31.3 t -58.51 151.9 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.958 1.879 . . . . 0.0 112.712 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.3 t -148.06 165.12 31.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.655 0.782 . . . . 0.0 111.763 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -42.09 -49.84 4.76 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.315 2.246 . . . . 0.0 112.417 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' HG13 ' A' ' 128' ' ' VAL . 3.3 mp0 -63.1 -14.19 45.49 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -85.92 -26.79 25.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.731 -1.856 . . . . 0.0 109.938 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.24 -39.72 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.956 -0.465 . . . . 0.0 112.075 160.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.287 1.3 m -57.46 -18.52 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -97.7 -26.17 14.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.286 1.403 . . . . 0.0 114.124 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -62.67 -41.46 99.1 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.832 1.253 . . . . 0.0 111.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -121.89 33.77 5.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.484 1.114 . . . . 0.0 113.067 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -21.63 8.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.63 -0.668 . . . . 0.0 112.607 157.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.65 -33.44 41.65 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.93 1.729 . . . . 0.0 114.965 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.0 167.46 21.19 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.554 1.542 . . . . 0.0 112.067 -158.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.43 140.14 29.77 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.866 -1.146 . . . . 0.0 111.739 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 45.1 mt -135.48 136.57 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.531 2.732 . . . . 0.0 107.831 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.07 152.08 84.82 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 118.958 -0.544 . . . . 0.0 111.408 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.77 -14.66 11.1 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.947 3.098 . . . . 0.0 119.967 -165.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -128.54 19.94 6.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.145 1.378 . . . . 0.0 111.759 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.55 -27.42 61.09 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.961 1.144 . . . . 0.0 115.961 -163.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 128' ' ' VAL . 70.4 mt -92.05 137.63 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 125.955 1.702 . . . . 0.0 109.738 -168.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.4 m -132.49 137.65 47.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.416 1.462 . . . . 0.0 113.465 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.29 90.06 50.87 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 127.192 2.197 . . . . 0.0 112.149 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.09 -63.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.103 1.202 . . . . 0.0 114.203 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.43 179.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 129.994 3.318 . . . . 0.0 108.081 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.502 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.3 p-10 -74.51 170.68 13.98 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 119.64 -1.913 . . . . 0.0 113.686 156.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.82 -0.61 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.727 3.618 . . . . 0.0 116.873 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -130.18 0.92 4.67 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.594 1.558 . . . . 0.0 111.556 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.01 39.4 23.98 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.119 1.207 . . . . 0.0 116.119 163.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -122.92 -25.55 4.57 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.496 1.518 . . . . 0.0 111.422 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 152' ' ' THR 0.274 0.0 OUTLIER -149.05 -111.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.417 -1.277 . . . . 0.0 113.231 -157.115 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -179.0 78.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 129.75 3.22 . . . . 0.0 108.576 -166.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.502 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -130.65 7.55 5.86 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 127.901 2.667 . . . . 0.0 114.384 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -136.44 160.41 38.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.123 1.369 . . . . 0.0 109.244 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -171.04 176.78 3.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.735 1.614 . . . . 0.0 110.549 -169.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.509 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.1 m-85 -148.37 159.58 43.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.408 1.083 . . . . 0.0 110.418 -171.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -163.48 124.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -94.14 132.48 38.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.042 2.137 . . . . 0.0 110.844 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.2 m-85 -92.73 -172.77 3.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.662 0.385 . . . . 0.0 110.701 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.35 -12.34 60.24 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.215 -1.553 . . . . 0.0 113.033 168.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.7 m -159.39 162.35 35.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.421 1.088 . . . . 0.0 113.202 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.42 -34.04 70.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.032 0.933 . . . . 0.0 113.015 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -71.49 -47.17 57.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.087 2.155 . . . . 0.0 112.782 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.24 -34.67 74.01 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.528 1.131 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.81 -16.93 60.02 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.151 0.501 . . . . 0.0 112.238 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -85.72 -33.13 21.57 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.389 -1.444 . . . . 0.0 109.363 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -36.79 85.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.778 1.631 . . . . 0.0 110.098 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -61.58 -47.0 87.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.26 1.824 . . . . 0.0 115.424 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 mp -48.89 -27.56 3.17 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.65 -13.54 51.54 Favored Glycine 0 CA--C 1.545 1.952 0 C-N-CA 125.06 1.314 . . . . 0.0 115.386 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -64.98 -22.91 67.07 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.463 1.631 . . . . 0.0 114.455 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 41.51 -53.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 1 C-N-CA 131.92 4.088 . . . . 0.0 119.742 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -145.42 19.26 1.54 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.311 2.244 . . . . 0.0 112.694 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.81 -179.67 0.29 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -119.64 155.76 31.71 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -161.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -139.74 131.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 130.061 3.344 . . . . 0.0 106.145 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.44 -85.36 0.01 OUTLIER Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.938 1.256 . . . . 0.0 113.368 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -147.06 13.98 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.405 1.882 . . . . 0.0 112.234 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -124.29 178.65 5.25 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.944 2.097 . . . . 0.0 111.19 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -149.92 91.27 1.77 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 123.231 1.491 . . . . 0.0 109.66 -113.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.504 ' CD1' HD12 ' A' ' 176' ' ' ILE . 6.6 mt -102.55 139.5 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.186 -141.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.69 151.26 45.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.334 2.254 . . . . 0.0 112.633 165.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.73 136.68 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.424 0.69 . . . . 0.0 112.075 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -142.74 150.53 40.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 109.884 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -61.36 152.47 29.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.935 0.894 . . . . 0.0 110.417 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.3 m -152.61 171.64 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.722 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -153.38 155.65 36.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.486 1.515 . . . . 0.0 111.16 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 25.9 tp60 -35.22 -1.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 1 C-N-CA 133.496 4.718 . . . . 0.0 120.17 177.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -117.85 -28.38 5.96 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 119.881 -1.762 . . . . 0.0 112.961 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -84.2 -19.96 33.14 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.628 -1.295 . . . . 0.0 109.745 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 112' ' ' PHE . 21.2 m . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 128.185 2.594 . . . . 0.0 112.922 -165.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.892 0.853 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.33 50.59 1.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.739 -158.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -70.76 91.89 0.43 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 127.446 2.451 . . . . 0.0 112.03 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 191' ' ' VAL . 18.7 m-85 -99.0 166.81 11.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.1 t -146.81 128.07 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.899 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 66.1 ttt180 -104.0 138.73 40.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.254 1.022 . . . . 0.0 111.244 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 153.19 23.4 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.409 2.683 . . . . 0.0 109.531 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -155.07 81.22 1.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 109.782 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.77 -5.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.081 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -168.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.651 HD13 ' SG ' ' A' ' 122' ' ' CYS . 0.3 OUTLIER -78.38 148.92 74.8 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.856 1.262 . . . . 0.0 111.119 -161.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 83.2 Cg_endo -80.42 170.75 15.65 Favored 'Trans proline' 0 N--CA 1.462 -0.37 1 C-N-CA 126.595 4.864 . . . . 0.0 113.056 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -53.75 118.44 3.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.555 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.61 66.53 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.304 -1.276 . . . . 0.0 115.73 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 118' ' ' LEU . 6.2 t -55.35 149.75 12.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.317 2.059 . . . . 0.0 112.257 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.4 164.15 33.35 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.454 1.102 . . . . 0.0 111.249 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.4 ttmt -43.69 -43.34 5.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.457 2.303 . . . . 0.0 113.164 173.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' A' ' 128' ' ' VAL . 36.5 mp0 -69.36 -18.0 63.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.949 1.299 . . . . 0.0 114.334 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 47.0 mm-40 -77.97 -27.59 49.2 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 119.709 -1.87 . . . . 0.0 110.458 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.421 HD12 HD21 ' A' ' 143' ' ' LEU . 19.9 mt -69.61 -36.83 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 110.465 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.274 1.4 m -63.57 -15.89 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.479 1.111 . . . . 0.0 113.701 169.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.1 pp0? -96.73 -25.04 15.67 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.529 1.513 . . . . 0.0 114.142 165.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.61 -46.96 88.29 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.423 1.489 . . . . 0.0 110.782 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -119.98 35.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.322 1.049 . . . . 0.0 112.509 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.6 p -49.6 -24.8 2.36 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 155.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.03 -33.3 68.74 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.058 1.789 . . . . 0.0 115.353 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -139.29 160.45 39.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 113.139 -155.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.52 136.39 33.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 112.438 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 48.2 mt -135.71 137.69 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 129.633 3.173 . . . . 0.0 107.911 -171.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.07 151.88 79.45 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.821 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.19 -23.06 21.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 N-CA-C 120.952 3.405 . . . . 0.0 120.952 -158.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 39.52 2.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.604 1.162 . . . . 0.0 110.13 167.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.97 -25.42 9.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.219 1.39 . . . . 0.0 114.936 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' CD1' HG12 ' A' ' 128' ' ' VAL . 63.2 mt -85.82 133.47 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.273 1.829 . . . . 0.0 109.631 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.1 m -129.18 136.62 50.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.078 1.751 . . . . 0.0 112.455 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.421 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -124.97 91.76 48.81 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 127.198 2.199 . . . . 0.0 111.142 -169.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 -79.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 123.366 2.711 . . . . 0.0 113.634 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.26 168.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 129.224 3.01 . . . . 0.0 109.737 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.515 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.4 p-10 -80.61 171.74 11.56 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.966 1.706 . . . . 0.0 114.118 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.49 -1.16 0.19 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 124.973 3.782 . . . . 0.0 117.478 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -127.83 0.3 6.02 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.975 1.71 . . . . 0.0 111.795 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 39.43 68.21 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 115.796 1.079 . . . . 0.0 115.796 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -127.82 -17.15 4.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.859 1.664 . . . . 0.0 112.005 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.57 HG23 ' H ' ' A' ' 152' ' ' THR 0.307 0.0 OUTLIER -141.51 -104.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.296 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.57 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.5 OUTLIER 172.56 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.352 3.461 . . . . 0.0 108.525 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.515 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -123.41 2.52 9.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 128.714 3.054 . . . . 0.0 114.373 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.53 162.8 23.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.152 0.476 . . . . 0.0 109.726 142.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.89 177.2 5.1 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 127.036 2.135 . . . . 0.0 110.274 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.78 ' CD1' HG12 ' A' ' 191' ' ' VAL . 87.9 m-85 -148.88 160.28 43.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.037 0.935 . . . . 0.0 110.923 -166.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -162.29 121.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 40.4 tp60 -90.19 132.74 35.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.838 2.055 . . . . 0.0 110.006 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.2 m-85 -89.12 -158.54 0.51 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.908 0.483 . . . . 0.0 110.197 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.47 -9.15 59.55 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 119.852 -1.78 . . . . 0.0 112.904 156.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.6 m -162.45 159.11 24.67 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.508 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 21.4 mm-40 -56.18 -30.99 63.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.158 1.383 . . . . 0.0 113.723 166.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -53.07 20.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.601 1.56 . . . . 0.0 111.414 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.64 -36.88 72.43 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.19 1.396 . . . . 0.0 111.319 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -72.94 -16.08 61.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.57 -32.14 15.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.526 1.53 . . . . 0.0 110.444 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -61.57 -40.04 93.31 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 125.787 1.635 . . . . 0.0 110.508 167.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -59.33 -47.24 86.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.24 1.816 . . . . 0.0 114.162 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -55.82 -20.18 14.24 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -62.34 -14.29 47.52 Favored Glycine 0 CA--C 1.547 2.054 0 C-N-CA 124.646 1.117 . . . . 0.0 115.016 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -63.16 -27.52 69.43 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.324 1.562 . . . . 0.0 113.442 162.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.77 -42.01 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 1 C-N-CA 133.191 4.596 . . . . 0.0 120.166 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -153.49 36.83 0.46 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.305 1.442 . . . . 0.0 112.053 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.02 -174.04 0.22 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.621 1.168 . . . . 0.0 114.041 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.31 148.96 44.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.372 1.469 . . . . 0.0 112.682 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.577 HD12 HD22 ' A' ' 118' ' ' LEU . 1.3 mt -138.47 131.52 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 129.283 3.033 . . . . 0.0 105.798 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 54.41 -99.89 0.07 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.148 1.356 . . . . 0.0 112.33 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -118.36 -5.15 10.84 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.24 1.416 . . . . 0.0 113.532 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.71 -172.43 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.241 1.816 . . . . 0.0 112.49 -169.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -151.09 109.71 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.991 -132.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.563 HG12 HD23 ' A' ' 118' ' ' LEU . 3.6 mp -124.27 128.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 122.783 1.278 . . . . 0.0 112.371 -139.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 160.58 13.23 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 127.559 2.344 . . . . 0.0 114.268 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.63 141.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.332 0.653 . . . . 0.0 112.433 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.81 142.75 31.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.198 1.799 . . . . 0.0 110.794 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 17.8 tptm -66.98 146.24 54.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.679 174.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -150.83 168.79 23.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.647 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.5 m -147.5 165.37 30.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.531 1.532 . . . . 0.0 110.761 164.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.54 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.7 tp60 -35.98 1.7 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 1 C-N-CA 133.32 4.648 . . . . 0.0 119.87 177.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -118.26 -30.26 5.31 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.636 -1.915 . . . . 0.0 112.669 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.662 -1.274 . . . . 0.0 109.611 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 156' ' ' PHE . 18.9 m . . . . . 0 C--N 1.332 -0.189 0 C-N-CA 127.585 2.354 . . . . 0.0 114.622 -153.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.8 p30 . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.37 36.91 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.181 3.793 . . . . 0.0 114.181 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -58.51 83.36 0.01 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 127.064 2.268 . . . . 0.0 113.602 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 158' ' ' GLN . 3.3 m-85 -92.31 160.53 15.08 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 168.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.08 113.13 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.736 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.341 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 77.3 ttt180 -89.02 131.02 35.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 123.459 0.704 . . . . 0.0 111.492 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.42 152.96 18.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 128.751 2.821 . . . . 0.0 110.438 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -157.84 70.92 0.59 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.91 1.284 . . . . 0.0 109.419 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.48 1.92 0.03 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 -162.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.8 mt -79.4 153.89 76.56 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 119.186 1.493 . . . . 0.0 112.434 -162.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.87 175.06 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 1 C-N-CA 125.759 4.306 . . . . 0.0 113.299 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -67.15 132.08 47.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.204 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.64 70.07 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 117.694 -1.615 . . . . 0.0 115.71 -171.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.25 149.38 20.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 120.392 2.096 . . . . 0.0 113.517 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.4 p -135.0 164.1 28.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.1 1.76 . . . . 0.0 111.82 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 128' ' ' VAL . 28.0 ttmt -48.56 -42.33 33.17 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 126.448 1.899 . . . . 0.0 112.449 166.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 121.193 1.815 . . . . 0.0 113.792 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -75.43 -31.68 60.43 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.658 -1.901 . . . . 0.0 110.0 167.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.481 HD12 HD21 ' A' ' 143' ' ' LEU . 49.1 mt -67.45 -39.04 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.496 0.718 . . . . 0.0 111.183 167.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 141' ' ' ILE . 1.9 m -62.17 -17.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.376 1.07 . . . . 0.0 112.964 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -96.05 -31.92 12.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.874 1.216 . . . . 0.0 112.719 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.46 -41.66 90.23 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.066 1.746 . . . . 0.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.87 33.39 5.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.918 1.287 . . . . 0.0 113.771 170.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.1 p -52.21 -22.2 4.12 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 157.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.22 -32.96 30.05 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.156 1.836 . . . . 0.0 115.212 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.66 166.49 24.22 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.888 1.275 . . . . 0.0 112.876 -156.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.57 137.53 32.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.68 1.592 . . . . 0.0 111.377 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 72.1 mt -138.62 137.64 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 128.221 2.608 . . . . 0.0 106.824 -170.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -60.39 153.55 58.83 Favored Pre-proline 0 N--CA 1.486 1.365 0 CA-C-N 118.643 0.656 . . . . 0.0 111.447 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.02 -21.06 20.19 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 120.927 3.395 . . . . 0.0 120.927 -159.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.74 40.9 2.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.791 1.178 . . . . 0.0 109.993 167.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.17 -14.71 6.31 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.148 1.356 . . . . 0.0 116.38 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 128' ' ' VAL . 76.2 mt -103.27 123.69 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 125.372 1.469 . . . . 0.0 109.384 -165.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.8 m -115.8 130.59 56.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.085 2.554 . . . . 0.0 112.695 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.76 78.78 56.64 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 127.014 2.126 . . . . 0.0 111.724 -170.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.27 -58.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.372 1.381 . . . . 0.0 113.249 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -178.3 173.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 130.681 3.592 . . . . 0.0 107.961 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.52 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.9 p-10 -69.63 169.44 12.49 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 120.236 -1.54 . . . . 0.0 113.747 159.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.41 2.59 0.1 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.931 3.754 . . . . 0.0 117.319 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -128.41 -2.76 5.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.555 1.542 . . . . 0.0 112.094 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.62 26.24 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -131.39 -15.52 3.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.415 1.607 . . . . 0.0 112.728 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.449 HG23 ' H ' ' A' ' 152' ' ' THR 0.29 0.0 OUTLIER -143.67 -114.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.738 1.215 . . . . 0.0 113.226 -170.134 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.449 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.24 75.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 129.342 3.057 . . . . 0.0 108.141 -167.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.52 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -125.25 4.68 8.27 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 127.561 2.505 . . . . 0.0 114.702 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.86 164.06 26.9 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.497 0.719 . . . . 0.0 109.972 150.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -172.34 168.98 5.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 126.834 2.054 . . . . 0.0 110.029 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 97.0 m-85 -141.25 152.62 44.69 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.582 0.753 . . . . 0.0 109.673 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.23 123.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 136' ' ' ILE . 39.3 tp60 -90.79 122.77 33.81 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.954 2.102 . . . . 0.0 110.344 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 5.1 m-85 -83.23 -165.55 1.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.576 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.79 -12.39 60.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.177 -1.577 . . . . 0.0 112.159 162.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.3 m -161.54 162.65 30.32 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.993 0.917 . . . . 0.0 113.411 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.466 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.67 -8.01 55.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.85 -53.2 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.324 2.25 . . . . 0.0 111.81 172.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.06 -37.89 67.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.026 1.73 . . . . 0.0 111.285 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.33 -15.84 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.68 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.46 -25.36 15.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.267 -1.521 . . . . 0.0 110.864 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.05 -41.08 97.51 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.323 1.449 . . . . 0.0 109.853 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.444 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -60.52 -46.29 90.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.548 1.939 . . . . 0.0 115.808 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.5 mp -48.19 -21.48 0.5 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 165.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.48 -10.02 59.45 Favored Glycine 0 CA--C 1.544 1.864 0 C-N-CA 123.965 0.793 . . . . 0.0 113.697 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -59.59 -32.82 70.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.228 1.411 . . . . 0.0 114.321 164.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.6 -56.51 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 131.196 3.799 . . . . 0.0 119.0 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -148.17 24.31 1.04 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.289 1.836 . . . . 0.0 113.443 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.61 179.4 0.12 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.772 1.629 . . . . 0.0 113.731 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 149.65 45.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.342 1.457 . . . . 0.0 111.799 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -92.39 -16.64 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.5 1.12 . . . . 0.0 112.77 175.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.62 -41.96 0.08 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.394 1.473 . . . . 0.0 112.607 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -149.66 -42.04 0.14 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.312 1.445 . . . . 0.0 112.854 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -86.14 174.55 9.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.109 0.957 . . . . 0.0 111.753 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.73 97.49 3.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.937 -126.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 176' ' ' ILE . 5.3 mt -99.78 119.48 47.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.733 -148.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 153.25 42.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.149 1.78 . . . . 0.0 112.372 163.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 132.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.499 0.719 . . . . 0.0 110.947 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -135.61 144.74 46.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.917 1.687 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 19.1 tptm -69.15 142.0 54.47 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.594 0.711 . . . . 0.0 110.41 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 m -150.38 164.12 36.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.09 -167.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 73.6 m -135.39 160.75 37.47 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.731 1.212 . . . . 0.0 110.916 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -46.66 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.768 1 C-N-CA 132.39 4.276 . . . . 0.0 118.148 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -128.67 -28.73 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.204 -1.56 . . . . 0.0 113.03 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.46 -23.48 62.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.859 -1.151 . . . . 0.0 110.564 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.465 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 1.7 p . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 124.676 1.191 . . . . 0.0 113.261 170.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -120.3 34.76 5.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.476 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 77.89 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 127.035 2.255 . . . . 0.0 113.353 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.621 ' CD1' HG11 ' A' ' 191' ' ' VAL . 7.3 m-85 -99.49 156.96 16.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.1 108.72 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.678 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -86.05 124.84 32.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.609 0.763 . . . . 0.0 111.444 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 181' ' ' ILE . 1.4 mm? -85.33 152.47 23.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.976 2.11 . . . . 0.0 110.808 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -155.1 76.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.263 1.425 . . . . 0.0 109.324 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.35 -11.01 0.02 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -161.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 13.0 mt -73.44 156.08 89.13 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -152.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 86.4 Cg_endo -78.4 169.69 19.62 Favored 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 125.634 4.223 . . . . 0.0 112.543 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.23 125.96 28.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.68 24.54 75.39 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.739 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 36.2 t -54.96 154.49 5.26 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.277 1.538 . . . . 0.0 112.773 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.1 t -147.31 164.41 33.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.047 0.927 . . . . 0.0 112.144 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 128' ' ' VAL . 32.0 ttmt -45.55 -40.64 8.93 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 127.055 2.142 . . . . 0.0 113.126 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -69.87 -16.7 63.29 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 121.596 1.998 . . . . 0.0 113.999 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -76.92 -35.09 57.57 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 120.043 -1.661 . . . . 0.0 109.327 166.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 143' ' ' LEU . 51.9 mt -64.1 -40.29 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.036 0.835 . . . . 0.0 111.141 169.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.5 m -65.77 -16.52 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.897 1.279 . . . . 0.0 112.683 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -94.94 -31.48 13.63 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.94 1.245 . . . . 0.0 112.425 164.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.86 -38.23 75.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.188 1.795 . . . . 0.0 111.593 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 23.9 m-85 -122.15 35.93 4.76 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.482 1.513 . . . . 0.0 112.68 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -64.37 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.173 1.463 . . . . 0.0 108.864 153.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.8 -48.04 0.08 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.795 -151.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.1 157.9 45.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.988 1.315 . . . . 0.0 112.09 -160.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB2' HD13 ' A' ' 164' ' ' LEU . 44.9 mt-10 -76.73 131.28 38.67 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.645 -0.659 . . . . 0.0 111.193 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 55.1 mt -131.08 132.26 63.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.832 2.453 . . . . 0.0 107.183 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.09 151.4 80.98 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.923 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.94 -16.89 12.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.069 3.179 . . . . 0.0 119.133 -165.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -122.95 16.43 10.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.593 1.557 . . . . 0.0 111.598 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.58 70.73 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 -159.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -95.17 134.77 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 124.856 1.262 . . . . 0.0 109.743 -166.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.4 m -133.44 133.55 42.46 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.575 1.55 . . . . 0.0 112.685 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -126.27 96.47 36.49 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 127.695 2.398 . . . . 0.0 111.326 -173.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.73 -81.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.078 1.852 . . . . 0.0 113.831 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.25 167.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 128.899 2.88 . . . . 0.0 109.991 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -70.86 170.65 10.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.493 1.917 . . . . 0.0 114.645 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.61 0.61 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 124.907 3.738 . . . . 0.0 117.576 170.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -126.91 -0.46 6.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.776 1.63 . . . . 0.0 111.928 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.28 37.32 54.75 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -129.16 -15.63 4.15 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.192 1.496 . . . . 0.0 112.37 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.442 HG23 ' H ' ' A' ' 152' ' ' THR 0.299 0.0 OUTLIER -141.67 -105.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.571 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 170.96 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.981 3.312 . . . . 0.0 107.983 -166.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.81 -1.45 5.9 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 129.942 3.639 . . . . 0.0 114.476 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -131.8 158.63 40.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.473 149.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.61 -179.47 3.38 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.339 2.256 . . . . 0.0 108.472 -167.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 191' ' ' VAL . 98.4 m-85 -152.01 157.65 42.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.789 0.436 . . . . 0.0 111.273 -167.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.52 125.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -90.8 127.0 36.19 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.937 2.095 . . . . 0.0 111.266 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.5 m-85 -92.11 -173.16 3.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.342 1.057 . . . . 0.0 110.313 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.97 -13.17 60.84 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.212 -1.555 . . . . 0.0 113.064 166.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.4 m -160.24 159.97 32.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.477 1.111 . . . . 0.0 113.347 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -60.69 -21.43 62.86 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.416 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 29.0 tp10 -78.96 -50.32 11.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.681 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 135' ' ' GLU . 80.3 mt -57.07 -36.8 70.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.518 1.127 . . . . 0.0 111.13 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.58 -20.86 63.64 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.975 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -91.06 -29.77 17.14 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.237 -1.54 . . . . 0.0 110.317 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -62.15 -34.08 75.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.916 0.886 . . . . 0.0 109.197 167.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.553 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -72.72 -42.63 63.95 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.2 mp -49.09 -31.88 8.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 120.615 1.552 . . . . 0.0 113.143 160.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -57.76 -16.47 23.86 Favored Glycine 0 CA--C 1.547 2.057 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 170.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -69.14 -19.72 64.02 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.171 1.986 . . . . 0.0 113.758 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 47.97 -65.51 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 130.969 3.708 . . . . 0.0 118.303 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -150.48 33.36 0.63 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.283 1.833 . . . . 0.0 112.484 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.83 -157.95 0.1 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.006 1.322 . . . . 0.0 113.312 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -135.35 149.11 49.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.895 2.078 . . . . 0.0 112.49 -169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.491 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -106.1 -17.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -170.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.16 -39.66 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.409 1.957 . . . . 0.0 111.58 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -151.7 -44.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.688 . . . . 0.0 111.773 169.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.7 177.97 5.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.441 1.096 . . . . 0.0 112.44 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.31 113.82 14.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.12 1.768 . . . . 0.0 109.891 -128.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 2.8 mt -121.16 111.83 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.57 1.652 . . . . 0.0 111.809 -146.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 150.94 33.64 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.206 -2.724 . . . . 0.0 112.494 158.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.17 123.16 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 110.204 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -119.63 146.45 45.54 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.683 1.593 . . . . 0.0 109.543 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -66.15 136.03 55.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -144.68 172.14 13.41 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -166.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 37.9 m -152.08 148.81 28.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.298 1.839 . . . . 0.0 109.729 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -31.29 -16.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 1 C-N-CA 132.147 4.179 . . . . 0.0 118.459 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -112.58 -16.71 12.79 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.91 1.684 . . . . 0.0 111.625 -168.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -80.48 -30.75 37.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 156.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 187' ' ' SER . 4.2 m . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -163.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.76 55.26 1.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.129 2.172 . . . . 0.0 112.179 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.23 95.13 0.57 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.093 1.33 . . . . 0.0 111.363 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.8 m-85 -99.69 164.35 12.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.92 113.49 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.369 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 68.5 ttt180 -89.87 115.07 26.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.922 0.889 . . . . 0.0 110.455 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.66 146.53 53.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.317 157.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.82 151.09 48.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 140.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.9 -13.6 0.76 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.173 -1.579 . . . . 0.0 113.857 159.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.582 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 10.4 mt -67.91 153.21 95.61 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -141.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 89.7 Cg_endo -73.09 171.21 18.03 Favored 'Trans proline' 0 C--N 1.346 0.416 1 C-N-CA 126.754 4.969 . . . . 0.0 112.368 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -68.71 132.74 47.35 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.093 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.59 25.22 62.98 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.647 -168.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 118' ' ' LEU . 37.9 t -54.14 149.18 9.9 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.503 1.652 . . . . 0.0 113.124 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 t -145.54 161.17 40.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.738 1.256 . . . . 0.0 112.044 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.7 ttmt -46.71 -37.72 8.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 127.774 2.43 . . . . 0.0 113.496 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -71.74 -19.54 62.02 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 121.083 1.765 . . . . 0.0 114.041 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.88 -31.91 57.11 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 120.208 -1.558 . . . . 0.0 109.156 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.441 HD12 HD21 ' A' ' 143' ' ' LEU . 59.7 mt -68.73 -39.09 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.522 0.729 . . . . 0.0 111.338 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.9 m -65.43 -16.07 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.961 1.304 . . . . 0.0 112.803 173.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -95.67 -28.77 14.65 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.315 0.962 . . . . 0.0 112.794 164.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.4 t80 -61.45 -44.85 96.39 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.751 1.62 . . . . 0.0 111.011 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -118.53 34.99 4.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.357 1.463 . . . . 0.0 113.091 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.6 p -50.08 -24.02 2.45 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 155.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.64 -33.23 54.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.437 1.97 . . . . 0.0 115.673 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.1 mp -138.28 161.76 36.08 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.215 1.007 . . . . 0.0 113.092 -156.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.01 132.73 33.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.143 1.377 . . . . 0.0 112.321 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 53.2 mt -133.27 138.26 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 128.995 2.918 . . . . 0.0 108.13 -172.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.81 152.0 87.75 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.784 -0.573 . . . . 0.0 111.513 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.65 -14.69 10.76 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.026 3.151 . . . . 0.0 120.013 -165.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.59 21.85 5.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.308 1.443 . . . . 0.0 111.544 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.79 -24.57 57.68 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -166.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 66.7 mt -94.5 130.73 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.187 1.395 . . . . 0.0 109.539 -167.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.9 m -124.62 132.0 53.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.058 1.743 . . . . 0.0 112.744 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.441 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -121.85 87.46 46.68 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 127.715 2.406 . . . . 0.0 110.412 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 -86.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.985 1.79 . . . . 0.0 112.646 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.22 156.98 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 128.945 2.898 . . . . 0.0 109.104 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.523 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 1.3 p-10 -64.28 178.24 0.47 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.001 3.321 . . . . 0.0 115.031 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.02 1.11 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.491 0 C-N-CA 124.48 3.453 . . . . 0.0 117.368 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -133.74 -32.84 1.1 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.279 1.854 . . . . 0.0 113.511 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.9 40.18 1.6 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.583 1.563 . . . . 0.0 114.911 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -132.35 -15.14 2.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 113.007 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -161.86 -163.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 127.793 2.437 . . . . 0.0 107.99 -168.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.641 ' H ' HD13 ' A' ' 151' ' ' ILE . 11.3 p -122.61 30.26 6.55 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 123.273 2.76 . . . . 0.0 112.988 -170.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -53.43 1.33 0.03 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.159 2.79 . . . . 0.0 117.245 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.25 152.59 38.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.095 0.95 . . . . 0.0 111.138 158.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.8 176.34 7.17 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 127.742 2.417 . . . . 0.0 108.938 -163.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.57 ' CD2' HG12 ' A' ' 191' ' ' VAL . 92.7 m-85 -149.42 163.41 37.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.709 -166.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.7 127.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 112' ' ' PHE . 46.1 tp60 -96.17 131.07 43.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.484 2.314 . . . . 0.0 110.3 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.2 m-85 -94.74 -168.43 1.82 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.289 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.2 -10.4 59.63 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.88 -1.763 . . . . 0.0 113.311 163.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 m -159.22 158.11 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.077 0.951 . . . . 0.0 113.096 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -57.13 -26.54 60.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.684 1.594 . . . . 0.0 114.483 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -54.8 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.822 1.649 . . . . 0.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.68 -37.81 66.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.85 1.66 . . . . 0.0 111.539 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.468 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.83 -17.2 64.43 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -110.3 -16.45 13.73 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.283 -1.511 . . . . 0.0 111.852 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.76 -38.69 86.1 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.963 0.905 . . . . 0.0 110.281 155.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.35 -44.04 80.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -51.09 -27.85 9.22 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.93 -1.106 . . . . 0.0 113.75 165.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.92 -14.85 32.78 Favored Glycine 0 CA--C 1.547 2.076 0 C-N-CA 125.262 1.411 . . . . 0.0 115.592 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -65.44 -17.66 64.72 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.886 1.843 . . . . 0.0 114.585 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 37.27 -47.57 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 C-N-CA 132.967 4.507 . . . . 0.0 120.982 171.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 19.5 1.11 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.166 1.787 . . . . 0.0 113.843 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -59.89 179.48 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.6 ttp85 -119.33 149.15 42.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.112 2.965 . . . . 0.0 109.043 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.47 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -115.88 -29.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.494 1.118 . . . . 0.0 113.041 -173.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -171.56 -112.02 0.27 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 127.074 2.273 . . . . 0.0 108.139 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -39.52 84.75 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.795 1.298 . . . . 0.0 113.151 164.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -177.87 3.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.462 1.505 . . . . 0.0 114.973 -164.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.685 1.594 . . . . 0.0 108.261 -140.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 5.1 mt -128.4 136.5 59.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.814 1.292 . . . . 0.0 112.362 -142.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.253 3.3 mp0 -83.13 156.42 23.27 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 130.589 3.556 . . . . 0.0 112.456 164.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.63 133.07 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.945 0.898 . . . . 0.0 111.091 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.24 144.75 47.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.967 1.707 . . . . 0.0 109.759 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -75.51 139.2 42.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.74 1.216 . . . . 0.0 110.703 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.7 m -149.39 166.77 28.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.741 -158.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 m -143.58 148.01 35.27 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.805 1.642 . . . . 0.0 108.798 165.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -13.79 -18.61 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 135.259 5.423 . . . . 0.0 120.642 169.104 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -122.46 -6.19 8.73 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 120.356 -1.465 . . . . 0.0 111.715 -167.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -76.51 -21.64 55.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.641 153.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 156' ' ' PHE . 3.8 m . . . . . 0 C--N 1.344 0.36 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -149.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.604 0.716 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.75 43.58 0.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 112.571 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.18 99.08 0.85 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.858 1.218 . . . . 0.0 111.218 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.688 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.7 m-85 -97.12 163.09 13.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 167.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.79 115.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.582 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -92.32 137.35 32.44 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.126 0.97 . . . . 0.0 112.79 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.62 151.16 23.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.236 2.614 . . . . 0.0 110.86 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -157.62 75.08 0.77 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.021 1.728 . . . . 0.0 108.599 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.67 -6.95 0.03 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -163.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 2.0 mt -77.46 153.89 81.6 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-N 118.18 0.99 . . . . 0.0 113.653 -157.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 90.7 Cg_endo -81.1 173.85 11.43 Favored 'Trans proline' 0 C--N 1.344 0.335 1 C-N-CA 126.937 5.091 . . . . 0.0 113.312 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -62.9 131.2 47.93 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.876 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.482 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 68.57 19.22 72.71 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 117.955 -1.469 . . . . 0.0 115.597 -172.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.8 t -56.56 149.23 17.82 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 120.14 1.97 . . . . 0.0 113.842 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.0 t -143.73 161.59 38.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.553 1.168 . . . . 0.0 112.806 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.647 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.4 ttmt -44.92 -42.4 8.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.598 2.759 . . . . 0.0 114.074 172.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.48 -21.36 66.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 121.25 1.841 . . . . 0.0 114.307 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -79.37 -33.32 42.98 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 119.787 -1.821 . . . . 0.0 109.674 170.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.499 HD12 HD21 ' A' ' 143' ' ' LEU . 66.7 mt -62.8 -38.67 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.456 -0.778 . . . . 0.0 111.038 166.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 124' ' ' LYS 0.268 1.1 m -68.34 -12.46 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 113.702 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.62 -27.29 14.88 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.673 1.124 . . . . 0.0 113.355 161.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -64.12 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.122 1.769 . . . . 0.0 111.266 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -120.84 34.61 5.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.833 1.653 . . . . 0.0 112.786 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -50.93 -22.62 2.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 156.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.6 -35.14 51.14 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.787 1.661 . . . . 0.0 115.301 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.5 156.46 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.201 1.0 . . . . 0.0 112.575 -149.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.3 140.51 33.55 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.224 -0.922 . . . . 0.0 112.098 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 47.7 mt -136.04 137.7 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 128.269 2.627 . . . . 0.0 107.524 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -62.18 153.05 76.5 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.29 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.51 -8.51 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.525 3.483 . . . . 0.0 120.607 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -140.13 21.76 2.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.871 2.068 . . . . 0.0 111.516 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.8 -16.98 53.46 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 61.6 mt -105.35 134.74 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 119.081 1.44 . . . . 0.0 109.497 -163.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.3 m -129.57 135.43 48.57 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.564 1.545 . . . . 0.0 112.773 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -123.01 86.07 50.92 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 127.033 2.133 . . . . 0.0 111.369 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 155' ' ' ALA . 65.6 Cg_endo -71.93 -66.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.338 2.025 . . . . 0.0 113.46 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.88 -179.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 130.188 3.395 . . . . 0.0 108.306 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -77.02 170.08 18.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 119.149 -2.219 . . . . 0.0 114.169 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -55.97 2.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 125.227 3.951 . . . . 0.0 117.198 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -127.65 2.28 6.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.603 1.561 . . . . 0.0 111.729 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.86 34.97 51.82 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.363 -1.243 . . . . 0.0 116.203 164.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -132.68 -14.35 2.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.654 1.727 . . . . 0.0 112.835 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 121' ' ' GLY 0.279 0.0 OUTLIER -143.85 -110.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 117.475 -1.25 . . . . 0.0 113.574 -168.642 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -178.78 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 130.088 3.355 . . . . 0.0 107.486 -167.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -137.84 1.3 2.84 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 129.258 3.313 . . . . 0.0 113.876 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -138.15 162.35 34.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.7 1.6 . . . . 0.0 109.445 159.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . . . -173.73 -178.7 1.64 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.509 1.924 . . . . 0.0 110.733 -168.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.503 ' CD1' HG12 ' A' ' 191' ' ' VAL . 96.9 m-85 -153.71 152.99 31.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.694 1.198 . . . . 0.0 110.315 -168.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.42 127.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -91.51 133.81 35.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.555 2.342 . . . . 0.0 110.328 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.6 m-85 -97.44 -175.38 3.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.846 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.51 58.56 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.707 -1.246 . . . . 0.0 113.191 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.0 m -166.4 158.57 13.87 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 111.998 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -84.71 50.16 1.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.125 1.37 . . . . 0.0 110.272 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.6 -55.07 0.56 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.15 2.98 . . . . 0.0 108.485 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 49.3 mt -54.41 -41.49 69.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.749 2.02 . . . . 0.0 111.65 164.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.52 -18.46 65.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.63 -29.15 15.6 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.794 -1.192 . . . . 0.0 109.15 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -66.12 -36.84 84.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.301 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.87 -39.03 87.41 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 165' ' ' ALA . 2.6 mp -51.27 -24.36 4.41 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 120.744 -1.223 . . . . 0.0 113.974 162.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -66.36 -17.46 66.32 Favored Glycine 0 CA--C 1.546 2.006 0 C-N-CA 124.98 1.276 . . . . 0.0 115.191 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -75.16 15.59 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.195 1.997 . . . . 0.0 115.605 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -51.82 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 130.317 3.447 . . . . 0.0 119.507 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.68 17.59 0.9 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.214 1.805 . . . . 0.0 114.222 -169.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -114.21 -170.8 1.79 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.059 1.344 . . . . 0.0 112.592 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.05 151.36 47.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.883 2.073 . . . . 0.0 110.977 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.23 -38.05 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.131 1.372 . . . . 0.0 112.695 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -156.41 -78.92 0.02 OUTLIER Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.951 1.262 . . . . 0.0 110.517 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -108.18 -18.84 13.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.407 1.083 . . . . 0.0 113.466 169.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -128.05 -178.06 4.38 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.14 1.776 . . . . 0.0 113.639 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -149.8 117.25 6.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -119.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.4 mt -123.96 129.26 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 123.537 1.637 . . . . 0.0 112.95 -138.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.16 153.18 36.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.843 2.857 . . . . 0.0 112.798 165.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.76 134.69 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 111.897 171.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -137.99 153.67 49.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.292 1.837 . . . . 0.0 110.258 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -75.03 145.99 41.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.386 0.675 . . . . 0.0 111.656 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.4 m -153.11 168.46 25.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 124.112 0.883 . . . . 0.0 111.728 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 67.2 m -149.62 158.3 44.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.422 1.489 . . . . 0.0 110.504 168.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.401 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp60 -33.43 -0.85 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 1 C-N-CA 134.019 4.928 . . . . 0.0 119.926 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.91 -10.89 3.42 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 119.951 -1.718 . . . . 0.0 113.519 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.96 -29.97 28.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 112' ' ' PHE . 34.9 m . . . . . 0 N--CA 1.456 -0.173 0 C-N-CA 124.718 1.207 . . . . 0.0 112.97 -158.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.256 4.5 p-10 -75.05 52.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.43 1.492 . . . . 0.0 113.628 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.03 99.64 1.3 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.686 2.088 . . . . 0.0 111.574 170.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.607 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -107.91 165.43 11.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.74 117.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.819 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -89.02 135.67 33.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.48 151.88 24.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.026 2.53 . . . . 0.0 110.467 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -157.66 76.13 0.8 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.098 1.759 . . . . 0.0 108.64 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.54 -13.2 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.756 1.462 . . . . 0.0 116.756 -163.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 181' ' ' ILE . 0.4 OUTLIER -76.5 151.13 82.84 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 118.422 1.111 . . . . 0.0 112.846 -153.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.82 175.13 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.271 1 C-N-CA 125.621 4.214 . . . . 0.0 113.431 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -68.47 134.44 50.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.87 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.38 14.7 67.06 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 117.935 -1.481 . . . . 0.0 115.179 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.91 151.48 18.1 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.412 2.106 . . . . 0.0 112.862 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.1 t -146.49 166.23 27.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.563 1.173 . . . . 0.0 111.45 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -47.49 -43.78 24.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 127.415 2.286 . . . . 0.0 112.488 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HA ' HG13 ' A' ' 128' ' ' VAL . 40.6 mp0 -67.17 -18.77 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.568 1.531 . . . . 0.0 113.846 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -79.73 -25.36 41.13 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 119.498 -2.001 . . . . 0.0 110.807 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 143' ' ' LEU . 52.6 mt -71.6 -36.54 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.484 0.714 . . . . 0.0 111.009 164.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.269 1.7 m -60.91 -18.73 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.326 168.005 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -97.82 -25.13 15.15 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.693 1.588 . . . . 0.0 113.347 165.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.88 -42.95 94.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.834 0.853 . . . . 0.0 110.333 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -117.74 42.04 2.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.529 1.131 . . . . 0.0 113.896 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.0 p -67.58 64.77 0.08 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.966 1.365 . . . . 0.0 110.822 154.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.32 -41.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.34 1.447 . . . . 0.0 112.178 -156.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.38 154.47 48.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.226 1.81 . . . . 0.0 110.785 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.11 140.53 45.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.114 0.965 . . . . 0.0 112.431 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.3 mt -143.9 131.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 128.903 2.881 . . . . 0.0 107.072 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.76 152.72 74.72 Favored Pre-proline 0 N--CA 1.486 1.373 0 CA-C-O 118.723 -0.655 . . . . 0.0 111.301 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.15 -25.47 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 120.287 3.149 . . . . 0.0 120.287 -160.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -133.36 41.75 3.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.631 1.173 . . . . 0.0 110.432 166.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.82 -29.14 49.5 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.028 1.299 . . . . 0.0 114.576 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 128' ' ' VAL . 71.8 mt -89.6 131.51 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 125.77 1.628 . . . . 0.0 109.342 -169.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -129.46 132.32 46.91 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.4 1.88 . . . . 0.0 112.888 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 127' ' ' ILE . 3.7 mm? -127.7 92.13 43.57 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 126.981 2.112 . . . . 0.0 112.373 -166.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.32 -65.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.605 1.536 . . . . 0.0 114.352 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.8 177.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 129.43 3.092 . . . . 0.0 109.094 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.3 p-10 -81.23 172.07 10.66 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 120.006 -1.684 . . . . 0.0 114.273 163.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.11 -0.34 0.28 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 125.019 3.813 . . . . 0.0 117.166 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -127.76 -0.91 6.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 111.786 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.66 39.68 48.13 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.34 -17.18 3.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.956 1.703 . . . . 0.0 112.307 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.559 HG23 ' H ' ' A' ' 152' ' ' THR 0.298 0.0 OUTLIER -143.49 -112.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -169.633 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.559 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.84 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.644 3.178 . . . . 0.0 109.161 -167.166 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.573 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -113.96 6.3 23.78 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.993 2.711 . . . . 0.0 114.413 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -134.41 157.53 46.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.852 1.261 . . . . 0.0 108.926 157.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.32 -178.93 3.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.206 1.402 . . . . 0.0 110.665 -167.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.625 ' CD1' HG12 ' A' ' 191' ' ' VAL . 95.6 m-85 -152.87 157.71 41.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.524 1.13 . . . . 0.0 109.421 -169.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.68 120.76 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 45.6 tp60 -83.18 135.43 34.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.546 1.938 . . . . 0.0 109.693 170.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.5 m-85 -92.39 -157.43 0.52 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.434 0.693 . . . . 0.0 110.335 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.04 59.26 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 120.131 -1.606 . . . . 0.0 112.335 157.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.65 166.99 31.38 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 4.7 tp60 -61.28 -16.92 50.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.759 1.623 . . . . 0.0 114.638 165.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -48.03 3.76 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.844 1.657 . . . . 0.0 111.232 -166.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.29 -37.19 23.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.686 1.194 . . . . 0.0 111.957 161.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -71.21 -23.12 61.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -88.03 -32.38 18.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.775 2.03 . . . . 0.0 110.329 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.67 -40.69 88.59 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 126.207 1.803 . . . . 0.0 110.346 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.13 -43.44 82.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 114.444 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -54.99 -21.34 11.56 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.8 -12.84 7.25 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 125.138 1.351 . . . . 0.0 115.213 172.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -53.57 -46.88 70.45 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.403 1.602 . . . . 0.0 113.175 161.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 51.03 -52.87 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.847 3.659 . . . . 0.0 117.0 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -147.27 106.72 3.91 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.507 2.323 . . . . 0.0 108.652 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.67 -166.7 2.19 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.639 1.176 . . . . 0.0 112.125 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -130.81 152.14 50.48 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.92 1.691 . . . . 0.0 114.088 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.401 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -99.93 -22.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.639 1.176 . . . . 0.0 112.845 173.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -178.44 -52.83 0.07 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.545 1.069 . . . . 0.0 112.755 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 -10.85 0.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.25 1.42 . . . . 0.0 114.49 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -123.8 -179.86 4.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.242 1.417 . . . . 0.0 112.427 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.68 108.77 5.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.601 -1.636 . . . . 0.0 107.696 -118.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.574 HD13 HD22 ' A' ' 118' ' ' LEU . 3.0 mt -117.33 116.57 52.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 123.138 1.447 . . . . 0.0 110.232 -144.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.15 156.16 25.94 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 128.852 2.861 . . . . 0.0 113.161 165.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.97 132.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.651 0.781 . . . . 0.0 111.36 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.28 144.43 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.146 1.778 . . . . 0.0 110.017 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -72.49 152.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.706 -0.622 . . . . 0.0 111.289 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.66 170.08 20.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.009 -160.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.7 m -155.72 162.48 40.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.216 1.806 . . . . 0.0 111.783 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.8 tp-100 -37.34 5.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 1 C-N-CA 133.118 4.567 . . . . 0.0 120.245 177.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.56 2.17 1.23 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 168.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.73 -20.39 21.6 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.701 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.625 HG12 ' CD1' ' A' ' 156' ' ' PHE . 34.5 m . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 128.302 2.641 . . . . 0.0 112.805 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.66 42.95 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.286 2.234 . . . . 0.0 112.275 173.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.431 ' HA2' ' CD ' ' A' ' 162' ' ' GLN . . . -53.06 99.24 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 128.15 2.786 . . . . 0.0 114.818 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.55 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.0 m-85 -116.84 161.3 19.52 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.859 1.329 . . . . 0.0 108.593 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.4 125.73 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.109 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt85 -94.08 142.36 27.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 0.0 111.227 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.89 154.66 21.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.044 2.538 . . . . 0.0 110.589 172.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -156.19 78.29 0.95 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 110.711 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.53 -15.36 0.02 OUTLIER Glycine 0 CA--C 1.544 1.844 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -65.28 159.15 68.36 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 128.444 2.698 . . . . 0.0 116.897 -153.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 74.0 Cg_endo -82.83 167.94 14.26 Favored 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 126.186 4.591 . . . . 0.0 113.988 -173.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -69.59 98.22 1.13 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.511 2.325 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.664 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 97.72 23.51 13.64 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.394 1.473 . . . . 0.0 114.704 -168.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.3 t -53.2 152.89 4.06 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.191 1.995 . . . . 0.0 113.879 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 t -143.64 159.57 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.114 0.959 . . . . 0.0 112.331 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -44.08 -46.43 8.55 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.609 1.963 . . . . 0.0 112.097 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' HG13 ' A' ' 128' ' ' VAL . 39.4 mp0 -65.61 -12.54 54.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.911 1.685 . . . . 0.0 114.717 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -82.65 -33.19 27.85 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 119.995 -1.691 . . . . 0.0 108.873 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.49 -40.19 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.909 -0.494 . . . . 0.0 111.987 164.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.262 1.4 m -58.19 -22.02 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.605 170.094 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.72 -25.55 17.39 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.462 1.483 . . . . 0.0 113.012 169.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.1 t80 -62.35 -49.48 75.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.685 1.194 . . . . 0.0 110.08 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.57 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 36.8 m-85 -113.14 31.88 6.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.736 1.214 . . . . 0.0 112.69 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -53.43 -20.96 5.27 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 157.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.75 43.74 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.989 1.757 . . . . 0.0 115.724 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.03 173.92 11.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 112.925 -156.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.1 118.93 33.66 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.39 1.476 . . . . 0.0 111.922 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.3 mt -118.29 135.23 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 128.885 2.874 . . . . 0.0 107.546 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.97 153.27 85.26 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.008 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.16 -13.83 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.662 1 N-CA-C 122.651 4.058 . . . . 0.0 122.651 -160.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -134.22 12.55 3.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.654 1.57 . . . . 0.0 111.906 172.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.87 -12.66 1.25 Allowed Glycine 0 N--CA 1.48 1.589 0 C-N-CA 128.016 2.722 . . . . 0.0 119.315 -150.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.448 ' CD1' HG12 ' A' ' 128' ' ' VAL . 66.9 mt -95.57 135.3 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 127.214 2.205 . . . . 0.0 109.826 -166.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.5 m -122.98 136.21 54.77 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.558 1.526 . . . . 0.0 113.381 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.38 97.33 40.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 127.64 2.376 . . . . 0.0 111.595 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.43 -86.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.429 2.086 . . . . 0.0 113.643 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.41 177.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 130.407 3.483 . . . . 0.0 107.972 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.527 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 6.7 p-10 -74.68 175.12 4.22 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.613 1.965 . . . . 0.0 114.669 171.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.55 -6.86 1.74 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.908 3.739 . . . . 0.0 117.789 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -118.08 -30.79 5.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.113 1.779 . . . . 0.0 111.342 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 111.41 37.5 1.61 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.927 161.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.82 -2.86 4.69 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.918 1.287 . . . . 0.0 113.506 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.664 HD11 ' H ' ' A' ' 121' ' ' GLY 0.302 0.0 OUTLIER -140.68 -100.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.501 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.4 OUTLIER 164.84 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.918 3.687 . . . . 0.0 108.785 -164.261 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.527 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.16 11.28 10.74 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 128.673 3.035 . . . . 0.0 114.707 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -140.41 158.99 43.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.946 1.698 . . . . 0.0 108.079 155.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.31 -179.86 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.689 1.996 . . . . 0.0 109.267 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -151.89 160.49 43.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.143 0.977 . . . . 0.0 110.031 -169.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -160.54 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.428 HE22 ' N ' ' A' ' 111' ' ' GLY . 67.9 tp60 -87.25 138.85 31.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.367 2.267 . . . . 0.0 111.575 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.3 m-85 -109.36 -175.67 2.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.496 1.518 . . . . 0.0 110.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.18 -10.2 59.52 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 119.396 -2.065 . . . . 0.0 113.025 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 m -161.87 158.7 25.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.589 1.156 . . . . 0.0 112.889 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.431 ' CD ' ' HA2' ' A' ' 111' ' ' GLY . 4.9 tp-100 -72.5 0.61 9.89 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.473 1.509 . . . . 0.0 113.696 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.75 -49.24 5.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.352 1.861 . . . . 0.0 111.429 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.3 mt -55.03 -36.57 65.65 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.754 1.222 . . . . 0.0 111.925 167.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.26 67.28 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.95 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -90.97 -27.62 18.56 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.659 1.584 . . . . 0.0 110.663 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -59.83 -36.43 76.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.884 1.273 . . . . 0.0 110.012 165.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.57 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -73.21 -39.77 65.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.312 1.845 . . . . 0.0 115.685 172.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -33.27 56.98 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.181 -1.574 . . . . 0.0 112.183 162.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.55 -13.7 8.15 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.832 1.682 . . . . 0.0 115.706 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -59.1 -39.12 81.25 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.4 1.6 . . . . 0.0 113.135 164.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.83 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 130.559 3.543 . . . . 0.0 117.954 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.77 119.84 4.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.364 1.465 . . . . 0.0 110.981 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -151.37 -147.28 0.22 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.321 1.449 . . . . 0.0 110.691 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.1 ttp85 -147.65 148.02 30.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.775 2.83 . . . . 0.0 109.643 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -114.71 -35.97 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.861 1.264 . . . . 0.0 111.585 -170.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -147.32 -117.94 1.02 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.413 1.958 . . . . 0.0 108.788 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -42.58 98.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.974 1.387 . . . . 0.0 111.954 162.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -95.94 -177.77 4.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.235 1.014 . . . . 0.0 113.708 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.514 ' C ' HD12 ' A' ' 181' ' ' ILE . 5.6 m-85 -133.98 116.94 16.13 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.065 2.146 . . . . 0.0 109.78 -144.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 118' ' ' LEU . 1.9 mp -122.84 157.42 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.789 1.757 . . . . 0.0 111.918 -149.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.262 1.1 mm-40 -128.2 159.42 35.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 130.992 3.717 . . . . 0.0 110.186 -164.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.69 142.61 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.28 150.14 35.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.097 2.159 . . . . 0.0 109.921 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -82.02 151.59 27.05 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.234 -0.916 . . . . 0.0 112.51 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 m -158.58 165.44 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.959 -161.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.35 156.48 42.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.749 1.619 . . . . 0.0 111.173 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.534 ' HA ' HG21 ' A' ' 191' ' ' VAL . 4.2 tp60 -40.81 2.94 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 1 C-N-CA 133.873 4.869 . . . . 0.0 120.269 -175.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -126.34 -22.24 4.05 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 119.772 -1.83 . . . . 0.0 112.247 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.48 -2.05 52.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.348 1.459 . . . . 0.0 110.558 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 156' ' ' PHE . 10.7 m . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 128.752 2.821 . . . . 0.0 113.15 -160.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.72 44.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 130.223 3.409 . . . . 0.0 113.744 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.22 95.41 0.43 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.824 2.154 . . . . 0.0 110.25 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 191' ' ' VAL . 2.9 m-85 -105.49 161.62 14.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.72 121.82 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.118 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 36.5 ttt85 -94.4 133.66 37.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.445 1.098 . . . . 0.0 111.381 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.28 152.42 19.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.365 1.866 . . . . 0.0 111.994 167.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 135.33 39.08 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 146.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 166.03 -18.81 0.1 OUTLIER Glycine 0 CA--C 1.531 1.086 0 O-C-N 119.823 -1.798 . . . . 0.0 113.77 152.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.543 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.4 mt -55.52 148.6 33.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.284 3.034 . . . . 0.0 115.335 -152.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.72 175.59 11.1 Favored 'Trans proline' 0 C--N 1.344 0.294 1 C-N-CA 126.35 4.7 . . . . 0.0 112.796 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -66.75 135.09 53.46 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.491 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.3 57.89 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-O 117.929 -1.484 . . . . 0.0 114.959 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 118' ' ' LEU . 35.4 t -57.24 151.43 15.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.037 1.918 . . . . 0.0 112.18 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 165.09 28.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 123.177 1.465 . . . . 0.0 112.267 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 128' ' ' VAL . 26.0 ttmt -44.99 -40.6 6.58 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 127.872 2.469 . . . . 0.0 113.534 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -70.39 -17.88 63.04 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 121.317 1.871 . . . . 0.0 114.027 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.09 -31.99 56.35 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 119.894 -1.754 . . . . 0.0 108.96 168.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 143' ' ' LEU . 52.5 mt -68.69 -38.1 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.155 -0.966 . . . . 0.0 111.815 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -63.72 -17.11 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.748 1.219 . . . . 0.0 112.924 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -23.7 15.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.11 1.323 . . . . 0.0 112.129 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 176' ' ' ILE . 9.9 t80 -61.22 -49.38 77.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.047 1.339 . . . . 0.0 109.777 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.86 33.23 5.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.443 1.497 . . . . 0.0 112.698 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 90.9 p -50.17 -22.03 1.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 156.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -49.49 -37.75 26.55 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.085 1.802 . . . . 0.0 115.347 168.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.04 168.01 20.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.428 1.091 . . . . 0.0 113.65 -153.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.62 128.6 36.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.914 1.685 . . . . 0.0 112.019 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 65.1 mt -128.8 134.81 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.659 2.784 . . . . 0.0 107.418 -174.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.2 m -65.19 154.03 88.06 Favored Pre-proline 0 N--CA 1.484 1.226 0 O-C-N 121.81 -0.556 . . . . 0.0 111.544 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.38 -7.33 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.239 3.293 . . . . 0.0 119.814 -169.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -127.35 12.97 7.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.004 1.322 . . . . 0.0 112.209 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.53 72.03 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -152.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.454 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 64.1 mt -93.93 132.23 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.832 1.253 . . . . 0.0 109.335 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.8 m -124.08 132.87 53.71 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.806 1.642 . . . . 0.0 112.67 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.511 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -121.95 93.13 48.75 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 127.511 2.324 . . . . 0.0 110.921 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.31 -65.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.235 1.29 . . . . 0.0 113.162 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.71 175.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 129.72 3.208 . . . . 0.0 109.163 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.514 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 11.0 p-10 -72.95 171.6 9.93 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 119.818 -1.801 . . . . 0.0 114.316 160.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.18 2.48 0.13 Allowed 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 124.729 3.619 . . . . 0.0 117.151 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -128.62 -1.32 5.48 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.686 1.594 . . . . 0.0 112.008 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.25 36.07 28.29 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -132.42 -16.22 2.74 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.713 1.756 . . . . 0.0 112.792 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -141.97 -112.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.508 -170.468 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.438 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.2 p -177.86 80.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.871 3.268 . . . . 0.0 107.433 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.56 5.59 6.64 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 128.151 2.786 . . . . 0.0 115.429 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.17 161.87 36.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.512 1.525 . . . . 0.0 108.365 157.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.43 -179.53 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.924 1.689 . . . . 0.0 109.063 -166.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.7 m-85 -153.4 158.76 41.95 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.342 0.657 . . . . 0.0 110.25 -167.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -158.54 123.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -92.47 129.92 38.28 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 127.557 2.343 . . . . 0.0 110.99 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.4 m-85 -97.87 -168.5 1.68 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 110.046 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.02 -10.23 59.5 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.024 -1.672 . . . . 0.0 113.733 165.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.9 m -162.65 158.33 23.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -69.99 43.79 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.829 2.452 . . . . 0.0 112.831 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -149.82 -56.53 0.18 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.613 1.965 . . . . 0.0 110.252 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.1 mt -54.2 -41.66 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.418 1.487 . . . . 0.0 111.339 163.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -70.21 -12.47 61.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -31.06 12.53 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.572 -1.33 . . . . 0.0 109.656 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -63.62 -35.36 80.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.951 1.3 . . . . 0.0 109.537 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.5 73.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.215 1.806 . . . . 0.0 115.544 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.7 mp -52.62 -32.64 42.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.536 -1.353 . . . . 0.0 113.279 164.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.6 -11.87 11.77 Favored Glycine 0 CA--C 1.546 1.984 0 C-N-CA 125.573 1.558 . . . . 0.0 115.631 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -59.21 -38.26 79.48 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.187 1.494 . . . . 0.0 113.474 165.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.79 -60.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 129.527 3.131 . . . . 0.0 116.423 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 105.19 4.55 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.897 2.079 . . . . 0.0 110.754 -174.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -145.58 -163.25 1.68 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.184 1.794 . . . . 0.0 110.335 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.23 44.76 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 128.651 2.781 . . . . 0.0 109.283 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.464 HD12 ' CD1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -123.77 -39.93 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.145 0.578 . . . . 0.0 111.509 -165.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.66 -98.56 0.48 Allowed Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.801 1.667 . . . . 0.0 109.956 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -46.28 14.64 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.799 1.3 . . . . 0.0 112.132 162.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -95.28 -178.1 4.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.919 1.288 . . . . 0.0 114.13 -167.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.502 ' C ' HD12 ' A' ' 181' ' ' ILE . 6.1 m-85 -132.78 125.68 30.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 110.568 -143.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.502 HD12 ' C ' ' A' ' 180' ' ' TYR . 1.8 mp -125.06 134.42 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 123.447 1.594 . . . . 0.0 112.553 -147.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.07 157.25 35.09 Favored 'General case' 0 CA--C 1.538 0.489 1 C-N-CA 132.127 4.171 . . . . 0.0 114.251 164.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.86 136.59 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.228 1.011 . . . . 0.0 111.463 168.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -138.91 151.64 47.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.076 2.151 . . . . 0.0 109.139 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -90.52 143.73 26.46 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.493 -0.754 . . . . 0.0 111.72 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -149.95 165.96 31.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.607 -157.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.12 160.26 42.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.107 1.763 . . . . 0.0 110.534 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.0 tp60 -40.51 4.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 1 C-N-CA 133.478 4.711 . . . . 0.0 119.021 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.66 -15.18 5.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.769 2.028 . . . . 0.0 114.028 -175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -114.3 -19.96 11.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.511 2.325 . . . . 0.0 110.109 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 112' ' ' PHE . 19.2 m . . . . . 0 CA--C 1.518 -0.27 0 C-N-CA 129.883 3.273 . . . . 0.0 114.31 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.49 51.15 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.477 1.132 . . . . 0.0 113.381 -163.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.26 89.6 0.9 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 126.169 1.842 . . . . 0.0 110.985 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CG ' HG11 ' A' ' 191' ' ' VAL . 5.0 m-85 -95.27 164.58 12.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.76 120.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 76.4 ttt180 -95.39 136.94 35.12 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.583 0.753 . . . . 0.0 111.95 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.67 148.89 26.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.653 2.781 . . . . 0.0 109.775 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -154.11 78.28 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 109.383 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 179.9 -3.81 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.5 OUTLIER -79.88 151.43 73.57 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 118.61 1.205 . . . . 0.0 112.117 -161.431 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.441 ' CG ' HG22 ' A' ' 176' ' ' ILE . 95.8 Cg_endo -80.17 174.91 10.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 1 C-N-CA 126.598 4.865 . . . . 0.0 113.715 -177.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.35 127.68 32.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.732 1.213 . . . . 0.0 111.42 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 71.7 14.84 75.47 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 117.959 -1.467 . . . . 0.0 115.681 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.486 ' SG ' HG21 ' A' ' 176' ' ' ILE . 29.5 t -58.0 152.48 16.33 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.366 2.083 . . . . 0.0 112.543 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.23 164.24 32.9 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 122.847 1.308 . . . . 0.0 111.371 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -45.08 -42.91 9.13 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 127.799 2.44 . . . . 0.0 112.919 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 128' ' ' VAL . 37.4 mp0 -68.92 -18.52 64.11 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.669 1.577 . . . . 0.0 113.893 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.65 -25.57 45.01 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.62 -1.925 . . . . 0.0 110.671 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.422 HD12 HD21 ' A' ' 143' ' ' LEU . 48.6 mt -73.06 -37.14 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.724 0.81 . . . . 0.0 110.995 165.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.261 2.2 m -59.92 -20.89 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.266 1.026 . . . . 0.0 113.151 169.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -93.5 -28.59 16.0 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.909 1.231 . . . . 0.0 113.448 168.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.87 -45.81 91.3 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.394 1.477 . . . . 0.0 111.168 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -116.17 33.51 5.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.625 1.17 . . . . 0.0 113.108 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.0 p -53.3 -22.49 7.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.79 -32.49 40.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.297 1.903 . . . . 0.0 115.232 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.73 169.71 17.31 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.18 1.392 . . . . 0.0 112.172 -157.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -99.62 136.26 39.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.372 1.469 . . . . 0.0 112.166 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.4 mt -134.19 139.12 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 128.887 2.875 . . . . 0.0 108.79 -168.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.7 152.13 76.3 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.667 -0.646 . . . . 0.0 110.887 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.85 -24.05 22.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -158.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.09 40.5 2.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.935 1.294 . . . . 0.0 109.872 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.61 16.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.15 1.357 . . . . 0.0 115.674 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 128' ' ' VAL . 65.5 mt -93.17 126.44 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 125.27 1.428 . . . . 0.0 109.451 -169.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.5 m -121.92 132.18 54.41 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.039 1.736 . . . . 0.0 112.869 -174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.422 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.67 91.35 49.79 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.178 2.191 . . . . 0.0 111.483 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.44 -70.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 121.771 1.647 . . . . 0.0 113.655 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.91 169.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 129.516 3.127 . . . . 0.0 108.809 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.543 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.4 p-10 -70.52 170.74 9.68 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 165.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.6 0.06 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 124.838 3.692 . . . . 0.0 117.13 171.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -129.15 0.38 5.19 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.74 1.616 . . . . 0.0 111.814 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.03 37.82 42.3 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -130.24 -16.72 3.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.161 1.481 . . . . 0.0 112.657 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.509 HG23 ' H ' ' A' ' 152' ' ' THR 0.294 0.0 OUTLIER -143.09 -112.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 113.482 -169.425 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -177.77 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.419 3.087 . . . . 0.0 108.028 -166.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.543 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -122.97 5.56 9.62 Favored Glycine 0 N--CA 1.466 0.7 0 C-N-CA 127.84 2.638 . . . . 0.0 114.685 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.36 159.04 42.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.22 0.608 . . . . 0.0 109.982 152.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.18 178.26 3.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.261 1.825 . . . . 0.0 110.751 -165.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.686 ' CD1' HG12 ' A' ' 191' ' ' VAL . 92.0 m-85 -149.79 156.26 41.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.918 1.287 . . . . 0.0 109.283 -168.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.3 p -156.13 121.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 31.6 tp60 -90.0 129.8 36.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.544 1.938 . . . . 0.0 109.444 176.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.3 m-85 -86.96 -165.33 1.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.54 -14.6 60.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.965 -1.709 . . . . 0.0 112.307 161.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.7 m -158.66 163.9 36.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 6.1 mm-40 -56.78 -33.17 66.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.19 1.396 . . . . 0.0 114.679 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 28.6 tp10 -72.58 -50.18 27.21 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 111.915 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.12 -35.87 69.99 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.069 1.348 . . . . 0.0 111.264 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.51 -17.38 59.3 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.216 0.532 . . . . 0.0 112.262 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -87.09 -32.05 20.14 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.611 -1.305 . . . . 0.0 109.698 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -63.88 -35.77 81.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.392 1.477 . . . . 0.0 109.711 169.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.64 -43.47 89.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.167 1.787 . . . . 0.0 115.592 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 mp -50.03 -25.74 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.8 -16.34 30.72 Favored Glycine 0 CA--C 1.547 2.09 0 C-N-CA 124.858 1.218 . . . . 0.0 115.335 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -68.97 -14.51 63.08 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.49 1.645 . . . . 0.0 114.77 167.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 39.96 -48.64 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 132.407 4.283 . . . . 0.0 121.16 170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 15.79 0.66 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.324 1.85 . . . . 0.0 113.338 -173.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -55.09 174.27 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -110.75 155.68 22.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.652 1.581 . . . . 0.0 114.148 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.4 mt -132.96 169.1 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 130.972 3.709 . . . . 0.0 106.558 169.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 2.49 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.475 1.274 0 C-N-CA 129.774 3.559 . . . . 0.0 116.616 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 -2.86 4.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 171.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -134.38 -179.01 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.406 1.482 . . . . 0.0 114.959 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -144.05 111.16 5.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.426 -126.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.542 ' CD1' HD12 ' A' ' 176' ' ' ILE . 15.1 mt -115.51 129.01 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.436 1.112 . . . . 0.0 111.898 -139.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 153.24 41.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.553 2.341 . . . . 0.0 113.195 166.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.25 135.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.399 0.68 . . . . 0.0 111.657 167.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -139.25 143.48 38.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.149 1.78 . . . . 0.0 109.386 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 185' ' ' LYS . 16.8 tptm -75.35 136.91 40.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.725 0.774 . . . . 0.0 109.91 175.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 m -141.82 166.46 24.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.727 -164.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -143.5 157.18 44.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.91 0.884 . . . . 0.0 110.616 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.46 ' HA ' HG21 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -33.84 5.44 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.907 1 C-N-CA 134.945 5.298 . . . . 0.0 120.037 176.935 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -126.71 -22.45 3.89 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.09 -1.631 . . . . 0.0 112.851 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.51 -21.91 61.12 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.471 -1.393 . . . . 0.0 109.708 172.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 156' ' ' PHE . 20.8 m . . . . . 0 C--N 1.333 -0.144 0 C-N-CA 126.855 2.062 . . . . 0.0 113.447 -150.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.7 p30 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -52.66 41.68 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 1 C-N-CA 133.664 4.786 . . . . 0.0 116.371 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.12 90.17 0.06 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.931 1.253 . . . . 0.0 111.737 162.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.7 m-85 -107.5 160.75 15.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.36 116.02 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 73.5 ttt180 -88.39 120.17 29.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.362 1.065 . . . . 0.0 111.382 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.45 151.21 41.18 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.525 1.53 . . . . 0.0 111.648 162.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 139.9 44.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 148.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.5 -20.65 0.82 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.523 -1.361 . . . . 0.0 112.885 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.84 HD23 ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -58.18 142.91 80.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.514 1.926 . . . . 0.0 113.544 -156.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.28 165.7 27.33 Favored 'Trans proline' 0 N--CA 1.458 -0.576 1 C-N-CA 126.231 4.621 . . . . 0.0 112.131 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.54 116.79 4.6 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.317 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.33 59.76 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.615 -1.103 . . . . 0.0 115.549 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.45 ' SG ' HD22 ' A' ' 118' ' ' LEU . 21.6 t -56.06 148.34 17.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.984 1.892 . . . . 0.0 110.938 165.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 125' ' ' GLU . 8.8 t -144.32 171.05 14.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.952 0.882 . . . . 0.0 110.076 170.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.2 ttmt -41.31 -40.93 1.79 Allowed 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 127.438 2.295 . . . . 0.0 112.978 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HB2' HG23 ' A' ' 123' ' ' THR . 27.6 mp0 -58.52 -32.67 69.07 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.25 2.22 . . . . 0.0 116.069 173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -77.01 -23.33 52.2 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 119.958 -1.714 . . . . 0.0 110.157 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 143' ' ' LEU . 13.4 mt -74.78 -37.33 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.641 -0.662 . . . . 0.0 110.993 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -62.15 -17.26 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.126 1.37 . . . . 0.0 113.054 171.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -98.17 -25.28 14.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.62 1.1 . . . . 0.0 113.937 168.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.81 -45.86 91.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.057 1.343 . . . . 0.0 110.575 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -121.48 33.25 5.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.038 1.335 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -54.24 -19.4 5.19 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.769 -0.582 . . . . 0.0 112.49 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.68 -35.0 44.99 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.588 1.566 . . . . 0.0 115.496 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.34 163.56 31.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -153.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.84 139.25 32.78 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 112.84 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 75.4 mt -144.51 133.37 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.639 2.375 . . . . 0.0 107.24 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.89 153.35 54.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.636 -0.665 . . . . 0.0 111.438 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.69 -23.96 28.2 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 120.842 3.362 . . . . 0.0 120.842 -160.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.48 39.43 2.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.674 1.19 . . . . 0.0 109.95 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.8 -26.45 17.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.89 1.233 . . . . 0.0 114.812 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -84.1 132.44 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.662 1.585 . . . . 0.0 108.883 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 m -126.19 131.57 51.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.263 1.825 . . . . 0.0 112.124 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 127' ' ' ILE . 3.8 mm? -128.2 84.96 61.75 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 126.572 1.949 . . . . 0.0 112.61 -167.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.83 -69.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 121.825 1.684 . . . . 0.0 115.512 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.64 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 127.252 2.221 . . . . 0.0 111.651 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.553 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.0 p-10 -79.06 173.26 8.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.893 2.077 . . . . 0.0 114.845 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.45 -4.31 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 125.074 3.849 . . . . 0.0 117.844 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.42 -32.0 3.94 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 121.35 1.886 . . . . 0.0 111.785 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 109.02 40.26 1.57 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.235 0.922 . . . . 0.0 114.641 165.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.4 -3.13 4.35 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 113.106 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 152' ' ' THR 0.318 0.0 OUTLIER -141.7 -102.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.998 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.612 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 165.98 68.0 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.444 3.498 . . . . 0.0 108.687 -159.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -114.58 4.02 23.15 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 129.266 3.317 . . . . 0.0 116.226 172.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -127.29 163.5 23.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.234 1.016 . . . . 0.0 109.632 142.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.85 178.36 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.405 2.282 . . . . 0.0 108.154 -168.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.3 m-85 -150.42 160.59 43.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.582 0.753 . . . . 0.0 109.512 -167.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.02 121.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 136' ' ' ILE . 55.7 tp60 -92.69 123.87 36.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 127.222 2.209 . . . . 0.0 111.386 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 11.3 m-85 -86.99 -173.63 4.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.329 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.98 -8.74 57.94 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.224 -1.548 . . . . 0.0 113.105 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.6 m -160.39 161.29 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.566 1.147 . . . . 0.0 112.944 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -57.4 -31.24 65.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.212 1.405 . . . . 0.0 113.508 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -84.67 -42.78 14.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.523 1.529 . . . . 0.0 113.014 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.4 mt -54.69 -35.47 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.449 1.5 . . . . 0.0 111.411 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.23 -10.05 57.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.07 -13.81 11.2 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.322 -1.486 . . . . 0.0 112.004 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -62.32 -40.31 95.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.702 0.801 . . . . 0.0 109.2 153.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.47 79.03 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -50.58 -27.0 5.95 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.694 1.588 . . . . 0.0 114.287 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.89 -19.82 56.58 Favored Glycine 0 CA--C 1.546 1.991 0 C-N-CA 125.077 1.322 . . . . 0.0 114.798 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.59 41.64 0.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.717 2.007 . . . . 0.0 112.61 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -51.31 -30.48 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.697 2.399 . . . . 0.0 114.888 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -147.58 107.3 3.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.264 1.026 . . . . 0.0 111.051 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -137.64 -161.21 1.14 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.654 1.582 . . . . 0.0 109.927 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -140.75 148.04 40.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.065 1.346 . . . . 0.0 111.718 -155.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.01 132.72 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.319 2.248 . . . . 0.0 108.132 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 59.54 -67.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.419 0 C-N-CA 127.605 2.526 . . . . 0.0 115.831 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.8 -9.85 0.21 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.714 2.406 . . . . 0.0 113.566 169.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -108.53 -175.03 2.66 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 127.139 2.176 . . . . 0.0 112.765 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -149.63 116.74 6.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -135.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.84 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.8 mt -127.03 135.8 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 122.776 1.274 . . . . 0.0 111.771 -139.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.8 159.27 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 130.955 3.702 . . . . 0.0 114.348 169.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.04 137.44 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.923 1.289 . . . . 0.0 111.005 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -138.42 146.88 42.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.205 1.802 . . . . 0.0 109.806 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -70.82 142.84 51.27 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.782 1.233 . . . . 0.0 110.884 177.257 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.412 ' H ' ' HE2' ' A' ' 185' ' ' LYS . 3.3 m -153.79 161.88 41.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.357 -164.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.5 m -146.2 157.38 43.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.084 1.354 . . . . 0.0 111.148 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.489 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.3 tp60 -40.93 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.129 4.572 . . . . 0.0 119.674 -175.3 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 -16.0 3.91 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.976 -1.702 . . . . 0.0 114.369 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.44 -29.14 18.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.767 1.627 . . . . 0.0 108.915 173.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.632 HG11 ' CG ' ' A' ' 112' ' ' PHE . 35.7 m . . . . . 0 C--N 1.333 -0.133 0 C-N-CA 129.111 2.965 . . . . 0.0 115.42 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 119.928 -0.082 . . . . 10.0 110.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 m 42.59 -20.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 1 C-N-CA 132.951 4.501 . . . . 10.0 120.346 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.2 -30.09 0.06 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.44 2.296 . . . . 10.0 112.382 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.35 136.88 20.19 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.144 1.164 . . . . 10.0 114.144 -172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.9 p -147.25 -47.47 0.17 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 140.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -175.21 -41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.32 1.848 . . . . 10.0 113.212 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -124.54 -32.31 3.14 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.385 1.624 . . . . 10.0 115.385 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.83 36.13 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.563 3.145 . . . . 10.0 114.934 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -61.39 101.36 0.32 Allowed Glycine 0 C--O 1.228 -0.229 0 CA-C-O 117.797 -1.557 . . . . 10.0 111.75 173.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.683 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -111.03 167.59 10.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.859 -1.904 . . . . 10.0 105.859 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.0 t -134.06 153.29 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.247 -1.797 . . . . 10.0 107.964 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 52.3 ttt180 -120.65 136.49 54.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.0 1.32 . . . . 10.0 111.959 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.88 147.19 29.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.409 3.084 . . . . 10.0 109.976 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -152.66 77.22 1.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.599 1.16 . . . . 10.0 109.936 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.07 9.4 0.02 OUTLIER Glycine 0 CA--C 1.532 1.125 0 N-CA-C 116.176 1.23 . . . . 10.0 116.176 -164.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.6 mt -80.44 155.41 74.04 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.797 1.239 . . . . 10.0 111.313 -166.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.511 ' CD ' HG22 ' A' ' 176' ' ' ILE . 23.8 Cg_endo -84.08 175.75 7.26 Favored 'Trans proline' 0 CA--C 1.532 0.384 1 C-N-CA 126.72 4.947 . . . . 10.0 112.489 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -63.98 135.17 56.24 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.421 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 69.58 15.1 70.47 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 118.247 -1.307 . . . . 10.0 115.585 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 176' ' ' ILE . 39.7 t -58.34 147.43 31.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.053 1.927 . . . . 10.0 112.78 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 171.86 16.68 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.028 0.918 . . . . 10.0 112.146 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 128' ' ' VAL . 6.7 mttm -38.44 -53.6 1.53 Allowed 'General case' 0 C--O 1.205 -1.237 0 CA-C-O 116.477 -1.725 . . . . 10.0 113.54 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.48 -19.76 63.89 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 121.585 1.993 . . . . 10.0 113.7 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -79.98 -29.39 39.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.16 -1.587 . . . . 10.0 110.767 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 143' ' ' LEU . 46.3 mt -73.12 -43.48 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.373 1.069 . . . . 10.0 111.17 168.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.3 m -56.64 -21.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.31 1.844 . . . . 10.0 113.303 169.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -96.39 -26.33 15.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.887 1.676 . . . . 10.0 112.37 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -58.81 -51.94 67.86 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.59 1.556 . . . . 10.0 109.864 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 39.8 m-85 -112.75 30.98 6.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.305 1.042 . . . . 10.0 112.841 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.5 p -53.23 -21.86 5.95 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.173 0.805 . . . . 10.0 113.173 156.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.3 -31.91 43.31 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.073 1.796 . . . . 10.0 115.208 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.28 166.21 24.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.116 1.366 . . . . 10.0 112.875 -157.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.32 134.77 34.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.147 1.379 . . . . 10.0 111.649 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 71.2 mt -137.27 140.62 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 128.371 2.668 . . . . 10.0 106.978 -170.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.15 156.08 61.25 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.535 -0.728 . . . . 10.0 111.432 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.22 -19.24 16.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 120.957 3.407 . . . . 10.0 120.957 -162.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.8 35.48 2.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.633 1.106 . . . . 10.0 110.657 166.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.12 45.3 0.58 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 126.692 2.091 . . . . 10.0 114.228 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 128' ' ' VAL . 86.3 mt -143.58 136.13 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 119.964 1.882 . . . . 10.0 106.012 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -132.52 131.54 41.71 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.24 1.836 . . . . 10.0 112.569 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 127' ' ' ILE . 2.9 mm? -124.94 84.06 59.23 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 127.263 2.225 . . . . 10.0 110.868 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.69 -65.18 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 121.081 1.188 . . . . 10.0 113.237 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.84 169.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 128.328 2.651 . . . . 10.0 110.149 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.1 p-10 -68.5 173.3 3.51 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.533 . . . . 10.0 114.778 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.37 -1.98 0.54 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.754 3.636 . . . . 10.0 117.624 172.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.72 -31.89 3.14 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.537 1.971 . . . . 10.0 112.28 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.04 37.66 1.22 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.88 -0.955 . . . . 10.0 115.445 163.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -135.34 -2.95 2.44 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.997 1.398 . . . . 10.0 113.808 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.611 HG23 ' H ' ' A' ' 152' ' ' THR 0.285 0.0 OUTLIER -143.7 -118.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.782 1.233 . . . . 10.0 113.496 -178.373 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.611 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.1 p -172.76 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.365 3.466 . . . . 10.0 107.051 -167.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.547 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.29 6.46 11.83 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 126.98 2.228 . . . . 10.0 114.751 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -132.08 156.55 46.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.016 0.912 . . . . 10.0 110.376 148.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.19 175.45 8.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 126.088 1.755 . . . . 10.0 110.423 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 86.1 m-85 -149.09 164.64 34.07 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.524 -169.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -159.41 119.52 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 114.381 1.252 . . . . 10.0 114.381 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 49.6 tp60 -90.38 123.55 34.21 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 129.477 3.111 . . . . 10.0 111.055 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.2 m-85 -89.1 -165.45 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 123.143 0.577 . . . . 10.0 110.248 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.65 -10.3 59.74 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.88 -1.763 . . . . 10.0 113.632 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.4 m -158.48 160.95 37.31 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.428 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 2.2 tp60 -58.63 -28.12 65.36 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 171.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -80.08 -48.15 13.71 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.782 1.233 . . . . 10.0 112.214 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.62 -37.7 63.32 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.349 1.46 . . . . 10.0 111.334 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.91 -8.87 57.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -112.99 -15.3 12.88 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.918 -1.739 . . . . 10.0 112.893 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -60.01 -37.46 79.8 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 156.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -67.82 -46.34 72.15 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.549 2.055 . . . . 10.0 116.549 172.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mp -48.0 -35.07 10.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 120.527 1.512 . . . . 10.0 113.189 162.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.41 -15.16 30.44 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 125.622 1.582 . . . . 10.0 115.85 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -64.6 -26.33 68.35 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.56 1.68 . . . . 10.0 114.65 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.3 t60 60.58 -47.58 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.922 2.889 . . . . 10.0 117.328 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -145.1 -66.76 0.32 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.64 1.576 . . . . 10.0 112.611 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 36.82 -142.3 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.575 1.55 . . . . 10.0 113.186 -167.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -151.25 155.51 38.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.864 . . . . 10.0 110.199 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.511 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.5 mt -132.93 135.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.151 2.58 . . . . 10.0 105.447 162.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 49.02 -86.95 0.01 OUTLIER Glycine 0 N--CA 1.474 1.167 0 C-N-CA 126.801 2.144 . . . . 10.0 114.178 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 5.04 3.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.632 1.573 . . . . 10.0 114.449 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.51 -179.53 5.21 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.25 1.82 . . . . 10.0 114.259 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -146.84 14.13 1.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.604 -1.18 . . . . 10.0 113.01 -124.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 176' ' ' ILE . 1.3 mt 42.96 107.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 116.983 2.216 . . . . 10.0 116.983 134.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 165.06 23.17 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 127.506 2.323 . . . . 10.0 113.649 160.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.6 140.34 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.664 0.786 . . . . 10.0 112.294 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -144.44 153.25 41.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.432 1.893 . . . . 10.0 110.507 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -74.31 154.62 38.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.809 0.844 . . . . 10.0 111.837 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.3 m -159.02 167.97 27.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.021 0.748 . . . . 10.0 113.021 -165.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 14.9 m -149.42 161.89 41.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.464 1.906 . . . . 10.0 109.64 159.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HG22 ' A' ' 191' ' ' VAL . 2.4 tp-100 -31.62 -10.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 1 C-N-CA 132.467 4.307 . . . . 10.0 120.595 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.3 -6.32 3.8 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.232 -2.168 . . . . 10.0 112.066 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -23.05 39.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 149.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.683 HG11 ' CD2' ' A' ' 112' ' ' PHE . 9.5 m -91.55 -35.65 7.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 115.443 1.646 . . . . 10.0 115.443 -164.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 192' ' ' ARG 0.342 0.0 OUTLIER -82.89 53.39 2.4 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.093 1.146 . . . . 10.0 114.093 -165.106 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.3 m -58.87 -13.52 6.49 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.171 0.989 . . . . 10.0 113.148 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.359 0 C-N-CA 128.856 2.862 . . . . 10.0 107.95 165.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 189' ' ' GLU . 8.5 t-20 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.2 p 58.45 -29.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 130.907 3.683 . . . . 0.0 120.311 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.08 50.35 0.65 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.555 1.542 . . . . 0.0 111.308 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.82 171.99 4.78 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 m -155.24 70.53 0.75 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.179 1.792 . . . . 0.0 111.872 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.46 -44.45 0.17 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -171.73 -46.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.73 1.612 . . . . 0.0 110.981 -166.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.08 45.22 0.09 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.591 3.156 . . . . 0.0 113.556 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.86 102.12 1.63 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.639 ' CD2' HG11 ' A' ' 191' ' ' VAL . 3.2 m-85 -99.48 160.57 14.19 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.5 118.33 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.273 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -104.11 125.8 50.72 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 -164.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.37 151.59 23.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.467 2.307 . . . . 0.0 110.494 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -155.58 79.55 1.02 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.682 1.593 . . . . 0.0 108.582 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.39 -11.96 0.02 OUTLIER Glycine 0 CA--C 1.536 1.401 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -162.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.828 HD23 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -73.36 152.69 90.07 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.608 1.163 . . . . 0.0 113.423 -155.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.481 ' CD ' HG22 ' A' ' 176' ' ' ILE . 69.7 Cg_endo -78.02 171.35 17.32 Favored 'Trans proline' 0 CA--C 1.531 0.352 1 C-N-CA 126.753 4.969 . . . . 0.0 112.653 173.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -57.37 133.9 55.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.068 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.2 19.24 68.03 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 118.775 -1.014 . . . . 0.0 115.169 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 118' ' ' LEU . 33.8 t -55.44 146.69 19.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.273 1.536 . . . . 0.0 111.722 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.0 t -150.7 163.5 38.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 112.164 -173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.5 mttt -39.2 -44.38 1.21 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 126.738 2.015 . . . . 0.0 115.684 173.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -69.84 -19.91 63.44 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.089 1.356 . . . . 0.0 112.957 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 2.2 mm-40 -78.12 -32.12 50.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.284 -1.51 . . . . 0.0 109.597 169.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.445 HD12 HD21 ' A' ' 143' ' ' LEU . 16.2 mt -69.59 -39.85 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 120.708 -1.245 . . . . 0.0 110.782 169.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 124' ' ' LYS 0.269 1.2 m -61.59 -13.46 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.613 1.565 . . . . 0.0 114.512 168.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.4 pp0? -101.86 -21.19 14.62 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 121.031 1.741 . . . . 0.0 113.728 166.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -49.2 75.04 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.614 1.566 . . . . 0.0 110.732 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -118.84 31.49 6.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.224 1.41 . . . . 0.0 112.069 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 84.2 p -46.59 -25.7 0.75 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 153.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.22 70.52 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.65 2.071 . . . . 0.0 116.246 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.06 159.73 41.03 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.647 1.224 . . . . 0.0 113.14 -154.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.55 127.68 34.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.997 1.319 . . . . 0.0 112.04 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 46.8 mt -129.49 139.18 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 128.358 2.663 . . . . 0.0 108.494 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.01 151.3 80.88 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.309 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -52.83 -24.87 25.27 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 120.671 3.296 . . . . 0.0 120.671 -158.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.39 42.45 2.36 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.792 1.237 . . . . 0.0 110.078 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.74 -23.68 30.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.909 1.243 . . . . 0.0 114.967 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.12 144.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 125.629 1.572 . . . . 0.0 109.481 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 77.6 m -140.28 136.29 33.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.056 -1.653 . . . . 0.0 113.52 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -125.74 89.88 51.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.101 2.56 . . . . 0.0 111.129 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.07 -72.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.017 1.812 . . . . 0.0 113.728 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.07 167.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 127.034 2.134 . . . . 0.0 111.183 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.3 p-10 -70.22 173.38 4.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.087 1.755 . . . . 0.0 114.875 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.46 -3.28 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.691 3.594 . . . . 0.0 117.886 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.08 -36.68 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.814 2.097 . . . . 0.0 111.881 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.04 42.13 0.67 Allowed Glycine 0 CA--C 1.532 1.117 0 N-CA-C 115.27 0.868 . . . . 0.0 115.27 163.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -134.0 -2.81 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.742 1.217 . . . . 0.0 113.631 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.626 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -143.47 -117.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.063 1.345 . . . . 0.0 113.47 -178.401 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.626 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -175.7 76.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 130.72 3.608 . . . . 0.0 106.08 -169.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -117.67 3.6 17.47 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 127.971 2.7 . . . . 0.0 115.646 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.03 157.84 41.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 122.307 1.051 . . . . 0.0 109.753 148.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.44 177.69 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.527 2.331 . . . . 0.0 108.188 -171.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.572 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -152.38 159.52 43.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 122.624 0.369 . . . . 0.0 110.871 -163.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.43 129.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 53.4 tp60 -104.23 138.53 40.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.382 2.273 . . . . 0.0 110.13 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 2.9 m-85 -106.02 -175.87 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.92 57.09 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.048 -1.658 . . . . 0.0 113.267 168.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.8 m -161.24 161.68 30.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.311 1.045 . . . . 0.0 112.444 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -62.57 -21.6 65.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.028 0.931 . . . . 0.0 113.122 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.5 -47.7 10.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.533 2.733 . . . . 0.0 112.776 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.37 -35.68 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.9 1.28 . . . . 0.0 111.139 168.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.05 -13.55 62.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.508 172.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -94.75 -29.57 14.7 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.147 -1.596 . . . . 0.0 110.644 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -61.24 -38.86 88.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.062 1.745 . . . . 0.0 109.844 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.25 -45.76 83.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.086 2.155 . . . . 0.0 116.02 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.59 -28.24 13.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 113.768 165.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.74 -19.52 55.28 Favored Glycine 0 CA--C 1.546 2.012 0 C-N-CA 125.344 1.45 . . . . 0.0 115.418 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -72.43 35.7 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.77 2.028 . . . . 0.0 113.402 164.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.416 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 1.6 t-80 -50.16 -31.05 12.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -154.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 27.75 3.47 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.284 1.433 . . . . 0.0 113.371 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -66.96 -170.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -138.11 148.7 45.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.354 1.862 . . . . 0.0 111.361 -153.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.8 mt -139.71 128.12 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 128.824 2.849 . . . . 0.0 106.41 173.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.88 -126.19 34.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -98.47 8.43 44.89 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.6 -179.94 4.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -153.03 111.69 3.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -119.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.828 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.7 mt -126.43 136.77 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 122.876 1.322 . . . . 0.0 112.6 -139.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 155.08 40.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.689 3.196 . . . . 0.0 113.287 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 172' ' ' HIS . 1.7 m -141.67 132.47 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.749 0.82 . . . . 0.0 111.664 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.28 151.0 44.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.391 1.876 . . . . 0.0 110.328 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -74.25 143.95 44.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.206 1.003 . . . . 0.0 111.578 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.19 170.76 18.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.911 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 191' ' ' VAL . 69.7 m -143.16 154.08 43.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.192 1.397 . . . . 0.0 110.018 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -29.33 4.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.139 1 C-N-CA 135.643 5.577 . . . . 0.0 120.305 174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 103' ' ' ASN . 13.2 mt-10 -137.51 -24.58 1.05 Allowed 'General case' 0 C--N 1.322 -0.619 0 O-C-N 119.861 -1.774 . . . . 0.0 112.448 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.36 -21.87 28.68 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 161.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 112' ' ' PHE . 32.4 m -77.76 -32.95 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 113.215 -165.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -87.11 36.62 0.74 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.231 1.812 . . . . 0.0 112.35 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.6 30.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 128.447 2.699 . . . . 0.0 117.894 -148.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 130.113 3.365 . . . . 0.0 113.159 -168.875 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.0 p -67.07 -165.15 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 131.002 3.721 . . . . 0.0 114.293 -3.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.31 -33.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.415 3.086 . . . . 0.0 116.087 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.97 144.8 50.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 0.0 108.382 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -146.39 -53.52 0.25 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.34 -72.82 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.817 1.247 . . . . 0.0 112.647 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.32 -18.62 2.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 37.87 0.52 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.269 3.028 . . . . 0.0 112.774 -163.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.67 108.88 2.64 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CD2' HG11 ' A' ' 191' ' ' VAL . 15.1 m-85 -97.02 166.68 11.48 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 164.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.31 110.67 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.315 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -87.28 121.11 29.29 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.543 0.737 . . . . 0.0 111.585 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.07 151.41 28.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.735 2.014 . . . . 0.0 110.598 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.67 89.86 1.59 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.107 1.363 . . . . 0.0 108.784 168.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.14 -24.75 0.02 OUTLIER Glycine 0 N--CA 1.468 0.781 0 C-N-CA 117.797 -2.144 . . . . 0.0 114.313 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -52.75 144.39 25.78 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.879 2.472 . . . . 0.0 114.864 -157.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.38 172.52 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.503 1 C-N-CA 126.783 4.988 . . . . 0.0 112.938 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -48.31 123.15 6.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.455 1.502 . . . . 0.0 111.786 165.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.82 19.08 76.15 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.79 154.68 3.72 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.341 1.57 . . . . 0.0 112.489 166.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.7 t -150.2 162.63 40.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.587 0.755 . . . . 0.0 112.59 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.4 mttt -35.54 -47.11 0.44 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 126.845 2.058 . . . . 0.0 114.487 166.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.29 -18.74 64.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 120.737 1.608 . . . . 0.0 113.686 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.94 -30.51 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.287 -1.508 . . . . 0.0 110.646 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 143' ' ' LEU . 18.8 mt -68.17 -42.59 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.855 167.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 124' ' ' LYS 0.25 1.0 OUTLIER -62.27 -14.69 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 113.92 170.528 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -25.77 14.9 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.581 1.537 . . . . 0.0 113.885 164.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -46.51 83.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 109.732 173.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.555 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 27.8 m-85 -121.77 33.97 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.202 1.401 . . . . 0.0 113.686 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 t -53.78 -21.57 7.66 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.511 0.672 . . . . 0.0 112.094 157.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.34 -30.04 60.99 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.061 1.791 . . . . 0.0 115.821 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.05 167.45 22.03 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.455 1.128 . . . . 0.0 113.016 -156.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.65 131.52 40.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 111.931 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.2 mt -128.82 137.83 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 128.277 2.631 . . . . 0.0 108.49 -171.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 m -65.7 154.4 88.72 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.732 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.21 -13.37 6.88 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.398 3.399 . . . . 0.0 119.85 -167.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -135.67 26.12 3.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.85 1.66 . . . . 0.0 111.438 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.03 67.07 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 -169.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.65 137.31 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.678 1.191 . . . . 0.0 108.91 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.0 m -131.68 138.4 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.042 1.737 . . . . 0.0 111.814 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -123.15 92.27 49.19 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 127.017 2.127 . . . . 0.0 110.873 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' A' ' 155' ' ' ALA . 88.9 Cg_endo -79.8 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.762 3.641 . . . . 0.0 113.14 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.68 173.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 130.123 3.369 . . . . 0.0 108.851 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.1 p-10 -77.91 172.78 8.9 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.851 2.061 . . . . 0.0 114.087 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.08 0.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 125.031 3.821 . . . . 0.0 117.499 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -126.5 -0.19 6.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.749 1.62 . . . . 0.0 111.938 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 35.46 48.2 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.514 -1.159 . . . . 0.0 115.961 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -130.05 -15.79 3.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.594 1.697 . . . . 0.0 112.635 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.326 0.0 OUTLIER -138.43 -98.4 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -170.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 164.33 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 129.917 3.287 . . . . 0.0 109.245 -165.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -124.8 4.47 8.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.71 3.528 . . . . 0.0 114.405 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -130.12 166.68 19.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.409 1.084 . . . . 0.0 108.866 145.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 144' ' ' PRO . . . -170.85 175.83 4.35 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 128.046 2.539 . . . . 0.0 109.049 -171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.5 m-85 -150.27 154.74 38.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.062 0.545 . . . . 0.0 110.713 -166.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.43 127.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -97.26 139.61 32.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.344 2.258 . . . . 0.0 111.403 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.1 m-85 -106.73 -177.4 3.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.387 0.675 . . . . 0.0 110.697 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.63 -10.22 59.54 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.143 -1.598 . . . . 0.0 112.946 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.1 m -159.86 157.33 28.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.237 1.015 . . . . 0.0 112.033 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -72.86 -13.87 61.37 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.651 -0.656 . . . . 0.0 112.446 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.415 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 41.6 tp10 -75.07 -51.5 13.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.784 2.434 . . . . 0.0 112.394 169.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.4 mt -57.14 -38.16 73.1 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.996 0.918 . . . . 0.0 110.447 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.23 62.16 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -104.33 -27.1 12.18 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.374 -1.454 . . . . 0.0 110.629 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER -61.81 -32.13 72.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.164 0.985 . . . . 0.0 109.072 165.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -69.69 -47.9 61.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mp -49.39 -33.51 13.95 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.031 1.287 . . . . 0.0 112.918 162.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.86 -16.61 32.26 Favored Glycine 0 CA--C 1.545 1.929 0 C-N-CA 125.823 1.678 . . . . 0.0 115.581 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -62.37 -33.48 74.82 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.642 1.721 . . . . 0.0 113.392 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 45.69 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 1 C-N-CA 132.418 4.287 . . . . 0.0 119.109 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 90.6 2.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.652 2.381 . . . . 0.0 109.726 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -130.55 -160.84 1.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.71 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -143.04 149.88 38.83 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 120.873 -1.142 . . . . 0.0 112.816 -156.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 118' ' ' LEU . 9.0 mt -140.06 133.09 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 128.306 2.643 . . . . 0.0 106.885 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 48.81 -136.31 19.26 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.229 1.871 . . . . 0.0 111.848 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.03 -8.21 54.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -179.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.686 1.194 . . . . 0.0 113.988 -160.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -137.87 118.39 13.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.503 -149.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 118' ' ' LEU . 1.7 mp -123.14 135.82 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.923 1.344 . . . . 0.0 110.952 -148.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 164.13 23.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.05 3.34 . . . . 0.0 115.449 169.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.02 132.14 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.808 1.243 . . . . 0.0 111.298 166.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.95 148.6 43.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.826 1.65 . . . . 0.0 110.966 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -71.33 135.09 47.18 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 111.122 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 m -146.87 167.56 23.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.044 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.4 m -154.32 156.12 36.37 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 0.0 112.375 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.496 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.1 tp-100 -32.86 2.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 1 C-N-CA 134.545 5.138 . . . . 0.0 121.151 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -130.4 -24.44 2.53 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.626 -1.921 . . . . 0.0 112.729 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -81.76 -7.18 59.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.01 1.324 . . . . 0.0 109.832 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.764 HG12 ' CD1' ' A' ' 156' ' ' PHE . 16.5 m -103.11 -22.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 128.566 2.746 . . . . 0.0 113.792 -171.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.7 mtm105 -78.31 70.99 4.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.543 1.537 . . . . 0.0 110.064 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 7.9 t -62.33 -17.31 58.5 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.827 -0.546 . . . . 0.0 111.942 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.281 0 C-N-CA 127.393 2.277 . . . . 0.0 114.656 -172.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.1 m -48.87 102.64 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -152.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.63 19.44 0.82 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.669 2.388 . . . . 0.0 112.833 -5.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -142.52 83.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.495 1.118 . . . . 0.0 113.825 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.0 t -165.68 106.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.009 1.724 . . . . 0.0 110.018 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.46 -9.85 0.73 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 130.292 3.437 . . . . 0.0 113.289 -6.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.51 24.35 2.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.162 2.185 . . . . 0.0 109.835 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.0 42.08 2.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.028 1.731 . . . . 0.0 109.616 -155.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.21 113.19 3.59 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.452 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.559 ' CD2' HG11 ' A' ' 191' ' ' VAL . 16.8 m-85 -106.41 162.48 13.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.31 119.5 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.924 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -96.27 120.96 37.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.142 1.377 . . . . 0.0 110.449 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 181' ' ' ILE . 2.0 mm? -72.49 146.08 47.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.12 158.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -139.01 140.33 38.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 141.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.27 1.36 0.39 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.644 0.618 . . . . 0.0 114.644 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.671 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 64.8 mt -69.01 152.11 96.95 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.184 1.394 . . . . 0.0 113.33 -153.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.461 ' CD ' HG22 ' A' ' 176' ' ' ILE . 68.7 Cg_endo -75.53 167.85 25.69 Favored 'Trans proline' 0 C--O 1.235 0.327 1 C-N-CA 125.722 4.281 . . . . 0.0 112.039 172.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -68.41 128.73 37.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.962 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.47 25.68 74.8 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.034 -0.87 . . . . 0.0 114.47 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 176' ' ' ILE . 42.8 t -53.09 150.28 5.93 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.549 1.175 . . . . 0.0 113.417 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 t -147.29 160.32 42.64 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 120.787 -1.195 . . . . 0.0 113.434 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.608 ' O ' HG13 ' A' ' 128' ' ' VAL . 5.0 mttm -39.11 -47.33 1.54 Allowed 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 126.663 1.985 . . . . 0.0 114.993 171.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -65.97 -19.64 65.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.589 1.541 . . . . 0.0 112.794 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 58.2 mt-10 -81.93 -29.45 32.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.4 -1.438 . . . . 0.0 109.744 171.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.437 HD12 HD21 ' A' ' 143' ' ' LEU . 31.9 mt -70.11 -41.99 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.202 -0.936 . . . . 0.0 111.325 166.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -62.11 -12.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.173 1.789 . . . . 0.0 114.162 170.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -100.56 -21.97 15.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.981 1.264 . . . . 0.0 114.4 164.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -48.91 78.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 169.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.18 34.75 5.1 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.16 1.384 . . . . 0.0 112.694 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.33 -23.42 2.32 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 156.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.04 -31.03 67.78 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.142 1.83 . . . . 0.0 115.988 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.35 161.39 37.07 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.297 1.049 . . . . 0.0 113.603 -154.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.44 143.37 30.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.162 1.385 . . . . 0.0 112.986 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 74.5 mt -146.09 135.46 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.519 2.328 . . . . 0.0 107.587 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -60.4 154.6 53.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 111.506 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.97 -1.75 8.37 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.288 1.992 . . . . 0.0 116.672 -163.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -133.4 17.34 4.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.266 1.826 . . . . 0.0 111.439 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.2 -29.39 72.8 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 121.355 -0.841 . . . . 0.0 114.531 -165.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.6 mt -85.95 129.37 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.761 1.624 . . . . 0.0 108.671 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.0 m -121.05 131.18 54.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.267 1.827 . . . . 0.0 111.458 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -120.24 92.24 47.01 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 127.152 2.181 . . . . 0.0 110.106 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.86 -86.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.352 2.701 . . . . 0.0 112.442 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.8 172.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 128.141 2.577 . . . . 0.0 110.941 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.77 174.53 5.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.747 2.019 . . . . 0.0 113.027 167.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.07 -6.4 1.28 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.868 3.712 . . . . 0.0 117.52 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -115.28 -14.16 11.69 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.685 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.04 12.45 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.35 -1.25 . . . . 0.0 115.124 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -125.13 -16.77 5.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.719 1.759 . . . . 0.0 112.261 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 152' ' ' THR 0.314 0.0 OUTLIER -140.74 -100.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -170.021 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.2 OUTLIER 166.16 83.89 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 130.511 3.524 . . . . 0.0 107.909 -165.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -113.03 -16.34 8.52 Favored Glycine 0 N--CA 1.47 0.959 1 C-N-CA 130.863 4.078 . . . . 0.0 113.585 176.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.68 163.95 25.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.726 1.61 . . . . 0.0 110.133 159.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.73 172.99 9.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.233 3.013 . . . . 0.0 107.213 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.648 ' CD2' HG12 ' A' ' 191' ' ' VAL . 90.3 m-85 -149.22 162.7 39.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 -167.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.45 120.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 43.2 tp60 -90.71 126.15 35.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.856 2.063 . . . . 0.0 108.779 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.0 m-85 -84.43 -167.82 1.93 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.425 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.85 -11.29 59.8 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.018 -1.676 . . . . 0.0 112.407 166.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.0 m -161.17 165.14 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.837 1.255 . . . . 0.0 112.856 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -61.06 -31.33 70.99 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.425 1.49 . . . . 0.0 113.077 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 31.5 tp10 -75.22 -48.05 25.29 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.975 2.11 . . . . 0.0 112.914 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 67.5 mt -57.54 -37.31 72.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.931 1.293 . . . . 0.0 110.697 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.2 -18.51 63.92 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -92.1 -32.89 14.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.636 1.574 . . . . 0.0 109.979 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -65.49 -36.1 82.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.435 1.494 . . . . 0.0 109.322 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.498 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.09 -43.16 88.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.545 1.938 . . . . 0.0 115.019 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -57.94 -19.73 32.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.12 -20.78 29.33 Favored Glycine 0 CA--C 1.548 2.118 0 C-N-CA 124.779 1.18 . . . . 0.0 114.579 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -71.09 43.84 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.099 2.16 . . . . 0.0 112.129 158.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -40.05 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.086 1.754 . . . . 0.0 113.937 -163.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -130.95 124.73 31.68 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.76 1.624 . . . . 0.0 107.525 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.0 -166.19 2.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.013 0.925 . . . . 0.0 110.959 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -129.27 149.3 51.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.265 1.426 . . . . 0.0 112.184 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.461 HG22 ' CD ' ' A' ' 119' ' ' PRO . 4.0 mt -139.69 120.27 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 129.015 2.926 . . . . 0.0 106.716 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 60.04 -123.39 32.94 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -90.14 -9.86 46.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -175.07 2.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.997 1.319 . . . . 0.0 113.357 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -154.1 115.71 4.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -126.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.531 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.8 mt -129.51 142.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.309 1.052 . . . . 0.0 112.094 -141.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.335 5.1 tp10 -89.04 163.88 15.31 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 129.465 3.106 . . . . 0.0 112.914 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 m -138.32 143.94 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.441 -0.787 . . . . 0.0 112.811 166.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.46 149.67 41.27 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.29 1.836 . . . . 0.0 110.605 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -68.32 152.78 44.95 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.615 0.766 . . . . 0.0 111.681 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.49 170.55 22.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.627 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.24 160.53 43.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.801 1.64 . . . . 0.0 111.275 166.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 tp-100 -42.68 5.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 131.722 4.009 . . . . 0.0 120.168 178.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER -130.55 -17.84 3.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.441 -2.037 . . . . 0.0 114.707 168.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.56 -26.65 32.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.599 1.56 . . . . 0.0 108.691 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.648 HG12 ' CD2' ' A' ' 156' ' ' PHE . 17.5 m -80.35 -11.85 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.056 2.542 . . . . 0.0 116.327 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 189' ' ' GLU . 8.3 mmm180 -75.87 52.55 0.7 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.698 2.399 . . . . 0.0 113.735 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 49.6 m -68.68 -1.28 6.58 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.082 153.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 8.4 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 130.84 3.656 . . . . 0.0 111.775 172.023 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.23 158.22 43.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -154.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -120.23 8.84 10.94 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.869 2.067 . . . . 0.0 112.111 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.35 165.71 7.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.116 1.766 . . . . 0.0 112.377 166.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.0 m -146.92 128.66 15.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.988 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.65 -54.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.704 1.202 . . . . 0.0 111.679 166.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.99 -41.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.19 53.61 0.65 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.698 1.999 . . . . 0.0 114.246 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.03 97.86 0.46 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.686 1.136 . . . . 0.0 110.913 161.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 191' ' ' VAL . 11.2 m-85 -108.15 163.82 12.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 1.8 t -137.76 150.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.661 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -121.14 143.72 48.95 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.058 1.343 . . . . 0.0 112.329 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.54 153.16 27.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.391 2.676 . . . . 0.0 111.124 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.22 71.47 0.51 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.052 1.741 . . . . 0.0 110.176 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.46 0.0 0.03 OUTLIER Glycine 0 N--CA 1.475 1.261 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -165.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -77.63 153.33 81.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 0.0 111.824 -165.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.84 171.85 11.5 Favored 'Trans proline' 0 CA--C 1.532 0.382 1 C-N-CA 126.704 4.936 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.37 123.02 16.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.933 0.893 . . . . 0.0 112.438 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 83.29 12.77 78.16 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.342 -174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.461 ' SG ' HG21 ' A' ' 176' ' ' ILE . 31.3 t -58.51 151.9 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.958 1.879 . . . . 0.0 112.712 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.3 t -148.06 165.12 31.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.655 0.782 . . . . 0.0 111.763 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -42.09 -49.84 4.76 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.315 2.246 . . . . 0.0 112.417 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' HG13 ' A' ' 128' ' ' VAL . 3.3 mp0 -63.1 -14.19 45.49 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -85.92 -26.79 25.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.731 -1.856 . . . . 0.0 109.938 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.24 -39.72 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.956 -0.465 . . . . 0.0 112.075 160.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.287 1.3 m -57.46 -18.52 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -97.7 -26.17 14.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.286 1.403 . . . . 0.0 114.124 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -62.67 -41.46 99.1 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.832 1.253 . . . . 0.0 111.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -121.89 33.77 5.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.484 1.114 . . . . 0.0 113.067 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -21.63 8.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.63 -0.668 . . . . 0.0 112.607 157.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.65 -33.44 41.65 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.93 1.729 . . . . 0.0 114.965 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.0 167.46 21.19 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.554 1.542 . . . . 0.0 112.067 -158.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.43 140.14 29.77 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.866 -1.146 . . . . 0.0 111.739 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 45.1 mt -135.48 136.57 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.531 2.732 . . . . 0.0 107.831 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.07 152.08 84.82 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 118.958 -0.544 . . . . 0.0 111.408 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.77 -14.66 11.1 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.947 3.098 . . . . 0.0 119.967 -165.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -128.54 19.94 6.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.145 1.378 . . . . 0.0 111.759 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.55 -27.42 61.09 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.961 1.144 . . . . 0.0 115.961 -163.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 128' ' ' VAL . 70.4 mt -92.05 137.63 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 125.955 1.702 . . . . 0.0 109.738 -168.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.4 m -132.49 137.65 47.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.416 1.462 . . . . 0.0 113.465 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.29 90.06 50.87 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 127.192 2.197 . . . . 0.0 112.149 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.09 -63.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.103 1.202 . . . . 0.0 114.203 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.43 179.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 129.994 3.318 . . . . 0.0 108.081 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.502 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.3 p-10 -74.51 170.68 13.98 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 119.64 -1.913 . . . . 0.0 113.686 156.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.82 -0.61 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.727 3.618 . . . . 0.0 116.873 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -130.18 0.92 4.67 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.594 1.558 . . . . 0.0 111.556 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.01 39.4 23.98 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.119 1.207 . . . . 0.0 116.119 163.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -122.92 -25.55 4.57 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.496 1.518 . . . . 0.0 111.422 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 152' ' ' THR 0.274 0.0 OUTLIER -149.05 -111.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.417 -1.277 . . . . 0.0 113.231 -157.115 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -179.0 78.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 129.75 3.22 . . . . 0.0 108.576 -166.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.502 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -130.65 7.55 5.86 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 127.901 2.667 . . . . 0.0 114.384 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -136.44 160.41 38.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.123 1.369 . . . . 0.0 109.244 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -171.04 176.78 3.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.735 1.614 . . . . 0.0 110.549 -169.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.509 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.1 m-85 -148.37 159.58 43.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.408 1.083 . . . . 0.0 110.418 -171.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -163.48 124.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -94.14 132.48 38.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.042 2.137 . . . . 0.0 110.844 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.2 m-85 -92.73 -172.77 3.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.662 0.385 . . . . 0.0 110.701 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.35 -12.34 60.24 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.215 -1.553 . . . . 0.0 113.033 168.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.7 m -159.39 162.35 35.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.421 1.088 . . . . 0.0 113.202 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.42 -34.04 70.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.032 0.933 . . . . 0.0 113.015 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -71.49 -47.17 57.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.087 2.155 . . . . 0.0 112.782 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.24 -34.67 74.01 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.528 1.131 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.81 -16.93 60.02 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.151 0.501 . . . . 0.0 112.238 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -85.72 -33.13 21.57 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.389 -1.444 . . . . 0.0 109.363 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -36.79 85.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.778 1.631 . . . . 0.0 110.098 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -61.58 -47.0 87.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.26 1.824 . . . . 0.0 115.424 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 mp -48.89 -27.56 3.17 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.65 -13.54 51.54 Favored Glycine 0 CA--C 1.545 1.952 0 C-N-CA 125.06 1.314 . . . . 0.0 115.386 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -64.98 -22.91 67.07 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.463 1.631 . . . . 0.0 114.455 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 41.51 -53.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 1 C-N-CA 131.92 4.088 . . . . 0.0 119.742 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -145.42 19.26 1.54 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.311 2.244 . . . . 0.0 112.694 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.81 -179.67 0.29 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -119.64 155.76 31.71 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -161.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -139.74 131.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 130.061 3.344 . . . . 0.0 106.145 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.44 -85.36 0.01 OUTLIER Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.938 1.256 . . . . 0.0 113.368 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -147.06 13.98 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.405 1.882 . . . . 0.0 112.234 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -124.29 178.65 5.25 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.944 2.097 . . . . 0.0 111.19 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -149.92 91.27 1.77 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 123.231 1.491 . . . . 0.0 109.66 -113.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.504 ' CD1' HD12 ' A' ' 176' ' ' ILE . 6.6 mt -102.55 139.5 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.186 -141.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.69 151.26 45.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.334 2.254 . . . . 0.0 112.633 165.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.73 136.68 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.424 0.69 . . . . 0.0 112.075 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -142.74 150.53 40.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 109.884 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -61.36 152.47 29.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.935 0.894 . . . . 0.0 110.417 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.3 m -152.61 171.64 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.722 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -153.38 155.65 36.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.486 1.515 . . . . 0.0 111.16 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 25.9 tp60 -35.22 -1.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 1 C-N-CA 133.496 4.718 . . . . 0.0 120.17 177.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -117.85 -28.38 5.96 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 119.881 -1.762 . . . . 0.0 112.961 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -84.2 -19.96 33.14 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.628 -1.295 . . . . 0.0 109.745 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 112' ' ' PHE . 21.2 m -87.96 -31.07 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 128.185 2.594 . . . . 0.0 112.922 -165.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 38.79 0.76 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.41 1.084 . . . . 0.0 111.556 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 36.7 m -69.5 30.42 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.401 1.881 . . . . 0.0 112.936 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 127.635 2.374 . . . . 0.0 111.542 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.533 ' H ' ' HA ' ' A' ' 105' ' ' ALA . 92.7 p -143.94 -16.51 0.6 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -175.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HA ' ' H ' ' A' ' 104' ' ' SER . . . -148.09 -32.59 0.26 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 125.955 3.98 . . . . 0.0 113.819 -3.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -157.04 151.79 25.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.865 1.266 . . . . 0.0 112.78 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.1 m -161.57 8.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.679 2.792 . . . . 0.0 112.325 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 54.01 142.1 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.475 2.71 . . . . 0.0 115.528 -156.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.05 2.76 4.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 130.469 3.508 . . . . 0.0 111.934 -8.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.33 50.59 1.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.739 -158.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -70.76 91.89 0.43 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 127.446 2.451 . . . . 0.0 112.03 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 191' ' ' VAL . 18.7 m-85 -99.0 166.81 11.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.1 t -146.81 128.07 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.899 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 66.1 ttt180 -104.0 138.73 40.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.254 1.022 . . . . 0.0 111.244 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 153.19 23.4 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.409 2.683 . . . . 0.0 109.531 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -155.07 81.22 1.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 109.782 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.77 -5.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.081 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -168.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.651 HD13 ' SG ' ' A' ' 122' ' ' CYS . 0.3 OUTLIER -78.38 148.92 74.8 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.856 1.262 . . . . 0.0 111.119 -161.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 83.2 Cg_endo -80.42 170.75 15.65 Favored 'Trans proline' 0 N--CA 1.462 -0.37 1 C-N-CA 126.595 4.864 . . . . 0.0 113.056 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -53.75 118.44 3.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.555 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.61 66.53 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.304 -1.276 . . . . 0.0 115.73 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 118' ' ' LEU . 6.2 t -55.35 149.75 12.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.317 2.059 . . . . 0.0 112.257 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.4 164.15 33.35 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.454 1.102 . . . . 0.0 111.249 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.4 ttmt -43.69 -43.34 5.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.457 2.303 . . . . 0.0 113.164 173.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' A' ' 128' ' ' VAL . 36.5 mp0 -69.36 -18.0 63.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.949 1.299 . . . . 0.0 114.334 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 47.0 mm-40 -77.97 -27.59 49.2 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 119.709 -1.87 . . . . 0.0 110.458 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.421 HD12 HD21 ' A' ' 143' ' ' LEU . 19.9 mt -69.61 -36.83 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 110.465 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.274 1.4 m -63.57 -15.89 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.479 1.111 . . . . 0.0 113.701 169.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.1 pp0? -96.73 -25.04 15.67 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.529 1.513 . . . . 0.0 114.142 165.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.61 -46.96 88.29 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.423 1.489 . . . . 0.0 110.782 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -119.98 35.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.322 1.049 . . . . 0.0 112.509 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.6 p -49.6 -24.8 2.36 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 155.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.03 -33.3 68.74 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.058 1.789 . . . . 0.0 115.353 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -139.29 160.45 39.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 113.139 -155.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.52 136.39 33.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 112.438 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 48.2 mt -135.71 137.69 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 129.633 3.173 . . . . 0.0 107.911 -171.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.07 151.88 79.45 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.821 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.19 -23.06 21.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 N-CA-C 120.952 3.405 . . . . 0.0 120.952 -158.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 39.52 2.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.604 1.162 . . . . 0.0 110.13 167.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.97 -25.42 9.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.219 1.39 . . . . 0.0 114.936 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' CD1' HG12 ' A' ' 128' ' ' VAL . 63.2 mt -85.82 133.47 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.273 1.829 . . . . 0.0 109.631 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.1 m -129.18 136.62 50.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.078 1.751 . . . . 0.0 112.455 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.421 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -124.97 91.76 48.81 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 127.198 2.199 . . . . 0.0 111.142 -169.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 -79.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 123.366 2.711 . . . . 0.0 113.634 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.26 168.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 129.224 3.01 . . . . 0.0 109.737 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.515 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.4 p-10 -80.61 171.74 11.56 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.966 1.706 . . . . 0.0 114.118 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.49 -1.16 0.19 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 124.973 3.782 . . . . 0.0 117.478 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -127.83 0.3 6.02 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.975 1.71 . . . . 0.0 111.795 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 39.43 68.21 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 115.796 1.079 . . . . 0.0 115.796 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -127.82 -17.15 4.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.859 1.664 . . . . 0.0 112.005 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.57 HG23 ' H ' ' A' ' 152' ' ' THR 0.307 0.0 OUTLIER -141.51 -104.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.296 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.57 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.5 OUTLIER 172.56 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.352 3.461 . . . . 0.0 108.525 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.515 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -123.41 2.52 9.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 128.714 3.054 . . . . 0.0 114.373 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.53 162.8 23.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.152 0.476 . . . . 0.0 109.726 142.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.89 177.2 5.1 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 127.036 2.135 . . . . 0.0 110.274 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.78 ' CD1' HG12 ' A' ' 191' ' ' VAL . 87.9 m-85 -148.88 160.28 43.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.037 0.935 . . . . 0.0 110.923 -166.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -162.29 121.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 40.4 tp60 -90.19 132.74 35.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.838 2.055 . . . . 0.0 110.006 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.2 m-85 -89.12 -158.54 0.51 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.908 0.483 . . . . 0.0 110.197 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.47 -9.15 59.55 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 119.852 -1.78 . . . . 0.0 112.904 156.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.6 m -162.45 159.11 24.67 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.508 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 21.4 mm-40 -56.18 -30.99 63.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.158 1.383 . . . . 0.0 113.723 166.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -53.07 20.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.601 1.56 . . . . 0.0 111.414 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.64 -36.88 72.43 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.19 1.396 . . . . 0.0 111.319 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -72.94 -16.08 61.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.57 -32.14 15.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.526 1.53 . . . . 0.0 110.444 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -61.57 -40.04 93.31 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 125.787 1.635 . . . . 0.0 110.508 167.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -59.33 -47.24 86.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.24 1.816 . . . . 0.0 114.162 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -55.82 -20.18 14.24 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -62.34 -14.29 47.52 Favored Glycine 0 CA--C 1.547 2.054 0 C-N-CA 124.646 1.117 . . . . 0.0 115.016 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -63.16 -27.52 69.43 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.324 1.562 . . . . 0.0 113.442 162.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.77 -42.01 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 1 C-N-CA 133.191 4.596 . . . . 0.0 120.166 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -153.49 36.83 0.46 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.305 1.442 . . . . 0.0 112.053 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.02 -174.04 0.22 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.621 1.168 . . . . 0.0 114.041 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.31 148.96 44.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.372 1.469 . . . . 0.0 112.682 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.577 HD12 HD22 ' A' ' 118' ' ' LEU . 1.3 mt -138.47 131.52 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 129.283 3.033 . . . . 0.0 105.798 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 54.41 -99.89 0.07 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.148 1.356 . . . . 0.0 112.33 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -118.36 -5.15 10.84 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.24 1.416 . . . . 0.0 113.532 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.71 -172.43 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.241 1.816 . . . . 0.0 112.49 -169.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -151.09 109.71 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.991 -132.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.563 HG12 HD23 ' A' ' 118' ' ' LEU . 3.6 mp -124.27 128.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 122.783 1.278 . . . . 0.0 112.371 -139.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 160.58 13.23 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 127.559 2.344 . . . . 0.0 114.268 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.63 141.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.332 0.653 . . . . 0.0 112.433 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.81 142.75 31.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.198 1.799 . . . . 0.0 110.794 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 17.8 tptm -66.98 146.24 54.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.679 174.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -150.83 168.79 23.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.647 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.5 m -147.5 165.37 30.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.531 1.532 . . . . 0.0 110.761 164.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.54 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.7 tp60 -35.98 1.7 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 1 C-N-CA 133.32 4.648 . . . . 0.0 119.87 177.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -118.26 -30.26 5.31 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.636 -1.915 . . . . 0.0 112.669 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.662 -1.274 . . . . 0.0 109.611 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 156' ' ' PHE . 18.9 m -102.35 -19.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 127.585 2.354 . . . . 0.0 114.622 -153.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -90.98 16.76 8.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.204 1.801 . . . . 0.0 112.518 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 m -75.21 44.71 0.26 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.217 2.607 . . . . 0.0 114.55 -169.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.823 2.049 . . . . 0.0 113.822 178.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.998 0.427 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.4 m -158.05 -20.43 0.08 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.996 2.118 . . . . 0.0 113.128 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -134.7 23.65 3.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.836 2.054 . . . . 0.0 110.126 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -172.39 162.69 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.079 2.152 . . . . 0.0 110.957 -157.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -140.66 -48.74 0.43 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.81 -57.85 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -139.5 -9.68 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.997 1.319 . . . . 0.0 114.472 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.37 36.91 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.181 3.793 . . . . 0.0 114.181 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -58.51 83.36 0.01 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 127.064 2.268 . . . . 0.0 113.602 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 158' ' ' GLN . 3.3 m-85 -92.31 160.53 15.08 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 168.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.08 113.13 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.736 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.341 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 77.3 ttt180 -89.02 131.02 35.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 123.459 0.704 . . . . 0.0 111.492 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.42 152.96 18.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 128.751 2.821 . . . . 0.0 110.438 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -157.84 70.92 0.59 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.91 1.284 . . . . 0.0 109.419 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.48 1.92 0.03 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 -162.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.8 mt -79.4 153.89 76.56 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 119.186 1.493 . . . . 0.0 112.434 -162.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.87 175.06 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 1 C-N-CA 125.759 4.306 . . . . 0.0 113.299 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -67.15 132.08 47.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.204 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.64 70.07 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 117.694 -1.615 . . . . 0.0 115.71 -171.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.25 149.38 20.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 120.392 2.096 . . . . 0.0 113.517 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.4 p -135.0 164.1 28.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.1 1.76 . . . . 0.0 111.82 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 128' ' ' VAL . 28.0 ttmt -48.56 -42.33 33.17 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 126.448 1.899 . . . . 0.0 112.449 166.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 121.193 1.815 . . . . 0.0 113.792 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -75.43 -31.68 60.43 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.658 -1.901 . . . . 0.0 110.0 167.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.481 HD12 HD21 ' A' ' 143' ' ' LEU . 49.1 mt -67.45 -39.04 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.496 0.718 . . . . 0.0 111.183 167.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 141' ' ' ILE . 1.9 m -62.17 -17.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.376 1.07 . . . . 0.0 112.964 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -96.05 -31.92 12.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.874 1.216 . . . . 0.0 112.719 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.46 -41.66 90.23 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.066 1.746 . . . . 0.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.87 33.39 5.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.918 1.287 . . . . 0.0 113.771 170.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.1 p -52.21 -22.2 4.12 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 157.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.22 -32.96 30.05 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.156 1.836 . . . . 0.0 115.212 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.66 166.49 24.22 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.888 1.275 . . . . 0.0 112.876 -156.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.57 137.53 32.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.68 1.592 . . . . 0.0 111.377 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 72.1 mt -138.62 137.64 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 128.221 2.608 . . . . 0.0 106.824 -170.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -60.39 153.55 58.83 Favored Pre-proline 0 N--CA 1.486 1.365 0 CA-C-N 118.643 0.656 . . . . 0.0 111.447 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.02 -21.06 20.19 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 120.927 3.395 . . . . 0.0 120.927 -159.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.74 40.9 2.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.791 1.178 . . . . 0.0 109.993 167.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.17 -14.71 6.31 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.148 1.356 . . . . 0.0 116.38 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 128' ' ' VAL . 76.2 mt -103.27 123.69 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 125.372 1.469 . . . . 0.0 109.384 -165.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.8 m -115.8 130.59 56.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.085 2.554 . . . . 0.0 112.695 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.76 78.78 56.64 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 127.014 2.126 . . . . 0.0 111.724 -170.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.27 -58.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.372 1.381 . . . . 0.0 113.249 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -178.3 173.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 130.681 3.592 . . . . 0.0 107.961 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.52 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.9 p-10 -69.63 169.44 12.49 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 120.236 -1.54 . . . . 0.0 113.747 159.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.41 2.59 0.1 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.931 3.754 . . . . 0.0 117.319 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -128.41 -2.76 5.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.555 1.542 . . . . 0.0 112.094 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.62 26.24 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -131.39 -15.52 3.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.415 1.607 . . . . 0.0 112.728 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.449 HG23 ' H ' ' A' ' 152' ' ' THR 0.29 0.0 OUTLIER -143.67 -114.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.738 1.215 . . . . 0.0 113.226 -170.134 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.449 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.24 75.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 129.342 3.057 . . . . 0.0 108.141 -167.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.52 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -125.25 4.68 8.27 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 127.561 2.505 . . . . 0.0 114.702 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.86 164.06 26.9 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.497 0.719 . . . . 0.0 109.972 150.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -172.34 168.98 5.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 126.834 2.054 . . . . 0.0 110.029 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 97.0 m-85 -141.25 152.62 44.69 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.582 0.753 . . . . 0.0 109.673 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.23 123.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 136' ' ' ILE . 39.3 tp60 -90.79 122.77 33.81 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.954 2.102 . . . . 0.0 110.344 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 5.1 m-85 -83.23 -165.55 1.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.576 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.79 -12.39 60.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.177 -1.577 . . . . 0.0 112.159 162.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.3 m -161.54 162.65 30.32 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.993 0.917 . . . . 0.0 113.411 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.466 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.67 -8.01 55.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.85 -53.2 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.324 2.25 . . . . 0.0 111.81 172.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.06 -37.89 67.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.026 1.73 . . . . 0.0 111.285 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.33 -15.84 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.68 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.46 -25.36 15.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.267 -1.521 . . . . 0.0 110.864 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.05 -41.08 97.51 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.323 1.449 . . . . 0.0 109.853 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.444 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -60.52 -46.29 90.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.548 1.939 . . . . 0.0 115.808 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.5 mp -48.19 -21.48 0.5 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 165.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.48 -10.02 59.45 Favored Glycine 0 CA--C 1.544 1.864 0 C-N-CA 123.965 0.793 . . . . 0.0 113.697 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -59.59 -32.82 70.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.228 1.411 . . . . 0.0 114.321 164.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.6 -56.51 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 131.196 3.799 . . . . 0.0 119.0 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -148.17 24.31 1.04 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.289 1.836 . . . . 0.0 113.443 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.61 179.4 0.12 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.772 1.629 . . . . 0.0 113.731 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 149.65 45.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.342 1.457 . . . . 0.0 111.799 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -92.39 -16.64 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.5 1.12 . . . . 0.0 112.77 175.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.62 -41.96 0.08 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.394 1.473 . . . . 0.0 112.607 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -149.66 -42.04 0.14 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.312 1.445 . . . . 0.0 112.854 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -86.14 174.55 9.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.109 0.957 . . . . 0.0 111.753 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.73 97.49 3.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.937 -126.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 176' ' ' ILE . 5.3 mt -99.78 119.48 47.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.733 -148.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 153.25 42.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.149 1.78 . . . . 0.0 112.372 163.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 132.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.499 0.719 . . . . 0.0 110.947 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -135.61 144.74 46.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.917 1.687 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 19.1 tptm -69.15 142.0 54.47 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.594 0.711 . . . . 0.0 110.41 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 m -150.38 164.12 36.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.09 -167.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 73.6 m -135.39 160.75 37.47 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.731 1.212 . . . . 0.0 110.916 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -46.66 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.768 1 C-N-CA 132.39 4.276 . . . . 0.0 118.148 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -128.67 -28.73 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.204 -1.56 . . . . 0.0 113.03 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.46 -23.48 62.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.859 -1.151 . . . . 0.0 110.564 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.465 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 1.7 p -68.8 -35.82 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 124.676 1.191 . . . . 0.0 113.261 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -90.68 66.82 6.24 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.286 -1.325 . . . . 0.0 113.093 -138.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.1 p -82.61 -9.91 59.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 158.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.152 0 C-N-CA 130.196 3.399 . . . . 0.0 114.062 -175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.8 m -152.25 27.37 0.59 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.556 1.542 . . . . 0.0 111.405 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.42 8.0 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.053 1.341 . . . . 0.0 113.328 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.35 169.29 16.22 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.477 1.911 . . . . 0.0 112.333 -168.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.51 ' H ' ' HG3' ' A' ' 162' ' ' GLN . 82.7 p -140.68 -83.34 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.472 1.509 . . . . 0.0 110.527 166.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.2 -34.79 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 129.553 3.141 . . . . 0.0 111.455 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -137.02 13.67 3.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -163.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -120.3 34.76 5.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.476 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 77.89 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 127.035 2.255 . . . . 0.0 113.353 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.621 ' CD1' HG11 ' A' ' 191' ' ' VAL . 7.3 m-85 -99.49 156.96 16.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.1 108.72 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.678 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -86.05 124.84 32.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.609 0.763 . . . . 0.0 111.444 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 181' ' ' ILE . 1.4 mm? -85.33 152.47 23.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.976 2.11 . . . . 0.0 110.808 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -155.1 76.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.263 1.425 . . . . 0.0 109.324 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.35 -11.01 0.02 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -161.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 13.0 mt -73.44 156.08 89.13 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -152.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 86.4 Cg_endo -78.4 169.69 19.62 Favored 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 125.634 4.223 . . . . 0.0 112.543 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.23 125.96 28.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.68 24.54 75.39 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.739 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 36.2 t -54.96 154.49 5.26 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.277 1.538 . . . . 0.0 112.773 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.1 t -147.31 164.41 33.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.047 0.927 . . . . 0.0 112.144 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 128' ' ' VAL . 32.0 ttmt -45.55 -40.64 8.93 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 127.055 2.142 . . . . 0.0 113.126 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -69.87 -16.7 63.29 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 121.596 1.998 . . . . 0.0 113.999 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -76.92 -35.09 57.57 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 120.043 -1.661 . . . . 0.0 109.327 166.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 143' ' ' LEU . 51.9 mt -64.1 -40.29 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.036 0.835 . . . . 0.0 111.141 169.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.5 m -65.77 -16.52 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.897 1.279 . . . . 0.0 112.683 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -94.94 -31.48 13.63 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.94 1.245 . . . . 0.0 112.425 164.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.86 -38.23 75.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.188 1.795 . . . . 0.0 111.593 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 23.9 m-85 -122.15 35.93 4.76 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.482 1.513 . . . . 0.0 112.68 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -64.37 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.173 1.463 . . . . 0.0 108.864 153.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.8 -48.04 0.08 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.795 -151.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.1 157.9 45.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.988 1.315 . . . . 0.0 112.09 -160.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB2' HD13 ' A' ' 164' ' ' LEU . 44.9 mt-10 -76.73 131.28 38.67 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.645 -0.659 . . . . 0.0 111.193 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 55.1 mt -131.08 132.26 63.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.832 2.453 . . . . 0.0 107.183 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.09 151.4 80.98 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.923 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.94 -16.89 12.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.069 3.179 . . . . 0.0 119.133 -165.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -122.95 16.43 10.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.593 1.557 . . . . 0.0 111.598 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.58 70.73 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 -159.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -95.17 134.77 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 124.856 1.262 . . . . 0.0 109.743 -166.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.4 m -133.44 133.55 42.46 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.575 1.55 . . . . 0.0 112.685 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -126.27 96.47 36.49 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 127.695 2.398 . . . . 0.0 111.326 -173.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.73 -81.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.078 1.852 . . . . 0.0 113.831 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.25 167.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 128.899 2.88 . . . . 0.0 109.991 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -70.86 170.65 10.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.493 1.917 . . . . 0.0 114.645 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.61 0.61 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 124.907 3.738 . . . . 0.0 117.576 170.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -126.91 -0.46 6.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.776 1.63 . . . . 0.0 111.928 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.28 37.32 54.75 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -129.16 -15.63 4.15 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.192 1.496 . . . . 0.0 112.37 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.442 HG23 ' H ' ' A' ' 152' ' ' THR 0.299 0.0 OUTLIER -141.67 -105.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.571 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 170.96 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.981 3.312 . . . . 0.0 107.983 -166.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.81 -1.45 5.9 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 129.942 3.639 . . . . 0.0 114.476 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -131.8 158.63 40.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.473 149.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.61 -179.47 3.38 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.339 2.256 . . . . 0.0 108.472 -167.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 191' ' ' VAL . 98.4 m-85 -152.01 157.65 42.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.789 0.436 . . . . 0.0 111.273 -167.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.52 125.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -90.8 127.0 36.19 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.937 2.095 . . . . 0.0 111.266 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.5 m-85 -92.11 -173.16 3.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.342 1.057 . . . . 0.0 110.313 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.97 -13.17 60.84 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.212 -1.555 . . . . 0.0 113.064 166.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.4 m -160.24 159.97 32.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.477 1.111 . . . . 0.0 113.347 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 107' ' ' SER . 19.5 mm-40 -60.69 -21.43 62.86 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 167.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.416 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 29.0 tp10 -78.96 -50.32 11.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.681 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 135' ' ' GLU . 80.3 mt -57.07 -36.8 70.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.518 1.127 . . . . 0.0 111.13 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.58 -20.86 63.64 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.975 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -91.06 -29.77 17.14 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.237 -1.54 . . . . 0.0 110.317 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -62.15 -34.08 75.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.916 0.886 . . . . 0.0 109.197 167.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.553 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -72.72 -42.63 63.95 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.2 mp -49.09 -31.88 8.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 120.615 1.552 . . . . 0.0 113.143 160.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -57.76 -16.47 23.86 Favored Glycine 0 CA--C 1.547 2.057 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 170.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -69.14 -19.72 64.02 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.171 1.986 . . . . 0.0 113.758 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 47.97 -65.51 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 130.969 3.708 . . . . 0.0 118.303 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -150.48 33.36 0.63 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.283 1.833 . . . . 0.0 112.484 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.83 -157.95 0.1 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.006 1.322 . . . . 0.0 113.312 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -135.35 149.11 49.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.895 2.078 . . . . 0.0 112.49 -169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.491 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -106.1 -17.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -170.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.16 -39.66 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.409 1.957 . . . . 0.0 111.58 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -151.7 -44.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.688 . . . . 0.0 111.773 169.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.7 177.97 5.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.441 1.096 . . . . 0.0 112.44 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.31 113.82 14.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.12 1.768 . . . . 0.0 109.891 -128.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 2.8 mt -121.16 111.83 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.57 1.652 . . . . 0.0 111.809 -146.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 150.94 33.64 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.206 -2.724 . . . . 0.0 112.494 158.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.17 123.16 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 110.204 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -119.63 146.45 45.54 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.683 1.593 . . . . 0.0 109.543 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -66.15 136.03 55.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -144.68 172.14 13.41 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -166.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 37.9 m -152.08 148.81 28.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.298 1.839 . . . . 0.0 109.729 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -31.29 -16.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 1 C-N-CA 132.147 4.179 . . . . 0.0 118.459 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -112.58 -16.71 12.79 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.91 1.684 . . . . 0.0 111.625 -168.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -80.48 -30.75 37.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 156.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 187' ' ' SER . 4.2 m -79.38 -42.48 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -163.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -79.47 -9.35 59.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.4 m -95.47 34.87 1.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.498 1.519 . . . . 0.0 111.62 -157.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.904 2.482 . . . . 0.0 111.94 -155.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -55.25 133.23 49.22 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.769 1.622 . . . . 0.0 110.773 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -138.37 150.35 46.47 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -153.87 150.74 28.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.868 1.267 . . . . 0.0 112.111 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.3 p 48.09 -50.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 1 C-N-CA 131.961 4.104 . . . . 0.0 119.257 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 136.25 -28.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 1 C-N-CA 132.987 4.515 . . . . 0.0 110.787 -169.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -134.65 -25.98 1.42 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -165.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.76 55.26 1.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.129 2.172 . . . . 0.0 112.179 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.23 95.13 0.57 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.093 1.33 . . . . 0.0 111.363 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.8 m-85 -99.69 164.35 12.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.92 113.49 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.369 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 68.5 ttt180 -89.87 115.07 26.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.922 0.889 . . . . 0.0 110.455 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.66 146.53 53.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.317 157.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.82 151.09 48.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 140.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.9 -13.6 0.76 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.173 -1.579 . . . . 0.0 113.857 159.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.582 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 10.4 mt -67.91 153.21 95.61 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -141.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 89.7 Cg_endo -73.09 171.21 18.03 Favored 'Trans proline' 0 C--N 1.346 0.416 1 C-N-CA 126.754 4.969 . . . . 0.0 112.368 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -68.71 132.74 47.35 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.093 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.59 25.22 62.98 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.647 -168.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 118' ' ' LEU . 37.9 t -54.14 149.18 9.9 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.503 1.652 . . . . 0.0 113.124 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 t -145.54 161.17 40.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.738 1.256 . . . . 0.0 112.044 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.7 ttmt -46.71 -37.72 8.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 127.774 2.43 . . . . 0.0 113.496 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -71.74 -19.54 62.02 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 121.083 1.765 . . . . 0.0 114.041 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.88 -31.91 57.11 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 120.208 -1.558 . . . . 0.0 109.156 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.441 HD12 HD21 ' A' ' 143' ' ' LEU . 59.7 mt -68.73 -39.09 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.522 0.729 . . . . 0.0 111.338 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.9 m -65.43 -16.07 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.961 1.304 . . . . 0.0 112.803 173.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -95.67 -28.77 14.65 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.315 0.962 . . . . 0.0 112.794 164.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.4 t80 -61.45 -44.85 96.39 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.751 1.62 . . . . 0.0 111.011 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -118.53 34.99 4.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.357 1.463 . . . . 0.0 113.091 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.6 p -50.08 -24.02 2.45 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 155.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.64 -33.23 54.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.437 1.97 . . . . 0.0 115.673 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.1 mp -138.28 161.76 36.08 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.215 1.007 . . . . 0.0 113.092 -156.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.01 132.73 33.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.143 1.377 . . . . 0.0 112.321 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 53.2 mt -133.27 138.26 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 128.995 2.918 . . . . 0.0 108.13 -172.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.81 152.0 87.75 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.784 -0.573 . . . . 0.0 111.513 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.65 -14.69 10.76 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.026 3.151 . . . . 0.0 120.013 -165.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.59 21.85 5.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.308 1.443 . . . . 0.0 111.544 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.79 -24.57 57.68 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -166.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 66.7 mt -94.5 130.73 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.187 1.395 . . . . 0.0 109.539 -167.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.9 m -124.62 132.0 53.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.058 1.743 . . . . 0.0 112.744 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.441 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -121.85 87.46 46.68 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 127.715 2.406 . . . . 0.0 110.412 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 -86.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.985 1.79 . . . . 0.0 112.646 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.22 156.98 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 128.945 2.898 . . . . 0.0 109.104 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.523 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 1.3 p-10 -64.28 178.24 0.47 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.001 3.321 . . . . 0.0 115.031 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.02 1.11 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.491 0 C-N-CA 124.48 3.453 . . . . 0.0 117.368 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -133.74 -32.84 1.1 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.279 1.854 . . . . 0.0 113.511 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.9 40.18 1.6 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.583 1.563 . . . . 0.0 114.911 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -132.35 -15.14 2.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 113.007 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -161.86 -163.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 127.793 2.437 . . . . 0.0 107.99 -168.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.641 ' H ' HD13 ' A' ' 151' ' ' ILE . 11.3 p -122.61 30.26 6.55 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 123.273 2.76 . . . . 0.0 112.988 -170.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -53.43 1.33 0.03 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.159 2.79 . . . . 0.0 117.245 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.25 152.59 38.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.095 0.95 . . . . 0.0 111.138 158.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.8 176.34 7.17 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 127.742 2.417 . . . . 0.0 108.938 -163.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.57 ' CD2' HG12 ' A' ' 191' ' ' VAL . 92.7 m-85 -149.42 163.41 37.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.709 -166.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.7 127.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 112' ' ' PHE . 46.1 tp60 -96.17 131.07 43.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.484 2.314 . . . . 0.0 110.3 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.2 m-85 -94.74 -168.43 1.82 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.289 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.2 -10.4 59.63 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.88 -1.763 . . . . 0.0 113.311 163.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 m -159.22 158.11 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.077 0.951 . . . . 0.0 113.096 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -57.13 -26.54 60.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.684 1.594 . . . . 0.0 114.483 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -54.8 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.822 1.649 . . . . 0.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.68 -37.81 66.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.85 1.66 . . . . 0.0 111.539 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.468 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.83 -17.2 64.43 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -110.3 -16.45 13.73 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.283 -1.511 . . . . 0.0 111.852 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.76 -38.69 86.1 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.963 0.905 . . . . 0.0 110.281 155.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.35 -44.04 80.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -51.09 -27.85 9.22 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.93 -1.106 . . . . 0.0 113.75 165.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.92 -14.85 32.78 Favored Glycine 0 CA--C 1.547 2.076 0 C-N-CA 125.262 1.411 . . . . 0.0 115.592 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -65.44 -17.66 64.72 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.886 1.843 . . . . 0.0 114.585 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 37.27 -47.57 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 C-N-CA 132.967 4.507 . . . . 0.0 120.982 171.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 19.5 1.11 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.166 1.787 . . . . 0.0 113.843 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -59.89 179.48 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.6 ttp85 -119.33 149.15 42.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.112 2.965 . . . . 0.0 109.043 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.47 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -115.88 -29.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.494 1.118 . . . . 0.0 113.041 -173.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -171.56 -112.02 0.27 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 127.074 2.273 . . . . 0.0 108.139 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -39.52 84.75 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.795 1.298 . . . . 0.0 113.151 164.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -177.87 3.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.462 1.505 . . . . 0.0 114.973 -164.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.685 1.594 . . . . 0.0 108.261 -140.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 5.1 mt -128.4 136.5 59.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.814 1.292 . . . . 0.0 112.362 -142.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.253 3.3 mp0 -83.13 156.42 23.27 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 130.589 3.556 . . . . 0.0 112.456 164.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.63 133.07 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.945 0.898 . . . . 0.0 111.091 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.24 144.75 47.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.967 1.707 . . . . 0.0 109.759 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -75.51 139.2 42.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.74 1.216 . . . . 0.0 110.703 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.7 m -149.39 166.77 28.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.741 -158.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 m -143.58 148.01 35.27 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.805 1.642 . . . . 0.0 108.798 165.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -13.79 -18.61 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 135.259 5.423 . . . . 0.0 120.642 169.104 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -122.46 -6.19 8.73 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 120.356 -1.465 . . . . 0.0 111.715 -167.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -76.51 -21.64 55.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.641 153.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 156' ' ' PHE . 3.8 m -96.09 -35.15 5.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -149.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.61 5.33 52.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 0.0 113.218 -171.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.6 m -81.68 40.64 0.6 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.056 2.143 . . . . 0.0 114.766 -155.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 126.92 2.088 . . . . 0.0 114.321 -177.115 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.273 5.5 p30 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m 161.91 -41.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 129.322 3.049 . . . . 0.0 111.32 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.12 -13.1 28.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.714 1.206 . . . . 0.0 113.914 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -79.8 176.94 9.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.958 2.103 . . . . 0.0 113.813 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.9 p -138.28 148.46 44.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -165.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.29 -61.27 0.38 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.446 1.899 . . . . 0.0 112.068 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.61 -40.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.092 1.757 . . . . 0.0 112.312 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.75 43.58 0.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 112.571 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.18 99.08 0.85 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.858 1.218 . . . . 0.0 111.218 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.688 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.7 m-85 -97.12 163.09 13.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 167.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.79 115.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.582 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -92.32 137.35 32.44 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.126 0.97 . . . . 0.0 112.79 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.62 151.16 23.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.236 2.614 . . . . 0.0 110.86 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -157.62 75.08 0.77 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.021 1.728 . . . . 0.0 108.599 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.67 -6.95 0.03 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -163.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 2.0 mt -77.46 153.89 81.6 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-N 118.18 0.99 . . . . 0.0 113.653 -157.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 90.7 Cg_endo -81.1 173.85 11.43 Favored 'Trans proline' 0 C--N 1.344 0.335 1 C-N-CA 126.937 5.091 . . . . 0.0 113.312 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -62.9 131.2 47.93 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.876 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.482 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 68.57 19.22 72.71 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 117.955 -1.469 . . . . 0.0 115.597 -172.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.8 t -56.56 149.23 17.82 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 120.14 1.97 . . . . 0.0 113.842 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.0 t -143.73 161.59 38.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.553 1.168 . . . . 0.0 112.806 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.647 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.4 ttmt -44.92 -42.4 8.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.598 2.759 . . . . 0.0 114.074 172.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.48 -21.36 66.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 121.25 1.841 . . . . 0.0 114.307 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -79.37 -33.32 42.98 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 119.787 -1.821 . . . . 0.0 109.674 170.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.499 HD12 HD21 ' A' ' 143' ' ' LEU . 66.7 mt -62.8 -38.67 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.456 -0.778 . . . . 0.0 111.038 166.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 124' ' ' LYS 0.268 1.1 m -68.34 -12.46 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 113.702 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.62 -27.29 14.88 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.673 1.124 . . . . 0.0 113.355 161.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -64.12 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.122 1.769 . . . . 0.0 111.266 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -120.84 34.61 5.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.833 1.653 . . . . 0.0 112.786 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -50.93 -22.62 2.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 156.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.6 -35.14 51.14 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.787 1.661 . . . . 0.0 115.301 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.5 156.46 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.201 1.0 . . . . 0.0 112.575 -149.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.3 140.51 33.55 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.224 -0.922 . . . . 0.0 112.098 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 47.7 mt -136.04 137.7 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 128.269 2.627 . . . . 0.0 107.524 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -62.18 153.05 76.5 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.29 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.51 -8.51 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.525 3.483 . . . . 0.0 120.607 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -140.13 21.76 2.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.871 2.068 . . . . 0.0 111.516 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.8 -16.98 53.46 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 61.6 mt -105.35 134.74 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 119.081 1.44 . . . . 0.0 109.497 -163.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.3 m -129.57 135.43 48.57 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.564 1.545 . . . . 0.0 112.773 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -123.01 86.07 50.92 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 127.033 2.133 . . . . 0.0 111.369 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 155' ' ' ALA . 65.6 Cg_endo -71.93 -66.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.338 2.025 . . . . 0.0 113.46 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.88 -179.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 130.188 3.395 . . . . 0.0 108.306 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -77.02 170.08 18.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 119.149 -2.219 . . . . 0.0 114.169 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -55.97 2.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 125.227 3.951 . . . . 0.0 117.198 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -127.65 2.28 6.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.603 1.561 . . . . 0.0 111.729 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.86 34.97 51.82 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.363 -1.243 . . . . 0.0 116.203 164.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -132.68 -14.35 2.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.654 1.727 . . . . 0.0 112.835 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 121' ' ' GLY 0.279 0.0 OUTLIER -143.85 -110.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 117.475 -1.25 . . . . 0.0 113.574 -168.642 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -178.78 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 130.088 3.355 . . . . 0.0 107.486 -167.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -137.84 1.3 2.84 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 129.258 3.313 . . . . 0.0 113.876 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -138.15 162.35 34.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.7 1.6 . . . . 0.0 109.445 159.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . . . -173.73 -178.7 1.64 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.509 1.924 . . . . 0.0 110.733 -168.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.503 ' CD1' HG12 ' A' ' 191' ' ' VAL . 96.9 m-85 -153.71 152.99 31.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.694 1.198 . . . . 0.0 110.315 -168.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.42 127.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -91.51 133.81 35.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.555 2.342 . . . . 0.0 110.328 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.6 m-85 -97.44 -175.38 3.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.846 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.51 58.56 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.707 -1.246 . . . . 0.0 113.191 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.0 m -166.4 158.57 13.87 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 111.998 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -84.71 50.16 1.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.125 1.37 . . . . 0.0 110.272 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.6 -55.07 0.56 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.15 2.98 . . . . 0.0 108.485 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 49.3 mt -54.41 -41.49 69.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.749 2.02 . . . . 0.0 111.65 164.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.52 -18.46 65.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.63 -29.15 15.6 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.794 -1.192 . . . . 0.0 109.15 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -66.12 -36.84 84.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.301 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.87 -39.03 87.41 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 165' ' ' ALA . 2.6 mp -51.27 -24.36 4.41 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 120.744 -1.223 . . . . 0.0 113.974 162.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -66.36 -17.46 66.32 Favored Glycine 0 CA--C 1.546 2.006 0 C-N-CA 124.98 1.276 . . . . 0.0 115.191 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -75.16 15.59 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.195 1.997 . . . . 0.0 115.605 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -51.82 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 130.317 3.447 . . . . 0.0 119.507 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.68 17.59 0.9 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.214 1.805 . . . . 0.0 114.222 -169.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -114.21 -170.8 1.79 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.059 1.344 . . . . 0.0 112.592 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.05 151.36 47.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.883 2.073 . . . . 0.0 110.977 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.23 -38.05 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.131 1.372 . . . . 0.0 112.695 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -156.41 -78.92 0.02 OUTLIER Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.951 1.262 . . . . 0.0 110.517 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -108.18 -18.84 13.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.407 1.083 . . . . 0.0 113.466 169.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -128.05 -178.06 4.38 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.14 1.776 . . . . 0.0 113.639 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -149.8 117.25 6.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -119.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.4 mt -123.96 129.26 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 123.537 1.637 . . . . 0.0 112.95 -138.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.16 153.18 36.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.843 2.857 . . . . 0.0 112.798 165.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.76 134.69 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 111.897 171.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -137.99 153.67 49.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.292 1.837 . . . . 0.0 110.258 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -75.03 145.99 41.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.386 0.675 . . . . 0.0 111.656 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.4 m -153.11 168.46 25.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 124.112 0.883 . . . . 0.0 111.728 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 67.2 m -149.62 158.3 44.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.422 1.489 . . . . 0.0 110.504 168.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.401 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp60 -33.43 -0.85 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 1 C-N-CA 134.019 4.928 . . . . 0.0 119.926 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.91 -10.89 3.42 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 119.951 -1.718 . . . . 0.0 113.519 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.96 -29.97 28.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 112' ' ' PHE . 34.9 m -80.44 -30.2 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.718 1.207 . . . . 0.0 112.97 -158.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -83.63 49.67 1.64 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.773 1.629 . . . . 0.0 111.409 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.0 t -66.93 -3.56 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.193 1.797 . . . . 0.0 114.163 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.276 0 C-N-CA 127.793 2.437 . . . . 0.0 115.17 -174.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.663 ' N ' ' HG ' ' A' ' 187' ' ' SER . 11.0 t-20 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.9 p 59.65 -35.05 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 129.008 2.923 . . . . 0.0 117.127 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.63 -38.08 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.882 2.473 . . . . 0.0 111.837 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.33 159.06 43.04 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.5 t 169.18 -172.26 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 130.427 3.491 . . . . 0.0 107.65 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.46 59.82 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.747 -1.221 . . . . 0.0 113.667 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 -26.23 0.38 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -167.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.256 4.5 p-10 -75.05 52.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.43 1.492 . . . . 0.0 113.628 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.03 99.64 1.3 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.686 2.088 . . . . 0.0 111.574 170.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.607 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -107.91 165.43 11.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.74 117.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.819 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -89.02 135.67 33.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.48 151.88 24.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.026 2.53 . . . . 0.0 110.467 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -157.66 76.13 0.8 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.098 1.759 . . . . 0.0 108.64 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.54 -13.2 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.756 1.462 . . . . 0.0 116.756 -163.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 181' ' ' ILE . 0.4 OUTLIER -76.5 151.13 82.84 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 118.422 1.111 . . . . 0.0 112.846 -153.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.82 175.13 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.271 1 C-N-CA 125.621 4.214 . . . . 0.0 113.431 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -68.47 134.44 50.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.87 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.38 14.7 67.06 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 117.935 -1.481 . . . . 0.0 115.179 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.91 151.48 18.1 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.412 2.106 . . . . 0.0 112.862 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.1 t -146.49 166.23 27.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.563 1.173 . . . . 0.0 111.45 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -47.49 -43.78 24.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 127.415 2.286 . . . . 0.0 112.488 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HA ' HG13 ' A' ' 128' ' ' VAL . 40.6 mp0 -67.17 -18.77 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.568 1.531 . . . . 0.0 113.846 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -79.73 -25.36 41.13 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 119.498 -2.001 . . . . 0.0 110.807 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 143' ' ' LEU . 52.6 mt -71.6 -36.54 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.484 0.714 . . . . 0.0 111.009 164.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.269 1.7 m -60.91 -18.73 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.326 168.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -97.82 -25.13 15.15 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.693 1.588 . . . . 0.0 113.347 165.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.88 -42.95 94.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.834 0.853 . . . . 0.0 110.333 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -117.74 42.04 2.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.529 1.131 . . . . 0.0 113.896 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.0 p -67.58 64.77 0.08 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.966 1.365 . . . . 0.0 110.822 154.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.32 -41.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.34 1.447 . . . . 0.0 112.178 -156.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.38 154.47 48.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.226 1.81 . . . . 0.0 110.785 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.11 140.53 45.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.114 0.965 . . . . 0.0 112.431 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.3 mt -143.9 131.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 128.903 2.881 . . . . 0.0 107.072 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.76 152.72 74.72 Favored Pre-proline 0 N--CA 1.486 1.373 0 CA-C-O 118.723 -0.655 . . . . 0.0 111.301 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.15 -25.47 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 120.287 3.149 . . . . 0.0 120.287 -160.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -133.36 41.75 3.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.631 1.173 . . . . 0.0 110.432 166.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.82 -29.14 49.5 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.028 1.299 . . . . 0.0 114.576 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 128' ' ' VAL . 71.8 mt -89.6 131.51 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 125.77 1.628 . . . . 0.0 109.342 -169.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -129.46 132.32 46.91 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.4 1.88 . . . . 0.0 112.888 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 127' ' ' ILE . 3.7 mm? -127.7 92.13 43.57 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 126.981 2.112 . . . . 0.0 112.373 -166.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.32 -65.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.605 1.536 . . . . 0.0 114.352 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.8 177.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 129.43 3.092 . . . . 0.0 109.094 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.3 p-10 -81.23 172.07 10.66 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 120.006 -1.684 . . . . 0.0 114.273 163.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.11 -0.34 0.28 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 125.019 3.813 . . . . 0.0 117.166 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -127.76 -0.91 6.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 111.786 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.66 39.68 48.13 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.34 -17.18 3.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.956 1.703 . . . . 0.0 112.307 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.559 HG23 ' H ' ' A' ' 152' ' ' THR 0.298 0.0 OUTLIER -143.49 -112.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -169.633 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.559 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.84 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.644 3.178 . . . . 0.0 109.161 -167.166 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.573 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -113.96 6.3 23.78 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.993 2.711 . . . . 0.0 114.413 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -134.41 157.53 46.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.852 1.261 . . . . 0.0 108.926 157.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.32 -178.93 3.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.206 1.402 . . . . 0.0 110.665 -167.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.625 ' CD1' HG12 ' A' ' 191' ' ' VAL . 95.6 m-85 -152.87 157.71 41.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.524 1.13 . . . . 0.0 109.421 -169.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.68 120.76 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 45.6 tp60 -83.18 135.43 34.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.546 1.938 . . . . 0.0 109.693 170.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.5 m-85 -92.39 -157.43 0.52 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.434 0.693 . . . . 0.0 110.335 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.04 59.26 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 120.131 -1.606 . . . . 0.0 112.335 157.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.65 166.99 31.38 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 4.7 tp60 -61.28 -16.92 50.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.759 1.623 . . . . 0.0 114.638 165.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -48.03 3.76 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.844 1.657 . . . . 0.0 111.232 -166.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.29 -37.19 23.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.686 1.194 . . . . 0.0 111.957 161.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -71.21 -23.12 61.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -88.03 -32.38 18.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.775 2.03 . . . . 0.0 110.329 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.67 -40.69 88.59 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 126.207 1.803 . . . . 0.0 110.346 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.13 -43.44 82.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 114.444 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -54.99 -21.34 11.56 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.8 -12.84 7.25 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 125.138 1.351 . . . . 0.0 115.213 172.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -53.57 -46.88 70.45 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.403 1.602 . . . . 0.0 113.175 161.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 51.03 -52.87 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.847 3.659 . . . . 0.0 117.0 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -147.27 106.72 3.91 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.507 2.323 . . . . 0.0 108.652 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.67 -166.7 2.19 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.639 1.176 . . . . 0.0 112.125 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -130.81 152.14 50.48 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.92 1.691 . . . . 0.0 114.088 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.401 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -99.93 -22.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.639 1.176 . . . . 0.0 112.845 173.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -178.44 -52.83 0.07 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.545 1.069 . . . . 0.0 112.755 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 -10.85 0.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.25 1.42 . . . . 0.0 114.49 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -123.8 -179.86 4.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.242 1.417 . . . . 0.0 112.427 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.68 108.77 5.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.601 -1.636 . . . . 0.0 107.696 -118.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.574 HD13 HD22 ' A' ' 118' ' ' LEU . 3.0 mt -117.33 116.57 52.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 123.138 1.447 . . . . 0.0 110.232 -144.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.15 156.16 25.94 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 128.852 2.861 . . . . 0.0 113.161 165.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.97 132.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.651 0.781 . . . . 0.0 111.36 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.28 144.43 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.146 1.778 . . . . 0.0 110.017 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -72.49 152.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.706 -0.622 . . . . 0.0 111.289 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.66 170.08 20.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.009 -160.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.663 ' HG ' ' N ' ' A' ' 103' ' ' ASN . 18.7 m -155.72 162.48 40.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.216 1.806 . . . . 0.0 111.783 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.8 tp-100 -37.34 5.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 1 C-N-CA 133.118 4.567 . . . . 0.0 120.245 177.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.56 2.17 1.23 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 168.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.73 -20.39 21.6 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.701 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.625 HG12 ' CD1' ' A' ' 156' ' ' PHE . 34.5 m -84.17 -23.97 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 128.302 2.641 . . . . 0.0 112.805 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -83.56 37.36 0.57 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.815 2.846 . . . . 0.0 113.56 -168.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.0 t -65.5 -4.13 5.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.272 1.029 . . . . 0.0 112.36 163.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.256 0 C-N-CA 127.055 2.142 . . . . 0.0 110.043 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.4 p 179.91 172.49 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.821 1.248 . . . . 0.0 112.632 -169.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.54 -17.48 53.91 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 165.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -153.44 154.83 35.18 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.306 1.442 . . . . 0.0 111.662 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -156.75 -118.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.353 1.461 . . . . 0.0 112.906 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.02 -40.89 0.08 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.515 1.926 . . . . 0.0 113.034 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -125.44 -41.88 2.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -167.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.66 42.95 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.286 2.234 . . . . 0.0 112.275 173.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.431 ' HA2' ' CD ' ' A' ' 162' ' ' GLN . . . -53.06 99.24 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 128.15 2.786 . . . . 0.0 114.818 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.55 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.0 m-85 -116.84 161.3 19.52 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.859 1.329 . . . . 0.0 108.593 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.4 125.73 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.109 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt85 -94.08 142.36 27.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 0.0 111.227 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.89 154.66 21.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.044 2.538 . . . . 0.0 110.589 172.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -156.19 78.29 0.95 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 110.711 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.53 -15.36 0.02 OUTLIER Glycine 0 CA--C 1.544 1.844 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -65.28 159.15 68.36 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 128.444 2.698 . . . . 0.0 116.897 -153.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 74.0 Cg_endo -82.83 167.94 14.26 Favored 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 126.186 4.591 . . . . 0.0 113.988 -173.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -69.59 98.22 1.13 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.511 2.325 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.664 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 97.72 23.51 13.64 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.394 1.473 . . . . 0.0 114.704 -168.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.3 t -53.2 152.89 4.06 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.191 1.995 . . . . 0.0 113.879 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 t -143.64 159.57 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.114 0.959 . . . . 0.0 112.331 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -44.08 -46.43 8.55 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.609 1.963 . . . . 0.0 112.097 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' HG13 ' A' ' 128' ' ' VAL . 39.4 mp0 -65.61 -12.54 54.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.911 1.685 . . . . 0.0 114.717 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -82.65 -33.19 27.85 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 119.995 -1.691 . . . . 0.0 108.873 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.49 -40.19 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.909 -0.494 . . . . 0.0 111.987 164.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.262 1.4 m -58.19 -22.02 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.605 170.094 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.72 -25.55 17.39 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.462 1.483 . . . . 0.0 113.012 169.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.1 t80 -62.35 -49.48 75.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.685 1.194 . . . . 0.0 110.08 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.57 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 36.8 m-85 -113.14 31.88 6.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.736 1.214 . . . . 0.0 112.69 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -53.43 -20.96 5.27 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 157.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.75 43.74 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.989 1.757 . . . . 0.0 115.724 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.03 173.92 11.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 112.925 -156.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.1 118.93 33.66 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.39 1.476 . . . . 0.0 111.922 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.3 mt -118.29 135.23 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 128.885 2.874 . . . . 0.0 107.546 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.97 153.27 85.26 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.008 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.16 -13.83 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.662 1 N-CA-C 122.651 4.058 . . . . 0.0 122.651 -160.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -134.22 12.55 3.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.654 1.57 . . . . 0.0 111.906 172.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.87 -12.66 1.25 Allowed Glycine 0 N--CA 1.48 1.589 0 C-N-CA 128.016 2.722 . . . . 0.0 119.315 -150.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.448 ' CD1' HG12 ' A' ' 128' ' ' VAL . 66.9 mt -95.57 135.3 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 127.214 2.205 . . . . 0.0 109.826 -166.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.5 m -122.98 136.21 54.77 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.558 1.526 . . . . 0.0 113.381 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.38 97.33 40.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 127.64 2.376 . . . . 0.0 111.595 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.43 -86.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.429 2.086 . . . . 0.0 113.643 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.41 177.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 130.407 3.483 . . . . 0.0 107.972 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.527 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 6.7 p-10 -74.68 175.12 4.22 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.613 1.965 . . . . 0.0 114.669 171.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.55 -6.86 1.74 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.908 3.739 . . . . 0.0 117.789 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -118.08 -30.79 5.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.113 1.779 . . . . 0.0 111.342 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 111.41 37.5 1.61 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.927 161.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.82 -2.86 4.69 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.918 1.287 . . . . 0.0 113.506 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.664 HD11 ' H ' ' A' ' 121' ' ' GLY 0.302 0.0 OUTLIER -140.68 -100.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.501 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.4 OUTLIER 164.84 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.918 3.687 . . . . 0.0 108.785 -164.261 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.527 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.16 11.28 10.74 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 128.673 3.035 . . . . 0.0 114.707 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -140.41 158.99 43.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.946 1.698 . . . . 0.0 108.079 155.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.31 -179.86 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.689 1.996 . . . . 0.0 109.267 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -151.89 160.49 43.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.143 0.977 . . . . 0.0 110.031 -169.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -160.54 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.428 HE22 ' N ' ' A' ' 111' ' ' GLY . 67.9 tp60 -87.25 138.85 31.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.367 2.267 . . . . 0.0 111.575 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.3 m-85 -109.36 -175.67 2.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.496 1.518 . . . . 0.0 110.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.18 -10.2 59.52 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 119.396 -2.065 . . . . 0.0 113.025 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 m -161.87 158.7 25.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.589 1.156 . . . . 0.0 112.889 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.431 ' CD ' ' HA2' ' A' ' 111' ' ' GLY . 4.9 tp-100 -72.5 0.61 9.89 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.473 1.509 . . . . 0.0 113.696 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.75 -49.24 5.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.352 1.861 . . . . 0.0 111.429 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.3 mt -55.03 -36.57 65.65 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.754 1.222 . . . . 0.0 111.925 167.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.26 67.28 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.95 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -90.97 -27.62 18.56 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.659 1.584 . . . . 0.0 110.663 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -59.83 -36.43 76.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.884 1.273 . . . . 0.0 110.012 165.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.57 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -73.21 -39.77 65.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.312 1.845 . . . . 0.0 115.685 172.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -33.27 56.98 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.181 -1.574 . . . . 0.0 112.183 162.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.55 -13.7 8.15 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.832 1.682 . . . . 0.0 115.706 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -59.1 -39.12 81.25 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.4 1.6 . . . . 0.0 113.135 164.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.83 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 130.559 3.543 . . . . 0.0 117.954 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.77 119.84 4.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.364 1.465 . . . . 0.0 110.981 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -151.37 -147.28 0.22 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.321 1.449 . . . . 0.0 110.691 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.1 ttp85 -147.65 148.02 30.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.775 2.83 . . . . 0.0 109.643 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -114.71 -35.97 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.861 1.264 . . . . 0.0 111.585 -170.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -147.32 -117.94 1.02 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.413 1.958 . . . . 0.0 108.788 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -42.58 98.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.974 1.387 . . . . 0.0 111.954 162.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -95.94 -177.77 4.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.235 1.014 . . . . 0.0 113.708 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.514 ' C ' HD12 ' A' ' 181' ' ' ILE . 5.6 m-85 -133.98 116.94 16.13 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.065 2.146 . . . . 0.0 109.78 -144.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 118' ' ' LEU . 1.9 mp -122.84 157.42 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.789 1.757 . . . . 0.0 111.918 -149.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.262 1.1 mm-40 -128.2 159.42 35.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 130.992 3.717 . . . . 0.0 110.186 -164.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.69 142.61 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.28 150.14 35.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.097 2.159 . . . . 0.0 109.921 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -82.02 151.59 27.05 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.234 -0.916 . . . . 0.0 112.51 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 m -158.58 165.44 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.959 -161.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.35 156.48 42.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.749 1.619 . . . . 0.0 111.173 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.534 ' HA ' HG21 ' A' ' 191' ' ' VAL . 4.2 tp60 -40.81 2.94 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 1 C-N-CA 133.873 4.869 . . . . 0.0 120.269 -175.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -126.34 -22.24 4.05 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 119.772 -1.83 . . . . 0.0 112.247 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.48 -2.05 52.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.348 1.459 . . . . 0.0 110.558 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 156' ' ' PHE . 10.7 m -118.72 -25.68 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 128.752 2.821 . . . . 0.0 113.15 -160.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -89.59 50.84 1.97 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.426 1.49 . . . . 0.0 111.481 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 7.2 t -69.63 8.1 0.72 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.825 2.05 . . . . 0.0 114.081 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.39 2.276 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.1 t -44.84 -42.98 8.38 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 -153.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.1 35.9 1.92 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.74 1.155 . . . . 0.0 111.793 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -159.78 -172.86 3.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.72 2.008 . . . . 0.0 111.799 -160.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 p -34.11 109.01 0.07 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.241 2.216 . . . . 0.0 114.743 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.86 -33.77 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.502 2.721 . . . . 0.0 114.596 1.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -127.25 -20.72 4.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.72 44.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 130.223 3.409 . . . . 0.0 113.744 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.22 95.41 0.43 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.824 2.154 . . . . 0.0 110.25 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 191' ' ' VAL . 2.9 m-85 -105.49 161.62 14.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.72 121.82 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.118 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 36.5 ttt85 -94.4 133.66 37.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.445 1.098 . . . . 0.0 111.381 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.28 152.42 19.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.365 1.866 . . . . 0.0 111.994 167.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 135.33 39.08 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 146.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 166.03 -18.81 0.1 OUTLIER Glycine 0 CA--C 1.531 1.086 0 O-C-N 119.823 -1.798 . . . . 0.0 113.77 152.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.543 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.4 mt -55.52 148.6 33.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.284 3.034 . . . . 0.0 115.335 -152.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.72 175.59 11.1 Favored 'Trans proline' 0 C--N 1.344 0.294 1 C-N-CA 126.35 4.7 . . . . 0.0 112.796 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -66.75 135.09 53.46 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.491 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.3 57.89 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-O 117.929 -1.484 . . . . 0.0 114.959 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 118' ' ' LEU . 35.4 t -57.24 151.43 15.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.037 1.918 . . . . 0.0 112.18 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 165.09 28.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 123.177 1.465 . . . . 0.0 112.267 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 128' ' ' VAL . 26.0 ttmt -44.99 -40.6 6.58 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 127.872 2.469 . . . . 0.0 113.534 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -70.39 -17.88 63.04 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 121.317 1.871 . . . . 0.0 114.027 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.09 -31.99 56.35 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 119.894 -1.754 . . . . 0.0 108.96 168.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 143' ' ' LEU . 52.5 mt -68.69 -38.1 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.155 -0.966 . . . . 0.0 111.815 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -63.72 -17.11 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.748 1.219 . . . . 0.0 112.924 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -23.7 15.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.11 1.323 . . . . 0.0 112.129 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 176' ' ' ILE . 9.9 t80 -61.22 -49.38 77.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.047 1.339 . . . . 0.0 109.777 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.86 33.23 5.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.443 1.497 . . . . 0.0 112.698 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 90.9 p -50.17 -22.03 1.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 156.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -49.49 -37.75 26.55 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.085 1.802 . . . . 0.0 115.347 168.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.04 168.01 20.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.428 1.091 . . . . 0.0 113.65 -153.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.62 128.6 36.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.914 1.685 . . . . 0.0 112.019 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 65.1 mt -128.8 134.81 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.659 2.784 . . . . 0.0 107.418 -174.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.2 m -65.19 154.03 88.06 Favored Pre-proline 0 N--CA 1.484 1.226 0 O-C-N 121.81 -0.556 . . . . 0.0 111.544 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.38 -7.33 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.239 3.293 . . . . 0.0 119.814 -169.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -127.35 12.97 7.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.004 1.322 . . . . 0.0 112.209 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.53 72.03 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -152.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.454 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 64.1 mt -93.93 132.23 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.832 1.253 . . . . 0.0 109.335 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.8 m -124.08 132.87 53.71 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.806 1.642 . . . . 0.0 112.67 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.511 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -121.95 93.13 48.75 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 127.511 2.324 . . . . 0.0 110.921 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.31 -65.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.235 1.29 . . . . 0.0 113.162 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.71 175.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 129.72 3.208 . . . . 0.0 109.163 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.514 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 11.0 p-10 -72.95 171.6 9.93 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 119.818 -1.801 . . . . 0.0 114.316 160.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.18 2.48 0.13 Allowed 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 124.729 3.619 . . . . 0.0 117.151 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -128.62 -1.32 5.48 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.686 1.594 . . . . 0.0 112.008 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.25 36.07 28.29 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -132.42 -16.22 2.74 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.713 1.756 . . . . 0.0 112.792 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -141.97 -112.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.508 -170.468 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.438 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.2 p -177.86 80.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.871 3.268 . . . . 0.0 107.433 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.56 5.59 6.64 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 128.151 2.786 . . . . 0.0 115.429 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.17 161.87 36.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.512 1.525 . . . . 0.0 108.365 157.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.43 -179.53 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.924 1.689 . . . . 0.0 109.063 -166.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.7 m-85 -153.4 158.76 41.95 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.342 0.657 . . . . 0.0 110.25 -167.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -158.54 123.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -92.47 129.92 38.28 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 127.557 2.343 . . . . 0.0 110.99 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.4 m-85 -97.87 -168.5 1.68 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 110.046 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.02 -10.23 59.5 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.024 -1.672 . . . . 0.0 113.733 165.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.9 m -162.65 158.33 23.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -69.99 43.79 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.829 2.452 . . . . 0.0 112.831 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -149.82 -56.53 0.18 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.613 1.965 . . . . 0.0 110.252 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.1 mt -54.2 -41.66 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.418 1.487 . . . . 0.0 111.339 163.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -70.21 -12.47 61.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -31.06 12.53 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.572 -1.33 . . . . 0.0 109.656 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -63.62 -35.36 80.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.951 1.3 . . . . 0.0 109.537 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.5 73.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.215 1.806 . . . . 0.0 115.544 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.7 mp -52.62 -32.64 42.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.536 -1.353 . . . . 0.0 113.279 164.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.6 -11.87 11.77 Favored Glycine 0 CA--C 1.546 1.984 0 C-N-CA 125.573 1.558 . . . . 0.0 115.631 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -59.21 -38.26 79.48 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.187 1.494 . . . . 0.0 113.474 165.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.79 -60.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 129.527 3.131 . . . . 0.0 116.423 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 105.19 4.55 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.897 2.079 . . . . 0.0 110.754 -174.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -145.58 -163.25 1.68 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.184 1.794 . . . . 0.0 110.335 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.23 44.76 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 128.651 2.781 . . . . 0.0 109.283 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.464 HD12 ' CD1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -123.77 -39.93 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.145 0.578 . . . . 0.0 111.509 -165.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.66 -98.56 0.48 Allowed Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.801 1.667 . . . . 0.0 109.956 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -46.28 14.64 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.799 1.3 . . . . 0.0 112.132 162.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -95.28 -178.1 4.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.919 1.288 . . . . 0.0 114.13 -167.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.502 ' C ' HD12 ' A' ' 181' ' ' ILE . 6.1 m-85 -132.78 125.68 30.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 110.568 -143.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.502 HD12 ' C ' ' A' ' 180' ' ' TYR . 1.8 mp -125.06 134.42 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 123.447 1.594 . . . . 0.0 112.553 -147.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.07 157.25 35.09 Favored 'General case' 0 CA--C 1.538 0.489 1 C-N-CA 132.127 4.171 . . . . 0.0 114.251 164.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.86 136.59 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.228 1.011 . . . . 0.0 111.463 168.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -138.91 151.64 47.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.076 2.151 . . . . 0.0 109.139 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -90.52 143.73 26.46 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.493 -0.754 . . . . 0.0 111.72 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -149.95 165.96 31.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.607 -157.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.12 160.26 42.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.107 1.763 . . . . 0.0 110.534 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.0 tp60 -40.51 4.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 1 C-N-CA 133.478 4.711 . . . . 0.0 119.021 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.66 -15.18 5.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.769 2.028 . . . . 0.0 114.028 -175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -114.3 -19.96 11.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.511 2.325 . . . . 0.0 110.109 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 112' ' ' PHE . 19.2 m -79.21 -23.08 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 129.883 3.273 . . . . 0.0 114.31 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.43 63.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.252 1.821 . . . . 0.0 109.193 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.1 m -54.79 -31.65 59.2 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.779 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.229 0 C-N-CA 128.4 2.68 . . . . 0.0 113.657 156.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.3 p30 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.4 m -147.3 32.65 0.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.31 1.844 . . . . 0.0 111.539 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.66 54.83 1.59 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.9 2.48 . . . . 0.0 107.998 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.34 159.45 26.07 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -147.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.2 t -166.79 -176.85 3.62 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.605 2.762 . . . . 0.0 108.964 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.45 -28.16 41.63 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.917 -1.114 . . . . 0.0 112.966 163.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -34.37 0.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 -167.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.49 51.15 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.477 1.132 . . . . 0.0 113.381 -163.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.26 89.6 0.9 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 126.169 1.842 . . . . 0.0 110.985 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CG ' HG11 ' A' ' 191' ' ' VAL . 5.0 m-85 -95.27 164.58 12.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.76 120.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 76.4 ttt180 -95.39 136.94 35.12 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.583 0.753 . . . . 0.0 111.95 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.67 148.89 26.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.653 2.781 . . . . 0.0 109.775 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -154.11 78.28 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 109.383 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 179.9 -3.81 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.5 OUTLIER -79.88 151.43 73.57 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 118.61 1.205 . . . . 0.0 112.117 -161.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' CG ' HG22 ' A' ' 176' ' ' ILE . 95.8 Cg_endo -80.17 174.91 10.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 1 C-N-CA 126.598 4.865 . . . . 0.0 113.715 -177.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.35 127.68 32.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.732 1.213 . . . . 0.0 111.42 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 71.7 14.84 75.47 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 117.959 -1.467 . . . . 0.0 115.681 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.486 ' SG ' HG21 ' A' ' 176' ' ' ILE . 29.5 t -58.0 152.48 16.33 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.366 2.083 . . . . 0.0 112.543 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.23 164.24 32.9 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 122.847 1.308 . . . . 0.0 111.371 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -45.08 -42.91 9.13 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 127.799 2.44 . . . . 0.0 112.919 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 128' ' ' VAL . 37.4 mp0 -68.92 -18.52 64.11 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.669 1.577 . . . . 0.0 113.893 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.65 -25.57 45.01 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.62 -1.925 . . . . 0.0 110.671 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.422 HD12 HD21 ' A' ' 143' ' ' LEU . 48.6 mt -73.06 -37.14 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.724 0.81 . . . . 0.0 110.995 165.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.261 2.2 m -59.92 -20.89 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.266 1.026 . . . . 0.0 113.151 169.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -93.5 -28.59 16.0 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.909 1.231 . . . . 0.0 113.448 168.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.87 -45.81 91.3 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.394 1.477 . . . . 0.0 111.168 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -116.17 33.51 5.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.625 1.17 . . . . 0.0 113.108 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.0 p -53.3 -22.49 7.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.79 -32.49 40.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.297 1.903 . . . . 0.0 115.232 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.73 169.71 17.31 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.18 1.392 . . . . 0.0 112.172 -157.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -99.62 136.26 39.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.372 1.469 . . . . 0.0 112.166 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.4 mt -134.19 139.12 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 128.887 2.875 . . . . 0.0 108.79 -168.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.7 152.13 76.3 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.667 -0.646 . . . . 0.0 110.887 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.85 -24.05 22.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -158.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.09 40.5 2.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.935 1.294 . . . . 0.0 109.872 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.61 16.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.15 1.357 . . . . 0.0 115.674 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 128' ' ' VAL . 65.5 mt -93.17 126.44 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 125.27 1.428 . . . . 0.0 109.451 -169.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.5 m -121.92 132.18 54.41 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.039 1.736 . . . . 0.0 112.869 -174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.422 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.67 91.35 49.79 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.178 2.191 . . . . 0.0 111.483 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.44 -70.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 121.771 1.647 . . . . 0.0 113.655 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.91 169.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 129.516 3.127 . . . . 0.0 108.809 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.543 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.4 p-10 -70.52 170.74 9.68 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 165.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.6 0.06 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 124.838 3.692 . . . . 0.0 117.13 171.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -129.15 0.38 5.19 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.74 1.616 . . . . 0.0 111.814 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.03 37.82 42.3 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -130.24 -16.72 3.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.161 1.481 . . . . 0.0 112.657 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.509 HG23 ' H ' ' A' ' 152' ' ' THR 0.294 0.0 OUTLIER -143.09 -112.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 113.482 -169.425 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -177.77 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.419 3.087 . . . . 0.0 108.028 -166.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.543 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -122.97 5.56 9.62 Favored Glycine 0 N--CA 1.466 0.7 0 C-N-CA 127.84 2.638 . . . . 0.0 114.685 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.36 159.04 42.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.22 0.608 . . . . 0.0 109.982 152.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.18 178.26 3.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.261 1.825 . . . . 0.0 110.751 -165.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.686 ' CD1' HG12 ' A' ' 191' ' ' VAL . 92.0 m-85 -149.79 156.26 41.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.918 1.287 . . . . 0.0 109.283 -168.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.3 p -156.13 121.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 31.6 tp60 -90.0 129.8 36.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.544 1.938 . . . . 0.0 109.444 176.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.3 m-85 -86.96 -165.33 1.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.54 -14.6 60.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.965 -1.709 . . . . 0.0 112.307 161.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.7 m -158.66 163.9 36.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 6.1 mm-40 -56.78 -33.17 66.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.19 1.396 . . . . 0.0 114.679 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 28.6 tp10 -72.58 -50.18 27.21 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 111.915 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.12 -35.87 69.99 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.069 1.348 . . . . 0.0 111.264 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.51 -17.38 59.3 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.216 0.532 . . . . 0.0 112.262 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -87.09 -32.05 20.14 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.611 -1.305 . . . . 0.0 109.698 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -63.88 -35.77 81.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.392 1.477 . . . . 0.0 109.711 169.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.64 -43.47 89.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.167 1.787 . . . . 0.0 115.592 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 mp -50.03 -25.74 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.8 -16.34 30.72 Favored Glycine 0 CA--C 1.547 2.09 0 C-N-CA 124.858 1.218 . . . . 0.0 115.335 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -68.97 -14.51 63.08 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.49 1.645 . . . . 0.0 114.77 167.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 39.96 -48.64 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 132.407 4.283 . . . . 0.0 121.16 170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 15.79 0.66 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.324 1.85 . . . . 0.0 113.338 -173.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -55.09 174.27 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -110.75 155.68 22.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.652 1.581 . . . . 0.0 114.148 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.4 mt -132.96 169.1 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 130.972 3.709 . . . . 0.0 106.558 169.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 2.49 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.475 1.274 0 C-N-CA 129.774 3.559 . . . . 0.0 116.616 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 -2.86 4.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 171.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -134.38 -179.01 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.406 1.482 . . . . 0.0 114.959 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -144.05 111.16 5.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.426 -126.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.542 ' CD1' HD12 ' A' ' 176' ' ' ILE . 15.1 mt -115.51 129.01 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.436 1.112 . . . . 0.0 111.898 -139.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 153.24 41.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.553 2.341 . . . . 0.0 113.195 166.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.25 135.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.399 0.68 . . . . 0.0 111.657 167.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -139.25 143.48 38.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.149 1.78 . . . . 0.0 109.386 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 185' ' ' LYS . 16.8 tptm -75.35 136.91 40.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.725 0.774 . . . . 0.0 109.91 175.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 m -141.82 166.46 24.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.727 -164.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -143.5 157.18 44.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.91 0.884 . . . . 0.0 110.616 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.46 ' HA ' HG21 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -33.84 5.44 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.907 1 C-N-CA 134.945 5.298 . . . . 0.0 120.037 176.935 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -126.71 -22.45 3.89 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.09 -1.631 . . . . 0.0 112.851 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.51 -21.91 61.12 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.471 -1.393 . . . . 0.0 109.708 172.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 156' ' ' PHE . 20.8 m -96.35 -28.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 126.855 2.062 . . . . 0.0 113.447 -150.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 56.34 3.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.793 1.237 . . . . 0.0 110.132 176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.8 t -61.54 -13.13 18.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.381 2.272 . . . . 0.0 112.624 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.91 0.386 . . . . 0.0 111.383 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.3 p -157.82 -15.4 0.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.791 2.037 . . . . 0.0 114.673 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.47 83.06 0.69 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.241 2.217 . . . . 0.0 108.238 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -150.52 159.2 44.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 0.0 112.752 -160.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.6 -60.08 0.89 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.58 -39.72 0.06 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -149.55 -23.02 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -52.66 41.68 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 1 C-N-CA 133.664 4.786 . . . . 0.0 116.371 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.12 90.17 0.06 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.931 1.253 . . . . 0.0 111.737 162.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.7 m-85 -107.5 160.75 15.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.36 116.02 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 73.5 ttt180 -88.39 120.17 29.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.362 1.065 . . . . 0.0 111.382 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.45 151.21 41.18 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.525 1.53 . . . . 0.0 111.648 162.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 139.9 44.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 148.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.5 -20.65 0.82 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.523 -1.361 . . . . 0.0 112.885 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.84 HD23 ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -58.18 142.91 80.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.514 1.926 . . . . 0.0 113.544 -156.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.28 165.7 27.33 Favored 'Trans proline' 0 N--CA 1.458 -0.576 1 C-N-CA 126.231 4.621 . . . . 0.0 112.131 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.54 116.79 4.6 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.317 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.33 59.76 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.615 -1.103 . . . . 0.0 115.549 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.45 ' SG ' HD22 ' A' ' 118' ' ' LEU . 21.6 t -56.06 148.34 17.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.984 1.892 . . . . 0.0 110.938 165.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 125' ' ' GLU . 8.8 t -144.32 171.05 14.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.952 0.882 . . . . 0.0 110.076 170.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.2 ttmt -41.31 -40.93 1.79 Allowed 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 127.438 2.295 . . . . 0.0 112.978 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HB2' HG23 ' A' ' 123' ' ' THR . 27.6 mp0 -58.52 -32.67 69.07 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.25 2.22 . . . . 0.0 116.069 173.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -77.01 -23.33 52.2 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 119.958 -1.714 . . . . 0.0 110.157 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 143' ' ' LEU . 13.4 mt -74.78 -37.33 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.641 -0.662 . . . . 0.0 110.993 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -62.15 -17.26 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.126 1.37 . . . . 0.0 113.054 171.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -98.17 -25.28 14.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.62 1.1 . . . . 0.0 113.937 168.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.81 -45.86 91.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.057 1.343 . . . . 0.0 110.575 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -121.48 33.25 5.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.038 1.335 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -54.24 -19.4 5.19 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.769 -0.582 . . . . 0.0 112.49 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.68 -35.0 44.99 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.588 1.566 . . . . 0.0 115.496 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.34 163.56 31.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -153.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.84 139.25 32.78 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 112.84 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 75.4 mt -144.51 133.37 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.639 2.375 . . . . 0.0 107.24 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.89 153.35 54.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.636 -0.665 . . . . 0.0 111.438 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.69 -23.96 28.2 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 120.842 3.362 . . . . 0.0 120.842 -160.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.48 39.43 2.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.674 1.19 . . . . 0.0 109.95 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.8 -26.45 17.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.89 1.233 . . . . 0.0 114.812 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -84.1 132.44 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.662 1.585 . . . . 0.0 108.883 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.6 HG23 ' CD1' ' A' ' 194' ' ' TYR . 1.3 m -126.19 131.57 51.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.263 1.825 . . . . 0.0 112.124 -174.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 127' ' ' ILE . 3.8 mm? -128.2 84.96 61.75 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 126.572 1.949 . . . . 0.0 112.61 -167.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.83 -69.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 121.825 1.684 . . . . 0.0 115.512 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.64 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 127.252 2.221 . . . . 0.0 111.651 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.553 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.0 p-10 -79.06 173.26 8.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.893 2.077 . . . . 0.0 114.845 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.45 -4.31 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 125.074 3.849 . . . . 0.0 117.844 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.42 -32.0 3.94 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 121.35 1.886 . . . . 0.0 111.785 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 109.02 40.26 1.57 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.235 0.922 . . . . 0.0 114.641 165.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.4 -3.13 4.35 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 113.106 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 152' ' ' THR 0.318 0.0 OUTLIER -141.7 -102.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.998 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.612 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 165.98 68.0 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.444 3.498 . . . . 0.0 108.687 -159.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -114.58 4.02 23.15 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 129.266 3.317 . . . . 0.0 116.226 172.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -127.29 163.5 23.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.234 1.016 . . . . 0.0 109.632 142.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.85 178.36 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.405 2.282 . . . . 0.0 108.154 -168.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.3 m-85 -150.42 160.59 43.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.582 0.753 . . . . 0.0 109.512 -167.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.02 121.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 136' ' ' ILE . 55.7 tp60 -92.69 123.87 36.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 127.222 2.209 . . . . 0.0 111.386 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 11.3 m-85 -86.99 -173.63 4.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.329 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.98 -8.74 57.94 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.224 -1.548 . . . . 0.0 113.105 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.6 m -160.39 161.29 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.566 1.147 . . . . 0.0 112.944 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -57.4 -31.24 65.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.212 1.405 . . . . 0.0 113.508 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -84.67 -42.78 14.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.523 1.529 . . . . 0.0 113.014 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.4 mt -54.69 -35.47 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.449 1.5 . . . . 0.0 111.411 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.23 -10.05 57.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.07 -13.81 11.2 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.322 -1.486 . . . . 0.0 112.004 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -62.32 -40.31 95.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.702 0.801 . . . . 0.0 109.2 153.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.47 79.03 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -50.58 -27.0 5.95 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.694 1.588 . . . . 0.0 114.287 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.89 -19.82 56.58 Favored Glycine 0 CA--C 1.546 1.991 0 C-N-CA 125.077 1.322 . . . . 0.0 114.798 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.59 41.64 0.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.717 2.007 . . . . 0.0 112.61 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -51.31 -30.48 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.697 2.399 . . . . 0.0 114.888 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -147.58 107.3 3.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.264 1.026 . . . . 0.0 111.051 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -137.64 -161.21 1.14 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.654 1.582 . . . . 0.0 109.927 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -140.75 148.04 40.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.065 1.346 . . . . 0.0 111.718 -155.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.01 132.72 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.319 2.248 . . . . 0.0 108.132 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 59.54 -67.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.419 0 C-N-CA 127.605 2.526 . . . . 0.0 115.831 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.8 -9.85 0.21 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.714 2.406 . . . . 0.0 113.566 169.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -108.53 -175.03 2.66 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 127.139 2.176 . . . . 0.0 112.765 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -149.63 116.74 6.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -135.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.84 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.8 mt -127.03 135.8 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 122.776 1.274 . . . . 0.0 111.771 -139.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.8 159.27 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 130.955 3.702 . . . . 0.0 114.348 169.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.04 137.44 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.923 1.289 . . . . 0.0 111.005 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -138.42 146.88 42.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.205 1.802 . . . . 0.0 109.806 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -70.82 142.84 51.27 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.782 1.233 . . . . 0.0 110.884 177.257 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.412 ' H ' ' HE2' ' A' ' 185' ' ' LYS . 3.3 m -153.79 161.88 41.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.357 -164.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.5 m -146.2 157.38 43.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.084 1.354 . . . . 0.0 111.148 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.489 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.3 tp60 -40.93 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.129 4.572 . . . . 0.0 119.674 -175.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 -16.0 3.91 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.976 -1.702 . . . . 0.0 114.369 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.44 -29.14 18.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.767 1.627 . . . . 0.0 108.915 173.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.632 HG11 ' CG ' ' A' ' 112' ' ' PHE . 35.7 m -73.23 -26.18 22.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 129.111 2.965 . . . . 0.0 115.42 172.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -73.45 28.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.251 2.621 . . . . 0.0 114.644 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.9 m -62.27 -7.87 4.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.464 1.105 . . . . 0.0 112.41 160.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.6 ' CD1' HG23 ' A' ' 142' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 C-N-CA 128.287 2.635 . . . . 0.0 107.216 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 115.385 1.624 . . . . 10.0 115.385 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.83 36.13 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.563 3.145 . . . . 10.0 114.934 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -61.39 101.36 0.32 Allowed Glycine 0 C--O 1.228 -0.229 0 CA-C-O 117.797 -1.557 . . . . 10.0 111.75 173.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.683 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -111.03 167.59 10.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.859 -1.904 . . . . 10.0 105.859 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.0 t -134.06 153.29 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.247 -1.797 . . . . 10.0 107.964 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 52.3 ttt180 -120.65 136.49 54.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.0 1.32 . . . . 10.0 111.959 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.88 147.19 29.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.409 3.084 . . . . 10.0 109.976 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -152.66 77.22 1.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.599 1.16 . . . . 10.0 109.936 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.07 9.4 0.02 OUTLIER Glycine 0 CA--C 1.532 1.125 0 N-CA-C 116.176 1.23 . . . . 10.0 116.176 -164.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.6 mt -80.44 155.41 74.04 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.797 1.239 . . . . 10.0 111.313 -166.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.511 ' CD ' HG22 ' A' ' 176' ' ' ILE . 23.8 Cg_endo -84.08 175.75 7.26 Favored 'Trans proline' 0 CA--C 1.532 0.384 1 C-N-CA 126.72 4.947 . . . . 10.0 112.489 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -63.98 135.17 56.24 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.421 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 69.58 15.1 70.47 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 118.247 -1.307 . . . . 10.0 115.585 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 176' ' ' ILE . 39.7 t -58.34 147.43 31.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.053 1.927 . . . . 10.0 112.78 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 171.86 16.68 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.028 0.918 . . . . 10.0 112.146 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 128' ' ' VAL . 6.7 mttm -38.44 -53.6 1.53 Allowed 'General case' 0 C--O 1.205 -1.237 0 CA-C-O 116.477 -1.725 . . . . 10.0 113.54 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.48 -19.76 63.89 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 121.585 1.993 . . . . 10.0 113.7 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -79.98 -29.39 39.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.16 -1.587 . . . . 10.0 110.767 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 143' ' ' LEU . 46.3 mt -73.12 -43.48 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.373 1.069 . . . . 10.0 111.17 168.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.3 m -56.64 -21.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.31 1.844 . . . . 10.0 113.303 169.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -96.39 -26.33 15.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.887 1.676 . . . . 10.0 112.37 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -58.81 -51.94 67.86 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.59 1.556 . . . . 10.0 109.864 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 39.8 m-85 -112.75 30.98 6.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.305 1.042 . . . . 10.0 112.841 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.5 p -53.23 -21.86 5.95 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.173 0.805 . . . . 10.0 113.173 156.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.3 -31.91 43.31 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.073 1.796 . . . . 10.0 115.208 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.28 166.21 24.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.116 1.366 . . . . 10.0 112.875 -157.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.32 134.77 34.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.147 1.379 . . . . 10.0 111.649 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 71.2 mt -137.27 140.62 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 128.371 2.668 . . . . 10.0 106.978 -170.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.15 156.08 61.25 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.535 -0.728 . . . . 10.0 111.432 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.22 -19.24 16.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 120.957 3.407 . . . . 10.0 120.957 -162.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.8 35.48 2.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.633 1.106 . . . . 10.0 110.657 166.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.12 45.3 0.58 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 126.692 2.091 . . . . 10.0 114.228 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 128' ' ' VAL . 86.3 mt -143.58 136.13 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 119.964 1.882 . . . . 10.0 106.012 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -132.52 131.54 41.71 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.24 1.836 . . . . 10.0 112.569 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 127' ' ' ILE . 2.9 mm? -124.94 84.06 59.23 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 127.263 2.225 . . . . 10.0 110.868 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.69 -65.18 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 121.081 1.188 . . . . 10.0 113.237 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.84 169.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 128.328 2.651 . . . . 10.0 110.149 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.1 p-10 -68.5 173.3 3.51 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.533 . . . . 10.0 114.778 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.37 -1.98 0.54 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.754 3.636 . . . . 10.0 117.624 172.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.72 -31.89 3.14 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.537 1.971 . . . . 10.0 112.28 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.04 37.66 1.22 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.88 -0.955 . . . . 10.0 115.445 163.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -135.34 -2.95 2.44 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.997 1.398 . . . . 10.0 113.808 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.611 HG23 ' H ' ' A' ' 152' ' ' THR 0.285 0.0 OUTLIER -143.7 -118.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.782 1.233 . . . . 10.0 113.496 -178.373 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.611 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.1 p -172.76 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.365 3.466 . . . . 10.0 107.051 -167.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.547 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.29 6.46 11.83 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 126.98 2.228 . . . . 10.0 114.751 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -132.08 156.55 46.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.016 0.912 . . . . 10.0 110.376 148.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.19 175.45 8.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 126.088 1.755 . . . . 10.0 110.423 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 86.1 m-85 -149.09 164.64 34.07 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.524 -169.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -159.41 119.52 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 114.381 1.252 . . . . 10.0 114.381 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 49.6 tp60 -90.38 123.55 34.21 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 129.477 3.111 . . . . 10.0 111.055 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.2 m-85 -89.1 -165.45 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 123.143 0.577 . . . . 10.0 110.248 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.65 -10.3 59.74 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.88 -1.763 . . . . 10.0 113.632 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.4 m -158.48 160.95 37.31 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.428 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 2.2 tp60 -58.63 -28.12 65.36 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 171.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -80.08 -48.15 13.71 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.782 1.233 . . . . 10.0 112.214 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.62 -37.7 63.32 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.349 1.46 . . . . 10.0 111.334 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.91 -8.87 57.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -112.99 -15.3 12.88 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.918 -1.739 . . . . 10.0 112.893 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -60.01 -37.46 79.8 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 156.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -67.82 -46.34 72.15 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.549 2.055 . . . . 10.0 116.549 172.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mp -48.0 -35.07 10.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 120.527 1.512 . . . . 10.0 113.189 162.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.41 -15.16 30.44 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 125.622 1.582 . . . . 10.0 115.85 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -64.6 -26.33 68.35 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.56 1.68 . . . . 10.0 114.65 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.3 t60 60.58 -47.58 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.922 2.889 . . . . 10.0 117.328 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -145.1 -66.76 0.32 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.64 1.576 . . . . 10.0 112.611 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 36.82 -142.3 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.575 1.55 . . . . 10.0 113.186 -167.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -151.25 155.51 38.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.864 . . . . 10.0 110.199 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.511 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.5 mt -132.93 135.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.151 2.58 . . . . 10.0 105.447 162.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 49.02 -86.95 0.01 OUTLIER Glycine 0 N--CA 1.474 1.167 0 C-N-CA 126.801 2.144 . . . . 10.0 114.178 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 5.04 3.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.632 1.573 . . . . 10.0 114.449 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.51 -179.53 5.21 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.25 1.82 . . . . 10.0 114.259 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -146.84 14.13 1.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.604 -1.18 . . . . 10.0 113.01 -124.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 176' ' ' ILE . 1.3 mt 42.96 107.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 116.983 2.216 . . . . 10.0 116.983 134.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 165.06 23.17 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 127.506 2.323 . . . . 10.0 113.649 160.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.6 140.34 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.664 0.786 . . . . 10.0 112.294 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -144.44 153.25 41.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.432 1.893 . . . . 10.0 110.507 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -74.31 154.62 38.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.809 0.844 . . . . 10.0 111.837 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.3 m -159.02 167.97 27.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.021 0.748 . . . . 10.0 113.021 -165.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 14.9 m -149.42 161.89 41.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.464 1.906 . . . . 10.0 109.64 159.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HG22 ' A' ' 191' ' ' VAL . 2.4 tp-100 -31.62 -10.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 1 C-N-CA 132.467 4.307 . . . . 10.0 120.595 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.3 -6.32 3.8 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.232 -2.168 . . . . 10.0 112.066 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -23.05 39.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 149.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.683 HG11 ' CD2' ' A' ' 112' ' ' PHE . 9.5 m . . . . . 0 C--N 1.35 0.601 0 N-CA-C 115.443 1.646 . . . . 10.0 115.443 -164.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 122.012 0.91 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.08 45.22 0.09 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.591 3.156 . . . . 0.0 113.556 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.86 102.12 1.63 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.639 ' CD2' HG11 ' A' ' 191' ' ' VAL . 3.2 m-85 -99.48 160.57 14.19 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.5 118.33 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.273 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -104.11 125.8 50.72 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 -164.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.37 151.59 23.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.467 2.307 . . . . 0.0 110.494 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -155.58 79.55 1.02 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.682 1.593 . . . . 0.0 108.582 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.39 -11.96 0.02 OUTLIER Glycine 0 CA--C 1.536 1.401 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -162.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.828 HD23 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -73.36 152.69 90.07 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.608 1.163 . . . . 0.0 113.423 -155.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.481 ' CD ' HG22 ' A' ' 176' ' ' ILE . 69.7 Cg_endo -78.02 171.35 17.32 Favored 'Trans proline' 0 CA--C 1.531 0.352 1 C-N-CA 126.753 4.969 . . . . 0.0 112.653 173.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -57.37 133.9 55.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.068 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.2 19.24 68.03 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 118.775 -1.014 . . . . 0.0 115.169 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 118' ' ' LEU . 33.8 t -55.44 146.69 19.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.273 1.536 . . . . 0.0 111.722 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.0 t -150.7 163.5 38.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 112.164 -173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.5 mttt -39.2 -44.38 1.21 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 126.738 2.015 . . . . 0.0 115.684 173.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -69.84 -19.91 63.44 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.089 1.356 . . . . 0.0 112.957 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 2.2 mm-40 -78.12 -32.12 50.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.284 -1.51 . . . . 0.0 109.597 169.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.445 HD12 HD21 ' A' ' 143' ' ' LEU . 16.2 mt -69.59 -39.85 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 120.708 -1.245 . . . . 0.0 110.782 169.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 124' ' ' LYS 0.269 1.2 m -61.59 -13.46 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.613 1.565 . . . . 0.0 114.512 168.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.4 pp0? -101.86 -21.19 14.62 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 121.031 1.741 . . . . 0.0 113.728 166.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -49.2 75.04 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.614 1.566 . . . . 0.0 110.732 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -118.84 31.49 6.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.224 1.41 . . . . 0.0 112.069 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 84.2 p -46.59 -25.7 0.75 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 153.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.22 70.52 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.65 2.071 . . . . 0.0 116.246 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.06 159.73 41.03 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.647 1.224 . . . . 0.0 113.14 -154.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.55 127.68 34.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.997 1.319 . . . . 0.0 112.04 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 46.8 mt -129.49 139.18 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 128.358 2.663 . . . . 0.0 108.494 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.01 151.3 80.88 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.309 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -52.83 -24.87 25.27 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 120.671 3.296 . . . . 0.0 120.671 -158.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.39 42.45 2.36 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.792 1.237 . . . . 0.0 110.078 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.74 -23.68 30.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.909 1.243 . . . . 0.0 114.967 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.12 144.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 125.629 1.572 . . . . 0.0 109.481 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 77.6 m -140.28 136.29 33.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.056 -1.653 . . . . 0.0 113.52 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -125.74 89.88 51.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.101 2.56 . . . . 0.0 111.129 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.07 -72.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.017 1.812 . . . . 0.0 113.728 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.07 167.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 127.034 2.134 . . . . 0.0 111.183 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.3 p-10 -70.22 173.38 4.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.087 1.755 . . . . 0.0 114.875 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.46 -3.28 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.691 3.594 . . . . 0.0 117.886 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.08 -36.68 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.814 2.097 . . . . 0.0 111.881 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.04 42.13 0.67 Allowed Glycine 0 CA--C 1.532 1.117 0 N-CA-C 115.27 0.868 . . . . 0.0 115.27 163.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -134.0 -2.81 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.742 1.217 . . . . 0.0 113.631 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.626 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -143.47 -117.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.063 1.345 . . . . 0.0 113.47 -178.401 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.626 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -175.7 76.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 130.72 3.608 . . . . 0.0 106.08 -169.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -117.67 3.6 17.47 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 127.971 2.7 . . . . 0.0 115.646 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.03 157.84 41.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 122.307 1.051 . . . . 0.0 109.753 148.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.44 177.69 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.527 2.331 . . . . 0.0 108.188 -171.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.572 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -152.38 159.52 43.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 122.624 0.369 . . . . 0.0 110.871 -163.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.43 129.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 53.4 tp60 -104.23 138.53 40.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.382 2.273 . . . . 0.0 110.13 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 2.9 m-85 -106.02 -175.87 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.92 57.09 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.048 -1.658 . . . . 0.0 113.267 168.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.8 m -161.24 161.68 30.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.311 1.045 . . . . 0.0 112.444 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -62.57 -21.6 65.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.028 0.931 . . . . 0.0 113.122 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.5 -47.7 10.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.533 2.733 . . . . 0.0 112.776 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.37 -35.68 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.9 1.28 . . . . 0.0 111.139 168.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.05 -13.55 62.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.508 172.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -94.75 -29.57 14.7 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.147 -1.596 . . . . 0.0 110.644 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -61.24 -38.86 88.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.062 1.745 . . . . 0.0 109.844 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.25 -45.76 83.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.086 2.155 . . . . 0.0 116.02 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.59 -28.24 13.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 113.768 165.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.74 -19.52 55.28 Favored Glycine 0 CA--C 1.546 2.012 0 C-N-CA 125.344 1.45 . . . . 0.0 115.418 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -72.43 35.7 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.77 2.028 . . . . 0.0 113.402 164.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.416 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 1.6 t-80 -50.16 -31.05 12.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -154.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 27.75 3.47 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.284 1.433 . . . . 0.0 113.371 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -66.96 -170.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -138.11 148.7 45.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.354 1.862 . . . . 0.0 111.361 -153.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.8 mt -139.71 128.12 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 128.824 2.849 . . . . 0.0 106.41 173.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.88 -126.19 34.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -98.47 8.43 44.89 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.6 -179.94 4.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -153.03 111.69 3.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -119.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.828 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.7 mt -126.43 136.77 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 122.876 1.322 . . . . 0.0 112.6 -139.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 155.08 40.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.689 3.196 . . . . 0.0 113.287 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 172' ' ' HIS . 1.7 m -141.67 132.47 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.749 0.82 . . . . 0.0 111.664 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.28 151.0 44.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.391 1.876 . . . . 0.0 110.328 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -74.25 143.95 44.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.206 1.003 . . . . 0.0 111.578 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.19 170.76 18.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.911 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 191' ' ' VAL . 69.7 m -143.16 154.08 43.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.192 1.397 . . . . 0.0 110.018 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -29.33 4.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.139 1 C-N-CA 135.643 5.577 . . . . 0.0 120.305 174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -137.51 -24.58 1.05 Allowed 'General case' 0 C--N 1.322 -0.619 0 O-C-N 119.861 -1.774 . . . . 0.0 112.448 -164.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.36 -21.87 28.68 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 161.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 112' ' ' PHE . 32.4 m . . . . . 0 CA--C 1.52 -0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 113.215 -165.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 37.87 0.52 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.269 3.028 . . . . 0.0 112.774 -163.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.67 108.88 2.64 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CD2' HG11 ' A' ' 191' ' ' VAL . 15.1 m-85 -97.02 166.68 11.48 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 164.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.31 110.67 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.315 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -87.28 121.11 29.29 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.543 0.737 . . . . 0.0 111.585 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.07 151.41 28.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.735 2.014 . . . . 0.0 110.598 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.67 89.86 1.59 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.107 1.363 . . . . 0.0 108.784 168.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.14 -24.75 0.02 OUTLIER Glycine 0 N--CA 1.468 0.781 0 C-N-CA 117.797 -2.144 . . . . 0.0 114.313 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -52.75 144.39 25.78 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.879 2.472 . . . . 0.0 114.864 -157.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.38 172.52 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.503 1 C-N-CA 126.783 4.988 . . . . 0.0 112.938 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -48.31 123.15 6.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.455 1.502 . . . . 0.0 111.786 165.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.82 19.08 76.15 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.79 154.68 3.72 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.341 1.57 . . . . 0.0 112.489 166.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.7 t -150.2 162.63 40.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.587 0.755 . . . . 0.0 112.59 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.4 mttt -35.54 -47.11 0.44 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 126.845 2.058 . . . . 0.0 114.487 166.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.29 -18.74 64.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 120.737 1.608 . . . . 0.0 113.686 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.94 -30.51 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.287 -1.508 . . . . 0.0 110.646 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 143' ' ' LEU . 18.8 mt -68.17 -42.59 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.855 167.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 124' ' ' LYS 0.25 1.0 OUTLIER -62.27 -14.69 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 113.92 170.528 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -25.77 14.9 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.581 1.537 . . . . 0.0 113.885 164.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -46.51 83.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 109.732 173.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.555 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 27.8 m-85 -121.77 33.97 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.202 1.401 . . . . 0.0 113.686 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 t -53.78 -21.57 7.66 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.511 0.672 . . . . 0.0 112.094 157.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.34 -30.04 60.99 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.061 1.791 . . . . 0.0 115.821 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.05 167.45 22.03 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.455 1.128 . . . . 0.0 113.016 -156.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.65 131.52 40.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 111.931 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.2 mt -128.82 137.83 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 128.277 2.631 . . . . 0.0 108.49 -171.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 m -65.7 154.4 88.72 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.732 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.21 -13.37 6.88 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.398 3.399 . . . . 0.0 119.85 -167.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -135.67 26.12 3.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.85 1.66 . . . . 0.0 111.438 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.03 67.07 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 -169.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.65 137.31 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.678 1.191 . . . . 0.0 108.91 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.0 m -131.68 138.4 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.042 1.737 . . . . 0.0 111.814 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -123.15 92.27 49.19 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 127.017 2.127 . . . . 0.0 110.873 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' A' ' 155' ' ' ALA . 88.9 Cg_endo -79.8 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.762 3.641 . . . . 0.0 113.14 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.68 173.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 130.123 3.369 . . . . 0.0 108.851 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.1 p-10 -77.91 172.78 8.9 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.851 2.061 . . . . 0.0 114.087 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.08 0.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 125.031 3.821 . . . . 0.0 117.499 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -126.5 -0.19 6.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.749 1.62 . . . . 0.0 111.938 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 35.46 48.2 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.514 -1.159 . . . . 0.0 115.961 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -130.05 -15.79 3.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.594 1.697 . . . . 0.0 112.635 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.326 0.0 OUTLIER -138.43 -98.4 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -170.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 164.33 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 129.917 3.287 . . . . 0.0 109.245 -165.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -124.8 4.47 8.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.71 3.528 . . . . 0.0 114.405 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -130.12 166.68 19.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.409 1.084 . . . . 0.0 108.866 145.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 144' ' ' PRO . . . -170.85 175.83 4.35 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 128.046 2.539 . . . . 0.0 109.049 -171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.5 m-85 -150.27 154.74 38.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.062 0.545 . . . . 0.0 110.713 -166.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.43 127.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -97.26 139.61 32.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.344 2.258 . . . . 0.0 111.403 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.1 m-85 -106.73 -177.4 3.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.387 0.675 . . . . 0.0 110.697 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.63 -10.22 59.54 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.143 -1.598 . . . . 0.0 112.946 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.1 m -159.86 157.33 28.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.237 1.015 . . . . 0.0 112.033 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -72.86 -13.87 61.37 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.651 -0.656 . . . . 0.0 112.446 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.415 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 41.6 tp10 -75.07 -51.5 13.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.784 2.434 . . . . 0.0 112.394 169.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.4 mt -57.14 -38.16 73.1 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.996 0.918 . . . . 0.0 110.447 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.23 62.16 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -104.33 -27.1 12.18 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.374 -1.454 . . . . 0.0 110.629 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER -61.81 -32.13 72.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.164 0.985 . . . . 0.0 109.072 165.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -69.69 -47.9 61.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mp -49.39 -33.51 13.95 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.031 1.287 . . . . 0.0 112.918 162.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.86 -16.61 32.26 Favored Glycine 0 CA--C 1.545 1.929 0 C-N-CA 125.823 1.678 . . . . 0.0 115.581 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -62.37 -33.48 74.82 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.642 1.721 . . . . 0.0 113.392 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 45.69 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 1 C-N-CA 132.418 4.287 . . . . 0.0 119.109 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 90.6 2.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.652 2.381 . . . . 0.0 109.726 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -130.55 -160.84 1.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.71 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -143.04 149.88 38.83 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 120.873 -1.142 . . . . 0.0 112.816 -156.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 118' ' ' LEU . 9.0 mt -140.06 133.09 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 128.306 2.643 . . . . 0.0 106.885 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 48.81 -136.31 19.26 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.229 1.871 . . . . 0.0 111.848 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.03 -8.21 54.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -179.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.686 1.194 . . . . 0.0 113.988 -160.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -137.87 118.39 13.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.503 -149.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 118' ' ' LEU . 1.7 mp -123.14 135.82 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.923 1.344 . . . . 0.0 110.952 -148.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 164.13 23.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.05 3.34 . . . . 0.0 115.449 169.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.02 132.14 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.808 1.243 . . . . 0.0 111.298 166.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.95 148.6 43.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.826 1.65 . . . . 0.0 110.966 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -71.33 135.09 47.18 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 111.122 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 m -146.87 167.56 23.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.044 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.4 m -154.32 156.12 36.37 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 0.0 112.375 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.496 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.1 tp-100 -32.86 2.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 1 C-N-CA 134.545 5.138 . . . . 0.0 121.151 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -130.4 -24.44 2.53 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.626 -1.921 . . . . 0.0 112.729 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -81.76 -7.18 59.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.01 1.324 . . . . 0.0 109.832 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.764 HG12 ' CD1' ' A' ' 156' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 128.566 2.746 . . . . 0.0 113.792 -171.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 CA-C-O 121.942 0.877 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.0 42.08 2.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.028 1.731 . . . . 0.0 109.616 -155.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.21 113.19 3.59 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.452 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.559 ' CD2' HG11 ' A' ' 191' ' ' VAL . 16.8 m-85 -106.41 162.48 13.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.31 119.5 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.924 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -96.27 120.96 37.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.142 1.377 . . . . 0.0 110.449 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 181' ' ' ILE . 2.0 mm? -72.49 146.08 47.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.12 158.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -139.01 140.33 38.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 141.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.27 1.36 0.39 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.644 0.618 . . . . 0.0 114.644 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.671 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 64.8 mt -69.01 152.11 96.95 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.184 1.394 . . . . 0.0 113.33 -153.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.461 ' CD ' HG22 ' A' ' 176' ' ' ILE . 68.7 Cg_endo -75.53 167.85 25.69 Favored 'Trans proline' 0 C--O 1.235 0.327 1 C-N-CA 125.722 4.281 . . . . 0.0 112.039 172.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -68.41 128.73 37.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.962 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.47 25.68 74.8 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.034 -0.87 . . . . 0.0 114.47 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 176' ' ' ILE . 42.8 t -53.09 150.28 5.93 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.549 1.175 . . . . 0.0 113.417 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 t -147.29 160.32 42.64 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 120.787 -1.195 . . . . 0.0 113.434 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.608 ' O ' HG13 ' A' ' 128' ' ' VAL . 5.0 mttm -39.11 -47.33 1.54 Allowed 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 126.663 1.985 . . . . 0.0 114.993 171.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -65.97 -19.64 65.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.589 1.541 . . . . 0.0 112.794 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 58.2 mt-10 -81.93 -29.45 32.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.4 -1.438 . . . . 0.0 109.744 171.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.437 HD12 HD21 ' A' ' 143' ' ' LEU . 31.9 mt -70.11 -41.99 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.202 -0.936 . . . . 0.0 111.325 166.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -62.11 -12.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.173 1.789 . . . . 0.0 114.162 170.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -100.56 -21.97 15.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.981 1.264 . . . . 0.0 114.4 164.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -48.91 78.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 169.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.18 34.75 5.1 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.16 1.384 . . . . 0.0 112.694 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.33 -23.42 2.32 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 156.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.04 -31.03 67.78 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.142 1.83 . . . . 0.0 115.988 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.35 161.39 37.07 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.297 1.049 . . . . 0.0 113.603 -154.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.44 143.37 30.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.162 1.385 . . . . 0.0 112.986 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 74.5 mt -146.09 135.46 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.519 2.328 . . . . 0.0 107.587 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -60.4 154.6 53.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 111.506 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.97 -1.75 8.37 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.288 1.992 . . . . 0.0 116.672 -163.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -133.4 17.34 4.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.266 1.826 . . . . 0.0 111.439 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.2 -29.39 72.8 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 121.355 -0.841 . . . . 0.0 114.531 -165.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.6 mt -85.95 129.37 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.761 1.624 . . . . 0.0 108.671 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.0 m -121.05 131.18 54.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.267 1.827 . . . . 0.0 111.458 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -120.24 92.24 47.01 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 127.152 2.181 . . . . 0.0 110.106 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.86 -86.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.352 2.701 . . . . 0.0 112.442 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.8 172.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 128.141 2.577 . . . . 0.0 110.941 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.77 174.53 5.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.747 2.019 . . . . 0.0 113.027 167.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.07 -6.4 1.28 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.868 3.712 . . . . 0.0 117.52 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -115.28 -14.16 11.69 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.685 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.04 12.45 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.35 -1.25 . . . . 0.0 115.124 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -125.13 -16.77 5.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.719 1.759 . . . . 0.0 112.261 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 152' ' ' THR 0.314 0.0 OUTLIER -140.74 -100.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -170.021 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.2 OUTLIER 166.16 83.89 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 130.511 3.524 . . . . 0.0 107.909 -165.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -113.03 -16.34 8.52 Favored Glycine 0 N--CA 1.47 0.959 1 C-N-CA 130.863 4.078 . . . . 0.0 113.585 176.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.68 163.95 25.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.726 1.61 . . . . 0.0 110.133 159.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.73 172.99 9.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.233 3.013 . . . . 0.0 107.213 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.648 ' CD2' HG12 ' A' ' 191' ' ' VAL . 90.3 m-85 -149.22 162.7 39.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 -167.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.45 120.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 43.2 tp60 -90.71 126.15 35.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.856 2.063 . . . . 0.0 108.779 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.0 m-85 -84.43 -167.82 1.93 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.425 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.85 -11.29 59.8 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.018 -1.676 . . . . 0.0 112.407 166.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.0 m -161.17 165.14 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.837 1.255 . . . . 0.0 112.856 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -61.06 -31.33 70.99 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.425 1.49 . . . . 0.0 113.077 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 31.5 tp10 -75.22 -48.05 25.29 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.975 2.11 . . . . 0.0 112.914 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 67.5 mt -57.54 -37.31 72.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.931 1.293 . . . . 0.0 110.697 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.2 -18.51 63.92 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -92.1 -32.89 14.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.636 1.574 . . . . 0.0 109.979 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -65.49 -36.1 82.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.435 1.494 . . . . 0.0 109.322 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.498 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.09 -43.16 88.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.545 1.938 . . . . 0.0 115.019 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -57.94 -19.73 32.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.12 -20.78 29.33 Favored Glycine 0 CA--C 1.548 2.118 0 C-N-CA 124.779 1.18 . . . . 0.0 114.579 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -71.09 43.84 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.099 2.16 . . . . 0.0 112.129 158.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -40.05 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.086 1.754 . . . . 0.0 113.937 -163.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -130.95 124.73 31.68 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.76 1.624 . . . . 0.0 107.525 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.0 -166.19 2.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.013 0.925 . . . . 0.0 110.959 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -129.27 149.3 51.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.265 1.426 . . . . 0.0 112.184 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.461 HG22 ' CD ' ' A' ' 119' ' ' PRO . 4.0 mt -139.69 120.27 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 129.015 2.926 . . . . 0.0 106.716 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 60.04 -123.39 32.94 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -90.14 -9.86 46.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -175.07 2.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.997 1.319 . . . . 0.0 113.357 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -154.1 115.71 4.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -126.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.531 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.8 mt -129.51 142.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.309 1.052 . . . . 0.0 112.094 -141.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.335 5.1 tp10 -89.04 163.88 15.31 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 129.465 3.106 . . . . 0.0 112.914 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 m -138.32 143.94 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.441 -0.787 . . . . 0.0 112.811 166.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.46 149.67 41.27 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.29 1.836 . . . . 0.0 110.605 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -68.32 152.78 44.95 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.615 0.766 . . . . 0.0 111.681 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.49 170.55 22.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.627 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.24 160.53 43.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.801 1.64 . . . . 0.0 111.275 166.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 tp-100 -42.68 5.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 131.722 4.009 . . . . 0.0 120.168 178.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.55 -17.84 3.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.441 -2.037 . . . . 0.0 114.707 168.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.56 -26.65 32.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.599 1.56 . . . . 0.0 108.691 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.648 HG12 ' CD2' ' A' ' 156' ' ' PHE . 17.5 m . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 128.056 2.542 . . . . 0.0 116.327 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.19 53.61 0.65 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.698 1.999 . . . . 0.0 114.246 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.03 97.86 0.46 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.686 1.136 . . . . 0.0 110.913 161.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 191' ' ' VAL . 11.2 m-85 -108.15 163.82 12.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 1.8 t -137.76 150.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.661 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -121.14 143.72 48.95 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.058 1.343 . . . . 0.0 112.329 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.54 153.16 27.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.391 2.676 . . . . 0.0 111.124 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.22 71.47 0.51 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.052 1.741 . . . . 0.0 110.176 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.46 0.0 0.03 OUTLIER Glycine 0 N--CA 1.475 1.261 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -165.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -77.63 153.33 81.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 0.0 111.824 -165.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.84 171.85 11.5 Favored 'Trans proline' 0 CA--C 1.532 0.382 1 C-N-CA 126.704 4.936 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.37 123.02 16.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.933 0.893 . . . . 0.0 112.438 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 83.29 12.77 78.16 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.342 -174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.461 ' SG ' HG21 ' A' ' 176' ' ' ILE . 31.3 t -58.51 151.9 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.958 1.879 . . . . 0.0 112.712 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.3 t -148.06 165.12 31.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.655 0.782 . . . . 0.0 111.763 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -42.09 -49.84 4.76 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.315 2.246 . . . . 0.0 112.417 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' HG13 ' A' ' 128' ' ' VAL . 3.3 mp0 -63.1 -14.19 45.49 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -85.92 -26.79 25.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.731 -1.856 . . . . 0.0 109.938 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.24 -39.72 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.956 -0.465 . . . . 0.0 112.075 160.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.287 1.3 m -57.46 -18.52 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -97.7 -26.17 14.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.286 1.403 . . . . 0.0 114.124 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -62.67 -41.46 99.1 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.832 1.253 . . . . 0.0 111.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -121.89 33.77 5.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.484 1.114 . . . . 0.0 113.067 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -21.63 8.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.63 -0.668 . . . . 0.0 112.607 157.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.65 -33.44 41.65 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.93 1.729 . . . . 0.0 114.965 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.0 167.46 21.19 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.554 1.542 . . . . 0.0 112.067 -158.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.43 140.14 29.77 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.866 -1.146 . . . . 0.0 111.739 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 45.1 mt -135.48 136.57 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.531 2.732 . . . . 0.0 107.831 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.07 152.08 84.82 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 118.958 -0.544 . . . . 0.0 111.408 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.77 -14.66 11.1 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.947 3.098 . . . . 0.0 119.967 -165.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -128.54 19.94 6.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.145 1.378 . . . . 0.0 111.759 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.55 -27.42 61.09 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.961 1.144 . . . . 0.0 115.961 -163.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 128' ' ' VAL . 70.4 mt -92.05 137.63 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 125.955 1.702 . . . . 0.0 109.738 -168.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.4 m -132.49 137.65 47.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.416 1.462 . . . . 0.0 113.465 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.29 90.06 50.87 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 127.192 2.197 . . . . 0.0 112.149 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.09 -63.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.103 1.202 . . . . 0.0 114.203 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.43 179.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 129.994 3.318 . . . . 0.0 108.081 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.502 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.3 p-10 -74.51 170.68 13.98 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 119.64 -1.913 . . . . 0.0 113.686 156.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.82 -0.61 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.727 3.618 . . . . 0.0 116.873 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -130.18 0.92 4.67 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.594 1.558 . . . . 0.0 111.556 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.01 39.4 23.98 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.119 1.207 . . . . 0.0 116.119 163.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -122.92 -25.55 4.57 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.496 1.518 . . . . 0.0 111.422 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 152' ' ' THR 0.274 0.0 OUTLIER -149.05 -111.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.417 -1.277 . . . . 0.0 113.231 -157.115 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -179.0 78.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 129.75 3.22 . . . . 0.0 108.576 -166.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.502 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -130.65 7.55 5.86 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 127.901 2.667 . . . . 0.0 114.384 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -136.44 160.41 38.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.123 1.369 . . . . 0.0 109.244 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -171.04 176.78 3.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.735 1.614 . . . . 0.0 110.549 -169.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.509 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.1 m-85 -148.37 159.58 43.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.408 1.083 . . . . 0.0 110.418 -171.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -163.48 124.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -94.14 132.48 38.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.042 2.137 . . . . 0.0 110.844 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.2 m-85 -92.73 -172.77 3.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.662 0.385 . . . . 0.0 110.701 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.35 -12.34 60.24 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.215 -1.553 . . . . 0.0 113.033 168.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.7 m -159.39 162.35 35.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.421 1.088 . . . . 0.0 113.202 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.42 -34.04 70.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.032 0.933 . . . . 0.0 113.015 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -71.49 -47.17 57.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.087 2.155 . . . . 0.0 112.782 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.24 -34.67 74.01 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.528 1.131 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.81 -16.93 60.02 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.151 0.501 . . . . 0.0 112.238 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -85.72 -33.13 21.57 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.389 -1.444 . . . . 0.0 109.363 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -36.79 85.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.778 1.631 . . . . 0.0 110.098 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -61.58 -47.0 87.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.26 1.824 . . . . 0.0 115.424 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 mp -48.89 -27.56 3.17 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.65 -13.54 51.54 Favored Glycine 0 CA--C 1.545 1.952 0 C-N-CA 125.06 1.314 . . . . 0.0 115.386 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -64.98 -22.91 67.07 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.463 1.631 . . . . 0.0 114.455 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 41.51 -53.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 1 C-N-CA 131.92 4.088 . . . . 0.0 119.742 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -145.42 19.26 1.54 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.311 2.244 . . . . 0.0 112.694 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.81 -179.67 0.29 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -119.64 155.76 31.71 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -161.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -139.74 131.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 130.061 3.344 . . . . 0.0 106.145 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.44 -85.36 0.01 OUTLIER Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.938 1.256 . . . . 0.0 113.368 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -147.06 13.98 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.405 1.882 . . . . 0.0 112.234 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -124.29 178.65 5.25 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.944 2.097 . . . . 0.0 111.19 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -149.92 91.27 1.77 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 123.231 1.491 . . . . 0.0 109.66 -113.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.504 ' CD1' HD12 ' A' ' 176' ' ' ILE . 6.6 mt -102.55 139.5 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.186 -141.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.69 151.26 45.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.334 2.254 . . . . 0.0 112.633 165.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.73 136.68 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.424 0.69 . . . . 0.0 112.075 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -142.74 150.53 40.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 109.884 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -61.36 152.47 29.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.935 0.894 . . . . 0.0 110.417 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.3 m -152.61 171.64 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.722 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -153.38 155.65 36.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.486 1.515 . . . . 0.0 111.16 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp-100 -35.22 -1.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 1 C-N-CA 133.496 4.718 . . . . 0.0 120.17 177.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -117.85 -28.38 5.96 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 119.881 -1.762 . . . . 0.0 112.961 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -84.2 -19.96 33.14 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.628 -1.295 . . . . 0.0 109.745 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 112' ' ' PHE . 21.2 m . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 128.185 2.594 . . . . 0.0 112.922 -165.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.892 0.853 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.33 50.59 1.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.739 -158.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -70.76 91.89 0.43 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 127.446 2.451 . . . . 0.0 112.03 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 191' ' ' VAL . 18.7 m-85 -99.0 166.81 11.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.1 t -146.81 128.07 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.899 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 66.1 ttt180 -104.0 138.73 40.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.254 1.022 . . . . 0.0 111.244 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 153.19 23.4 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.409 2.683 . . . . 0.0 109.531 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -155.07 81.22 1.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 109.782 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.77 -5.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.081 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -168.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.651 HD13 ' SG ' ' A' ' 122' ' ' CYS . 0.3 OUTLIER -78.38 148.92 74.8 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.856 1.262 . . . . 0.0 111.119 -161.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 83.2 Cg_endo -80.42 170.75 15.65 Favored 'Trans proline' 0 N--CA 1.462 -0.37 1 C-N-CA 126.595 4.864 . . . . 0.0 113.056 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -53.75 118.44 3.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.555 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.61 66.53 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.304 -1.276 . . . . 0.0 115.73 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 118' ' ' LEU . 6.2 t -55.35 149.75 12.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.317 2.059 . . . . 0.0 112.257 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.4 164.15 33.35 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.454 1.102 . . . . 0.0 111.249 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.4 ttmt -43.69 -43.34 5.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.457 2.303 . . . . 0.0 113.164 173.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' A' ' 128' ' ' VAL . 36.5 mp0 -69.36 -18.0 63.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.949 1.299 . . . . 0.0 114.334 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 47.0 mm-40 -77.97 -27.59 49.2 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 119.709 -1.87 . . . . 0.0 110.458 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.421 HD12 HD21 ' A' ' 143' ' ' LEU . 19.9 mt -69.61 -36.83 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 110.465 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.274 1.4 m -63.57 -15.89 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.479 1.111 . . . . 0.0 113.701 169.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.1 pp0? -96.73 -25.04 15.67 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.529 1.513 . . . . 0.0 114.142 165.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.61 -46.96 88.29 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.423 1.489 . . . . 0.0 110.782 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -119.98 35.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.322 1.049 . . . . 0.0 112.509 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.6 p -49.6 -24.8 2.36 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 155.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.03 -33.3 68.74 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.058 1.789 . . . . 0.0 115.353 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -139.29 160.45 39.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 113.139 -155.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.52 136.39 33.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 112.438 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 48.2 mt -135.71 137.69 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 129.633 3.173 . . . . 0.0 107.911 -171.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.07 151.88 79.45 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.821 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.19 -23.06 21.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 N-CA-C 120.952 3.405 . . . . 0.0 120.952 -158.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 39.52 2.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.604 1.162 . . . . 0.0 110.13 167.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.97 -25.42 9.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.219 1.39 . . . . 0.0 114.936 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' CD1' HG12 ' A' ' 128' ' ' VAL . 63.2 mt -85.82 133.47 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.273 1.829 . . . . 0.0 109.631 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.1 m -129.18 136.62 50.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.078 1.751 . . . . 0.0 112.455 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.421 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -124.97 91.76 48.81 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 127.198 2.199 . . . . 0.0 111.142 -169.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 -79.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 123.366 2.711 . . . . 0.0 113.634 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.26 168.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 129.224 3.01 . . . . 0.0 109.737 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.515 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.4 p-10 -80.61 171.74 11.56 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.966 1.706 . . . . 0.0 114.118 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.49 -1.16 0.19 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 124.973 3.782 . . . . 0.0 117.478 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -127.83 0.3 6.02 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.975 1.71 . . . . 0.0 111.795 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 39.43 68.21 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 115.796 1.079 . . . . 0.0 115.796 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -127.82 -17.15 4.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.859 1.664 . . . . 0.0 112.005 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.57 HG23 ' H ' ' A' ' 152' ' ' THR 0.307 0.0 OUTLIER -141.51 -104.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.296 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.57 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.5 OUTLIER 172.56 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.352 3.461 . . . . 0.0 108.525 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.515 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -123.41 2.52 9.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 128.714 3.054 . . . . 0.0 114.373 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.53 162.8 23.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.152 0.476 . . . . 0.0 109.726 142.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.89 177.2 5.1 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 127.036 2.135 . . . . 0.0 110.274 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.78 ' CD1' HG12 ' A' ' 191' ' ' VAL . 87.9 m-85 -148.88 160.28 43.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.037 0.935 . . . . 0.0 110.923 -166.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -162.29 121.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 40.4 tp60 -90.19 132.74 35.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.838 2.055 . . . . 0.0 110.006 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.2 m-85 -89.12 -158.54 0.51 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.908 0.483 . . . . 0.0 110.197 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.47 -9.15 59.55 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 119.852 -1.78 . . . . 0.0 112.904 156.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.6 m -162.45 159.11 24.67 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.508 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 21.4 mm-40 -56.18 -30.99 63.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.158 1.383 . . . . 0.0 113.723 166.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -53.07 20.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.601 1.56 . . . . 0.0 111.414 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.64 -36.88 72.43 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.19 1.396 . . . . 0.0 111.319 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -72.94 -16.08 61.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.57 -32.14 15.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.526 1.53 . . . . 0.0 110.444 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -61.57 -40.04 93.31 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 125.787 1.635 . . . . 0.0 110.508 167.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -59.33 -47.24 86.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.24 1.816 . . . . 0.0 114.162 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -55.82 -20.18 14.24 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -62.34 -14.29 47.52 Favored Glycine 0 CA--C 1.547 2.054 0 C-N-CA 124.646 1.117 . . . . 0.0 115.016 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -63.16 -27.52 69.43 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.324 1.562 . . . . 0.0 113.442 162.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.77 -42.01 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 1 C-N-CA 133.191 4.596 . . . . 0.0 120.166 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -153.49 36.83 0.46 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.305 1.442 . . . . 0.0 112.053 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.02 -174.04 0.22 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.621 1.168 . . . . 0.0 114.041 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.31 148.96 44.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.372 1.469 . . . . 0.0 112.682 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.577 HD12 HD22 ' A' ' 118' ' ' LEU . 1.3 mt -138.47 131.52 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 129.283 3.033 . . . . 0.0 105.798 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 54.41 -99.89 0.07 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.148 1.356 . . . . 0.0 112.33 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -118.36 -5.15 10.84 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.24 1.416 . . . . 0.0 113.532 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.71 -172.43 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.241 1.816 . . . . 0.0 112.49 -169.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -151.09 109.71 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.991 -132.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.563 HG12 HD23 ' A' ' 118' ' ' LEU . 3.6 mp -124.27 128.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 122.783 1.278 . . . . 0.0 112.371 -139.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 160.58 13.23 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 127.559 2.344 . . . . 0.0 114.268 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.63 141.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.332 0.653 . . . . 0.0 112.433 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.81 142.75 31.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.198 1.799 . . . . 0.0 110.794 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 17.8 tptm -66.98 146.24 54.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.679 174.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -150.83 168.79 23.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.647 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.5 m -147.5 165.37 30.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.531 1.532 . . . . 0.0 110.761 164.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.54 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.7 tp60 -35.98 1.7 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 1 C-N-CA 133.32 4.648 . . . . 0.0 119.87 177.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -118.26 -30.26 5.31 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.636 -1.915 . . . . 0.0 112.669 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.662 -1.274 . . . . 0.0 109.611 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 156' ' ' PHE . 18.9 m . . . . . 0 C--N 1.332 -0.189 0 C-N-CA 127.585 2.354 . . . . 0.0 114.622 -153.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.8 p30 . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.37 36.91 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.181 3.793 . . . . 0.0 114.181 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -58.51 83.36 0.01 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 127.064 2.268 . . . . 0.0 113.602 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 158' ' ' GLN . 3.3 m-85 -92.31 160.53 15.08 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 168.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.08 113.13 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.736 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.341 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 77.3 ttt180 -89.02 131.02 35.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 123.459 0.704 . . . . 0.0 111.492 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.42 152.96 18.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 128.751 2.821 . . . . 0.0 110.438 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -157.84 70.92 0.59 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.91 1.284 . . . . 0.0 109.419 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.48 1.92 0.03 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 -162.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.8 mt -79.4 153.89 76.56 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 119.186 1.493 . . . . 0.0 112.434 -162.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.87 175.06 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 1 C-N-CA 125.759 4.306 . . . . 0.0 113.299 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -67.15 132.08 47.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.204 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.64 70.07 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 117.694 -1.615 . . . . 0.0 115.71 -171.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.25 149.38 20.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 120.392 2.096 . . . . 0.0 113.517 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.4 p -135.0 164.1 28.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.1 1.76 . . . . 0.0 111.82 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 128' ' ' VAL . 28.0 ttmt -48.56 -42.33 33.17 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 126.448 1.899 . . . . 0.0 112.449 166.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 121.193 1.815 . . . . 0.0 113.792 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -75.43 -31.68 60.43 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.658 -1.901 . . . . 0.0 110.0 167.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.481 HD12 HD21 ' A' ' 143' ' ' LEU . 49.1 mt -67.45 -39.04 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.496 0.718 . . . . 0.0 111.183 167.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 141' ' ' ILE . 1.9 m -62.17 -17.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.376 1.07 . . . . 0.0 112.964 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -96.05 -31.92 12.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.874 1.216 . . . . 0.0 112.719 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.46 -41.66 90.23 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.066 1.746 . . . . 0.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.87 33.39 5.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.918 1.287 . . . . 0.0 113.771 170.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.1 p -52.21 -22.2 4.12 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 157.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.22 -32.96 30.05 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.156 1.836 . . . . 0.0 115.212 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.66 166.49 24.22 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.888 1.275 . . . . 0.0 112.876 -156.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.57 137.53 32.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.68 1.592 . . . . 0.0 111.377 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 72.1 mt -138.62 137.64 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 128.221 2.608 . . . . 0.0 106.824 -170.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -60.39 153.55 58.83 Favored Pre-proline 0 N--CA 1.486 1.365 0 CA-C-N 118.643 0.656 . . . . 0.0 111.447 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.02 -21.06 20.19 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 120.927 3.395 . . . . 0.0 120.927 -159.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.74 40.9 2.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.791 1.178 . . . . 0.0 109.993 167.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.17 -14.71 6.31 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.148 1.356 . . . . 0.0 116.38 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 128' ' ' VAL . 76.2 mt -103.27 123.69 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 125.372 1.469 . . . . 0.0 109.384 -165.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.8 m -115.8 130.59 56.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.085 2.554 . . . . 0.0 112.695 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.76 78.78 56.64 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 127.014 2.126 . . . . 0.0 111.724 -170.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.27 -58.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.372 1.381 . . . . 0.0 113.249 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -178.3 173.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 130.681 3.592 . . . . 0.0 107.961 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.52 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.9 p-10 -69.63 169.44 12.49 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 120.236 -1.54 . . . . 0.0 113.747 159.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.41 2.59 0.1 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.931 3.754 . . . . 0.0 117.319 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -128.41 -2.76 5.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.555 1.542 . . . . 0.0 112.094 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.62 26.24 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -131.39 -15.52 3.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.415 1.607 . . . . 0.0 112.728 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.449 HG23 ' H ' ' A' ' 152' ' ' THR 0.29 0.0 OUTLIER -143.67 -114.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.738 1.215 . . . . 0.0 113.226 -170.134 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.449 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.24 75.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 129.342 3.057 . . . . 0.0 108.141 -167.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.52 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -125.25 4.68 8.27 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 127.561 2.505 . . . . 0.0 114.702 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.86 164.06 26.9 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.497 0.719 . . . . 0.0 109.972 150.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -172.34 168.98 5.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 126.834 2.054 . . . . 0.0 110.029 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 97.0 m-85 -141.25 152.62 44.69 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.582 0.753 . . . . 0.0 109.673 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.23 123.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 136' ' ' ILE . 39.3 tp60 -90.79 122.77 33.81 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.954 2.102 . . . . 0.0 110.344 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 5.1 m-85 -83.23 -165.55 1.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.576 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.79 -12.39 60.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.177 -1.577 . . . . 0.0 112.159 162.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.3 m -161.54 162.65 30.32 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.993 0.917 . . . . 0.0 113.411 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.466 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.67 -8.01 55.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.85 -53.2 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.324 2.25 . . . . 0.0 111.81 172.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.06 -37.89 67.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.026 1.73 . . . . 0.0 111.285 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.33 -15.84 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.68 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.46 -25.36 15.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.267 -1.521 . . . . 0.0 110.864 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.05 -41.08 97.51 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.323 1.449 . . . . 0.0 109.853 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.444 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -60.52 -46.29 90.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.548 1.939 . . . . 0.0 115.808 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.5 mp -48.19 -21.48 0.5 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 165.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.48 -10.02 59.45 Favored Glycine 0 CA--C 1.544 1.864 0 C-N-CA 123.965 0.793 . . . . 0.0 113.697 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -59.59 -32.82 70.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.228 1.411 . . . . 0.0 114.321 164.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.6 -56.51 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 131.196 3.799 . . . . 0.0 119.0 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -148.17 24.31 1.04 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.289 1.836 . . . . 0.0 113.443 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.61 179.4 0.12 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.772 1.629 . . . . 0.0 113.731 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 149.65 45.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.342 1.457 . . . . 0.0 111.799 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -92.39 -16.64 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.5 1.12 . . . . 0.0 112.77 175.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.62 -41.96 0.08 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.394 1.473 . . . . 0.0 112.607 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -149.66 -42.04 0.14 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.312 1.445 . . . . 0.0 112.854 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -86.14 174.55 9.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.109 0.957 . . . . 0.0 111.753 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.73 97.49 3.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.937 -126.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 176' ' ' ILE . 5.3 mt -99.78 119.48 47.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.733 -148.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 153.25 42.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.149 1.78 . . . . 0.0 112.372 163.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 132.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.499 0.719 . . . . 0.0 110.947 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -135.61 144.74 46.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.917 1.687 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 19.1 tptm -69.15 142.0 54.47 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.594 0.711 . . . . 0.0 110.41 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 m -150.38 164.12 36.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.09 -167.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 73.6 m -135.39 160.75 37.47 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.731 1.212 . . . . 0.0 110.916 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -46.66 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.768 1 C-N-CA 132.39 4.276 . . . . 0.0 118.148 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -128.67 -28.73 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.204 -1.56 . . . . 0.0 113.03 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.46 -23.48 62.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.859 -1.151 . . . . 0.0 110.564 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.465 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 1.7 p . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 124.676 1.191 . . . . 0.0 113.261 170.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -120.3 34.76 5.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.476 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 77.89 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 127.035 2.255 . . . . 0.0 113.353 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.621 ' CD1' HG11 ' A' ' 191' ' ' VAL . 7.3 m-85 -99.49 156.96 16.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.1 108.72 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.678 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -86.05 124.84 32.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.609 0.763 . . . . 0.0 111.444 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 181' ' ' ILE . 1.4 mm? -85.33 152.47 23.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.976 2.11 . . . . 0.0 110.808 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -155.1 76.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.263 1.425 . . . . 0.0 109.324 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.35 -11.01 0.02 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -161.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 13.0 mt -73.44 156.08 89.13 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -152.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 86.4 Cg_endo -78.4 169.69 19.62 Favored 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 125.634 4.223 . . . . 0.0 112.543 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.23 125.96 28.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.68 24.54 75.39 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.739 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 36.2 t -54.96 154.49 5.26 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.277 1.538 . . . . 0.0 112.773 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.1 t -147.31 164.41 33.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.047 0.927 . . . . 0.0 112.144 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 128' ' ' VAL . 32.0 ttmt -45.55 -40.64 8.93 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 127.055 2.142 . . . . 0.0 113.126 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -69.87 -16.7 63.29 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 121.596 1.998 . . . . 0.0 113.999 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -76.92 -35.09 57.57 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 120.043 -1.661 . . . . 0.0 109.327 166.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 143' ' ' LEU . 51.9 mt -64.1 -40.29 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.036 0.835 . . . . 0.0 111.141 169.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.5 m -65.77 -16.52 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.897 1.279 . . . . 0.0 112.683 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -94.94 -31.48 13.63 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.94 1.245 . . . . 0.0 112.425 164.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.86 -38.23 75.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.188 1.795 . . . . 0.0 111.593 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 23.9 m-85 -122.15 35.93 4.76 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.482 1.513 . . . . 0.0 112.68 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -64.37 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.173 1.463 . . . . 0.0 108.864 153.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.8 -48.04 0.08 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.795 -151.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.1 157.9 45.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.988 1.315 . . . . 0.0 112.09 -160.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB2' HD13 ' A' ' 164' ' ' LEU . 44.9 mt-10 -76.73 131.28 38.67 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.645 -0.659 . . . . 0.0 111.193 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 55.1 mt -131.08 132.26 63.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.832 2.453 . . . . 0.0 107.183 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.09 151.4 80.98 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.923 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.94 -16.89 12.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.069 3.179 . . . . 0.0 119.133 -165.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -122.95 16.43 10.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.593 1.557 . . . . 0.0 111.598 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.58 70.73 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 -159.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -95.17 134.77 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 124.856 1.262 . . . . 0.0 109.743 -166.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.4 m -133.44 133.55 42.46 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.575 1.55 . . . . 0.0 112.685 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -126.27 96.47 36.49 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 127.695 2.398 . . . . 0.0 111.326 -173.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.73 -81.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.078 1.852 . . . . 0.0 113.831 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.25 167.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 128.899 2.88 . . . . 0.0 109.991 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -70.86 170.65 10.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.493 1.917 . . . . 0.0 114.645 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.61 0.61 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 124.907 3.738 . . . . 0.0 117.576 170.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -126.91 -0.46 6.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.776 1.63 . . . . 0.0 111.928 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.28 37.32 54.75 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -129.16 -15.63 4.15 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.192 1.496 . . . . 0.0 112.37 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.442 HG23 ' H ' ' A' ' 152' ' ' THR 0.299 0.0 OUTLIER -141.67 -105.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.571 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 170.96 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.981 3.312 . . . . 0.0 107.983 -166.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.81 -1.45 5.9 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 129.942 3.639 . . . . 0.0 114.476 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -131.8 158.63 40.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.473 149.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.61 -179.47 3.38 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.339 2.256 . . . . 0.0 108.472 -167.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 191' ' ' VAL . 98.4 m-85 -152.01 157.65 42.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.789 0.436 . . . . 0.0 111.273 -167.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.52 125.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -90.8 127.0 36.19 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.937 2.095 . . . . 0.0 111.266 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.5 m-85 -92.11 -173.16 3.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.342 1.057 . . . . 0.0 110.313 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.97 -13.17 60.84 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.212 -1.555 . . . . 0.0 113.064 166.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.4 m -160.24 159.97 32.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.477 1.111 . . . . 0.0 113.347 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -60.69 -21.43 62.86 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.416 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 29.0 tp10 -78.96 -50.32 11.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.681 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 135' ' ' GLU . 80.3 mt -57.07 -36.8 70.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.518 1.127 . . . . 0.0 111.13 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.58 -20.86 63.64 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.975 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -91.06 -29.77 17.14 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.237 -1.54 . . . . 0.0 110.317 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -62.15 -34.08 75.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.916 0.886 . . . . 0.0 109.197 167.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.553 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -72.72 -42.63 63.95 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.2 mp -49.09 -31.88 8.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 120.615 1.552 . . . . 0.0 113.143 160.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -57.76 -16.47 23.86 Favored Glycine 0 CA--C 1.547 2.057 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 170.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -69.14 -19.72 64.02 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.171 1.986 . . . . 0.0 113.758 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 47.97 -65.51 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 130.969 3.708 . . . . 0.0 118.303 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -150.48 33.36 0.63 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.283 1.833 . . . . 0.0 112.484 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.83 -157.95 0.1 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.006 1.322 . . . . 0.0 113.312 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -135.35 149.11 49.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.895 2.078 . . . . 0.0 112.49 -169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.491 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -106.1 -17.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -170.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.16 -39.66 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.409 1.957 . . . . 0.0 111.58 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -151.7 -44.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.688 . . . . 0.0 111.773 169.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.7 177.97 5.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.441 1.096 . . . . 0.0 112.44 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.31 113.82 14.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.12 1.768 . . . . 0.0 109.891 -128.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 2.8 mt -121.16 111.83 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.57 1.652 . . . . 0.0 111.809 -146.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 150.94 33.64 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.206 -2.724 . . . . 0.0 112.494 158.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.17 123.16 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 110.204 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -119.63 146.45 45.54 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.683 1.593 . . . . 0.0 109.543 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -66.15 136.03 55.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -144.68 172.14 13.41 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -166.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 37.9 m -152.08 148.81 28.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.298 1.839 . . . . 0.0 109.729 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -31.29 -16.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 1 C-N-CA 132.147 4.179 . . . . 0.0 118.459 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -112.58 -16.71 12.79 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.91 1.684 . . . . 0.0 111.625 -168.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -80.48 -30.75 37.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 156.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 187' ' ' SER . 4.2 m . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -163.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.76 55.26 1.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.129 2.172 . . . . 0.0 112.179 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.23 95.13 0.57 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.093 1.33 . . . . 0.0 111.363 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.8 m-85 -99.69 164.35 12.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.92 113.49 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.369 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 68.5 ttt180 -89.87 115.07 26.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.922 0.889 . . . . 0.0 110.455 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.66 146.53 53.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.317 157.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.82 151.09 48.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 140.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.9 -13.6 0.76 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.173 -1.579 . . . . 0.0 113.857 159.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.582 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 10.4 mt -67.91 153.21 95.61 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -141.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 89.7 Cg_endo -73.09 171.21 18.03 Favored 'Trans proline' 0 C--N 1.346 0.416 1 C-N-CA 126.754 4.969 . . . . 0.0 112.368 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -68.71 132.74 47.35 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.093 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.59 25.22 62.98 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.647 -168.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 118' ' ' LEU . 37.9 t -54.14 149.18 9.9 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.503 1.652 . . . . 0.0 113.124 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 t -145.54 161.17 40.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.738 1.256 . . . . 0.0 112.044 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.7 ttmt -46.71 -37.72 8.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 127.774 2.43 . . . . 0.0 113.496 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -71.74 -19.54 62.02 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 121.083 1.765 . . . . 0.0 114.041 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.88 -31.91 57.11 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 120.208 -1.558 . . . . 0.0 109.156 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.441 HD12 HD21 ' A' ' 143' ' ' LEU . 59.7 mt -68.73 -39.09 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.522 0.729 . . . . 0.0 111.338 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.9 m -65.43 -16.07 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.961 1.304 . . . . 0.0 112.803 173.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -95.67 -28.77 14.65 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.315 0.962 . . . . 0.0 112.794 164.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.4 t80 -61.45 -44.85 96.39 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.751 1.62 . . . . 0.0 111.011 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -118.53 34.99 4.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.357 1.463 . . . . 0.0 113.091 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.6 p -50.08 -24.02 2.45 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 155.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.64 -33.23 54.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.437 1.97 . . . . 0.0 115.673 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.1 mp -138.28 161.76 36.08 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.215 1.007 . . . . 0.0 113.092 -156.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.01 132.73 33.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.143 1.377 . . . . 0.0 112.321 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 53.2 mt -133.27 138.26 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 128.995 2.918 . . . . 0.0 108.13 -172.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.81 152.0 87.75 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.784 -0.573 . . . . 0.0 111.513 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.65 -14.69 10.76 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.026 3.151 . . . . 0.0 120.013 -165.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.59 21.85 5.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.308 1.443 . . . . 0.0 111.544 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.79 -24.57 57.68 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -166.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 66.7 mt -94.5 130.73 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.187 1.395 . . . . 0.0 109.539 -167.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.9 m -124.62 132.0 53.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.058 1.743 . . . . 0.0 112.744 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.441 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -121.85 87.46 46.68 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 127.715 2.406 . . . . 0.0 110.412 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 -86.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.985 1.79 . . . . 0.0 112.646 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.22 156.98 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 128.945 2.898 . . . . 0.0 109.104 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.523 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 1.3 p-10 -64.28 178.24 0.47 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.001 3.321 . . . . 0.0 115.031 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.02 1.11 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.491 0 C-N-CA 124.48 3.453 . . . . 0.0 117.368 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -133.74 -32.84 1.1 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.279 1.854 . . . . 0.0 113.511 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.9 40.18 1.6 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.583 1.563 . . . . 0.0 114.911 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -132.35 -15.14 2.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 113.007 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -161.86 -163.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 127.793 2.437 . . . . 0.0 107.99 -168.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.641 ' H ' HD13 ' A' ' 151' ' ' ILE . 11.3 p -122.61 30.26 6.55 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 123.273 2.76 . . . . 0.0 112.988 -170.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -53.43 1.33 0.03 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.159 2.79 . . . . 0.0 117.245 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.25 152.59 38.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.095 0.95 . . . . 0.0 111.138 158.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.8 176.34 7.17 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 127.742 2.417 . . . . 0.0 108.938 -163.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.57 ' CD2' HG12 ' A' ' 191' ' ' VAL . 92.7 m-85 -149.42 163.41 37.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.709 -166.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.7 127.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 112' ' ' PHE . 46.1 tp60 -96.17 131.07 43.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.484 2.314 . . . . 0.0 110.3 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.2 m-85 -94.74 -168.43 1.82 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.289 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.2 -10.4 59.63 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.88 -1.763 . . . . 0.0 113.311 163.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 m -159.22 158.11 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.077 0.951 . . . . 0.0 113.096 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -57.13 -26.54 60.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.684 1.594 . . . . 0.0 114.483 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -54.8 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.822 1.649 . . . . 0.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.68 -37.81 66.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.85 1.66 . . . . 0.0 111.539 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.468 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.83 -17.2 64.43 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -110.3 -16.45 13.73 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.283 -1.511 . . . . 0.0 111.852 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.76 -38.69 86.1 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.963 0.905 . . . . 0.0 110.281 155.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.35 -44.04 80.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -51.09 -27.85 9.22 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.93 -1.106 . . . . 0.0 113.75 165.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.92 -14.85 32.78 Favored Glycine 0 CA--C 1.547 2.076 0 C-N-CA 125.262 1.411 . . . . 0.0 115.592 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -65.44 -17.66 64.72 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.886 1.843 . . . . 0.0 114.585 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 37.27 -47.57 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 C-N-CA 132.967 4.507 . . . . 0.0 120.982 171.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 19.5 1.11 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.166 1.787 . . . . 0.0 113.843 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -59.89 179.48 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.6 ttp85 -119.33 149.15 42.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.112 2.965 . . . . 0.0 109.043 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.47 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -115.88 -29.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.494 1.118 . . . . 0.0 113.041 -173.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -171.56 -112.02 0.27 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 127.074 2.273 . . . . 0.0 108.139 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -39.52 84.75 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.795 1.298 . . . . 0.0 113.151 164.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -177.87 3.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.462 1.505 . . . . 0.0 114.973 -164.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.685 1.594 . . . . 0.0 108.261 -140.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 5.1 mt -128.4 136.5 59.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.814 1.292 . . . . 0.0 112.362 -142.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.253 3.3 mp0 -83.13 156.42 23.27 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 130.589 3.556 . . . . 0.0 112.456 164.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.63 133.07 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.945 0.898 . . . . 0.0 111.091 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.24 144.75 47.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.967 1.707 . . . . 0.0 109.759 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -75.51 139.2 42.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.74 1.216 . . . . 0.0 110.703 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.7 m -149.39 166.77 28.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.741 -158.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 m -143.58 148.01 35.27 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.805 1.642 . . . . 0.0 108.798 165.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -13.79 -18.61 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 135.259 5.423 . . . . 0.0 120.642 169.104 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -122.46 -6.19 8.73 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 120.356 -1.465 . . . . 0.0 111.715 -167.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -76.51 -21.64 55.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.641 153.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 156' ' ' PHE . 3.8 m . . . . . 0 C--N 1.344 0.36 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -149.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.604 0.716 . . . . 0.0 112.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.75 43.58 0.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 112.571 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.18 99.08 0.85 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.858 1.218 . . . . 0.0 111.218 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.688 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.7 m-85 -97.12 163.09 13.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 167.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.79 115.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.582 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -92.32 137.35 32.44 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.126 0.97 . . . . 0.0 112.79 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.62 151.16 23.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.236 2.614 . . . . 0.0 110.86 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -157.62 75.08 0.77 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.021 1.728 . . . . 0.0 108.599 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.67 -6.95 0.03 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -163.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 2.0 mt -77.46 153.89 81.6 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-N 118.18 0.99 . . . . 0.0 113.653 -157.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 90.7 Cg_endo -81.1 173.85 11.43 Favored 'Trans proline' 0 C--N 1.344 0.335 1 C-N-CA 126.937 5.091 . . . . 0.0 113.312 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -62.9 131.2 47.93 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.876 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.482 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 68.57 19.22 72.71 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 117.955 -1.469 . . . . 0.0 115.597 -172.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.8 t -56.56 149.23 17.82 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 120.14 1.97 . . . . 0.0 113.842 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.0 t -143.73 161.59 38.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.553 1.168 . . . . 0.0 112.806 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.647 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.4 ttmt -44.92 -42.4 8.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.598 2.759 . . . . 0.0 114.074 172.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.48 -21.36 66.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 121.25 1.841 . . . . 0.0 114.307 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -79.37 -33.32 42.98 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 119.787 -1.821 . . . . 0.0 109.674 170.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.499 HD12 HD21 ' A' ' 143' ' ' LEU . 66.7 mt -62.8 -38.67 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.456 -0.778 . . . . 0.0 111.038 166.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 124' ' ' LYS 0.268 1.1 m -68.34 -12.46 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 113.702 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.62 -27.29 14.88 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.673 1.124 . . . . 0.0 113.355 161.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -64.12 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.122 1.769 . . . . 0.0 111.266 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -120.84 34.61 5.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.833 1.653 . . . . 0.0 112.786 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -50.93 -22.62 2.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 156.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.6 -35.14 51.14 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.787 1.661 . . . . 0.0 115.301 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.5 156.46 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.201 1.0 . . . . 0.0 112.575 -149.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.3 140.51 33.55 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.224 -0.922 . . . . 0.0 112.098 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 47.7 mt -136.04 137.7 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 128.269 2.627 . . . . 0.0 107.524 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -62.18 153.05 76.5 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.29 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.51 -8.51 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.525 3.483 . . . . 0.0 120.607 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -140.13 21.76 2.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.871 2.068 . . . . 0.0 111.516 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.8 -16.98 53.46 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 61.6 mt -105.35 134.74 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 119.081 1.44 . . . . 0.0 109.497 -163.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.3 m -129.57 135.43 48.57 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.564 1.545 . . . . 0.0 112.773 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -123.01 86.07 50.92 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 127.033 2.133 . . . . 0.0 111.369 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 155' ' ' ALA . 65.6 Cg_endo -71.93 -66.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.338 2.025 . . . . 0.0 113.46 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.88 -179.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 130.188 3.395 . . . . 0.0 108.306 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -77.02 170.08 18.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 119.149 -2.219 . . . . 0.0 114.169 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -55.97 2.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 125.227 3.951 . . . . 0.0 117.198 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -127.65 2.28 6.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.603 1.561 . . . . 0.0 111.729 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.86 34.97 51.82 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.363 -1.243 . . . . 0.0 116.203 164.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -132.68 -14.35 2.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.654 1.727 . . . . 0.0 112.835 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 121' ' ' GLY 0.279 0.0 OUTLIER -143.85 -110.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 117.475 -1.25 . . . . 0.0 113.574 -168.642 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -178.78 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 130.088 3.355 . . . . 0.0 107.486 -167.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -137.84 1.3 2.84 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 129.258 3.313 . . . . 0.0 113.876 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -138.15 162.35 34.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.7 1.6 . . . . 0.0 109.445 159.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . . . -173.73 -178.7 1.64 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.509 1.924 . . . . 0.0 110.733 -168.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.503 ' CD1' HG12 ' A' ' 191' ' ' VAL . 96.9 m-85 -153.71 152.99 31.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.694 1.198 . . . . 0.0 110.315 -168.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.42 127.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -91.51 133.81 35.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.555 2.342 . . . . 0.0 110.328 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.6 m-85 -97.44 -175.38 3.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.846 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.51 58.56 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.707 -1.246 . . . . 0.0 113.191 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.0 m -166.4 158.57 13.87 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 111.998 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -84.71 50.16 1.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.125 1.37 . . . . 0.0 110.272 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.6 -55.07 0.56 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.15 2.98 . . . . 0.0 108.485 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 49.3 mt -54.41 -41.49 69.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.749 2.02 . . . . 0.0 111.65 164.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.52 -18.46 65.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.63 -29.15 15.6 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.794 -1.192 . . . . 0.0 109.15 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -66.12 -36.84 84.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.301 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.87 -39.03 87.41 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 165' ' ' ALA . 2.6 mp -51.27 -24.36 4.41 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 120.744 -1.223 . . . . 0.0 113.974 162.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -66.36 -17.46 66.32 Favored Glycine 0 CA--C 1.546 2.006 0 C-N-CA 124.98 1.276 . . . . 0.0 115.191 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -75.16 15.59 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.195 1.997 . . . . 0.0 115.605 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -51.82 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 130.317 3.447 . . . . 0.0 119.507 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.68 17.59 0.9 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.214 1.805 . . . . 0.0 114.222 -169.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -114.21 -170.8 1.79 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.059 1.344 . . . . 0.0 112.592 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.05 151.36 47.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.883 2.073 . . . . 0.0 110.977 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.23 -38.05 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.131 1.372 . . . . 0.0 112.695 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -156.41 -78.92 0.02 OUTLIER Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.951 1.262 . . . . 0.0 110.517 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -108.18 -18.84 13.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.407 1.083 . . . . 0.0 113.466 169.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -128.05 -178.06 4.38 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.14 1.776 . . . . 0.0 113.639 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -149.8 117.25 6.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -119.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.4 mt -123.96 129.26 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 123.537 1.637 . . . . 0.0 112.95 -138.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.16 153.18 36.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.843 2.857 . . . . 0.0 112.798 165.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.76 134.69 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 111.897 171.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -137.99 153.67 49.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.292 1.837 . . . . 0.0 110.258 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -75.03 145.99 41.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.386 0.675 . . . . 0.0 111.656 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.4 m -153.11 168.46 25.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 124.112 0.883 . . . . 0.0 111.728 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 67.2 m -149.62 158.3 44.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.422 1.489 . . . . 0.0 110.504 168.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.401 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp60 -33.43 -0.85 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 1 C-N-CA 134.019 4.928 . . . . 0.0 119.926 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.91 -10.89 3.42 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 119.951 -1.718 . . . . 0.0 113.519 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.96 -29.97 28.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 112' ' ' PHE . 34.9 m . . . . . 0 N--CA 1.456 -0.173 0 C-N-CA 124.718 1.207 . . . . 0.0 112.97 -158.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.256 4.5 p-10 -75.05 52.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.43 1.492 . . . . 0.0 113.628 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.03 99.64 1.3 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.686 2.088 . . . . 0.0 111.574 170.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.607 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -107.91 165.43 11.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.74 117.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.819 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -89.02 135.67 33.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.48 151.88 24.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.026 2.53 . . . . 0.0 110.467 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -157.66 76.13 0.8 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.098 1.759 . . . . 0.0 108.64 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.54 -13.2 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.756 1.462 . . . . 0.0 116.756 -163.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 181' ' ' ILE . 0.4 OUTLIER -76.5 151.13 82.84 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 118.422 1.111 . . . . 0.0 112.846 -153.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.82 175.13 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.271 1 C-N-CA 125.621 4.214 . . . . 0.0 113.431 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -68.47 134.44 50.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.87 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.38 14.7 67.06 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 117.935 -1.481 . . . . 0.0 115.179 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.91 151.48 18.1 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.412 2.106 . . . . 0.0 112.862 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.1 t -146.49 166.23 27.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.563 1.173 . . . . 0.0 111.45 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -47.49 -43.78 24.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 127.415 2.286 . . . . 0.0 112.488 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HA ' HG13 ' A' ' 128' ' ' VAL . 40.6 mp0 -67.17 -18.77 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.568 1.531 . . . . 0.0 113.846 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -79.73 -25.36 41.13 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 119.498 -2.001 . . . . 0.0 110.807 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 143' ' ' LEU . 52.6 mt -71.6 -36.54 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.484 0.714 . . . . 0.0 111.009 164.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.269 1.7 m -60.91 -18.73 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.326 168.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -97.82 -25.13 15.15 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.693 1.588 . . . . 0.0 113.347 165.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.88 -42.95 94.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.834 0.853 . . . . 0.0 110.333 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -117.74 42.04 2.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.529 1.131 . . . . 0.0 113.896 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.0 p -67.58 64.77 0.08 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.966 1.365 . . . . 0.0 110.822 154.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.32 -41.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.34 1.447 . . . . 0.0 112.178 -156.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.38 154.47 48.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.226 1.81 . . . . 0.0 110.785 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.11 140.53 45.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.114 0.965 . . . . 0.0 112.431 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.3 mt -143.9 131.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 128.903 2.881 . . . . 0.0 107.072 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.76 152.72 74.72 Favored Pre-proline 0 N--CA 1.486 1.373 0 CA-C-O 118.723 -0.655 . . . . 0.0 111.301 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.15 -25.47 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 120.287 3.149 . . . . 0.0 120.287 -160.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -133.36 41.75 3.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.631 1.173 . . . . 0.0 110.432 166.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.82 -29.14 49.5 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.028 1.299 . . . . 0.0 114.576 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 128' ' ' VAL . 71.8 mt -89.6 131.51 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 125.77 1.628 . . . . 0.0 109.342 -169.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -129.46 132.32 46.91 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.4 1.88 . . . . 0.0 112.888 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 127' ' ' ILE . 3.7 mm? -127.7 92.13 43.57 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 126.981 2.112 . . . . 0.0 112.373 -166.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.32 -65.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.605 1.536 . . . . 0.0 114.352 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.8 177.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 129.43 3.092 . . . . 0.0 109.094 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.573 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.3 p-10 -81.23 172.07 10.66 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 120.006 -1.684 . . . . 0.0 114.273 163.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.11 -0.34 0.28 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 125.019 3.813 . . . . 0.0 117.166 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -127.76 -0.91 6.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 111.786 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.66 39.68 48.13 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.34 -17.18 3.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.956 1.703 . . . . 0.0 112.307 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.559 HG23 ' H ' ' A' ' 152' ' ' THR 0.298 0.0 OUTLIER -143.49 -112.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -169.633 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.559 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.84 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.644 3.178 . . . . 0.0 109.161 -167.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.573 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -113.96 6.3 23.78 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.993 2.711 . . . . 0.0 114.413 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -134.41 157.53 46.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.852 1.261 . . . . 0.0 108.926 157.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.32 -178.93 3.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.206 1.402 . . . . 0.0 110.665 -167.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.625 ' CD1' HG12 ' A' ' 191' ' ' VAL . 95.6 m-85 -152.87 157.71 41.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.524 1.13 . . . . 0.0 109.421 -169.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.68 120.76 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 45.6 tp60 -83.18 135.43 34.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.546 1.938 . . . . 0.0 109.693 170.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.5 m-85 -92.39 -157.43 0.52 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.434 0.693 . . . . 0.0 110.335 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.04 59.26 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 120.131 -1.606 . . . . 0.0 112.335 157.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.65 166.99 31.38 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 4.7 tp60 -61.28 -16.92 50.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.759 1.623 . . . . 0.0 114.638 165.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -48.03 3.76 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.844 1.657 . . . . 0.0 111.232 -166.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.29 -37.19 23.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.686 1.194 . . . . 0.0 111.957 161.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -71.21 -23.12 61.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -88.03 -32.38 18.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.775 2.03 . . . . 0.0 110.329 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.67 -40.69 88.59 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 126.207 1.803 . . . . 0.0 110.346 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.13 -43.44 82.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 114.444 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -54.99 -21.34 11.56 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.8 -12.84 7.25 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 125.138 1.351 . . . . 0.0 115.213 172.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -53.57 -46.88 70.45 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.403 1.602 . . . . 0.0 113.175 161.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 51.03 -52.87 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.847 3.659 . . . . 0.0 117.0 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -147.27 106.72 3.91 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.507 2.323 . . . . 0.0 108.652 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.67 -166.7 2.19 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.639 1.176 . . . . 0.0 112.125 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -130.81 152.14 50.48 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.92 1.691 . . . . 0.0 114.088 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.401 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -99.93 -22.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.639 1.176 . . . . 0.0 112.845 173.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -178.44 -52.83 0.07 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.545 1.069 . . . . 0.0 112.755 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 -10.85 0.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.25 1.42 . . . . 0.0 114.49 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -123.8 -179.86 4.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.242 1.417 . . . . 0.0 112.427 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.68 108.77 5.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.601 -1.636 . . . . 0.0 107.696 -118.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.574 HD13 HD22 ' A' ' 118' ' ' LEU . 3.0 mt -117.33 116.57 52.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 123.138 1.447 . . . . 0.0 110.232 -144.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.15 156.16 25.94 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 128.852 2.861 . . . . 0.0 113.161 165.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.97 132.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.651 0.781 . . . . 0.0 111.36 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.28 144.43 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.146 1.778 . . . . 0.0 110.017 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -72.49 152.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.706 -0.622 . . . . 0.0 111.289 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.66 170.08 20.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.009 -160.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.7 m -155.72 162.48 40.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.216 1.806 . . . . 0.0 111.783 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.8 tp-100 -37.34 5.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 1 C-N-CA 133.118 4.567 . . . . 0.0 120.245 177.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.56 2.17 1.23 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 168.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.73 -20.39 21.6 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.701 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.625 HG12 ' CD1' ' A' ' 156' ' ' PHE . 34.5 m . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 128.302 2.641 . . . . 0.0 112.805 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.66 42.95 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.286 2.234 . . . . 0.0 112.275 173.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.431 ' HA2' ' CD ' ' A' ' 162' ' ' GLN . . . -53.06 99.24 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 128.15 2.786 . . . . 0.0 114.818 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.55 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.0 m-85 -116.84 161.3 19.52 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.859 1.329 . . . . 0.0 108.593 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.4 125.73 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.109 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt85 -94.08 142.36 27.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 0.0 111.227 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.89 154.66 21.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.044 2.538 . . . . 0.0 110.589 172.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -156.19 78.29 0.95 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 110.711 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.53 -15.36 0.02 OUTLIER Glycine 0 CA--C 1.544 1.844 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -65.28 159.15 68.36 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 128.444 2.698 . . . . 0.0 116.897 -153.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 74.0 Cg_endo -82.83 167.94 14.26 Favored 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 126.186 4.591 . . . . 0.0 113.988 -173.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -69.59 98.22 1.13 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.511 2.325 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.664 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 97.72 23.51 13.64 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.394 1.473 . . . . 0.0 114.704 -168.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.3 t -53.2 152.89 4.06 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.191 1.995 . . . . 0.0 113.879 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 t -143.64 159.57 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.114 0.959 . . . . 0.0 112.331 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -44.08 -46.43 8.55 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.609 1.963 . . . . 0.0 112.097 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' HG13 ' A' ' 128' ' ' VAL . 39.4 mp0 -65.61 -12.54 54.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.911 1.685 . . . . 0.0 114.717 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -82.65 -33.19 27.85 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 119.995 -1.691 . . . . 0.0 108.873 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.49 -40.19 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.909 -0.494 . . . . 0.0 111.987 164.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.262 1.4 m -58.19 -22.02 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.605 170.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.72 -25.55 17.39 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.462 1.483 . . . . 0.0 113.012 169.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.1 t80 -62.35 -49.48 75.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.685 1.194 . . . . 0.0 110.08 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.57 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 36.8 m-85 -113.14 31.88 6.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.736 1.214 . . . . 0.0 112.69 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -53.43 -20.96 5.27 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 157.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.75 43.74 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.989 1.757 . . . . 0.0 115.724 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.03 173.92 11.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 112.925 -156.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.1 118.93 33.66 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.39 1.476 . . . . 0.0 111.922 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.3 mt -118.29 135.23 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 128.885 2.874 . . . . 0.0 107.546 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.97 153.27 85.26 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.008 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.16 -13.83 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.662 1 N-CA-C 122.651 4.058 . . . . 0.0 122.651 -160.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -134.22 12.55 3.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.654 1.57 . . . . 0.0 111.906 172.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.87 -12.66 1.25 Allowed Glycine 0 N--CA 1.48 1.589 0 C-N-CA 128.016 2.722 . . . . 0.0 119.315 -150.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.448 ' CD1' HG12 ' A' ' 128' ' ' VAL . 66.9 mt -95.57 135.3 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 127.214 2.205 . . . . 0.0 109.826 -166.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.5 m -122.98 136.21 54.77 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.558 1.526 . . . . 0.0 113.381 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.38 97.33 40.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 127.64 2.376 . . . . 0.0 111.595 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.43 -86.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.429 2.086 . . . . 0.0 113.643 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.41 177.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 130.407 3.483 . . . . 0.0 107.972 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.527 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 6.7 p-10 -74.68 175.12 4.22 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.613 1.965 . . . . 0.0 114.669 171.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.55 -6.86 1.74 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.908 3.739 . . . . 0.0 117.789 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -118.08 -30.79 5.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.113 1.779 . . . . 0.0 111.342 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 111.41 37.5 1.61 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.927 161.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.82 -2.86 4.69 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.918 1.287 . . . . 0.0 113.506 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.664 HD11 ' H ' ' A' ' 121' ' ' GLY 0.302 0.0 OUTLIER -140.68 -100.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.501 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.4 OUTLIER 164.84 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.918 3.687 . . . . 0.0 108.785 -164.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.527 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.16 11.28 10.74 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 128.673 3.035 . . . . 0.0 114.707 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -140.41 158.99 43.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.946 1.698 . . . . 0.0 108.079 155.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.31 -179.86 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.689 1.996 . . . . 0.0 109.267 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -151.89 160.49 43.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.143 0.977 . . . . 0.0 110.031 -169.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -160.54 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.428 HE22 ' N ' ' A' ' 111' ' ' GLY . 67.9 tp60 -87.25 138.85 31.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.367 2.267 . . . . 0.0 111.575 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.3 m-85 -109.36 -175.67 2.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.496 1.518 . . . . 0.0 110.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.18 -10.2 59.52 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 119.396 -2.065 . . . . 0.0 113.025 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 m -161.87 158.7 25.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.589 1.156 . . . . 0.0 112.889 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.431 ' CD ' ' HA2' ' A' ' 111' ' ' GLY . 4.9 tp-100 -72.5 0.61 9.89 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.473 1.509 . . . . 0.0 113.696 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.75 -49.24 5.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.352 1.861 . . . . 0.0 111.429 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.3 mt -55.03 -36.57 65.65 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.754 1.222 . . . . 0.0 111.925 167.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.26 67.28 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.95 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -90.97 -27.62 18.56 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.659 1.584 . . . . 0.0 110.663 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -59.83 -36.43 76.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.884 1.273 . . . . 0.0 110.012 165.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.57 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -73.21 -39.77 65.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.312 1.845 . . . . 0.0 115.685 172.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -33.27 56.98 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.181 -1.574 . . . . 0.0 112.183 162.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.55 -13.7 8.15 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.832 1.682 . . . . 0.0 115.706 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -59.1 -39.12 81.25 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.4 1.6 . . . . 0.0 113.135 164.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.83 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 130.559 3.543 . . . . 0.0 117.954 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.77 119.84 4.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.364 1.465 . . . . 0.0 110.981 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -151.37 -147.28 0.22 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.321 1.449 . . . . 0.0 110.691 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.1 ttp85 -147.65 148.02 30.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.775 2.83 . . . . 0.0 109.643 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -114.71 -35.97 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.861 1.264 . . . . 0.0 111.585 -170.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -147.32 -117.94 1.02 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.413 1.958 . . . . 0.0 108.788 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -42.58 98.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.974 1.387 . . . . 0.0 111.954 162.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -95.94 -177.77 4.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.235 1.014 . . . . 0.0 113.708 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.514 ' C ' HD12 ' A' ' 181' ' ' ILE . 5.6 m-85 -133.98 116.94 16.13 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.065 2.146 . . . . 0.0 109.78 -144.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 118' ' ' LEU . 1.9 mp -122.84 157.42 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.789 1.757 . . . . 0.0 111.918 -149.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.262 1.1 mm-40 -128.2 159.42 35.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 130.992 3.717 . . . . 0.0 110.186 -164.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.69 142.61 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.28 150.14 35.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.097 2.159 . . . . 0.0 109.921 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -82.02 151.59 27.05 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.234 -0.916 . . . . 0.0 112.51 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 m -158.58 165.44 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.959 -161.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.35 156.48 42.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.749 1.619 . . . . 0.0 111.173 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.534 ' HA ' HG21 ' A' ' 191' ' ' VAL . 4.2 tp60 -40.81 2.94 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 1 C-N-CA 133.873 4.869 . . . . 0.0 120.269 -175.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -126.34 -22.24 4.05 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 119.772 -1.83 . . . . 0.0 112.247 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.48 -2.05 52.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.348 1.459 . . . . 0.0 110.558 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 156' ' ' PHE . 10.7 m . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 128.752 2.821 . . . . 0.0 113.15 -160.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.72 44.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 130.223 3.409 . . . . 0.0 113.744 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.22 95.41 0.43 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.824 2.154 . . . . 0.0 110.25 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 191' ' ' VAL . 2.9 m-85 -105.49 161.62 14.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.72 121.82 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.118 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 36.5 ttt85 -94.4 133.66 37.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.445 1.098 . . . . 0.0 111.381 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.28 152.42 19.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.365 1.866 . . . . 0.0 111.994 167.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 135.33 39.08 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 146.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 166.03 -18.81 0.1 OUTLIER Glycine 0 CA--C 1.531 1.086 0 O-C-N 119.823 -1.798 . . . . 0.0 113.77 152.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.543 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.4 mt -55.52 148.6 33.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.284 3.034 . . . . 0.0 115.335 -152.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.72 175.59 11.1 Favored 'Trans proline' 0 C--N 1.344 0.294 1 C-N-CA 126.35 4.7 . . . . 0.0 112.796 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -66.75 135.09 53.46 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.491 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.3 57.89 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-O 117.929 -1.484 . . . . 0.0 114.959 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 118' ' ' LEU . 35.4 t -57.24 151.43 15.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.037 1.918 . . . . 0.0 112.18 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 165.09 28.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 123.177 1.465 . . . . 0.0 112.267 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 128' ' ' VAL . 26.0 ttmt -44.99 -40.6 6.58 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 127.872 2.469 . . . . 0.0 113.534 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -70.39 -17.88 63.04 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 121.317 1.871 . . . . 0.0 114.027 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.09 -31.99 56.35 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 119.894 -1.754 . . . . 0.0 108.96 168.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 143' ' ' LEU . 52.5 mt -68.69 -38.1 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.155 -0.966 . . . . 0.0 111.815 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -63.72 -17.11 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.748 1.219 . . . . 0.0 112.924 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -23.7 15.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.11 1.323 . . . . 0.0 112.129 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 176' ' ' ILE . 9.9 t80 -61.22 -49.38 77.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.047 1.339 . . . . 0.0 109.777 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.86 33.23 5.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.443 1.497 . . . . 0.0 112.698 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 90.9 p -50.17 -22.03 1.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 156.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -49.49 -37.75 26.55 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.085 1.802 . . . . 0.0 115.347 168.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.04 168.01 20.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.428 1.091 . . . . 0.0 113.65 -153.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.62 128.6 36.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.914 1.685 . . . . 0.0 112.019 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 65.1 mt -128.8 134.81 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.659 2.784 . . . . 0.0 107.418 -174.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.2 m -65.19 154.03 88.06 Favored Pre-proline 0 N--CA 1.484 1.226 0 O-C-N 121.81 -0.556 . . . . 0.0 111.544 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.38 -7.33 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.239 3.293 . . . . 0.0 119.814 -169.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -127.35 12.97 7.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.004 1.322 . . . . 0.0 112.209 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.53 72.03 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -152.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.454 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 64.1 mt -93.93 132.23 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.832 1.253 . . . . 0.0 109.335 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.8 m -124.08 132.87 53.71 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.806 1.642 . . . . 0.0 112.67 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.511 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -121.95 93.13 48.75 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 127.511 2.324 . . . . 0.0 110.921 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.31 -65.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.235 1.29 . . . . 0.0 113.162 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.71 175.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 129.72 3.208 . . . . 0.0 109.163 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.514 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 11.0 p-10 -72.95 171.6 9.93 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 119.818 -1.801 . . . . 0.0 114.316 160.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.18 2.48 0.13 Allowed 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 124.729 3.619 . . . . 0.0 117.151 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -128.62 -1.32 5.48 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.686 1.594 . . . . 0.0 112.008 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.25 36.07 28.29 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -132.42 -16.22 2.74 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.713 1.756 . . . . 0.0 112.792 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -141.97 -112.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.508 -170.468 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.438 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.2 p -177.86 80.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.871 3.268 . . . . 0.0 107.433 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.56 5.59 6.64 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 128.151 2.786 . . . . 0.0 115.429 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.17 161.87 36.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.512 1.525 . . . . 0.0 108.365 157.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.43 -179.53 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.924 1.689 . . . . 0.0 109.063 -166.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.7 m-85 -153.4 158.76 41.95 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.342 0.657 . . . . 0.0 110.25 -167.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -158.54 123.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -92.47 129.92 38.28 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 127.557 2.343 . . . . 0.0 110.99 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.4 m-85 -97.87 -168.5 1.68 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 110.046 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.02 -10.23 59.5 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.024 -1.672 . . . . 0.0 113.733 165.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.9 m -162.65 158.33 23.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -69.99 43.79 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.829 2.452 . . . . 0.0 112.831 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -149.82 -56.53 0.18 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.613 1.965 . . . . 0.0 110.252 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.1 mt -54.2 -41.66 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.418 1.487 . . . . 0.0 111.339 163.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -70.21 -12.47 61.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -31.06 12.53 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.572 -1.33 . . . . 0.0 109.656 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -63.62 -35.36 80.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.951 1.3 . . . . 0.0 109.537 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.5 73.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.215 1.806 . . . . 0.0 115.544 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.7 mp -52.62 -32.64 42.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.536 -1.353 . . . . 0.0 113.279 164.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.6 -11.87 11.77 Favored Glycine 0 CA--C 1.546 1.984 0 C-N-CA 125.573 1.558 . . . . 0.0 115.631 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -59.21 -38.26 79.48 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.187 1.494 . . . . 0.0 113.474 165.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.79 -60.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 129.527 3.131 . . . . 0.0 116.423 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 105.19 4.55 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.897 2.079 . . . . 0.0 110.754 -174.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -145.58 -163.25 1.68 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.184 1.794 . . . . 0.0 110.335 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.23 44.76 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 128.651 2.781 . . . . 0.0 109.283 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.464 HD12 ' CD1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -123.77 -39.93 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.145 0.578 . . . . 0.0 111.509 -165.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.66 -98.56 0.48 Allowed Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.801 1.667 . . . . 0.0 109.956 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -46.28 14.64 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.799 1.3 . . . . 0.0 112.132 162.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -95.28 -178.1 4.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.919 1.288 . . . . 0.0 114.13 -167.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.502 ' C ' HD12 ' A' ' 181' ' ' ILE . 6.1 m-85 -132.78 125.68 30.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 110.568 -143.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.502 HD12 ' C ' ' A' ' 180' ' ' TYR . 1.8 mp -125.06 134.42 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 123.447 1.594 . . . . 0.0 112.553 -147.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.07 157.25 35.09 Favored 'General case' 0 CA--C 1.538 0.489 1 C-N-CA 132.127 4.171 . . . . 0.0 114.251 164.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.86 136.59 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.228 1.011 . . . . 0.0 111.463 168.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -138.91 151.64 47.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.076 2.151 . . . . 0.0 109.139 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -90.52 143.73 26.46 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.493 -0.754 . . . . 0.0 111.72 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -149.95 165.96 31.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.607 -157.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.12 160.26 42.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.107 1.763 . . . . 0.0 110.534 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.0 tp60 -40.51 4.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 1 C-N-CA 133.478 4.711 . . . . 0.0 119.021 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.66 -15.18 5.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.769 2.028 . . . . 0.0 114.028 -175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -114.3 -19.96 11.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.511 2.325 . . . . 0.0 110.109 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 112' ' ' PHE . 19.2 m . . . . . 0 CA--C 1.518 -0.27 0 C-N-CA 129.883 3.273 . . . . 0.0 114.31 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.49 51.15 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.477 1.132 . . . . 0.0 113.381 -163.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.26 89.6 0.9 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 126.169 1.842 . . . . 0.0 110.985 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CG ' HG11 ' A' ' 191' ' ' VAL . 5.0 m-85 -95.27 164.58 12.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.76 120.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 76.4 ttt180 -95.39 136.94 35.12 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.583 0.753 . . . . 0.0 111.95 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.67 148.89 26.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.653 2.781 . . . . 0.0 109.775 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -154.11 78.28 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 109.383 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 179.9 -3.81 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.5 OUTLIER -79.88 151.43 73.57 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 118.61 1.205 . . . . 0.0 112.117 -161.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.441 ' CG ' HG22 ' A' ' 176' ' ' ILE . 95.8 Cg_endo -80.17 174.91 10.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 1 C-N-CA 126.598 4.865 . . . . 0.0 113.715 -177.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.35 127.68 32.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.732 1.213 . . . . 0.0 111.42 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 71.7 14.84 75.47 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 117.959 -1.467 . . . . 0.0 115.681 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.486 ' SG ' HG21 ' A' ' 176' ' ' ILE . 29.5 t -58.0 152.48 16.33 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.366 2.083 . . . . 0.0 112.543 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.23 164.24 32.9 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 122.847 1.308 . . . . 0.0 111.371 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -45.08 -42.91 9.13 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 127.799 2.44 . . . . 0.0 112.919 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 128' ' ' VAL . 37.4 mp0 -68.92 -18.52 64.11 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.669 1.577 . . . . 0.0 113.893 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.65 -25.57 45.01 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.62 -1.925 . . . . 0.0 110.671 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.422 HD12 HD21 ' A' ' 143' ' ' LEU . 48.6 mt -73.06 -37.14 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.724 0.81 . . . . 0.0 110.995 165.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.261 2.2 m -59.92 -20.89 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.266 1.026 . . . . 0.0 113.151 169.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -93.5 -28.59 16.0 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.909 1.231 . . . . 0.0 113.448 168.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.87 -45.81 91.3 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.394 1.477 . . . . 0.0 111.168 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -116.17 33.51 5.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.625 1.17 . . . . 0.0 113.108 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.0 p -53.3 -22.49 7.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.79 -32.49 40.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.297 1.903 . . . . 0.0 115.232 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.73 169.71 17.31 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.18 1.392 . . . . 0.0 112.172 -157.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -99.62 136.26 39.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.372 1.469 . . . . 0.0 112.166 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.4 mt -134.19 139.12 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 128.887 2.875 . . . . 0.0 108.79 -168.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.7 152.13 76.3 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.667 -0.646 . . . . 0.0 110.887 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.85 -24.05 22.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -158.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.09 40.5 2.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.935 1.294 . . . . 0.0 109.872 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.61 16.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.15 1.357 . . . . 0.0 115.674 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 128' ' ' VAL . 65.5 mt -93.17 126.44 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 125.27 1.428 . . . . 0.0 109.451 -169.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.5 m -121.92 132.18 54.41 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.039 1.736 . . . . 0.0 112.869 -174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.422 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.67 91.35 49.79 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.178 2.191 . . . . 0.0 111.483 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.44 -70.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 121.771 1.647 . . . . 0.0 113.655 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.91 169.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 129.516 3.127 . . . . 0.0 108.809 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.543 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.4 p-10 -70.52 170.74 9.68 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 165.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.6 0.06 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 124.838 3.692 . . . . 0.0 117.13 171.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -129.15 0.38 5.19 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.74 1.616 . . . . 0.0 111.814 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.03 37.82 42.3 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -130.24 -16.72 3.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.161 1.481 . . . . 0.0 112.657 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.509 HG23 ' H ' ' A' ' 152' ' ' THR 0.294 0.0 OUTLIER -143.09 -112.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 113.482 -169.425 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -177.77 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.419 3.087 . . . . 0.0 108.028 -166.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.543 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -122.97 5.56 9.62 Favored Glycine 0 N--CA 1.466 0.7 0 C-N-CA 127.84 2.638 . . . . 0.0 114.685 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.36 159.04 42.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.22 0.608 . . . . 0.0 109.982 152.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.18 178.26 3.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.261 1.825 . . . . 0.0 110.751 -165.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.686 ' CD1' HG12 ' A' ' 191' ' ' VAL . 92.0 m-85 -149.79 156.26 41.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.918 1.287 . . . . 0.0 109.283 -168.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.3 p -156.13 121.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 31.6 tp60 -90.0 129.8 36.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.544 1.938 . . . . 0.0 109.444 176.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.3 m-85 -86.96 -165.33 1.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.54 -14.6 60.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.965 -1.709 . . . . 0.0 112.307 161.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.7 m -158.66 163.9 36.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 6.1 mm-40 -56.78 -33.17 66.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.19 1.396 . . . . 0.0 114.679 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 28.6 tp10 -72.58 -50.18 27.21 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 111.915 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.12 -35.87 69.99 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.069 1.348 . . . . 0.0 111.264 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.51 -17.38 59.3 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.216 0.532 . . . . 0.0 112.262 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -87.09 -32.05 20.14 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.611 -1.305 . . . . 0.0 109.698 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -63.88 -35.77 81.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.392 1.477 . . . . 0.0 109.711 169.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.64 -43.47 89.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.167 1.787 . . . . 0.0 115.592 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 mp -50.03 -25.74 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.8 -16.34 30.72 Favored Glycine 0 CA--C 1.547 2.09 0 C-N-CA 124.858 1.218 . . . . 0.0 115.335 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -68.97 -14.51 63.08 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.49 1.645 . . . . 0.0 114.77 167.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 39.96 -48.64 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 132.407 4.283 . . . . 0.0 121.16 170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 15.79 0.66 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.324 1.85 . . . . 0.0 113.338 -173.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -55.09 174.27 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -110.75 155.68 22.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.652 1.581 . . . . 0.0 114.148 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.4 mt -132.96 169.1 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 130.972 3.709 . . . . 0.0 106.558 169.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 2.49 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.475 1.274 0 C-N-CA 129.774 3.559 . . . . 0.0 116.616 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 -2.86 4.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 171.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -134.38 -179.01 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.406 1.482 . . . . 0.0 114.959 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -144.05 111.16 5.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.426 -126.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.542 ' CD1' HD12 ' A' ' 176' ' ' ILE . 15.1 mt -115.51 129.01 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.436 1.112 . . . . 0.0 111.898 -139.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 153.24 41.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.553 2.341 . . . . 0.0 113.195 166.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.25 135.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.399 0.68 . . . . 0.0 111.657 167.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -139.25 143.48 38.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.149 1.78 . . . . 0.0 109.386 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 185' ' ' LYS . 16.8 tptm -75.35 136.91 40.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.725 0.774 . . . . 0.0 109.91 175.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 m -141.82 166.46 24.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.727 -164.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -143.5 157.18 44.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.91 0.884 . . . . 0.0 110.616 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.46 ' HA ' HG21 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -33.84 5.44 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.907 1 C-N-CA 134.945 5.298 . . . . 0.0 120.037 176.935 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -126.71 -22.45 3.89 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.09 -1.631 . . . . 0.0 112.851 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.51 -21.91 61.12 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.471 -1.393 . . . . 0.0 109.708 172.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 156' ' ' PHE . 20.8 m . . . . . 0 C--N 1.333 -0.144 0 C-N-CA 126.855 2.062 . . . . 0.0 113.447 -150.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.7 p30 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -52.66 41.68 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 1 C-N-CA 133.664 4.786 . . . . 0.0 116.371 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.12 90.17 0.06 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.931 1.253 . . . . 0.0 111.737 162.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.7 m-85 -107.5 160.75 15.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.36 116.02 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 73.5 ttt180 -88.39 120.17 29.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.362 1.065 . . . . 0.0 111.382 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.45 151.21 41.18 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.525 1.53 . . . . 0.0 111.648 162.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 139.9 44.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 148.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.5 -20.65 0.82 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.523 -1.361 . . . . 0.0 112.885 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.84 HD23 ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -58.18 142.91 80.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.514 1.926 . . . . 0.0 113.544 -156.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.28 165.7 27.33 Favored 'Trans proline' 0 N--CA 1.458 -0.576 1 C-N-CA 126.231 4.621 . . . . 0.0 112.131 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.54 116.79 4.6 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.317 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.33 59.76 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.615 -1.103 . . . . 0.0 115.549 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.45 ' SG ' HD22 ' A' ' 118' ' ' LEU . 21.6 t -56.06 148.34 17.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.984 1.892 . . . . 0.0 110.938 165.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 125' ' ' GLU . 8.8 t -144.32 171.05 14.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.952 0.882 . . . . 0.0 110.076 170.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.2 ttmt -41.31 -40.93 1.79 Allowed 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 127.438 2.295 . . . . 0.0 112.978 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HB2' HG23 ' A' ' 123' ' ' THR . 27.6 mp0 -58.52 -32.67 69.07 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.25 2.22 . . . . 0.0 116.069 173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -77.01 -23.33 52.2 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 119.958 -1.714 . . . . 0.0 110.157 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 143' ' ' LEU . 13.4 mt -74.78 -37.33 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.641 -0.662 . . . . 0.0 110.993 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -62.15 -17.26 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.126 1.37 . . . . 0.0 113.054 171.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -98.17 -25.28 14.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.62 1.1 . . . . 0.0 113.937 168.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.81 -45.86 91.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.057 1.343 . . . . 0.0 110.575 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -121.48 33.25 5.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.038 1.335 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -54.24 -19.4 5.19 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.769 -0.582 . . . . 0.0 112.49 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.68 -35.0 44.99 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.588 1.566 . . . . 0.0 115.496 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.34 163.56 31.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -153.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.84 139.25 32.78 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 112.84 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 75.4 mt -144.51 133.37 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.639 2.375 . . . . 0.0 107.24 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.89 153.35 54.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.636 -0.665 . . . . 0.0 111.438 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.69 -23.96 28.2 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 120.842 3.362 . . . . 0.0 120.842 -160.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.48 39.43 2.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.674 1.19 . . . . 0.0 109.95 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.8 -26.45 17.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.89 1.233 . . . . 0.0 114.812 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -84.1 132.44 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.662 1.585 . . . . 0.0 108.883 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 m -126.19 131.57 51.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.263 1.825 . . . . 0.0 112.124 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 127' ' ' ILE . 3.8 mm? -128.2 84.96 61.75 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 126.572 1.949 . . . . 0.0 112.61 -167.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.83 -69.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 121.825 1.684 . . . . 0.0 115.512 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.64 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 127.252 2.221 . . . . 0.0 111.651 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.553 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.0 p-10 -79.06 173.26 8.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.893 2.077 . . . . 0.0 114.845 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.45 -4.31 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 125.074 3.849 . . . . 0.0 117.844 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.42 -32.0 3.94 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 121.35 1.886 . . . . 0.0 111.785 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 109.02 40.26 1.57 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.235 0.922 . . . . 0.0 114.641 165.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.4 -3.13 4.35 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 113.106 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 152' ' ' THR 0.318 0.0 OUTLIER -141.7 -102.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.998 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.612 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 165.98 68.0 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.444 3.498 . . . . 0.0 108.687 -159.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -114.58 4.02 23.15 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 129.266 3.317 . . . . 0.0 116.226 172.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -127.29 163.5 23.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.234 1.016 . . . . 0.0 109.632 142.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.85 178.36 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.405 2.282 . . . . 0.0 108.154 -168.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.3 m-85 -150.42 160.59 43.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.582 0.753 . . . . 0.0 109.512 -167.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.02 121.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 136' ' ' ILE . 55.7 tp60 -92.69 123.87 36.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 127.222 2.209 . . . . 0.0 111.386 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 11.3 m-85 -86.99 -173.63 4.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.329 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.98 -8.74 57.94 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.224 -1.548 . . . . 0.0 113.105 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.6 m -160.39 161.29 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.566 1.147 . . . . 0.0 112.944 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -57.4 -31.24 65.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.212 1.405 . . . . 0.0 113.508 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -84.67 -42.78 14.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.523 1.529 . . . . 0.0 113.014 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.4 mt -54.69 -35.47 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.449 1.5 . . . . 0.0 111.411 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.23 -10.05 57.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.07 -13.81 11.2 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.322 -1.486 . . . . 0.0 112.004 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -62.32 -40.31 95.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.702 0.801 . . . . 0.0 109.2 153.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.47 79.03 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -50.58 -27.0 5.95 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.694 1.588 . . . . 0.0 114.287 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.89 -19.82 56.58 Favored Glycine 0 CA--C 1.546 1.991 0 C-N-CA 125.077 1.322 . . . . 0.0 114.798 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.59 41.64 0.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.717 2.007 . . . . 0.0 112.61 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -51.31 -30.48 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.697 2.399 . . . . 0.0 114.888 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -147.58 107.3 3.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.264 1.026 . . . . 0.0 111.051 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -137.64 -161.21 1.14 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.654 1.582 . . . . 0.0 109.927 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -140.75 148.04 40.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.065 1.346 . . . . 0.0 111.718 -155.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.01 132.72 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.319 2.248 . . . . 0.0 108.132 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 59.54 -67.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.419 0 C-N-CA 127.605 2.526 . . . . 0.0 115.831 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.8 -9.85 0.21 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.714 2.406 . . . . 0.0 113.566 169.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -108.53 -175.03 2.66 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 127.139 2.176 . . . . 0.0 112.765 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -149.63 116.74 6.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -135.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.84 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.8 mt -127.03 135.8 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 122.776 1.274 . . . . 0.0 111.771 -139.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.8 159.27 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 130.955 3.702 . . . . 0.0 114.348 169.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.04 137.44 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.923 1.289 . . . . 0.0 111.005 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -138.42 146.88 42.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.205 1.802 . . . . 0.0 109.806 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -70.82 142.84 51.27 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.782 1.233 . . . . 0.0 110.884 177.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.412 ' H ' ' HE2' ' A' ' 185' ' ' LYS . 3.3 m -153.79 161.88 41.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.357 -164.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.5 m -146.2 157.38 43.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.084 1.354 . . . . 0.0 111.148 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.489 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.3 tp60 -40.93 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.129 4.572 . . . . 0.0 119.674 -175.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 -16.0 3.91 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.976 -1.702 . . . . 0.0 114.369 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.44 -29.14 18.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.767 1.627 . . . . 0.0 108.915 173.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.632 HG11 ' CG ' ' A' ' 112' ' ' PHE . 35.7 m . . . . . 0 C--N 1.333 -0.133 0 C-N-CA 129.111 2.965 . . . . 0.0 115.42 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 119.928 -0.082 . . . . 10.0 110.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 m 42.59 -20.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 1 C-N-CA 132.951 4.501 . . . . 10.0 120.346 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.2 -30.09 0.06 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.44 2.296 . . . . 10.0 112.382 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.35 136.88 20.19 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.144 1.164 . . . . 10.0 114.144 -172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.9 p -147.25 -47.47 0.17 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 140.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -175.21 -41.93 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.32 1.848 . . . . 10.0 113.212 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -124.54 -32.31 3.14 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.385 1.624 . . . . 10.0 115.385 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -70.83 36.13 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.563 3.145 . . . . 10.0 114.934 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -61.39 101.36 0.32 Allowed Glycine 0 C--O 1.228 -0.229 0 CA-C-O 117.797 -1.557 . . . . 10.0 111.75 173.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.683 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -111.03 167.59 10.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.859 -1.904 . . . . 10.0 105.859 170.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.0 t -134.06 153.29 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.247 -1.797 . . . . 10.0 107.964 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 52.3 ttt180 -120.65 136.49 54.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.0 1.32 . . . . 10.0 111.959 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.88 147.19 29.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.409 3.084 . . . . 10.0 109.976 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -152.66 77.22 1.17 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.599 1.16 . . . . 10.0 109.936 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.07 9.4 0.02 OUTLIER Glycine 0 CA--C 1.532 1.125 0 N-CA-C 116.176 1.23 . . . . 10.0 116.176 -164.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.6 mt -80.44 155.41 74.04 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.797 1.239 . . . . 10.0 111.313 -166.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.511 ' CD ' HG22 ' A' ' 176' ' ' ILE . 23.8 Cg_endo -84.08 175.75 7.26 Favored 'Trans proline' 0 CA--C 1.532 0.384 1 C-N-CA 126.72 4.947 . . . . 10.0 112.489 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -63.98 135.17 56.24 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.421 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 69.58 15.1 70.47 Favored Glycine 0 CA--C 1.54 1.604 0 CA-C-O 118.247 -1.307 . . . . 10.0 115.585 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 176' ' ' ILE . 39.7 t -58.34 147.43 31.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.053 1.927 . . . . 10.0 112.78 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 171.86 16.68 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.028 0.918 . . . . 10.0 112.146 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 128' ' ' VAL . 6.7 mttm -38.44 -53.6 1.53 Allowed 'General case' 0 C--O 1.205 -1.237 0 CA-C-O 116.477 -1.725 . . . . 10.0 113.54 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.48 -19.76 63.89 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 121.585 1.993 . . . . 10.0 113.7 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -79.98 -29.39 39.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.16 -1.587 . . . . 10.0 110.767 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 143' ' ' LEU . 46.3 mt -73.12 -43.48 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.373 1.069 . . . . 10.0 111.17 168.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.3 m -56.64 -21.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.31 1.844 . . . . 10.0 113.303 169.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -96.39 -26.33 15.38 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.887 1.676 . . . . 10.0 112.37 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -58.81 -51.94 67.86 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.59 1.556 . . . . 10.0 109.864 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 39.8 m-85 -112.75 30.98 6.7 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.305 1.042 . . . . 10.0 112.841 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.5 p -53.23 -21.86 5.95 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.173 0.805 . . . . 10.0 113.173 156.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.3 -31.91 43.31 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 126.073 1.796 . . . . 10.0 115.208 169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.28 166.21 24.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.116 1.366 . . . . 10.0 112.875 -157.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.32 134.77 34.6 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.147 1.379 . . . . 10.0 111.649 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 71.2 mt -137.27 140.62 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 128.371 2.668 . . . . 10.0 106.978 -170.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.4 m -62.15 156.08 61.25 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.535 -0.728 . . . . 10.0 111.432 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -54.22 -19.24 16.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 N-CA-C 120.957 3.407 . . . . 10.0 120.957 -162.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.8 35.48 2.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.633 1.106 . . . . 10.0 110.657 166.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.12 45.3 0.58 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 126.692 2.091 . . . . 10.0 114.228 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 128' ' ' VAL . 86.3 mt -143.58 136.13 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 119.964 1.882 . . . . 10.0 106.012 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 17.1 m -132.52 131.54 41.71 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.24 1.836 . . . . 10.0 112.569 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 127' ' ' ILE . 2.9 mm? -124.94 84.06 59.23 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 127.263 2.225 . . . . 10.0 110.868 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.69 -65.18 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 121.081 1.188 . . . . 10.0 113.237 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.84 169.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 128.328 2.651 . . . . 10.0 110.149 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.1 p-10 -68.5 173.3 3.51 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.534 1.533 . . . . 10.0 114.778 164.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.37 -1.98 0.54 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.754 3.636 . . . . 10.0 117.624 172.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.72 -31.89 3.14 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 121.537 1.971 . . . . 10.0 112.28 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.04 37.66 1.22 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.88 -0.955 . . . . 10.0 115.445 163.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -135.34 -2.95 2.44 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.997 1.398 . . . . 10.0 113.808 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.611 HG23 ' H ' ' A' ' 152' ' ' THR 0.285 0.0 OUTLIER -143.7 -118.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.782 1.233 . . . . 10.0 113.496 -178.373 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.611 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.1 p -172.76 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.365 3.466 . . . . 10.0 107.051 -167.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.547 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.29 6.46 11.83 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 126.98 2.228 . . . . 10.0 114.751 173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -132.08 156.55 46.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.016 0.912 . . . . 10.0 110.376 148.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.19 175.45 8.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 126.088 1.755 . . . . 10.0 110.423 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 86.1 m-85 -149.09 164.64 34.07 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.524 -169.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -159.41 119.52 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 114.381 1.252 . . . . 10.0 114.381 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 49.6 tp60 -90.38 123.55 34.21 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 129.477 3.111 . . . . 10.0 111.055 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.2 m-85 -89.1 -165.45 1.35 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 123.143 0.577 . . . . 10.0 110.248 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.65 -10.3 59.74 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.88 -1.763 . . . . 10.0 113.632 163.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.4 m -158.48 160.95 37.31 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.428 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 2.2 tp60 -58.63 -28.12 65.36 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.736 1.013 . . . . 10.0 113.736 171.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -80.08 -48.15 13.71 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.782 1.233 . . . . 10.0 112.214 -174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.1 mt -53.62 -37.7 63.32 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.349 1.46 . . . . 10.0 111.334 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.91 -8.87 57.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -112.99 -15.3 12.88 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 119.918 -1.739 . . . . 10.0 112.893 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -60.01 -37.46 79.8 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 156.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.414 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -67.82 -46.34 72.15 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.549 2.055 . . . . 10.0 116.549 172.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mp -48.0 -35.07 10.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 120.527 1.512 . . . . 10.0 113.189 162.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.41 -15.16 30.44 Favored Glycine 0 CA--C 1.545 1.927 0 C-N-CA 125.622 1.582 . . . . 10.0 115.85 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -64.6 -26.33 68.35 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.56 1.68 . . . . 10.0 114.65 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.3 t60 60.58 -47.58 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 128.922 2.889 . . . . 10.0 117.328 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -145.1 -66.76 0.32 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.64 1.576 . . . . 10.0 112.611 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 36.82 -142.3 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.575 1.55 . . . . 10.0 113.186 -167.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -151.25 155.51 38.93 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.864 . . . . 10.0 110.199 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.511 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.5 mt -132.93 135.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.151 2.58 . . . . 10.0 105.447 162.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 49.02 -86.95 0.01 OUTLIER Glycine 0 N--CA 1.474 1.167 0 C-N-CA 126.801 2.144 . . . . 10.0 114.178 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 5.04 3.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.632 1.573 . . . . 10.0 114.449 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.51 -179.53 5.21 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.25 1.82 . . . . 10.0 114.259 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -146.84 14.13 1.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.604 -1.18 . . . . 10.0 113.01 -124.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.483 ' CD1' HD12 ' A' ' 176' ' ' ILE . 1.3 mt 42.96 107.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 116.983 2.216 . . . . 10.0 116.983 134.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.35 165.06 23.17 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 127.506 2.323 . . . . 10.0 113.649 160.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.9 m -139.6 140.34 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.664 0.786 . . . . 10.0 112.294 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -144.44 153.25 41.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.432 1.893 . . . . 10.0 110.507 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -74.31 154.62 38.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.809 0.844 . . . . 10.0 111.837 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.3 m -159.02 167.97 27.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.021 0.748 . . . . 10.0 113.021 -165.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 14.9 m -149.42 161.89 41.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.464 1.906 . . . . 10.0 109.64 159.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HG22 ' A' ' 191' ' ' VAL . 2.4 tp-100 -31.62 -10.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 1 C-N-CA 132.467 4.307 . . . . 10.0 120.595 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.3 -6.32 3.8 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 119.232 -2.168 . . . . 10.0 112.066 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -23.05 39.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 149.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.683 HG11 ' CD2' ' A' ' 112' ' ' PHE . 9.5 m -91.55 -35.65 7.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 N-CA-C 115.443 1.646 . . . . 10.0 115.443 -164.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 192' ' ' ARG 0.342 0.0 OUTLIER -82.89 53.39 2.4 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.093 1.146 . . . . 10.0 114.093 -165.106 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.3 m -58.87 -13.52 6.49 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.171 0.989 . . . . 10.0 113.148 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.359 0 C-N-CA 128.856 2.862 . . . . 10.0 107.95 165.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 189' ' ' GLU . 8.5 t-20 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.2 p 58.45 -29.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 130.907 3.683 . . . . 0.0 120.311 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.08 50.35 0.65 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.555 1.542 . . . . 0.0 111.308 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.82 171.99 4.78 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -172.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 m -155.24 70.53 0.75 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.179 1.792 . . . . 0.0 111.872 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.46 -44.45 0.17 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -171.73 -46.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.73 1.612 . . . . 0.0 110.981 -166.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.08 45.22 0.09 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.591 3.156 . . . . 0.0 113.556 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.86 102.12 1.63 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.639 ' CD2' HG11 ' A' ' 191' ' ' VAL . 3.2 m-85 -99.48 160.57 14.19 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.5 118.33 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.273 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -104.11 125.8 50.72 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 124.267 1.027 . . . . 0.0 112.75 -164.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.37 151.59 23.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.467 2.307 . . . . 0.0 110.494 171.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -155.58 79.55 1.02 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.682 1.593 . . . . 0.0 108.582 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.39 -11.96 0.02 OUTLIER Glycine 0 CA--C 1.536 1.401 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -162.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.828 HD23 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -73.36 152.69 90.07 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.608 1.163 . . . . 0.0 113.423 -155.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.481 ' CD ' HG22 ' A' ' 176' ' ' ILE . 69.7 Cg_endo -78.02 171.35 17.32 Favored 'Trans proline' 0 CA--C 1.531 0.352 1 C-N-CA 126.753 4.969 . . . . 0.0 112.653 173.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -57.37 133.9 55.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.068 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.2 19.24 68.03 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 118.775 -1.014 . . . . 0.0 115.169 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 118' ' ' LEU . 33.8 t -55.44 146.69 19.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.273 1.536 . . . . 0.0 111.722 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.0 t -150.7 163.5 38.41 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 112.164 -173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.5 mttt -39.2 -44.38 1.21 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 126.738 2.015 . . . . 0.0 115.684 173.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -69.84 -19.91 63.44 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.089 1.356 . . . . 0.0 112.957 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 2.2 mm-40 -78.12 -32.12 50.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 120.284 -1.51 . . . . 0.0 109.597 169.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.445 HD12 HD21 ' A' ' 143' ' ' LEU . 16.2 mt -69.59 -39.85 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 120.708 -1.245 . . . . 0.0 110.782 169.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 124' ' ' LYS 0.269 1.2 m -61.59 -13.46 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.613 1.565 . . . . 0.0 114.512 168.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.426 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.4 pp0? -101.86 -21.19 14.62 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 121.031 1.741 . . . . 0.0 113.728 166.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -49.2 75.04 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.614 1.566 . . . . 0.0 110.732 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -118.84 31.49 6.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.224 1.41 . . . . 0.0 112.069 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 84.2 p -46.59 -25.7 0.75 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 153.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.22 70.52 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.65 2.071 . . . . 0.0 116.246 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.06 159.73 41.03 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.647 1.224 . . . . 0.0 113.14 -154.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.55 127.68 34.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.997 1.319 . . . . 0.0 112.04 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 46.8 mt -129.49 139.18 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 128.358 2.663 . . . . 0.0 108.494 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.01 151.3 80.88 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.309 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -52.83 -24.87 25.27 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 120.671 3.296 . . . . 0.0 120.671 -158.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.39 42.45 2.36 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.792 1.237 . . . . 0.0 110.078 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.74 -23.68 30.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.909 1.243 . . . . 0.0 114.967 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.12 144.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 125.629 1.572 . . . . 0.0 109.481 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 77.6 m -140.28 136.29 33.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.056 -1.653 . . . . 0.0 113.52 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -125.74 89.88 51.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 128.101 2.56 . . . . 0.0 111.129 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.07 -72.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 122.017 1.812 . . . . 0.0 113.728 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.07 167.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 127.034 2.134 . . . . 0.0 111.183 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.547 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.3 p-10 -70.22 173.38 4.46 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.087 1.755 . . . . 0.0 114.875 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.46 -3.28 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.691 3.594 . . . . 0.0 117.886 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.08 -36.68 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.814 2.097 . . . . 0.0 111.881 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.04 42.13 0.67 Allowed Glycine 0 CA--C 1.532 1.117 0 N-CA-C 115.27 0.868 . . . . 0.0 115.27 163.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HD2' HG22 ' A' ' 151' ' ' ILE . 0.3 OUTLIER -134.0 -2.81 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.742 1.217 . . . . 0.0 113.631 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.626 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -143.47 -117.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.063 1.345 . . . . 0.0 113.47 -178.401 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.626 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -175.7 76.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 130.72 3.608 . . . . 0.0 106.08 -169.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -117.67 3.6 17.47 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 127.971 2.7 . . . . 0.0 115.646 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -131.03 157.84 41.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 122.307 1.051 . . . . 0.0 109.753 148.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -165.44 177.69 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.527 2.331 . . . . 0.0 108.188 -171.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.572 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -152.38 159.52 43.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 122.624 0.369 . . . . 0.0 110.871 -163.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.43 129.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 53.4 tp60 -104.23 138.53 40.57 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.382 2.273 . . . . 0.0 110.13 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 2.9 m-85 -106.02 -175.87 2.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -174.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.92 57.09 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.048 -1.658 . . . . 0.0 113.267 168.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.8 m -161.24 161.68 30.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.311 1.045 . . . . 0.0 112.444 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -62.57 -21.6 65.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.028 0.931 . . . . 0.0 113.122 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.5 -47.7 10.34 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.533 2.733 . . . . 0.0 112.776 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.37 -35.68 72.34 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.9 1.28 . . . . 0.0 111.139 168.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.05 -13.55 62.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.508 172.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -94.75 -29.57 14.7 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.147 -1.596 . . . . 0.0 110.644 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -61.24 -38.86 88.17 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.062 1.745 . . . . 0.0 109.844 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.25 -45.76 83.29 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.086 2.155 . . . . 0.0 116.02 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -51.59 -28.24 13.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 113.768 165.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.74 -19.52 55.28 Favored Glycine 0 CA--C 1.546 2.012 0 C-N-CA 125.344 1.45 . . . . 0.0 115.418 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -72.43 35.7 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.77 2.028 . . . . 0.0 113.402 164.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.416 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 1.6 t-80 -50.16 -31.05 12.61 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -154.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 27.75 3.47 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.284 1.433 . . . . 0.0 113.371 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -66.96 -170.44 0.11 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -138.11 148.7 45.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.354 1.862 . . . . 0.0 111.361 -153.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' CD ' ' A' ' 119' ' ' PRO . 3.8 mt -139.71 128.12 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 128.824 2.849 . . . . 0.0 106.41 173.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 53.88 -126.19 34.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -98.47 8.43 44.89 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.6 -179.94 4.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.517 1.527 . . . . 0.0 112.85 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -153.03 111.69 3.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -119.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.828 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.7 mt -126.43 136.77 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 122.876 1.322 . . . . 0.0 112.6 -139.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 155.08 40.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 129.689 3.196 . . . . 0.0 113.287 168.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 172' ' ' HIS . 1.7 m -141.67 132.47 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.749 0.82 . . . . 0.0 111.664 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.28 151.0 44.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.391 1.876 . . . . 0.0 110.328 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -74.25 143.95 44.87 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.206 1.003 . . . . 0.0 111.578 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.19 170.76 18.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.911 -165.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.538 ' O ' HG13 ' A' ' 191' ' ' VAL . 69.7 m -143.16 154.08 43.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.192 1.397 . . . . 0.0 110.018 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -29.33 4.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.139 1 C-N-CA 135.643 5.577 . . . . 0.0 120.305 174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 103' ' ' ASN . 13.2 mt-10 -137.51 -24.58 1.05 Allowed 'General case' 0 C--N 1.322 -0.619 0 O-C-N 119.861 -1.774 . . . . 0.0 112.448 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -85.36 -21.87 28.68 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 161.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' A' ' 112' ' ' PHE . 32.4 m -77.76 -32.95 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 124.339 1.056 . . . . 0.0 113.215 -165.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -87.11 36.62 0.74 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.231 1.812 . . . . 0.0 112.35 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.6 30.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 128.447 2.699 . . . . 0.0 117.894 -148.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 130.113 3.365 . . . . 0.0 113.159 -168.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.0 p -67.07 -165.15 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 131.002 3.721 . . . . 0.0 114.293 -3.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.31 -33.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.415 3.086 . . . . 0.0 116.087 -174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.97 144.8 50.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 0.0 108.382 172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.4 p -146.39 -53.52 0.25 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -162.34 -72.82 0.05 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.817 1.247 . . . . 0.0 112.647 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.32 -18.62 2.23 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 37.87 0.52 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.269 3.028 . . . . 0.0 112.774 -163.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.67 108.88 2.64 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.515 ' CD2' HG11 ' A' ' 191' ' ' VAL . 15.1 m-85 -97.02 166.68 11.48 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 164.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.31 110.67 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.315 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -87.28 121.11 29.29 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 123.543 0.737 . . . . 0.0 111.585 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.07 151.41 28.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.735 2.014 . . . . 0.0 110.598 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.67 89.86 1.59 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.107 1.363 . . . . 0.0 108.784 168.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.14 -24.75 0.02 OUTLIER Glycine 0 N--CA 1.468 0.781 0 C-N-CA 117.797 -2.144 . . . . 0.0 114.313 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -52.75 144.39 25.78 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.879 2.472 . . . . 0.0 114.864 -157.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.38 172.52 8.19 Favored 'Trans proline' 0 N--CA 1.459 -0.503 1 C-N-CA 126.783 4.988 . . . . 0.0 112.938 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -48.31 123.15 6.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.455 1.502 . . . . 0.0 111.786 165.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.82 19.08 76.15 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.647 ' SG ' HD13 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.79 154.68 3.72 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.341 1.57 . . . . 0.0 112.489 166.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.7 t -150.2 162.63 40.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.587 0.755 . . . . 0.0 112.59 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.4 mttt -35.54 -47.11 0.44 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 126.845 2.058 . . . . 0.0 114.487 166.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -68.29 -18.74 64.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 120.737 1.608 . . . . 0.0 113.686 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -78.94 -30.51 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 120.287 -1.508 . . . . 0.0 110.646 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 143' ' ' LEU . 18.8 mt -68.17 -42.59 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.855 167.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 124' ' ' LYS 0.25 1.0 OUTLIER -62.27 -14.69 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.718 1.607 . . . . 0.0 113.92 170.528 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -25.77 14.9 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.581 1.537 . . . . 0.0 113.885 164.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -46.51 83.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 109.732 173.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.555 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 27.8 m-85 -121.77 33.97 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.202 1.401 . . . . 0.0 113.686 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 t -53.78 -21.57 7.66 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.511 0.672 . . . . 0.0 112.094 157.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.34 -30.04 60.99 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.061 1.791 . . . . 0.0 115.821 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -139.05 167.45 22.03 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.455 1.128 . . . . 0.0 113.016 -156.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -94.65 131.52 40.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.304 1.442 . . . . 0.0 111.931 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.2 mt -128.82 137.83 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 128.277 2.631 . . . . 0.0 108.49 -171.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 m -65.7 154.4 88.72 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.732 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.21 -13.37 6.88 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.398 3.399 . . . . 0.0 119.85 -167.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -135.67 26.12 3.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.85 1.66 . . . . 0.0 111.438 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.58 -28.03 67.07 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 -169.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.8 mt -93.65 137.31 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.678 1.191 . . . . 0.0 108.91 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 21.0 m -131.68 138.4 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.042 1.737 . . . . 0.0 111.814 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -123.15 92.27 49.19 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 127.017 2.127 . . . . 0.0 110.873 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' CD ' ' HA ' ' A' ' 155' ' ' ALA . 88.9 Cg_endo -79.8 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.762 3.641 . . . . 0.0 113.14 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.68 173.36 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 130.123 3.369 . . . . 0.0 108.851 174.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.1 p-10 -77.91 172.78 8.9 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.851 2.061 . . . . 0.0 114.087 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.08 0.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 125.031 3.821 . . . . 0.0 117.499 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -126.5 -0.19 6.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.749 1.62 . . . . 0.0 111.938 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.29 35.46 48.2 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.514 -1.159 . . . . 0.0 115.961 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -130.05 -15.79 3.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.594 1.697 . . . . 0.0 112.635 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.326 0.0 OUTLIER -138.43 -98.4 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -170.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 164.33 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 129.917 3.287 . . . . 0.0 109.245 -165.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -124.8 4.47 8.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.71 3.528 . . . . 0.0 114.405 176.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -130.12 166.68 19.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.409 1.084 . . . . 0.0 108.866 145.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 144' ' ' PRO . . . -170.85 175.83 4.35 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 128.046 2.539 . . . . 0.0 109.049 -171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.5 m-85 -150.27 154.74 38.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.062 0.545 . . . . 0.0 110.713 -166.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.43 127.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -97.26 139.61 32.97 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.344 2.258 . . . . 0.0 111.403 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.1 m-85 -106.73 -177.4 3.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.387 0.675 . . . . 0.0 110.697 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.63 -10.22 59.54 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.143 -1.598 . . . . 0.0 112.946 169.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.1 m -159.86 157.33 28.94 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.237 1.015 . . . . 0.0 112.033 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -72.86 -13.87 61.37 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.651 -0.656 . . . . 0.0 112.446 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.415 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 41.6 tp10 -75.07 -51.5 13.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.784 2.434 . . . . 0.0 112.394 169.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.4 mt -57.14 -38.16 73.1 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.996 0.918 . . . . 0.0 110.447 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.23 62.16 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -104.33 -27.1 12.18 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.374 -1.454 . . . . 0.0 110.629 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER -61.81 -32.13 72.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.164 0.985 . . . . 0.0 109.072 165.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -69.69 -47.9 61.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mp -49.39 -33.51 13.95 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.031 1.287 . . . . 0.0 112.918 162.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.86 -16.61 32.26 Favored Glycine 0 CA--C 1.545 1.929 0 C-N-CA 125.823 1.678 . . . . 0.0 115.581 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -62.37 -33.48 74.82 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.642 1.721 . . . . 0.0 113.392 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 45.69 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 1 C-N-CA 132.418 4.287 . . . . 0.0 119.109 -175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 90.6 2.06 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.652 2.381 . . . . 0.0 109.726 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -130.55 -160.84 1.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.71 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -143.04 149.88 38.83 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 120.873 -1.142 . . . . 0.0 112.816 -156.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 118' ' ' LEU . 9.0 mt -140.06 133.09 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 128.306 2.643 . . . . 0.0 106.885 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 48.81 -136.31 19.26 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.229 1.871 . . . . 0.0 111.848 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.03 -8.21 54.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 174.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 -179.68 3.72 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.686 1.194 . . . . 0.0 113.988 -160.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -137.87 118.39 13.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.503 -149.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 118' ' ' LEU . 1.7 mp -123.14 135.82 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 122.923 1.344 . . . . 0.0 110.952 -148.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 164.13 23.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.05 3.34 . . . . 0.0 115.449 169.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.02 132.14 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.808 1.243 . . . . 0.0 111.298 166.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.95 148.6 43.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.826 1.65 . . . . 0.0 110.966 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -71.33 135.09 47.18 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 111.122 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.2 m -146.87 167.56 23.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.872 -1.513 . . . . 0.0 111.044 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.4 m -154.32 156.12 36.37 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.848 0.859 . . . . 0.0 112.375 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.496 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.1 tp-100 -32.86 2.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 1 C-N-CA 134.545 5.138 . . . . 0.0 121.151 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -130.4 -24.44 2.53 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 119.626 -1.921 . . . . 0.0 112.729 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -81.76 -7.18 59.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.01 1.324 . . . . 0.0 109.832 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.764 HG12 ' CD1' ' A' ' 156' ' ' PHE . 16.5 m -103.11 -22.02 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 128.566 2.746 . . . . 0.0 113.792 -171.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.7 mtm105 -78.31 70.99 4.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.543 1.537 . . . . 0.0 110.064 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 7.9 t -62.33 -17.31 58.5 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.827 -0.546 . . . . 0.0 111.942 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.281 0 C-N-CA 127.393 2.277 . . . . 0.0 114.656 -172.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.1 m -48.87 102.64 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -152.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.63 19.44 0.82 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.669 2.388 . . . . 0.0 112.833 -5.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -142.52 83.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.495 1.118 . . . . 0.0 113.825 -164.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.0 t -165.68 106.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.009 1.724 . . . . 0.0 110.018 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.46 -9.85 0.73 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 130.292 3.437 . . . . 0.0 113.289 -6.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.51 24.35 2.92 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.162 2.185 . . . . 0.0 109.835 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.0 42.08 2.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.028 1.731 . . . . 0.0 109.616 -155.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.21 113.19 3.59 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.452 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.559 ' CD2' HG11 ' A' ' 191' ' ' VAL . 16.8 m-85 -106.41 162.48 13.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.31 119.5 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.924 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -96.27 120.96 37.51 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.142 1.377 . . . . 0.0 110.449 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 181' ' ' ILE . 2.0 mm? -72.49 146.08 47.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.12 158.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -139.01 140.33 38.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 141.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.27 1.36 0.39 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.644 0.618 . . . . 0.0 114.644 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.671 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 64.8 mt -69.01 152.11 96.95 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.184 1.394 . . . . 0.0 113.33 -153.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.461 ' CD ' HG22 ' A' ' 176' ' ' ILE . 68.7 Cg_endo -75.53 167.85 25.69 Favored 'Trans proline' 0 C--O 1.235 0.327 1 C-N-CA 125.722 4.281 . . . . 0.0 112.039 172.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -68.41 128.73 37.65 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.962 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.47 25.68 74.8 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.034 -0.87 . . . . 0.0 114.47 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 176' ' ' ILE . 42.8 t -53.09 150.28 5.93 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.549 1.175 . . . . 0.0 113.417 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.9 t -147.29 160.32 42.64 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 120.787 -1.195 . . . . 0.0 113.434 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.608 ' O ' HG13 ' A' ' 128' ' ' VAL . 5.0 mttm -39.11 -47.33 1.54 Allowed 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 126.663 1.985 . . . . 0.0 114.993 171.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -65.97 -19.64 65.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.589 1.541 . . . . 0.0 112.794 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 58.2 mt-10 -81.93 -29.45 32.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.4 -1.438 . . . . 0.0 109.744 171.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.437 HD12 HD21 ' A' ' 143' ' ' LEU . 31.9 mt -70.11 -41.99 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.202 -0.936 . . . . 0.0 111.325 166.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -62.11 -12.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.173 1.789 . . . . 0.0 114.162 170.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -100.56 -21.97 15.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.981 1.264 . . . . 0.0 114.4 164.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -48.91 78.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 169.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.18 34.75 5.1 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.16 1.384 . . . . 0.0 112.694 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.33 -23.42 2.32 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 156.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.04 -31.03 67.78 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.142 1.83 . . . . 0.0 115.988 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.5 mp -138.35 161.39 37.07 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.297 1.049 . . . . 0.0 113.603 -154.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.44 143.37 30.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.162 1.385 . . . . 0.0 112.986 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 74.5 mt -146.09 135.46 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.519 2.328 . . . . 0.0 107.587 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -60.4 154.6 53.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 111.506 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.97 -1.75 8.37 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.288 1.992 . . . . 0.0 116.672 -163.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -133.4 17.34 4.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.266 1.826 . . . . 0.0 111.439 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.2 -29.39 72.8 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 121.355 -0.841 . . . . 0.0 114.531 -165.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.6 mt -85.95 129.37 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.761 1.624 . . . . 0.0 108.671 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.0 m -121.05 131.18 54.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.267 1.827 . . . . 0.0 111.458 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -120.24 92.24 47.01 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 127.152 2.181 . . . . 0.0 110.106 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.86 -86.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.352 2.701 . . . . 0.0 112.442 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.8 172.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 128.141 2.577 . . . . 0.0 110.941 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.77 174.53 5.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.747 2.019 . . . . 0.0 113.027 167.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.07 -6.4 1.28 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.868 3.712 . . . . 0.0 117.52 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -115.28 -14.16 11.69 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.302 1.841 . . . . 0.0 111.685 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.62 37.04 12.45 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.35 -1.25 . . . . 0.0 115.124 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -125.13 -16.77 5.92 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.719 1.759 . . . . 0.0 112.261 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.405 HG23 ' H ' ' A' ' 152' ' ' THR 0.314 0.0 OUTLIER -140.74 -100.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -170.021 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.2 OUTLIER 166.16 83.89 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 130.511 3.524 . . . . 0.0 107.909 -165.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -113.03 -16.34 8.52 Favored Glycine 0 N--CA 1.47 0.959 1 C-N-CA 130.863 4.078 . . . . 0.0 113.585 176.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -129.68 163.95 25.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.726 1.61 . . . . 0.0 110.133 159.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.73 172.99 9.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.233 3.013 . . . . 0.0 107.213 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.648 ' CD2' HG12 ' A' ' 191' ' ' VAL . 90.3 m-85 -149.22 162.7 39.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 -167.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -157.45 120.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.482 ' O ' HG23 ' A' ' 136' ' ' ILE . 43.2 tp60 -90.71 126.15 35.9 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.856 2.063 . . . . 0.0 108.779 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.0 m-85 -84.43 -167.82 1.93 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.425 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.85 -11.29 59.8 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.018 -1.676 . . . . 0.0 112.407 166.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.0 m -161.17 165.14 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.837 1.255 . . . . 0.0 112.856 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -61.06 -31.33 70.99 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.425 1.49 . . . . 0.0 113.077 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.4 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 31.5 tp10 -75.22 -48.05 25.29 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.975 2.11 . . . . 0.0 112.914 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 67.5 mt -57.54 -37.31 72.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.931 1.293 . . . . 0.0 110.697 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.2 -18.51 63.92 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -92.1 -32.89 14.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.636 1.574 . . . . 0.0 109.979 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -65.49 -36.1 82.85 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.435 1.494 . . . . 0.0 109.322 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.498 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.09 -43.16 88.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.545 1.938 . . . . 0.0 115.019 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -57.94 -19.73 32.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.12 -20.78 29.33 Favored Glycine 0 CA--C 1.548 2.118 0 C-N-CA 124.779 1.18 . . . . 0.0 114.579 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -71.09 43.84 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.099 2.16 . . . . 0.0 112.129 158.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.52 -40.05 58.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.086 1.754 . . . . 0.0 113.937 -163.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -130.95 124.73 31.68 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.76 1.624 . . . . 0.0 107.525 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -150.0 -166.19 2.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.013 0.925 . . . . 0.0 110.959 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -129.27 149.3 51.12 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.265 1.426 . . . . 0.0 112.184 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.461 HG22 ' CD ' ' A' ' 119' ' ' PRO . 4.0 mt -139.69 120.27 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 129.015 2.926 . . . . 0.0 106.716 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 60.04 -123.39 32.94 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -90.14 -9.86 46.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.5 -175.07 2.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.997 1.319 . . . . 0.0 113.357 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -154.1 115.71 4.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -126.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.531 ' CD1' HD23 ' A' ' 118' ' ' LEU . 2.8 mt -129.51 142.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.309 1.052 . . . . 0.0 112.094 -141.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.335 5.1 tp10 -89.04 163.88 15.31 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 129.465 3.106 . . . . 0.0 112.914 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.2 m -138.32 143.94 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.441 -0.787 . . . . 0.0 112.811 166.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -141.46 149.67 41.27 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.29 1.836 . . . . 0.0 110.605 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -68.32 152.78 44.95 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.615 0.766 . . . . 0.0 111.681 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.49 170.55 22.09 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.627 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.24 160.53 43.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.801 1.64 . . . . 0.0 111.275 166.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 tp-100 -42.68 5.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 1 C-N-CA 131.722 4.009 . . . . 0.0 120.168 178.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER -130.55 -17.84 3.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.441 -2.037 . . . . 0.0 114.707 168.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -82.56 -26.65 32.2 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.599 1.56 . . . . 0.0 108.691 173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.648 HG12 ' CD2' ' A' ' 156' ' ' PHE . 17.5 m -80.35 -11.85 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.056 2.542 . . . . 0.0 116.327 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 189' ' ' GLU . 8.3 mmm180 -75.87 52.55 0.7 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.698 2.399 . . . . 0.0 113.735 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 49.6 m -68.68 -1.28 6.58 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.082 153.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 8.4 p90 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 130.84 3.656 . . . . 0.0 111.775 172.023 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.23 158.22 43.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -154.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -120.23 8.84 10.94 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.869 2.067 . . . . 0.0 112.111 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.35 165.71 7.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.116 1.766 . . . . 0.0 112.377 166.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.0 m -146.92 128.66 15.24 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.12 0.968 . . . . 0.0 112.988 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.65 -54.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.704 1.202 . . . . 0.0 111.679 166.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.99 -41.16 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.19 53.61 0.65 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.698 1.999 . . . . 0.0 114.246 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.03 97.86 0.46 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.686 1.136 . . . . 0.0 110.913 161.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 191' ' ' VAL . 11.2 m-85 -108.15 163.82 12.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 1.8 t -137.76 150.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.661 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.3 ttt85 -121.14 143.72 48.95 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.058 1.343 . . . . 0.0 112.329 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.54 153.16 27.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.391 2.676 . . . . 0.0 111.124 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.22 71.47 0.51 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.052 1.741 . . . . 0.0 110.176 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.46 0.0 0.03 OUTLIER Glycine 0 N--CA 1.475 1.261 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -165.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -77.63 153.33 81.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 0.0 111.824 -165.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.84 171.85 11.5 Favored 'Trans proline' 0 CA--C 1.532 0.382 1 C-N-CA 126.704 4.936 . . . . 0.0 113.639 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.37 123.02 16.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.933 0.893 . . . . 0.0 112.438 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 83.29 12.77 78.16 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.342 -174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.461 ' SG ' HG21 ' A' ' 176' ' ' ILE . 31.3 t -58.51 151.9 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.958 1.879 . . . . 0.0 112.712 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.3 t -148.06 165.12 31.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.655 0.782 . . . . 0.0 111.763 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -42.09 -49.84 4.76 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.315 2.246 . . . . 0.0 112.417 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' HG13 ' A' ' 128' ' ' VAL . 3.3 mp0 -63.1 -14.19 45.49 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -85.92 -26.79 25.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.731 -1.856 . . . . 0.0 109.938 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.24 -39.72 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.956 -0.465 . . . . 0.0 112.075 160.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.287 1.3 m -57.46 -18.52 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -97.7 -26.17 14.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.286 1.403 . . . . 0.0 114.124 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -62.67 -41.46 99.1 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.832 1.253 . . . . 0.0 111.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -121.89 33.77 5.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.484 1.114 . . . . 0.0 113.067 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.97 -21.63 8.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.63 -0.668 . . . . 0.0 112.607 157.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.65 -33.44 41.65 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 125.93 1.729 . . . . 0.0 114.965 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.0 167.46 21.19 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.554 1.542 . . . . 0.0 112.067 -158.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.43 140.14 29.77 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.866 -1.146 . . . . 0.0 111.739 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 45.1 mt -135.48 136.57 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.531 2.732 . . . . 0.0 107.831 -177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.6 m -63.07 152.08 84.82 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-O 118.958 -0.544 . . . . 0.0 111.408 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.77 -14.66 11.1 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.947 3.098 . . . . 0.0 119.967 -165.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -128.54 19.94 6.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.145 1.378 . . . . 0.0 111.759 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.55 -27.42 61.09 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 115.961 1.144 . . . . 0.0 115.961 -163.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 128' ' ' VAL . 70.4 mt -92.05 137.63 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 125.955 1.702 . . . . 0.0 109.738 -168.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.4 m -132.49 137.65 47.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.416 1.462 . . . . 0.0 113.465 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.29 90.06 50.87 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 127.192 2.197 . . . . 0.0 112.149 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.09 -63.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.103 1.202 . . . . 0.0 114.203 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.43 179.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 129.994 3.318 . . . . 0.0 108.081 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.502 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.3 p-10 -74.51 170.68 13.98 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 119.64 -1.913 . . . . 0.0 113.686 156.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.82 -0.61 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.727 3.618 . . . . 0.0 116.873 173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -130.18 0.92 4.67 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.594 1.558 . . . . 0.0 111.556 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.01 39.4 23.98 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.119 1.207 . . . . 0.0 116.119 163.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -122.92 -25.55 4.57 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.496 1.518 . . . . 0.0 111.422 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 152' ' ' THR 0.274 0.0 OUTLIER -149.05 -111.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.417 -1.277 . . . . 0.0 113.231 -157.115 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -179.0 78.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 129.75 3.22 . . . . 0.0 108.576 -166.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.502 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -130.65 7.55 5.86 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 127.901 2.667 . . . . 0.0 114.384 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -136.44 160.41 38.85 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.123 1.369 . . . . 0.0 109.244 157.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -171.04 176.78 3.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.735 1.614 . . . . 0.0 110.549 -169.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.509 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.1 m-85 -148.37 159.58 43.88 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.408 1.083 . . . . 0.0 110.418 -171.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.7 p -163.48 124.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -94.14 132.48 38.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.042 2.137 . . . . 0.0 110.844 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.2 m-85 -92.73 -172.77 3.13 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.662 0.385 . . . . 0.0 110.701 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.35 -12.34 60.24 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.215 -1.553 . . . . 0.0 113.033 168.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 58.7 m -159.39 162.35 35.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.421 1.088 . . . . 0.0 113.202 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.42 -34.04 70.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.032 0.933 . . . . 0.0 113.015 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -71.49 -47.17 57.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.087 2.155 . . . . 0.0 112.782 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.24 -34.67 74.01 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.528 1.131 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.81 -16.93 60.02 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.151 0.501 . . . . 0.0 112.238 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -85.72 -33.13 21.57 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.389 -1.444 . . . . 0.0 109.363 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -36.79 85.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.778 1.631 . . . . 0.0 110.098 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -61.58 -47.0 87.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.26 1.824 . . . . 0.0 115.424 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.5 mp -48.89 -27.56 3.17 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.65 -13.54 51.54 Favored Glycine 0 CA--C 1.545 1.952 0 C-N-CA 125.06 1.314 . . . . 0.0 115.386 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -64.98 -22.91 67.07 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.463 1.631 . . . . 0.0 114.455 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 41.51 -53.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 1 C-N-CA 131.92 4.088 . . . . 0.0 119.742 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -145.42 19.26 1.54 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.311 2.244 . . . . 0.0 112.694 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.81 -179.67 0.29 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -119.64 155.76 31.71 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -161.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.5 mt -139.74 131.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 130.061 3.344 . . . . 0.0 106.145 171.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 57.44 -85.36 0.01 OUTLIER Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.938 1.256 . . . . 0.0 113.368 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -147.06 13.98 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.405 1.882 . . . . 0.0 112.234 169.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -124.29 178.65 5.25 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.944 2.097 . . . . 0.0 111.19 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -149.92 91.27 1.77 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 123.231 1.491 . . . . 0.0 109.66 -113.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.504 ' CD1' HD12 ' A' ' 176' ' ' ILE . 6.6 mt -102.55 139.5 23.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.186 -141.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.69 151.26 45.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.334 2.254 . . . . 0.0 112.633 165.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.73 136.68 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.424 0.69 . . . . 0.0 112.075 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -142.74 150.53 40.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.343 1.857 . . . . 0.0 109.884 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -61.36 152.47 29.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.935 0.894 . . . . 0.0 110.417 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.3 m -152.61 171.64 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.722 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -153.38 155.65 36.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.486 1.515 . . . . 0.0 111.16 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp-100 -35.22 -1.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 1 C-N-CA 133.496 4.718 . . . . 0.0 120.17 177.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -117.85 -28.38 5.96 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 119.881 -1.762 . . . . 0.0 112.961 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -84.2 -19.96 33.14 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.628 -1.295 . . . . 0.0 109.745 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 112' ' ' PHE . 21.2 m -87.96 -31.07 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 128.185 2.594 . . . . 0.0 112.922 -165.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.71 38.79 0.76 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.41 1.084 . . . . 0.0 111.556 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 36.7 m -69.5 30.42 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.401 1.881 . . . . 0.0 112.936 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.353 0 C-N-CA 127.635 2.374 . . . . 0.0 111.542 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.533 ' H ' ' HA ' ' A' ' 105' ' ' ALA . 92.7 p -143.94 -16.51 0.6 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -175.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HA ' ' H ' ' A' ' 104' ' ' SER . . . -148.09 -32.59 0.26 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 125.955 3.98 . . . . 0.0 113.819 -3.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -157.04 151.79 25.71 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.865 1.266 . . . . 0.0 112.78 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.1 m -161.57 8.42 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.679 2.792 . . . . 0.0 112.325 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 54.01 142.1 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.475 2.71 . . . . 0.0 115.528 -156.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.05 2.76 4.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 130.469 3.508 . . . . 0.0 111.934 -8.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.33 50.59 1.77 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.739 -158.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -70.76 91.89 0.43 Allowed Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 127.446 2.451 . . . . 0.0 112.03 174.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' CD2' HG11 ' A' ' 191' ' ' VAL . 18.7 m-85 -99.0 166.81 11.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 156' ' ' PHE . 2.1 t -146.81 128.07 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.899 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 66.1 ttt180 -104.0 138.73 40.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.254 1.022 . . . . 0.0 111.244 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 153.19 23.4 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.409 2.683 . . . . 0.0 109.531 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -155.07 81.22 1.07 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 109.782 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.77 -5.61 0.02 OUTLIER Glycine 0 CA--C 1.531 1.081 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -168.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.651 HD13 ' SG ' ' A' ' 122' ' ' CYS . 0.3 OUTLIER -78.38 148.92 74.8 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.856 1.262 . . . . 0.0 111.119 -161.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 83.2 Cg_endo -80.42 170.75 15.65 Favored 'Trans proline' 0 N--CA 1.462 -0.37 1 C-N-CA 126.595 4.864 . . . . 0.0 113.056 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -53.75 118.44 3.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.555 165.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.61 66.53 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.304 -1.276 . . . . 0.0 115.73 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 118' ' ' LEU . 6.2 t -55.35 149.75 12.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 120.317 2.059 . . . . 0.0 112.257 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.4 164.15 33.35 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.454 1.102 . . . . 0.0 111.249 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.4 ttmt -43.69 -43.34 5.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.457 2.303 . . . . 0.0 113.164 173.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' HA ' HG13 ' A' ' 128' ' ' VAL . 36.5 mp0 -69.36 -18.0 63.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.949 1.299 . . . . 0.0 114.334 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' A' ' 129' ' ' GLN . 47.0 mm-40 -77.97 -27.59 49.2 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 119.709 -1.87 . . . . 0.0 110.458 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.421 HD12 HD21 ' A' ' 143' ' ' LEU . 19.9 mt -69.61 -36.83 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 110.465 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.274 1.4 m -63.57 -15.89 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.479 1.111 . . . . 0.0 113.701 169.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 1.1 pp0? -96.73 -25.04 15.67 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.529 1.513 . . . . 0.0 114.142 165.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.61 -46.96 88.29 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.423 1.489 . . . . 0.0 110.782 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -119.98 35.0 5.0 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.322 1.049 . . . . 0.0 112.509 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.6 p -49.6 -24.8 2.36 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 155.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.03 -33.3 68.74 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.058 1.789 . . . . 0.0 115.353 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -139.29 160.45 39.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 113.139 -155.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.52 136.39 33.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 112.438 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 48.2 mt -135.71 137.69 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 129.633 3.173 . . . . 0.0 107.911 -171.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.07 151.88 79.45 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.628 -0.701 . . . . 0.0 110.821 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.19 -23.06 21.57 Favored 'Trans proline' 0 C--N 1.347 0.483 0 N-CA-C 120.952 3.405 . . . . 0.0 120.952 -158.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 39.52 2.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.604 1.162 . . . . 0.0 110.13 167.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.97 -25.42 9.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.219 1.39 . . . . 0.0 114.936 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' CD1' HG12 ' A' ' 128' ' ' VAL . 63.2 mt -85.82 133.47 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.273 1.829 . . . . 0.0 109.631 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.1 m -129.18 136.62 50.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.078 1.751 . . . . 0.0 112.455 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.421 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -124.97 91.76 48.81 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 127.198 2.199 . . . . 0.0 111.142 -169.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 -79.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 123.366 2.711 . . . . 0.0 113.634 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.26 168.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 129.224 3.01 . . . . 0.0 109.737 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.515 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.4 p-10 -80.61 171.74 11.56 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.966 1.706 . . . . 0.0 114.118 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -55.49 -1.16 0.19 Allowed 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 124.973 3.782 . . . . 0.0 117.478 171.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -127.83 0.3 6.02 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.975 1.71 . . . . 0.0 111.795 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 39.43 68.21 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 115.796 1.079 . . . . 0.0 115.796 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -127.82 -17.15 4.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.859 1.664 . . . . 0.0 112.005 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.57 HG23 ' H ' ' A' ' 152' ' ' THR 0.307 0.0 OUTLIER -141.51 -104.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.296 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.57 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.5 OUTLIER 172.56 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.352 3.461 . . . . 0.0 108.525 -163.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.515 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -123.41 2.52 9.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 128.714 3.054 . . . . 0.0 114.373 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.53 162.8 23.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.152 0.476 . . . . 0.0 109.726 142.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.89 177.2 5.1 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 127.036 2.135 . . . . 0.0 110.274 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.78 ' CD1' HG12 ' A' ' 191' ' ' VAL . 87.9 m-85 -148.88 160.28 43.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.037 0.935 . . . . 0.0 110.923 -166.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -162.29 121.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 40.4 tp60 -90.19 132.74 35.32 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.838 2.055 . . . . 0.0 110.006 173.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.2 m-85 -89.12 -158.54 0.51 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.908 0.483 . . . . 0.0 110.197 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.47 -9.15 59.55 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 119.852 -1.78 . . . . 0.0 112.904 156.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.6 m -162.45 159.11 24.67 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.508 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 21.4 mm-40 -56.18 -30.99 63.0 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.158 1.383 . . . . 0.0 113.723 166.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -53.07 20.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.601 1.56 . . . . 0.0 111.414 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.64 -36.88 72.43 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.19 1.396 . . . . 0.0 111.319 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -72.94 -16.08 61.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.57 -32.14 15.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.526 1.53 . . . . 0.0 110.444 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -61.57 -40.04 93.31 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 125.787 1.635 . . . . 0.0 110.508 167.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -59.33 -47.24 86.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.24 1.816 . . . . 0.0 114.162 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -55.82 -20.18 14.24 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 172.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -62.34 -14.29 47.52 Favored Glycine 0 CA--C 1.547 2.054 0 C-N-CA 124.646 1.117 . . . . 0.0 115.016 171.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -63.16 -27.52 69.43 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.324 1.562 . . . . 0.0 113.442 162.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.77 -42.01 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.905 1 C-N-CA 133.191 4.596 . . . . 0.0 120.166 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -153.49 36.83 0.46 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.305 1.442 . . . . 0.0 112.053 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -66.02 -174.04 0.22 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.621 1.168 . . . . 0.0 114.041 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.31 148.96 44.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.372 1.469 . . . . 0.0 112.682 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.577 HD12 HD22 ' A' ' 118' ' ' LEU . 1.3 mt -138.47 131.52 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 129.283 3.033 . . . . 0.0 105.798 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 54.41 -99.89 0.07 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.148 1.356 . . . . 0.0 112.33 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -118.36 -5.15 10.84 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.24 1.416 . . . . 0.0 113.532 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -116.71 -172.43 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.241 1.816 . . . . 0.0 112.49 -169.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -151.09 109.71 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.991 -132.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.563 HG12 HD23 ' A' ' 118' ' ' LEU . 3.6 mp -124.27 128.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 122.783 1.278 . . . . 0.0 112.371 -139.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.42 160.58 13.23 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 127.559 2.344 . . . . 0.0 114.268 171.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.63 141.18 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.332 0.653 . . . . 0.0 112.433 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -143.81 142.75 31.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.198 1.799 . . . . 0.0 110.794 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 17.8 tptm -66.98 146.24 54.58 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.642 0.734 . . . . 0.0 110.679 174.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -150.83 168.79 23.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.647 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 60.5 m -147.5 165.37 30.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.531 1.532 . . . . 0.0 110.761 164.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.54 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.7 tp60 -35.98 1.7 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.372 1 C-N-CA 133.32 4.648 . . . . 0.0 119.87 177.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -118.26 -30.26 5.31 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.636 -1.915 . . . . 0.0 112.669 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.662 -1.274 . . . . 0.0 109.611 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 156' ' ' PHE . 18.9 m -102.35 -19.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 127.585 2.354 . . . . 0.0 114.622 -153.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -90.98 16.76 8.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.204 1.801 . . . . 0.0 112.518 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 m -75.21 44.71 0.26 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.217 2.607 . . . . 0.0 114.55 -169.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.823 2.049 . . . . 0.0 113.822 178.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.998 0.427 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.4 m -158.05 -20.43 0.08 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.996 2.118 . . . . 0.0 113.128 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -134.7 23.65 3.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.836 2.054 . . . . 0.0 110.126 168.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -172.39 162.69 5.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.079 2.152 . . . . 0.0 110.957 -157.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -140.66 -48.74 0.43 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.81 -57.85 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -139.5 -9.68 1.24 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.997 1.319 . . . . 0.0 114.472 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.37 36.91 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.181 3.793 . . . . 0.0 114.181 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -58.51 83.36 0.01 OUTLIER Glycine 0 C--N 1.33 0.25 0 C-N-CA 127.064 2.268 . . . . 0.0 113.602 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 158' ' ' GLN . 3.3 m-85 -92.31 160.53 15.08 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 168.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.08 113.13 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.736 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.341 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 77.3 ttt180 -89.02 131.02 35.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 123.459 0.704 . . . . 0.0 111.492 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.42 152.96 18.94 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 128.751 2.821 . . . . 0.0 110.438 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -157.84 70.92 0.59 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.91 1.284 . . . . 0.0 109.419 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.48 1.92 0.03 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 -162.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.8 mt -79.4 153.89 76.56 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 119.186 1.493 . . . . 0.0 112.434 -162.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.87 175.06 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 1 C-N-CA 125.759 4.306 . . . . 0.0 113.299 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -67.15 132.08 47.09 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.204 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.64 70.07 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 117.694 -1.615 . . . . 0.0 115.71 -171.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.25 149.38 20.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 120.392 2.096 . . . . 0.0 113.517 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.4 p -135.0 164.1 28.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.1 1.76 . . . . 0.0 111.82 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 128' ' ' VAL . 28.0 ttmt -48.56 -42.33 33.17 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 126.448 1.899 . . . . 0.0 112.449 166.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 121.193 1.815 . . . . 0.0 113.792 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -75.43 -31.68 60.43 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 119.658 -1.901 . . . . 0.0 110.0 167.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.481 HD12 HD21 ' A' ' 143' ' ' LEU . 49.1 mt -67.45 -39.04 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.496 0.718 . . . . 0.0 111.183 167.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 141' ' ' ILE . 1.9 m -62.17 -17.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.376 1.07 . . . . 0.0 112.964 171.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -96.05 -31.92 12.8 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.874 1.216 . . . . 0.0 112.719 166.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -59.46 -41.66 90.23 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.066 1.746 . . . . 0.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -119.87 33.39 5.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.918 1.287 . . . . 0.0 113.771 170.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.1 p -52.21 -22.2 4.12 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 157.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -51.22 -32.96 30.05 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 126.156 1.836 . . . . 0.0 115.212 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.66 166.49 24.22 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.888 1.275 . . . . 0.0 112.876 -156.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.57 137.53 32.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.68 1.592 . . . . 0.0 111.377 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 72.1 mt -138.62 137.64 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 128.221 2.608 . . . . 0.0 106.824 -170.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -60.39 153.55 58.83 Favored Pre-proline 0 N--CA 1.486 1.365 0 CA-C-N 118.643 0.656 . . . . 0.0 111.447 172.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.02 -21.06 20.19 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 120.927 3.395 . . . . 0.0 120.927 -159.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.74 40.9 2.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.791 1.178 . . . . 0.0 109.993 167.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.17 -14.71 6.31 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.148 1.356 . . . . 0.0 116.38 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 128' ' ' VAL . 76.2 mt -103.27 123.69 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 C-N-CA 125.372 1.469 . . . . 0.0 109.384 -165.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 15.8 m -115.8 130.59 56.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.085 2.554 . . . . 0.0 112.695 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.76 78.78 56.64 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 127.014 2.126 . . . . 0.0 111.724 -170.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.27 -58.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.372 1.381 . . . . 0.0 113.249 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -178.3 173.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 130.681 3.592 . . . . 0.0 107.961 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.52 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 12.9 p-10 -69.63 169.44 12.49 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 120.236 -1.54 . . . . 0.0 113.747 159.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.41 2.59 0.1 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 124.931 3.754 . . . . 0.0 117.319 171.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -128.41 -2.76 5.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.555 1.542 . . . . 0.0 112.094 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.44 36.62 26.24 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.047 1.179 . . . . 0.0 116.047 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -131.39 -15.52 3.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.415 1.607 . . . . 0.0 112.728 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.449 HG23 ' H ' ' A' ' 152' ' ' THR 0.29 0.0 OUTLIER -143.67 -114.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.738 1.215 . . . . 0.0 113.226 -170.134 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.449 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.24 75.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 129.342 3.057 . . . . 0.0 108.141 -167.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.52 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -125.25 4.68 8.27 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 127.561 2.505 . . . . 0.0 114.702 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -131.86 164.06 26.9 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.497 0.719 . . . . 0.0 109.972 150.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -172.34 168.98 5.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 126.834 2.054 . . . . 0.0 110.029 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 191' ' ' VAL . 97.0 m-85 -141.25 152.62 44.69 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.582 0.753 . . . . 0.0 109.673 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.23 123.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.509 ' O ' HG23 ' A' ' 136' ' ' ILE . 39.3 tp60 -90.79 122.77 33.81 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.954 2.102 . . . . 0.0 110.344 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 5.1 m-85 -83.23 -165.55 1.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.576 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.79 -12.39 60.02 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.177 -1.577 . . . . 0.0 112.159 162.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.3 m -161.54 162.65 30.32 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.993 0.917 . . . . 0.0 113.411 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.466 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.67 -8.01 55.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.85 -53.2 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.324 2.25 . . . . 0.0 111.81 172.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.06 -37.89 67.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.026 1.73 . . . . 0.0 111.285 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.33 -15.84 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.68 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -97.46 -25.36 15.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.267 -1.521 . . . . 0.0 110.864 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.05 -41.08 97.51 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.323 1.449 . . . . 0.0 109.853 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.444 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -60.52 -46.29 90.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.548 1.939 . . . . 0.0 115.808 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.5 mp -48.19 -21.48 0.5 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 165.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -68.48 -10.02 59.45 Favored Glycine 0 CA--C 1.544 1.864 0 C-N-CA 123.965 0.793 . . . . 0.0 113.697 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -59.59 -32.82 70.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.228 1.411 . . . . 0.0 114.321 164.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.6 -56.51 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 131.196 3.799 . . . . 0.0 119.0 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -148.17 24.31 1.04 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.289 1.836 . . . . 0.0 113.443 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -59.61 179.4 0.12 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.772 1.629 . . . . 0.0 113.731 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.61 149.65 45.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.342 1.457 . . . . 0.0 111.799 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -92.39 -16.64 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.5 1.12 . . . . 0.0 112.77 175.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.62 -41.96 0.08 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.394 1.473 . . . . 0.0 112.607 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -149.66 -42.04 0.14 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.312 1.445 . . . . 0.0 112.854 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -86.14 174.55 9.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.109 0.957 . . . . 0.0 111.753 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.73 97.49 3.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.937 -126.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 176' ' ' ILE . 5.3 mt -99.78 119.48 47.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.733 -148.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 153.25 42.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.149 1.78 . . . . 0.0 112.372 163.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 132.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.499 0.719 . . . . 0.0 110.947 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -135.61 144.74 46.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.917 1.687 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 185' ' ' LYS . 19.1 tptm -69.15 142.0 54.47 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.594 0.711 . . . . 0.0 110.41 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 m -150.38 164.12 36.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.09 -167.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 73.6 m -135.39 160.75 37.47 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.731 1.212 . . . . 0.0 110.916 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -46.66 4.97 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.768 1 C-N-CA 132.39 4.276 . . . . 0.0 118.148 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -128.67 -28.73 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.204 -1.56 . . . . 0.0 113.03 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.46 -23.48 62.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.859 -1.151 . . . . 0.0 110.564 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.465 ' HA ' ' CE2' ' A' ' 156' ' ' PHE . 1.7 p -68.8 -35.82 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 124.676 1.191 . . . . 0.0 113.261 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 6.2 ttt85 -90.68 66.82 6.24 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.286 -1.325 . . . . 0.0 113.093 -138.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.1 p -82.61 -9.91 59.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 158.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.152 0 C-N-CA 130.196 3.399 . . . . 0.0 114.062 -175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 36.8 m -152.25 27.37 0.59 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.556 1.542 . . . . 0.0 111.405 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.6 179.42 8.0 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.053 1.341 . . . . 0.0 113.328 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.35 169.29 16.22 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.477 1.911 . . . . 0.0 112.333 -168.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.51 ' H ' ' HG3' ' A' ' 162' ' ' GLN . 82.7 p -140.68 -83.34 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.472 1.509 . . . . 0.0 110.527 166.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -167.2 -34.79 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 129.553 3.141 . . . . 0.0 111.455 169.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -137.02 13.67 3.09 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -163.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -120.3 34.76 5.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.476 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 77.89 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 127.035 2.255 . . . . 0.0 113.353 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.621 ' CD1' HG11 ' A' ' 191' ' ' VAL . 7.3 m-85 -99.49 156.96 16.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 174.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.1 108.72 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.678 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -86.05 124.84 32.94 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.609 0.763 . . . . 0.0 111.444 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 181' ' ' ILE . 1.4 mm? -85.33 152.47 23.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.976 2.11 . . . . 0.0 110.808 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -155.1 76.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.263 1.425 . . . . 0.0 109.324 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.35 -11.01 0.02 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -161.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.604 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 13.0 mt -73.44 156.08 89.13 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -152.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 86.4 Cg_endo -78.4 169.69 19.62 Favored 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 125.634 4.223 . . . . 0.0 112.543 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.23 125.96 28.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.68 24.54 75.39 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.789 -1.006 . . . . 0.0 114.739 -170.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 36.2 t -54.96 154.49 5.26 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.277 1.538 . . . . 0.0 112.773 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.1 t -147.31 164.41 33.33 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.047 0.927 . . . . 0.0 112.144 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 128' ' ' VAL . 32.0 ttmt -45.55 -40.64 8.93 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 127.055 2.142 . . . . 0.0 113.126 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -69.87 -16.7 63.29 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 121.596 1.998 . . . . 0.0 113.999 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -76.92 -35.09 57.57 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 120.043 -1.661 . . . . 0.0 109.327 166.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 143' ' ' LEU . 51.9 mt -64.1 -40.29 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.036 0.835 . . . . 0.0 111.141 169.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.5 m -65.77 -16.52 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.897 1.279 . . . . 0.0 112.683 174.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -94.94 -31.48 13.63 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.94 1.245 . . . . 0.0 112.425 164.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.86 -38.23 75.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.188 1.795 . . . . 0.0 111.593 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 23.9 m-85 -122.15 35.93 4.76 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.482 1.513 . . . . 0.0 112.68 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -64.37 78.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.173 1.463 . . . . 0.0 108.864 153.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.8 -48.04 0.08 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.795 -151.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.1 157.9 45.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.988 1.315 . . . . 0.0 112.09 -160.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB2' HD13 ' A' ' 164' ' ' LEU . 44.9 mt-10 -76.73 131.28 38.67 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.645 -0.659 . . . . 0.0 111.193 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 55.1 mt -131.08 132.26 63.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.832 2.453 . . . . 0.0 107.183 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.09 151.4 80.98 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.923 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.94 -16.89 12.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.069 3.179 . . . . 0.0 119.133 -165.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -122.95 16.43 10.07 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.593 1.557 . . . . 0.0 111.598 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.58 70.73 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 -159.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -95.17 134.77 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 124.856 1.262 . . . . 0.0 109.743 -166.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.4 m -133.44 133.55 42.46 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.575 1.55 . . . . 0.0 112.685 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 127' ' ' ILE . 3.6 mm? -126.27 96.47 36.49 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 127.695 2.398 . . . . 0.0 111.326 -173.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.73 -81.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 122.078 1.852 . . . . 0.0 113.831 175.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.25 167.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 128.899 2.88 . . . . 0.0 109.991 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -70.86 170.65 10.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.493 1.917 . . . . 0.0 114.645 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.61 0.61 0.13 Allowed 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 124.907 3.738 . . . . 0.0 117.576 170.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -126.91 -0.46 6.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.776 1.63 . . . . 0.0 111.928 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.28 37.32 54.75 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 167.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -129.16 -15.63 4.15 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.192 1.496 . . . . 0.0 112.37 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.442 HG23 ' H ' ' A' ' 152' ' ' THR 0.299 0.0 OUTLIER -141.67 -105.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.571 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 170.96 80.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.981 3.312 . . . . 0.0 107.983 -166.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.81 -1.45 5.9 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 129.942 3.639 . . . . 0.0 114.476 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -131.8 158.63 40.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.961 0.886 . . . . 0.0 109.473 149.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.61 -179.47 3.38 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.339 2.256 . . . . 0.0 108.472 -167.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.592 ' CD2' HG12 ' A' ' 191' ' ' VAL . 98.4 m-85 -152.01 157.65 42.0 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.789 0.436 . . . . 0.0 111.273 -167.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.52 125.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -90.8 127.0 36.19 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.937 2.095 . . . . 0.0 111.266 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.5 m-85 -92.11 -173.16 3.37 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.342 1.057 . . . . 0.0 110.313 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.97 -13.17 60.84 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.212 -1.555 . . . . 0.0 113.064 166.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 49.4 m -160.24 159.97 32.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.477 1.111 . . . . 0.0 113.347 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 107' ' ' SER . 19.5 mm-40 -60.69 -21.43 62.86 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 167.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.416 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 29.0 tp10 -78.96 -50.32 11.32 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.786 1.234 . . . . 0.0 111.681 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 135' ' ' GLU . 80.3 mt -57.07 -36.8 70.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.518 1.127 . . . . 0.0 111.13 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -69.58 -20.86 63.64 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.975 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -91.06 -29.77 17.14 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.237 -1.54 . . . . 0.0 110.317 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -62.15 -34.08 75.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.916 0.886 . . . . 0.0 109.197 167.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.553 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -72.72 -42.63 63.95 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 170.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 165' ' ' ALA . 3.2 mp -49.09 -31.88 8.75 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 120.615 1.552 . . . . 0.0 113.143 160.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -57.76 -16.47 23.86 Favored Glycine 0 CA--C 1.547 2.057 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 170.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -69.14 -19.72 64.02 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.171 1.986 . . . . 0.0 113.758 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 47.97 -65.51 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 130.969 3.708 . . . . 0.0 118.303 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -150.48 33.36 0.63 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.283 1.833 . . . . 0.0 112.484 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.83 -157.95 0.1 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.006 1.322 . . . . 0.0 113.312 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -135.35 149.11 49.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.895 2.078 . . . . 0.0 112.49 -169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.491 ' HB ' ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -106.1 -17.33 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -170.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.16 -39.66 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.409 1.957 . . . . 0.0 111.58 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -151.7 -44.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.688 . . . . 0.0 111.773 169.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.7 177.97 5.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.441 1.096 . . . . 0.0 112.44 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.31 113.82 14.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.12 1.768 . . . . 0.0 109.891 -128.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 2.8 mt -121.16 111.83 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.57 1.652 . . . . 0.0 111.809 -146.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 150.94 33.64 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 111.206 -2.724 . . . . 0.0 112.494 158.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.17 123.16 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 110.204 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -119.63 146.45 45.54 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.683 1.593 . . . . 0.0 109.543 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -66.15 136.03 55.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -144.68 172.14 13.41 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -166.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.636 ' O ' HG13 ' A' ' 191' ' ' VAL . 37.9 m -152.08 148.81 28.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.298 1.839 . . . . 0.0 109.729 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -31.29 -16.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.439 1 C-N-CA 132.147 4.179 . . . . 0.0 118.459 172.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -112.58 -16.71 12.79 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.91 1.684 . . . . 0.0 111.625 -168.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -80.48 -30.75 37.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 156.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 187' ' ' SER . 4.2 m -79.38 -42.48 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -163.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -79.47 -9.35 59.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.4 m -95.47 34.87 1.4 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.498 1.519 . . . . 0.0 111.62 -157.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.904 2.482 . . . . 0.0 111.94 -155.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -55.25 133.23 49.22 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.769 1.622 . . . . 0.0 110.773 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -138.37 150.35 46.47 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -153.87 150.74 28.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.868 1.267 . . . . 0.0 112.111 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.3 p 48.09 -50.51 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 1 C-N-CA 131.961 4.104 . . . . 0.0 119.257 -171.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 136.25 -28.84 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 1 C-N-CA 132.987 4.515 . . . . 0.0 110.787 -169.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -134.65 -25.98 1.42 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -165.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.76 55.26 1.05 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.129 2.172 . . . . 0.0 112.179 -177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.23 95.13 0.57 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 125.093 1.33 . . . . 0.0 111.363 164.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.8 m-85 -99.69 164.35 12.09 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 170.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.92 113.49 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.369 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 68.5 ttt180 -89.87 115.07 26.91 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.922 0.889 . . . . 0.0 110.455 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -67.66 146.53 53.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.317 157.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.82 151.09 48.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 140.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.9 -13.6 0.76 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.173 -1.579 . . . . 0.0 113.857 159.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.582 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 10.4 mt -67.91 153.21 95.61 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -141.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 89.7 Cg_endo -73.09 171.21 18.03 Favored 'Trans proline' 0 C--N 1.346 0.416 1 C-N-CA 126.754 4.969 . . . . 0.0 112.368 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -68.71 132.74 47.35 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.093 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.59 25.22 62.98 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.647 -168.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 118' ' ' LEU . 37.9 t -54.14 149.18 9.9 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.503 1.652 . . . . 0.0 113.124 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 t -145.54 161.17 40.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.738 1.256 . . . . 0.0 112.044 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.7 ttmt -46.71 -37.72 8.84 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 127.774 2.43 . . . . 0.0 113.496 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -71.74 -19.54 62.02 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 121.083 1.765 . . . . 0.0 114.041 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.88 -31.91 57.11 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 120.208 -1.558 . . . . 0.0 109.156 168.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.441 HD12 HD21 ' A' ' 143' ' ' LEU . 59.7 mt -68.73 -39.09 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.522 0.729 . . . . 0.0 111.338 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.9 m -65.43 -16.07 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.961 1.304 . . . . 0.0 112.803 173.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -95.67 -28.77 14.65 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.315 0.962 . . . . 0.0 112.794 164.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.4 t80 -61.45 -44.85 96.39 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.751 1.62 . . . . 0.0 111.011 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -118.53 34.99 4.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.357 1.463 . . . . 0.0 113.091 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 88.6 p -50.08 -24.02 2.45 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 155.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.64 -33.23 54.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.437 1.97 . . . . 0.0 115.673 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.1 mp -138.28 161.76 36.08 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.215 1.007 . . . . 0.0 113.092 -156.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.01 132.73 33.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.143 1.377 . . . . 0.0 112.321 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 53.2 mt -133.27 138.26 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 128.995 2.918 . . . . 0.0 108.13 -172.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.81 152.0 87.75 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.784 -0.573 . . . . 0.0 111.513 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.65 -14.69 10.76 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.026 3.151 . . . . 0.0 120.013 -165.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.59 21.85 5.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.308 1.443 . . . . 0.0 111.544 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.79 -24.57 57.68 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -166.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 66.7 mt -94.5 130.73 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.187 1.395 . . . . 0.0 109.539 -167.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 25.9 m -124.62 132.0 53.45 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.058 1.743 . . . . 0.0 112.744 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.441 HD21 HD12 ' A' ' 127' ' ' ILE . 3.0 mm? -121.85 87.46 46.68 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 127.715 2.406 . . . . 0.0 110.412 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.87 -86.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.985 1.79 . . . . 0.0 112.646 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.22 156.98 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 128.945 2.898 . . . . 0.0 109.104 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.523 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 1.3 p-10 -64.28 178.24 0.47 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 130.001 3.321 . . . . 0.0 115.031 -175.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.02 1.11 0.16 Allowed 'Trans proline' 0 CA--C 1.554 1.491 0 C-N-CA 124.48 3.453 . . . . 0.0 117.368 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -133.74 -32.84 1.1 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.279 1.854 . . . . 0.0 113.511 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.9 40.18 1.6 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.583 1.563 . . . . 0.0 114.911 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -132.35 -15.14 2.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 113.007 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.641 HD13 ' H ' ' A' ' 152' ' ' THR . 0.0 OUTLIER -161.86 -163.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 127.793 2.437 . . . . 0.0 107.99 -168.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.641 ' H ' HD13 ' A' ' 151' ' ' ILE . 11.3 p -122.61 30.26 6.55 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 123.273 2.76 . . . . 0.0 112.988 -170.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -53.43 1.33 0.03 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.159 2.79 . . . . 0.0 117.245 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.25 152.59 38.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.095 0.95 . . . . 0.0 111.138 158.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -166.8 176.34 7.17 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 127.742 2.417 . . . . 0.0 108.938 -163.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.57 ' CD2' HG12 ' A' ' 191' ' ' VAL . 92.7 m-85 -149.42 163.41 37.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.709 -166.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.7 127.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 112' ' ' PHE . 46.1 tp60 -96.17 131.07 43.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.484 2.314 . . . . 0.0 110.3 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.2 m-85 -94.74 -168.43 1.82 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.289 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.2 -10.4 59.63 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.88 -1.763 . . . . 0.0 113.311 163.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 m -159.22 158.11 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.077 0.951 . . . . 0.0 113.096 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -57.13 -26.54 60.69 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.684 1.594 . . . . 0.0 114.483 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.28 -54.8 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.822 1.649 . . . . 0.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.68 -37.81 66.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.85 1.66 . . . . 0.0 111.539 173.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.468 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.83 -17.2 64.43 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -110.3 -16.45 13.73 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.283 -1.511 . . . . 0.0 111.852 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.76 -38.69 86.1 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.963 0.905 . . . . 0.0 110.281 155.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.35 -44.04 80.0 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.3 mp -51.09 -27.85 9.22 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.93 -1.106 . . . . 0.0 113.75 165.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.92 -14.85 32.78 Favored Glycine 0 CA--C 1.547 2.076 0 C-N-CA 125.262 1.411 . . . . 0.0 115.592 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -65.44 -17.66 64.72 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 119.886 1.843 . . . . 0.0 114.585 165.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 37.27 -47.57 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 C-N-CA 132.967 4.507 . . . . 0.0 120.982 171.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 19.5 1.11 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.166 1.787 . . . . 0.0 113.843 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -59.89 179.48 0.13 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.6 ttp85 -119.33 149.15 42.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.112 2.965 . . . . 0.0 109.043 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.47 HG13 ' CD1' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -115.88 -29.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.494 1.118 . . . . 0.0 113.041 -173.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -171.56 -112.02 0.27 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 127.074 2.273 . . . . 0.0 108.139 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.61 -39.52 84.75 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.795 1.298 . . . . 0.0 113.151 164.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 -177.87 3.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.462 1.505 . . . . 0.0 114.973 -164.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.685 1.594 . . . . 0.0 108.261 -140.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 176' ' ' ILE . 5.1 mt -128.4 136.5 59.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 122.814 1.292 . . . . 0.0 112.362 -142.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.253 3.3 mp0 -83.13 156.42 23.27 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 130.589 3.556 . . . . 0.0 112.456 164.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.63 133.07 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.945 0.898 . . . . 0.0 111.091 172.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.24 144.75 47.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.967 1.707 . . . . 0.0 109.759 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -75.51 139.2 42.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.74 1.216 . . . . 0.0 110.703 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.7 m -149.39 166.77 28.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.741 -158.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 m -143.58 148.01 35.27 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.805 1.642 . . . . 0.0 108.798 165.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.436 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -13.79 -18.61 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 135.259 5.423 . . . . 0.0 120.642 169.104 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -122.46 -6.19 8.73 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 120.356 -1.465 . . . . 0.0 111.715 -167.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -76.51 -21.64 55.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.641 153.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.57 HG12 ' CD2' ' A' ' 156' ' ' PHE . 3.8 m -96.09 -35.15 5.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -149.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.61 5.33 52.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 0.0 113.218 -171.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.6 m -81.68 40.64 0.6 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.056 2.143 . . . . 0.0 114.766 -155.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 126.92 2.088 . . . . 0.0 114.321 -177.115 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.273 5.5 p30 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m 161.91 -41.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 129.322 3.049 . . . . 0.0 111.32 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.12 -13.1 28.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.714 1.206 . . . . 0.0 113.914 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -79.8 176.94 9.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.958 2.103 . . . . 0.0 113.813 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.9 p -138.28 148.46 44.71 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -165.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.29 -61.27 0.38 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.446 1.899 . . . . 0.0 112.068 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.61 -40.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.092 1.757 . . . . 0.0 112.312 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.75 43.58 0.34 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 112.571 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.18 99.08 0.85 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.858 1.218 . . . . 0.0 111.218 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.688 ' CD2' HG11 ' A' ' 191' ' ' VAL . 23.7 m-85 -97.12 163.09 13.08 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 167.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.79 115.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.582 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -92.32 137.35 32.44 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.126 0.97 . . . . 0.0 112.79 -173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.62 151.16 23.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.236 2.614 . . . . 0.0 110.86 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -157.62 75.08 0.77 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.021 1.728 . . . . 0.0 108.599 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.67 -6.95 0.03 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -163.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 2.0 mt -77.46 153.89 81.6 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-N 118.18 0.99 . . . . 0.0 113.653 -157.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 90.7 Cg_endo -81.1 173.85 11.43 Favored 'Trans proline' 0 C--N 1.344 0.335 1 C-N-CA 126.937 5.091 . . . . 0.0 113.312 -179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -62.9 131.2 47.93 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.876 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.482 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 68.57 19.22 72.71 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 117.955 -1.469 . . . . 0.0 115.597 -172.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 37.8 t -56.56 149.23 17.82 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 120.14 1.97 . . . . 0.0 113.842 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.0 t -143.73 161.59 38.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.553 1.168 . . . . 0.0 112.806 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.647 ' O ' HG13 ' A' ' 128' ' ' VAL . 23.4 ttmt -44.92 -42.4 8.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.598 2.759 . . . . 0.0 114.074 172.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.48 -21.36 66.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 121.25 1.841 . . . . 0.0 114.307 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -79.37 -33.32 42.98 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 119.787 -1.821 . . . . 0.0 109.674 170.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.499 HD12 HD21 ' A' ' 143' ' ' LEU . 66.7 mt -62.8 -38.67 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.456 -0.778 . . . . 0.0 111.038 166.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 124' ' ' LYS 0.268 1.1 m -68.34 -12.46 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 113.702 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.62 -27.29 14.88 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.673 1.124 . . . . 0.0 113.355 161.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -64.12 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.122 1.769 . . . . 0.0 111.266 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -120.84 34.61 5.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.833 1.653 . . . . 0.0 112.786 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.1 p -50.93 -22.62 2.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 156.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.6 -35.14 51.14 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.787 1.661 . . . . 0.0 115.301 170.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.5 156.46 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.201 1.0 . . . . 0.0 112.575 -149.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.3 140.51 33.55 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.224 -0.922 . . . . 0.0 112.098 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 47.7 mt -136.04 137.7 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 128.269 2.627 . . . . 0.0 107.524 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -62.18 153.05 76.5 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-O 118.842 -0.599 . . . . 0.0 111.29 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.51 -8.51 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.525 3.483 . . . . 0.0 120.607 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -140.13 21.76 2.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.871 2.068 . . . . 0.0 111.516 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.8 -16.98 53.46 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 -163.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 61.6 mt -105.35 134.74 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 119.081 1.44 . . . . 0.0 109.497 -163.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.3 m -129.57 135.43 48.57 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.564 1.545 . . . . 0.0 112.773 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -123.01 86.07 50.92 Favored Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 127.033 2.133 . . . . 0.0 111.369 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 155' ' ' ALA . 65.6 Cg_endo -71.93 -66.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.338 2.025 . . . . 0.0 113.46 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.88 -179.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 130.188 3.395 . . . . 0.0 108.306 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -77.02 170.08 18.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 119.149 -2.219 . . . . 0.0 114.169 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -55.97 2.82 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 125.227 3.951 . . . . 0.0 117.198 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -127.65 2.28 6.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.603 1.561 . . . . 0.0 111.729 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.86 34.97 51.82 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.363 -1.243 . . . . 0.0 116.203 164.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -132.68 -14.35 2.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.654 1.727 . . . . 0.0 112.835 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 121' ' ' GLY 0.279 0.0 OUTLIER -143.85 -110.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 117.475 -1.25 . . . . 0.0 113.574 -168.642 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 151' ' ' ILE . 1.4 p -178.78 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 130.088 3.355 . . . . 0.0 107.486 -167.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -137.84 1.3 2.84 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 129.258 3.313 . . . . 0.0 113.876 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -138.15 162.35 34.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.7 1.6 . . . . 0.0 109.445 159.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . . . -173.73 -178.7 1.64 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.509 1.924 . . . . 0.0 110.733 -168.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.503 ' CD1' HG12 ' A' ' 191' ' ' VAL . 96.9 m-85 -153.71 152.99 31.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.694 1.198 . . . . 0.0 110.315 -168.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.42 127.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -91.51 133.81 35.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.555 2.342 . . . . 0.0 110.328 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 4.6 m-85 -97.44 -175.38 3.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.846 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.51 58.56 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.707 -1.246 . . . . 0.0 113.191 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.0 m -166.4 158.57 13.87 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.025 1.33 . . . . 0.0 111.998 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -84.71 50.16 1.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.125 1.37 . . . . 0.0 110.272 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -139.6 -55.07 0.56 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.15 2.98 . . . . 0.0 108.485 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 49.3 mt -54.41 -41.49 69.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.749 2.02 . . . . 0.0 111.65 164.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -67.52 -18.46 65.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.63 -29.15 15.6 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.794 -1.192 . . . . 0.0 109.15 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -66.12 -36.84 84.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.301 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -66.87 -39.03 87.41 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 165' ' ' ALA . 2.6 mp -51.27 -24.36 4.41 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 120.744 -1.223 . . . . 0.0 113.974 162.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -66.36 -17.46 66.32 Favored Glycine 0 CA--C 1.546 2.006 0 C-N-CA 124.98 1.276 . . . . 0.0 115.191 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -75.16 15.59 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.195 1.997 . . . . 0.0 115.605 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -51.82 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 130.317 3.447 . . . . 0.0 119.507 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.68 17.59 0.9 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.214 1.805 . . . . 0.0 114.222 -169.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -114.21 -170.8 1.79 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.059 1.344 . . . . 0.0 112.592 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.05 151.36 47.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.883 2.073 . . . . 0.0 110.977 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.23 -38.05 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.131 1.372 . . . . 0.0 112.695 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -156.41 -78.92 0.02 OUTLIER Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.951 1.262 . . . . 0.0 110.517 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -108.18 -18.84 13.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.407 1.083 . . . . 0.0 113.466 169.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -128.05 -178.06 4.38 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.14 1.776 . . . . 0.0 113.639 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -149.8 117.25 6.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -119.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.4 mt -123.96 129.26 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 123.537 1.637 . . . . 0.0 112.95 -138.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.16 153.18 36.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.843 2.857 . . . . 0.0 112.798 165.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.76 134.69 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 111.897 171.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -137.99 153.67 49.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.292 1.837 . . . . 0.0 110.258 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -75.03 145.99 41.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.386 0.675 . . . . 0.0 111.656 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.4 m -153.11 168.46 25.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 124.112 0.883 . . . . 0.0 111.728 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 67.2 m -149.62 158.3 44.05 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.422 1.489 . . . . 0.0 110.504 168.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.401 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 2.6 tp60 -33.43 -0.85 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 1 C-N-CA 134.019 4.928 . . . . 0.0 119.926 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -131.91 -10.89 3.42 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 119.951 -1.718 . . . . 0.0 113.519 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.96 -29.97 28.66 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 112' ' ' PHE . 34.9 m -80.44 -30.2 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.718 1.207 . . . . 0.0 112.97 -158.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -83.63 49.67 1.64 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.773 1.629 . . . . 0.0 111.409 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.0 t -66.93 -3.56 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.193 1.797 . . . . 0.0 114.163 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.276 0 C-N-CA 127.793 2.437 . . . . 0.0 115.17 -174.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.663 ' N ' ' HG ' ' A' ' 187' ' ' SER . 11.0 t-20 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.227 -0.892 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.9 p 59.65 -35.05 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 129.008 2.923 . . . . 0.0 117.127 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.63 -38.08 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.882 2.473 . . . . 0.0 111.837 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -139.33 159.06 43.04 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.5 t 169.18 -172.26 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 130.427 3.491 . . . . 0.0 107.65 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.46 59.82 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.747 -1.221 . . . . 0.0 113.667 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 -26.23 0.38 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -167.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.256 4.5 p-10 -75.05 52.82 0.58 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.43 1.492 . . . . 0.0 113.628 177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.03 99.64 1.3 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.686 2.088 . . . . 0.0 111.574 170.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.607 ' CD2' HG11 ' A' ' 191' ' ' VAL . 25.7 m-85 -107.91 165.43 11.46 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.74 117.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.819 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -89.02 135.67 33.43 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.48 151.88 24.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.026 2.53 . . . . 0.0 110.467 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -157.66 76.13 0.8 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.098 1.759 . . . . 0.0 108.64 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.54 -13.2 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 116.756 1.462 . . . . 0.0 116.756 -163.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.574 HD22 HD13 ' A' ' 181' ' ' ILE . 0.4 OUTLIER -76.5 151.13 82.84 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 118.422 1.111 . . . . 0.0 112.846 -153.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.82 175.13 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.271 1 C-N-CA 125.621 4.214 . . . . 0.0 113.431 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -68.47 134.44 50.13 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.87 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.38 14.7 67.06 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 117.935 -1.481 . . . . 0.0 115.179 -170.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.91 151.48 18.1 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.412 2.106 . . . . 0.0 112.862 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.1 t -146.49 166.23 27.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.563 1.173 . . . . 0.0 111.45 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -47.49 -43.78 24.84 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 127.415 2.286 . . . . 0.0 112.488 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HA ' HG13 ' A' ' 128' ' ' VAL . 40.6 mp0 -67.17 -18.77 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.568 1.531 . . . . 0.0 113.846 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -79.73 -25.36 41.13 Favored 'General case' 0 C--O 1.227 -0.097 0 O-C-N 119.498 -2.001 . . . . 0.0 110.807 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 143' ' ' LEU . 52.6 mt -71.6 -36.54 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.484 0.714 . . . . 0.0 111.009 164.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.269 1.7 m -60.91 -18.73 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.326 168.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -97.82 -25.13 15.15 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.693 1.588 . . . . 0.0 113.347 165.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.88 -42.95 94.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.834 0.853 . . . . 0.0 110.333 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -117.74 42.04 2.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.529 1.131 . . . . 0.0 113.896 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.0 p -67.58 64.77 0.08 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.966 1.365 . . . . 0.0 110.822 154.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.32 -41.21 0.02 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.34 1.447 . . . . 0.0 112.178 -156.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 mp -138.38 154.47 48.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.226 1.81 . . . . 0.0 110.785 -168.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.11 140.53 45.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.114 0.965 . . . . 0.0 112.431 -177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.3 mt -143.9 131.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 128.903 2.881 . . . . 0.0 107.072 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.76 152.72 74.72 Favored Pre-proline 0 N--CA 1.486 1.373 0 CA-C-O 118.723 -0.655 . . . . 0.0 111.301 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.15 -25.47 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 N-CA-C 120.287 3.149 . . . . 0.0 120.287 -160.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -133.36 41.75 3.06 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.631 1.173 . . . . 0.0 110.432 166.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.82 -29.14 49.5 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.028 1.299 . . . . 0.0 114.576 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 128' ' ' VAL . 71.8 mt -89.6 131.51 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 125.77 1.628 . . . . 0.0 109.342 -169.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 16.3 m -129.46 132.32 46.91 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.4 1.88 . . . . 0.0 112.888 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 127' ' ' ILE . 3.7 mm? -127.7 92.13 43.57 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 126.981 2.112 . . . . 0.0 112.373 -166.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.32 -65.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.605 1.536 . . . . 0.0 114.352 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.8 177.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 129.43 3.092 . . . . 0.0 109.094 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.573 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.3 p-10 -81.23 172.07 10.66 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 120.006 -1.684 . . . . 0.0 114.273 163.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.11 -0.34 0.28 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 C-N-CA 125.019 3.813 . . . . 0.0 117.166 171.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -127.76 -0.91 6.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 111.786 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.66 39.68 48.13 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -129.34 -17.18 3.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.956 1.703 . . . . 0.0 112.307 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.559 HG23 ' H ' ' A' ' 152' ' ' THR 0.298 0.0 OUTLIER -143.49 -112.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -169.633 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.559 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -176.84 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.644 3.178 . . . . 0.0 109.161 -167.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.573 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -113.96 6.3 23.78 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.993 2.711 . . . . 0.0 114.413 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -134.41 157.53 46.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.852 1.261 . . . . 0.0 108.926 157.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.32 -178.93 3.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.206 1.402 . . . . 0.0 110.665 -167.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.625 ' CD1' HG12 ' A' ' 191' ' ' VAL . 95.6 m-85 -152.87 157.71 41.09 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.524 1.13 . . . . 0.0 109.421 -169.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.68 120.76 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 45.6 tp60 -83.18 135.43 34.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 126.546 1.938 . . . . 0.0 109.693 170.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.5 m-85 -92.39 -157.43 0.52 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.434 0.693 . . . . 0.0 110.335 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.04 59.26 Favored 'General case' 0 CA--C 1.549 0.935 0 O-C-N 120.131 -1.606 . . . . 0.0 112.335 157.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.65 166.99 31.38 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 4.7 tp60 -61.28 -16.92 50.55 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.759 1.623 . . . . 0.0 114.638 165.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 -48.03 3.76 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.844 1.657 . . . . 0.0 111.232 -166.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.29 -37.19 23.1 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.686 1.194 . . . . 0.0 111.957 161.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -71.21 -23.12 61.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -88.03 -32.38 18.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.775 2.03 . . . . 0.0 110.329 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.67 -40.69 88.59 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 126.207 1.803 . . . . 0.0 110.346 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -67.13 -43.44 82.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.497 1.919 . . . . 0.0 114.444 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -54.99 -21.34 11.56 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 171.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.8 -12.84 7.25 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 125.138 1.351 . . . . 0.0 115.213 172.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -53.57 -46.88 70.45 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.403 1.602 . . . . 0.0 113.175 161.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 51.03 -52.87 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.847 3.659 . . . . 0.0 117.0 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -147.27 106.72 3.91 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.507 2.323 . . . . 0.0 108.652 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.67 -166.7 2.19 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.639 1.176 . . . . 0.0 112.125 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -130.81 152.14 50.48 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.92 1.691 . . . . 0.0 114.088 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.401 ' HB ' HD11 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -99.93 -22.88 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.639 1.176 . . . . 0.0 112.845 173.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -178.44 -52.83 0.07 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.545 1.069 . . . . 0.0 112.755 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 -10.85 0.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.25 1.42 . . . . 0.0 114.49 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -123.8 -179.86 4.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.242 1.417 . . . . 0.0 112.427 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.68 108.77 5.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.601 -1.636 . . . . 0.0 107.696 -118.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.574 HD13 HD22 ' A' ' 118' ' ' LEU . 3.0 mt -117.33 116.57 52.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 123.138 1.447 . . . . 0.0 110.232 -144.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.15 156.16 25.94 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 128.852 2.861 . . . . 0.0 113.161 165.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.97 132.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.651 0.781 . . . . 0.0 111.36 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.28 144.43 40.49 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.146 1.778 . . . . 0.0 110.017 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.2 tttt -72.49 152.54 41.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.706 -0.622 . . . . 0.0 111.289 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.66 170.08 20.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.009 -160.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.663 ' HG ' ' N ' ' A' ' 103' ' ' ASN . 18.7 m -155.72 162.48 40.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.216 1.806 . . . . 0.0 111.783 171.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 3.8 tp-100 -37.34 5.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 1 C-N-CA 133.118 4.567 . . . . 0.0 120.245 177.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -143.56 2.17 1.23 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 168.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.73 -20.39 21.6 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.701 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.625 HG12 ' CD1' ' A' ' 156' ' ' PHE . 34.5 m -84.17 -23.97 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 128.302 2.641 . . . . 0.0 112.805 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -83.56 37.36 0.57 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.815 2.846 . . . . 0.0 113.56 -168.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.0 t -65.5 -4.13 5.44 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.272 1.029 . . . . 0.0 112.36 163.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.256 0 C-N-CA 127.055 2.142 . . . . 0.0 110.043 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.4 p 179.91 172.49 1.02 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.821 1.248 . . . . 0.0 112.632 -169.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.54 -17.48 53.91 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 165.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -153.44 154.83 35.18 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.306 1.442 . . . . 0.0 111.662 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.5 p -156.75 -118.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.353 1.461 . . . . 0.0 112.906 -169.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.02 -40.89 0.08 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.515 1.926 . . . . 0.0 113.034 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -125.44 -41.88 2.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -167.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.66 42.95 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.286 2.234 . . . . 0.0 112.275 173.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.431 ' HA2' ' CD ' ' A' ' 162' ' ' GLN . . . -53.06 99.24 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 128.15 2.786 . . . . 0.0 114.818 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.55 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.0 m-85 -116.84 161.3 19.52 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.859 1.329 . . . . 0.0 108.593 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.4 125.73 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.109 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt85 -94.08 142.36 27.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 0.0 111.227 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.89 154.66 21.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.044 2.538 . . . . 0.0 110.589 172.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -156.19 78.29 0.95 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 110.711 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.53 -15.36 0.02 OUTLIER Glycine 0 CA--C 1.544 1.844 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -174.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 176' ' ' ILE . 0.7 OUTLIER -65.28 159.15 68.36 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 128.444 2.698 . . . . 0.0 116.897 -153.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 74.0 Cg_endo -82.83 167.94 14.26 Favored 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 126.186 4.591 . . . . 0.0 113.988 -173.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -69.59 98.22 1.13 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.511 2.325 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.664 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 97.72 23.51 13.64 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.394 1.473 . . . . 0.0 114.704 -168.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.3 t -53.2 152.89 4.06 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.191 1.995 . . . . 0.0 113.879 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 t -143.64 159.57 42.23 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.114 0.959 . . . . 0.0 112.331 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -44.08 -46.43 8.55 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.609 1.963 . . . . 0.0 112.097 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.458 ' HA ' HG13 ' A' ' 128' ' ' VAL . 39.4 mp0 -65.61 -12.54 54.15 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.911 1.685 . . . . 0.0 114.717 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -82.65 -33.19 27.85 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 119.995 -1.691 . . . . 0.0 108.873 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.49 -40.19 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.909 -0.494 . . . . 0.0 111.987 164.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.262 1.4 m -58.19 -22.02 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.605 170.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.72 -25.55 17.39 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.462 1.483 . . . . 0.0 113.012 169.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 176' ' ' ILE . 6.1 t80 -62.35 -49.48 75.43 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.685 1.194 . . . . 0.0 110.08 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.57 ' CE1' ' HB1' ' A' ' 168' ' ' ALA . 36.8 m-85 -113.14 31.88 6.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.736 1.214 . . . . 0.0 112.69 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -53.43 -20.96 5.27 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 157.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.75 43.74 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.989 1.757 . . . . 0.0 115.724 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.03 173.92 11.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 112.925 -156.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.1 118.93 33.66 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.39 1.476 . . . . 0.0 111.922 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 49.3 mt -118.29 135.23 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 128.885 2.874 . . . . 0.0 107.546 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.97 153.27 85.26 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.008 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -51.16 -13.83 1.25 Allowed 'Trans proline' 0 CA--C 1.537 0.662 1 N-CA-C 122.651 4.058 . . . . 0.0 122.651 -160.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -134.22 12.55 3.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.654 1.57 . . . . 0.0 111.906 172.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.87 -12.66 1.25 Allowed Glycine 0 N--CA 1.48 1.589 0 C-N-CA 128.016 2.722 . . . . 0.0 119.315 -150.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.448 ' CD1' HG12 ' A' ' 128' ' ' VAL . 66.9 mt -95.57 135.3 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 127.214 2.205 . . . . 0.0 109.826 -166.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.5 m -122.98 136.21 54.77 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.558 1.526 . . . . 0.0 113.381 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.38 97.33 40.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 127.64 2.376 . . . . 0.0 111.595 -173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.43 -86.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.429 2.086 . . . . 0.0 113.643 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.41 177.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 130.407 3.483 . . . . 0.0 107.972 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.527 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 6.7 p-10 -74.68 175.12 4.22 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.613 1.965 . . . . 0.0 114.669 171.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.55 -6.86 1.74 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.908 3.739 . . . . 0.0 117.789 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -118.08 -30.79 5.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.113 1.779 . . . . 0.0 111.342 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 111.41 37.5 1.61 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.148 -0.807 . . . . 0.0 114.927 161.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.82 -2.86 4.69 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.918 1.287 . . . . 0.0 113.506 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.664 HD11 ' H ' ' A' ' 121' ' ' GLY 0.302 0.0 OUTLIER -140.68 -100.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.501 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.577 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.4 OUTLIER 164.84 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.918 3.687 . . . . 0.0 108.785 -164.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.527 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -120.16 11.28 10.74 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 128.673 3.035 . . . . 0.0 114.707 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -140.41 158.99 43.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.946 1.698 . . . . 0.0 108.079 155.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -168.31 -179.86 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.689 1.996 . . . . 0.0 109.267 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.9 m-85 -151.89 160.49 43.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.143 0.977 . . . . 0.0 110.031 -169.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.6 p -160.54 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.428 HE22 ' N ' ' A' ' 111' ' ' GLY . 67.9 tp60 -87.25 138.85 31.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.367 2.267 . . . . 0.0 111.575 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 6.3 m-85 -109.36 -175.67 2.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.496 1.518 . . . . 0.0 110.278 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.18 -10.2 59.52 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 119.396 -2.065 . . . . 0.0 113.025 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 m -161.87 158.7 25.85 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.589 1.156 . . . . 0.0 112.889 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.431 ' CD ' ' HA2' ' A' ' 111' ' ' GLY . 4.9 tp-100 -72.5 0.61 9.89 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.473 1.509 . . . . 0.0 113.696 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.75 -49.24 5.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.352 1.861 . . . . 0.0 111.429 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.3 mt -55.03 -36.57 65.65 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.754 1.222 . . . . 0.0 111.925 167.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.26 67.28 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.95 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -90.97 -27.62 18.56 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.659 1.584 . . . . 0.0 110.663 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -59.83 -36.43 76.79 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.884 1.273 . . . . 0.0 110.012 165.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.57 ' HB1' ' CE1' ' A' ' 131' ' ' PHE . . . -73.21 -39.77 65.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.312 1.845 . . . . 0.0 115.685 172.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.05 -33.27 56.98 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.181 -1.574 . . . . 0.0 112.183 162.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -56.55 -13.7 8.15 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 125.832 1.682 . . . . 0.0 115.706 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -59.1 -39.12 81.25 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 119.4 1.6 . . . . 0.0 113.135 164.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 50.83 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 130.559 3.543 . . . . 0.0 117.954 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.77 119.84 4.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.364 1.465 . . . . 0.0 110.981 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -151.37 -147.28 0.22 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.321 1.449 . . . . 0.0 110.691 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.1 ttp85 -147.65 148.02 30.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.775 2.83 . . . . 0.0 109.643 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -114.71 -35.97 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.861 1.264 . . . . 0.0 111.585 -170.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -147.32 -117.94 1.02 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.413 1.958 . . . . 0.0 108.788 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -42.58 98.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.974 1.387 . . . . 0.0 111.954 162.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -95.94 -177.77 4.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.235 1.014 . . . . 0.0 113.708 -169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.514 ' C ' HD12 ' A' ' 181' ' ' ILE . 5.6 m-85 -133.98 116.94 16.13 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.065 2.146 . . . . 0.0 109.78 -144.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.548 HD11 ' HA ' ' A' ' 118' ' ' LEU . 1.9 mp -122.84 157.42 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 123.789 1.757 . . . . 0.0 111.918 -149.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . 0.262 1.1 mm-40 -128.2 159.42 35.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 130.992 3.717 . . . . 0.0 110.186 -164.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.69 142.61 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.28 150.14 35.19 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.097 2.159 . . . . 0.0 109.921 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -82.02 151.59 27.05 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.234 -0.916 . . . . 0.0 112.51 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 m -158.58 165.44 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.959 -161.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.35 156.48 42.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.749 1.619 . . . . 0.0 111.173 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.534 ' HA ' HG21 ' A' ' 191' ' ' VAL . 4.2 tp60 -40.81 2.94 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 1 C-N-CA 133.873 4.869 . . . . 0.0 120.269 -175.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -126.34 -22.24 4.05 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 119.772 -1.83 . . . . 0.0 112.247 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.48 -2.05 52.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.348 1.459 . . . . 0.0 110.558 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 156' ' ' PHE . 10.7 m -118.72 -25.68 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 128.752 2.821 . . . . 0.0 113.15 -160.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -89.59 50.84 1.97 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.426 1.49 . . . . 0.0 111.481 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 7.2 t -69.63 8.1 0.72 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.825 2.05 . . . . 0.0 114.081 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.39 2.276 . . . . 0.0 111.162 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.1 t -44.84 -42.98 8.38 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 -153.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.1 35.9 1.92 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.74 1.155 . . . . 0.0 111.793 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -159.78 -172.86 3.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.72 2.008 . . . . 0.0 111.799 -160.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 p -34.11 109.01 0.07 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.241 2.216 . . . . 0.0 114.743 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.86 -33.77 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.502 2.721 . . . . 0.0 114.596 1.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -127.25 -20.72 4.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -71.72 44.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 130.223 3.409 . . . . 0.0 113.744 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.22 95.41 0.43 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.824 2.154 . . . . 0.0 110.25 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 191' ' ' VAL . 2.9 m-85 -105.49 161.62 14.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.72 121.82 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.118 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 156' ' ' PHE . 36.5 ttt85 -94.4 133.66 37.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 124.445 1.098 . . . . 0.0 111.381 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.28 152.42 19.81 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.365 1.866 . . . . 0.0 111.994 167.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 135.33 39.08 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 146.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 166.03 -18.81 0.1 OUTLIER Glycine 0 CA--C 1.531 1.086 0 O-C-N 119.823 -1.798 . . . . 0.0 113.77 152.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.543 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 1.4 mt -55.52 148.6 33.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.284 3.034 . . . . 0.0 115.335 -152.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.72 175.59 11.1 Favored 'Trans proline' 0 C--N 1.344 0.294 1 C-N-CA 126.35 4.7 . . . . 0.0 112.796 178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -66.75 135.09 53.46 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.491 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.14 22.3 57.89 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-O 117.929 -1.484 . . . . 0.0 114.959 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 118' ' ' LEU . 35.4 t -57.24 151.43 15.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.037 1.918 . . . . 0.0 112.18 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 165.09 28.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 123.177 1.465 . . . . 0.0 112.267 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 128' ' ' VAL . 26.0 ttmt -44.99 -40.6 6.58 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 127.872 2.469 . . . . 0.0 113.534 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -70.39 -17.88 63.04 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 121.317 1.871 . . . . 0.0 114.027 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -77.09 -31.99 56.35 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 119.894 -1.754 . . . . 0.0 108.96 168.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 143' ' ' LEU . 52.5 mt -68.69 -38.1 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 O-C-N 121.155 -0.966 . . . . 0.0 111.815 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -63.72 -17.11 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.748 1.219 . . . . 0.0 112.924 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.79 -23.7 15.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.11 1.323 . . . . 0.0 112.129 166.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 176' ' ' ILE . 9.9 t80 -61.22 -49.38 77.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.047 1.339 . . . . 0.0 109.777 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.86 33.23 5.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.443 1.497 . . . . 0.0 112.698 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 90.9 p -50.17 -22.03 1.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 156.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -49.49 -37.75 26.55 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.085 1.802 . . . . 0.0 115.347 168.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.04 168.01 20.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.428 1.091 . . . . 0.0 113.65 -153.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.62 128.6 36.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.914 1.685 . . . . 0.0 112.019 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 65.1 mt -128.8 134.81 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 128.659 2.784 . . . . 0.0 107.418 -174.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.2 m -65.19 154.03 88.06 Favored Pre-proline 0 N--CA 1.484 1.226 0 O-C-N 121.81 -0.556 . . . . 0.0 111.544 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.38 -7.33 1.92 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.239 3.293 . . . . 0.0 119.814 -169.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -127.35 12.97 7.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.004 1.322 . . . . 0.0 112.209 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.53 72.03 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -152.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.454 ' CG2' ' HG3' ' A' ' 124' ' ' LYS . 64.1 mt -93.93 132.23 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.832 1.253 . . . . 0.0 109.335 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.8 m -124.08 132.87 53.71 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.806 1.642 . . . . 0.0 112.67 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.511 HD21 HD12 ' A' ' 127' ' ' ILE . 3.1 mm? -121.95 93.13 48.75 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 127.511 2.324 . . . . 0.0 110.921 -175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.31 -65.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.235 1.29 . . . . 0.0 113.162 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.71 175.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 129.72 3.208 . . . . 0.0 109.163 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.514 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 11.0 p-10 -72.95 171.6 9.93 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 119.818 -1.801 . . . . 0.0 114.316 160.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.18 2.48 0.13 Allowed 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 124.729 3.619 . . . . 0.0 117.151 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -128.62 -1.32 5.48 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.686 1.594 . . . . 0.0 112.008 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.25 36.07 28.29 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -132.42 -16.22 2.74 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.713 1.756 . . . . 0.0 112.792 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 152' ' ' THR 0.288 0.0 OUTLIER -141.97 -112.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 117.627 -1.178 . . . . 0.0 113.508 -170.468 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.438 ' H ' HG23 ' A' ' 151' ' ' ILE . 1.2 p -177.86 80.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.871 3.268 . . . . 0.0 107.433 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -128.56 5.59 6.64 Favored Glycine 0 N--CA 1.474 1.218 0 C-N-CA 128.151 2.786 . . . . 0.0 115.429 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.17 161.87 36.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.512 1.525 . . . . 0.0 108.365 157.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.43 -179.53 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.924 1.689 . . . . 0.0 109.063 -166.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.549 ' CD1' HG12 ' A' ' 191' ' ' VAL . 97.7 m-85 -153.4 158.76 41.95 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.342 0.657 . . . . 0.0 110.25 -167.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -158.54 123.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -92.47 129.92 38.28 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 127.557 2.343 . . . . 0.0 110.99 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 7.4 m-85 -97.87 -168.5 1.68 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 110.046 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.02 -10.23 59.5 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.024 -1.672 . . . . 0.0 113.733 165.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.9 m -162.65 158.33 23.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -69.99 43.79 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.829 2.452 . . . . 0.0 112.831 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -149.82 -56.53 0.18 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.613 1.965 . . . . 0.0 110.252 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.1 mt -54.2 -41.66 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.418 1.487 . . . . 0.0 111.339 163.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 169' ' ' LEU . . . -70.21 -12.47 61.62 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.51 -31.06 12.53 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.572 -1.33 . . . . 0.0 109.656 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -63.62 -35.36 80.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.951 1.3 . . . . 0.0 109.537 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.5 73.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.215 1.806 . . . . 0.0 115.544 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 165' ' ' ALA . 1.7 mp -52.62 -32.64 42.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.536 -1.353 . . . . 0.0 113.279 164.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.6 -11.87 11.77 Favored Glycine 0 CA--C 1.546 1.984 0 C-N-CA 125.573 1.558 . . . . 0.0 115.631 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -59.21 -38.26 79.48 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.187 1.494 . . . . 0.0 113.474 165.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.79 -60.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 129.527 3.131 . . . . 0.0 116.423 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 105.19 4.55 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.897 2.079 . . . . 0.0 110.754 -174.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -145.58 -163.25 1.68 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.184 1.794 . . . . 0.0 110.335 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.11 156.23 44.76 Favored 'General case' 0 C--O 1.23 0.079 0 C-N-CA 128.651 2.781 . . . . 0.0 109.283 -173.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.464 HD12 ' CD1' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -123.77 -39.93 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.145 0.578 . . . . 0.0 111.509 -165.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.66 -98.56 0.48 Allowed Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.801 1.667 . . . . 0.0 109.956 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -46.28 14.64 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.799 1.3 . . . . 0.0 112.132 162.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -95.28 -178.1 4.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.919 1.288 . . . . 0.0 114.13 -167.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.502 ' C ' HD12 ' A' ' 181' ' ' ILE . 6.1 m-85 -132.78 125.68 30.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 110.568 -143.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.502 HD12 ' C ' ' A' ' 180' ' ' TYR . 1.8 mp -125.06 134.42 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 123.447 1.594 . . . . 0.0 112.553 -147.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.07 157.25 35.09 Favored 'General case' 0 CA--C 1.538 0.489 1 C-N-CA 132.127 4.171 . . . . 0.0 114.251 164.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 9.1 m -136.86 136.59 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.228 1.011 . . . . 0.0 111.463 168.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -138.91 151.64 47.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.076 2.151 . . . . 0.0 109.139 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -90.52 143.73 26.46 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.493 -0.754 . . . . 0.0 111.72 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -149.95 165.96 31.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.607 -157.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 5.0 m -147.12 160.26 42.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.107 1.763 . . . . 0.0 110.534 170.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.0 tp60 -40.51 4.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.1 1 C-N-CA 133.478 4.711 . . . . 0.0 119.021 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.66 -15.18 5.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.769 2.028 . . . . 0.0 114.028 -175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -114.3 -19.96 11.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.511 2.325 . . . . 0.0 110.109 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 112' ' ' PHE . 19.2 m -79.21 -23.08 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 129.883 3.273 . . . . 0.0 114.31 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.43 63.86 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.252 1.821 . . . . 0.0 109.193 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.1 m -54.79 -31.65 59.2 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.779 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.229 0 C-N-CA 128.4 2.68 . . . . 0.0 113.657 156.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.3 p30 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.4 m -147.3 32.65 0.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.31 1.844 . . . . 0.0 111.539 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.66 54.83 1.59 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.9 2.48 . . . . 0.0 107.998 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.34 159.45 26.07 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -147.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.2 t -166.79 -176.85 3.62 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.605 2.762 . . . . 0.0 108.964 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.45 -28.16 41.63 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.917 -1.114 . . . . 0.0 112.966 163.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -34.37 0.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 -167.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.49 51.15 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.477 1.132 . . . . 0.0 113.381 -163.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 162' ' ' GLN . . . -76.26 89.6 0.9 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 126.169 1.842 . . . . 0.0 110.985 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CG ' HG11 ' A' ' 191' ' ' VAL . 5.0 m-85 -95.27 164.58 12.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 167.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.76 120.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 76.4 ttt180 -95.39 136.94 35.12 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.583 0.753 . . . . 0.0 111.95 -176.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -105.67 148.89 26.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.653 2.781 . . . . 0.0 109.775 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -154.11 78.28 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.948 1.299 . . . . 0.0 109.383 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 179.9 -3.81 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 -163.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 153' ' ' GLY . 0.5 OUTLIER -79.88 151.43 73.57 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 118.61 1.205 . . . . 0.0 112.117 -161.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' CG ' HG22 ' A' ' 176' ' ' ILE . 95.8 Cg_endo -80.17 174.91 10.89 Favored 'Trans proline' 0 CA--C 1.533 0.473 1 C-N-CA 126.598 4.865 . . . . 0.0 113.715 -177.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.35 127.68 32.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.732 1.213 . . . . 0.0 111.42 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' H ' HD11 ' A' ' 151' ' ' ILE . . . 71.7 14.84 75.47 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 117.959 -1.467 . . . . 0.0 115.681 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.486 ' SG ' HG21 ' A' ' 176' ' ' ILE . 29.5 t -58.0 152.48 16.33 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.366 2.083 . . . . 0.0 112.543 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 t -146.23 164.24 32.9 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 122.847 1.308 . . . . 0.0 111.371 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -45.08 -42.91 9.13 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 127.799 2.44 . . . . 0.0 112.919 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' HG13 ' A' ' 128' ' ' VAL . 37.4 mp0 -68.92 -18.52 64.11 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.669 1.577 . . . . 0.0 113.893 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.65 -25.57 45.01 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 119.62 -1.925 . . . . 0.0 110.671 168.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.422 HD12 HD21 ' A' ' 143' ' ' LEU . 48.6 mt -73.06 -37.14 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.724 0.81 . . . . 0.0 110.995 165.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 125' ' ' GLU 0.261 2.2 m -59.92 -20.89 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.266 1.026 . . . . 0.0 113.151 169.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -93.5 -28.59 16.0 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.909 1.231 . . . . 0.0 113.448 168.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.87 -45.81 91.3 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.394 1.477 . . . . 0.0 111.168 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -116.17 33.51 5.49 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.625 1.17 . . . . 0.0 113.108 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.0 p -53.3 -22.49 7.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.79 -32.49 40.67 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.297 1.903 . . . . 0.0 115.232 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.73 169.71 17.31 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.18 1.392 . . . . 0.0 112.172 -157.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -99.62 136.26 39.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.372 1.469 . . . . 0.0 112.166 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 52.4 mt -134.19 139.12 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 128.887 2.875 . . . . 0.0 108.79 -168.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.7 152.13 76.3 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.667 -0.646 . . . . 0.0 110.887 171.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.85 -24.05 22.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 N-CA-C 120.893 3.382 . . . . 0.0 120.893 -158.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.09 40.5 2.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.935 1.294 . . . . 0.0 109.872 167.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.61 16.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.15 1.357 . . . . 0.0 115.674 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.459 ' CD1' HG12 ' A' ' 128' ' ' VAL . 65.5 mt -93.17 126.44 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 C-N-CA 125.27 1.428 . . . . 0.0 109.451 -169.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.5 m -121.92 132.18 54.41 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.039 1.736 . . . . 0.0 112.869 -174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.422 HD21 HD12 ' A' ' 127' ' ' ILE . 3.3 mm? -123.67 91.35 49.79 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 127.178 2.191 . . . . 0.0 111.483 -169.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.44 -70.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 121.771 1.647 . . . . 0.0 113.655 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -170.91 169.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 129.516 3.127 . . . . 0.0 108.809 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.543 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 8.4 p-10 -70.52 170.74 9.68 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 165.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.6 0.06 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 124.838 3.692 . . . . 0.0 117.13 171.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -129.15 0.38 5.19 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.74 1.616 . . . . 0.0 111.814 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.03 37.82 42.3 Favored Glycine 0 CA--C 1.536 1.394 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -130.24 -16.72 3.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.161 1.481 . . . . 0.0 112.657 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.509 HG23 ' H ' ' A' ' 152' ' ' THR 0.294 0.0 OUTLIER -143.09 -112.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.485 1.114 . . . . 0.0 113.482 -169.425 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -177.77 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.419 3.087 . . . . 0.0 108.028 -166.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.543 ' H ' ' CA ' ' A' ' 146' ' ' ASP . . . -122.97 5.56 9.62 Favored Glycine 0 N--CA 1.466 0.7 0 C-N-CA 127.84 2.638 . . . . 0.0 114.685 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.36 159.04 42.26 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.22 0.608 . . . . 0.0 109.982 152.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -170.18 178.26 3.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.261 1.825 . . . . 0.0 110.751 -165.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.686 ' CD1' HG12 ' A' ' 191' ' ' VAL . 92.0 m-85 -149.79 156.26 41.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.918 1.287 . . . . 0.0 109.283 -168.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.3 p -156.13 121.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 31.6 tp60 -90.0 129.8 36.28 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.544 1.938 . . . . 0.0 109.444 176.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 3.3 m-85 -86.96 -165.33 1.26 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.54 -14.6 60.0 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.965 -1.709 . . . . 0.0 112.307 161.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.7 m -158.66 163.9 36.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 6.1 mm-40 -56.78 -33.17 66.37 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.19 1.396 . . . . 0.0 114.679 167.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 167' ' ' LYS . 28.6 tp10 -72.58 -50.18 27.21 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 111.915 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.0 mt -57.12 -35.87 69.99 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.069 1.348 . . . . 0.0 111.264 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.51 -17.38 59.3 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.216 0.532 . . . . 0.0 112.262 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -87.09 -32.05 20.14 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.611 -1.305 . . . . 0.0 109.698 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -63.88 -35.77 81.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.392 1.477 . . . . 0.0 109.711 169.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . . . -65.64 -43.47 89.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.167 1.787 . . . . 0.0 115.592 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.1 mp -50.03 -25.74 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -58.8 -16.34 30.72 Favored Glycine 0 CA--C 1.547 2.09 0 C-N-CA 124.858 1.218 . . . . 0.0 115.335 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -68.97 -14.51 63.08 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.49 1.645 . . . . 0.0 114.77 167.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 39.96 -48.64 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 1 C-N-CA 132.407 4.283 . . . . 0.0 121.16 170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 15.79 0.66 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.324 1.85 . . . . 0.0 113.338 -173.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -55.09 174.27 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -110.75 155.68 22.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.652 1.581 . . . . 0.0 114.148 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.542 HD12 ' CD1' ' A' ' 181' ' ' ILE . 3.4 mt -132.96 169.1 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 130.972 3.709 . . . . 0.0 106.558 169.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 2.49 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.475 1.274 0 C-N-CA 129.774 3.559 . . . . 0.0 116.616 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 -2.86 4.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 171.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -134.38 -179.01 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.406 1.482 . . . . 0.0 114.959 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -144.05 111.16 5.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.426 -126.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.542 ' CD1' HD12 ' A' ' 176' ' ' ILE . 15.1 mt -115.51 129.01 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.436 1.112 . . . . 0.0 111.898 -139.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 153.24 41.35 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.553 2.341 . . . . 0.0 113.195 166.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.5 m -139.25 135.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.399 0.68 . . . . 0.0 111.657 167.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -139.25 143.48 38.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.149 1.78 . . . . 0.0 109.386 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 185' ' ' LYS . 16.8 tptm -75.35 136.91 40.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.725 0.774 . . . . 0.0 109.91 175.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.1 m -141.82 166.46 24.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.727 -164.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -143.5 157.18 44.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.91 0.884 . . . . 0.0 110.616 168.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.46 ' HA ' HG21 ' A' ' 191' ' ' VAL . 0.5 OUTLIER -33.84 5.44 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.907 1 C-N-CA 134.945 5.298 . . . . 0.0 120.037 176.935 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -126.71 -22.45 3.89 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.09 -1.631 . . . . 0.0 112.851 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -72.51 -21.91 61.12 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.471 -1.393 . . . . 0.0 109.708 172.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 156' ' ' PHE . 20.8 m -96.35 -28.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 126.855 2.062 . . . . 0.0 113.447 -150.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 56.34 3.97 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.793 1.237 . . . . 0.0 110.132 176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.8 t -61.54 -13.13 18.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 127.381 2.272 . . . . 0.0 112.624 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.91 0.386 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.3 p -157.82 -15.4 0.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.791 2.037 . . . . 0.0 114.673 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.47 83.06 0.69 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.241 2.217 . . . . 0.0 108.238 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -150.52 159.2 44.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 0.0 112.752 -160.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.6 -60.08 0.89 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.58 -39.72 0.06 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -149.55 -23.02 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -52.66 41.68 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.894 1 C-N-CA 133.664 4.786 . . . . 0.0 116.371 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.12 90.17 0.06 OUTLIER Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.931 1.253 . . . . 0.0 111.737 162.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' CG ' HG11 ' A' ' 191' ' ' VAL . 2.7 m-85 -107.5 160.75 15.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.36 116.02 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 73.5 ttt180 -88.39 120.17 29.51 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.362 1.065 . . . . 0.0 111.382 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.45 151.21 41.18 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 125.525 1.53 . . . . 0.0 111.648 162.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.21 139.9 44.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 148.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.5 -20.65 0.82 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.523 -1.361 . . . . 0.0 112.885 159.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.84 HD23 ' CD1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -58.18 142.91 80.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.514 1.926 . . . . 0.0 113.544 -156.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.28 165.7 27.33 Favored 'Trans proline' 0 N--CA 1.458 -0.576 1 C-N-CA 126.231 4.621 . . . . 0.0 112.131 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.54 116.79 4.6 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.317 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.03 7.33 59.76 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.615 -1.103 . . . . 0.0 115.549 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.45 ' SG ' HD22 ' A' ' 118' ' ' LEU . 21.6 t -56.06 148.34 17.95 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.984 1.892 . . . . 0.0 110.938 165.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 125' ' ' GLU . 8.8 t -144.32 171.05 14.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.952 0.882 . . . . 0.0 110.076 170.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 128' ' ' VAL . 15.2 ttmt -41.31 -40.93 1.79 Allowed 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 127.438 2.295 . . . . 0.0 112.978 174.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HB2' HG23 ' A' ' 123' ' ' THR . 27.6 mp0 -58.52 -32.67 69.07 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.25 2.22 . . . . 0.0 116.069 173.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -77.01 -23.33 52.2 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 119.958 -1.714 . . . . 0.0 110.157 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 143' ' ' LEU . 13.4 mt -74.78 -37.33 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.641 -0.662 . . . . 0.0 110.993 166.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 124' ' ' LYS . 1.7 m -62.15 -17.26 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.126 1.37 . . . . 0.0 113.054 171.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -98.17 -25.28 14.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.62 1.1 . . . . 0.0 113.937 168.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.81 -45.86 91.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.057 1.343 . . . . 0.0 110.575 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -121.48 33.25 5.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.038 1.335 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -54.24 -19.4 5.19 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.769 -0.582 . . . . 0.0 112.49 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -52.68 -35.0 44.99 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.588 1.566 . . . . 0.0 115.496 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.34 163.56 31.51 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -153.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.84 139.25 32.78 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 112.84 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 75.4 mt -144.51 133.37 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.639 2.375 . . . . 0.0 107.24 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.89 153.35 54.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.636 -0.665 . . . . 0.0 111.438 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.69 -23.96 28.2 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 120.842 3.362 . . . . 0.0 120.842 -160.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.48 39.43 2.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.674 1.19 . . . . 0.0 109.95 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -51.8 -26.45 17.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.89 1.233 . . . . 0.0 114.812 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -84.1 132.44 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 125.662 1.585 . . . . 0.0 108.883 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.6 HG23 ' CD1' ' A' ' 194' ' ' TYR . 1.3 m -126.19 131.57 51.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.263 1.825 . . . . 0.0 112.124 -174.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 127' ' ' ILE . 3.8 mm? -128.2 84.96 61.75 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 126.572 1.949 . . . . 0.0 112.61 -167.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.83 -69.56 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 121.825 1.684 . . . . 0.0 115.512 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.64 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 127.252 2.221 . . . . 0.0 111.651 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.553 ' CA ' ' H ' ' A' ' 153' ' ' GLY . 7.0 p-10 -79.06 173.26 8.01 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.893 2.077 . . . . 0.0 114.845 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.45 -4.31 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 125.074 3.849 . . . . 0.0 117.844 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.42 -32.0 3.94 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 121.35 1.886 . . . . 0.0 111.785 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 109.02 40.26 1.57 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.235 0.922 . . . . 0.0 114.641 165.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.4 -3.13 4.35 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.057 1.343 . . . . 0.0 113.106 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.612 HG23 ' H ' ' A' ' 152' ' ' THR 0.318 0.0 OUTLIER -141.7 -102.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 179.998 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.612 ' H ' HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER 165.98 68.0 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 130.444 3.498 . . . . 0.0 108.687 -159.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 118' ' ' LEU . . . -114.58 4.02 23.15 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 129.266 3.317 . . . . 0.0 116.226 172.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -127.29 163.5 23.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.234 1.016 . . . . 0.0 109.632 142.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -169.85 178.36 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.405 2.282 . . . . 0.0 108.154 -168.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 191' ' ' VAL . 97.3 m-85 -150.42 160.59 43.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.582 0.753 . . . . 0.0 109.512 -167.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.02 121.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 136' ' ' ILE . 55.7 tp60 -92.69 123.87 36.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 127.222 2.209 . . . . 0.0 111.386 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 11.3 m-85 -86.99 -173.63 4.54 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.329 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.98 -8.74 57.94 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.224 -1.548 . . . . 0.0 113.105 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.6 m -160.39 161.29 33.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.566 1.147 . . . . 0.0 112.944 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -57.4 -31.24 65.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.212 1.405 . . . . 0.0 113.508 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -84.67 -42.78 14.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.523 1.529 . . . . 0.0 113.014 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 46.4 mt -54.69 -35.47 63.62 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.449 1.5 . . . . 0.0 111.411 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.23 -10.05 57.69 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.07 -13.81 11.2 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.322 -1.486 . . . . 0.0 112.004 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -62.32 -40.31 95.92 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.702 0.801 . . . . 0.0 109.2 153.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.47 79.03 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.8 mp -50.58 -27.0 5.95 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.694 1.588 . . . . 0.0 114.287 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.89 -19.82 56.58 Favored Glycine 0 CA--C 1.546 1.991 0 C-N-CA 125.077 1.322 . . . . 0.0 114.798 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.59 41.64 0.12 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.717 2.007 . . . . 0.0 112.61 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -51.31 -30.48 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.697 2.399 . . . . 0.0 114.888 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -147.58 107.3 3.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.264 1.026 . . . . 0.0 111.051 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -137.64 -161.21 1.14 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.654 1.582 . . . . 0.0 109.927 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -140.75 148.04 40.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.065 1.346 . . . . 0.0 111.718 -155.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mt -143.01 132.72 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.319 2.248 . . . . 0.0 108.132 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 59.54 -67.77 0.01 OUTLIER Glycine 0 CA--C 1.537 1.419 0 C-N-CA 127.605 2.526 . . . . 0.0 115.831 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.8 -9.85 0.21 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.714 2.406 . . . . 0.0 113.566 169.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -108.53 -175.03 2.66 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 127.139 2.176 . . . . 0.0 112.765 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -149.63 116.74 6.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -135.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.84 ' CD1' HD23 ' A' ' 118' ' ' LEU . 1.8 mt -127.03 135.8 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 122.776 1.274 . . . . 0.0 111.771 -139.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.8 159.27 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 130.955 3.702 . . . . 0.0 114.348 169.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.04 137.44 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.923 1.289 . . . . 0.0 111.005 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -138.42 146.88 42.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.205 1.802 . . . . 0.0 109.806 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -70.82 142.84 51.27 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.782 1.233 . . . . 0.0 110.884 177.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.412 ' H ' ' HE2' ' A' ' 185' ' ' LYS . 3.3 m -153.79 161.88 41.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.357 -164.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.5 m -146.2 157.38 43.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.084 1.354 . . . . 0.0 111.148 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.489 ' HA ' ' CG2' ' A' ' 191' ' ' VAL . 4.3 tp60 -40.93 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.129 4.572 . . . . 0.0 119.674 -175.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 -16.0 3.91 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.976 -1.702 . . . . 0.0 114.369 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.44 -29.14 18.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.767 1.627 . . . . 0.0 108.915 173.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.632 HG11 ' CG ' ' A' ' 112' ' ' PHE . 35.7 m -73.23 -26.18 22.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 129.111 2.965 . . . . 0.0 115.42 172.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -73.45 28.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.251 2.621 . . . . 0.0 114.644 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.9 m -62.27 -7.87 4.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.464 1.105 . . . . 0.0 112.41 160.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.6 ' CD1' HG23 ' A' ' 142' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 C-N-CA 128.287 2.635 . . . . 0.0 107.216 176.765 . . . . . . . . 2 2 . 1 stop_ save_